Sentence,class,file
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/88/fb/copd-12-541.PMC5308595.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).International Journal of COPD 2017:12 541–550International Journal of COPD Dove press submit your manuscript | www.dovepress.co m Dove press  541OrIg Inal researChopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/COPD.S11944 3 airway gene expression of Il-1 pathway mediators  predicts exacerbation risk in obstructive airway  disease Katherine J Baines1,2 Juan-juan Fu3 Vanessa M McDonald1,2 Peter g gibson1,2 1Faculty of health and Medicine,   Priority research Centre for healthy  lungs, hunter Medical research  Institute, The University of newcastle,   2Department of respiratory and  sleep Medicine, John hunter hospital,   new lambton, nsW, australia;   3respiratory group, Department  of Integrated Traditional Chinese  and West Medicine, West China  hospital, sichuan University, People’s  republic of ChinaBackground:  Exacerbations of asthma and COPD are a major cause of morbidity and mortality  and are responsible for significant health care costs.",Non-OADS,/arxiv_data1/oa_pdf/88/fb/copd-12-541.PMC5308595.pdf
"Although some clinical factors have been identified to be associated  with frequent exacerbations of asthma2,9 and COPD,10 the underlying mechanisms, Correspondence: Katherine J Baines Priority research Centre for healthy  lungs, hunter Medical research Institute,  level 2 West, locked Bag 1000, new  lambton, nsW 2305, australia Tel +61 2 4042 0090 Fax +61 2 40420 046 email katherine.baines@newcastle.edu.a u Journal name: International Journal of COPD Article Designation: Original Research Y ear: 2017 Volume: 12 Running head verso: Baines et al Running head recto: IL-1 pathway and exacerbations of COPD DOI: http://dx.doi.org/10.2147/COPD.S119443",Non-OADS,/arxiv_data1/oa_pdf/88/fb/copd-12-541.PMC5308595.pdf
"International Journal of COPD Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-chronic-obstructive-pulmonary-disease-journa lThe International Journal of COPD is an international, peer-reviewed  journal of therapeutics and pharmacology focusing on concise rapid  reporting of clinical studies and reviews in COPD.",Non-OADS,/arxiv_data1/oa_pdf/88/fb/copd-12-541.PMC5308595.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/88/fb/copd-12-541.PMC5308595.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/1b/22/opth-11-305.PMC5308596.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).Clinical Ophthalmology 2017:11 305–310Clinical Ophthalmology Dove press submit your manuscript | www.dovepress.co m Dove press  305Original researChopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/OPTH.S12137 5 serum hypercoagulability states in Coats’ disease Fariba ghassemi1 Carol l shields2 Masoumeh Mohebbi1 Mehdi nili ahmadabadi1 Fatemeh Morsali1 siamak sabour3,4 1Ocular Oncology and retina and  Vitreous service, Farabi eye hospital,   T ehran University of Medical sciences,   T ehran, iran; 2Ocular Oncology  service, Wills eye hospital, Thomas  Jefferson University, Philadelphia,   Pa, Usa; 3safety Promotion and  injury Prevention research Centre,   4Department of Clinical epidemiology,   school of health, shahid Beheshti  University of Medical sciences,   T ehran,  iranPurpose:  The purpose of this study was to investigate the serum hypercoagulability state and  common viral and protozoan infections in Coats’ disease versus a normal control group.",Non-OADS,/arxiv_data1/oa_pdf/1b/22/opth-11-305.PMC5308596.pdf
"Herein, we evaluated serum hypercoagulable factors and viral and protozoan diseases  in patients with Coats’ disease versus normal controls.Correspondence: siamak sabour safety Promotions and injury Prevention  research Centre, shahid Beheshti  University of Medical sciences,   7th Floor, Bldg no 2 sBUMs, arabi ave,  Daneshjoo Blvd, Velenjak, Tehran, iran Tel/fax +98 21 2242 1813 email s.sabour@gmail.co m Journal name: Clinical Ophthalmology Article Designation: Original Research Y ear: 2017 Volume: 11 Running head verso: Ghassemi et al Running head recto: Serum hypercoagulability states in Coats’ disease DOI: http://dx.doi.org/10.2147/OPTH.S121375",Non-OADS,/arxiv_data1/oa_pdf/1b/22/opth-11-305.PMC5308596.pdf
"Clinical Ophthalmology Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/clinical-ophthalmology-journa lClinical Ophthalmology is an international, peer-reviewed journal  covering all subspecialties within ophthalmology.",Non-OADS,/arxiv_data1/oa_pdf/1b/22/opth-11-305.PMC5308596.pdf
Visit http://www.dovepress.com/ testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/1b/22/opth-11-305.PMC5308596.pdf
"Available from: http://www.tip.hacettepe.edu.tr/ actamedica/2013/Acta13(2).pd f. Accessed December 20, 2016.",OADS,/arxiv_data1/oa_pdf/1b/22/opth-11-305.PMC5308596.pdf
Available from:  http://accessmedicine.mhmedical.com/content.aspx?bookid =331&  sectionid=4072685 0.,Non-OADS,/arxiv_data1/oa_pdf/1b/22/opth-11-305.PMC5308596.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/02/61/ndt-13-411.PMC5308597.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).Neuropsychiatric Disease and Treatment 2017:13 411–419Neuropsychiatric Disease and Treatment Dove press submit your manuscript | www.dovepress.co m Dove press  411OrigiNal researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/NDT .S12099 5 The dynamic relationship between emotional and  physical states: an observational study of personal  health records Ye-seul lee1 Won-Mo Jung1 hyunchul Jang2 sanghyun Kim2 sun-Y ong chung3 Y ounbyoung chae1 1acupuncture and Meridian science  research center, college of Korean  Medicine, Kyung hee University,   seoul, 2Mibyeong research center,   Korean institute of Oriental  Medicine, Daejeon, 3Department of  Neuropsychiatry, college of Korean  Medicine, Kyung hee University, seoul,   republic of KoreaObjectives:  Recently, there has been increasing interest in preventing and managing diseases  both inside and outside medical institutions, and these concerns have supported the development  of the individual Personal Health Record (PHR).",Non-OADS,/arxiv_data1/oa_pdf/02/61/ndt-13-411.PMC5308597.pdf
"One PHR model utilizes patient-generated data about  health and lifestyle that are recorded using a personal computer or Web application  and that help address specific health concerns.4,5 Because a PHR records health-related  data generated by a patient, it is not only a repository of that patient’s data but also  a tool that facilitates interactions between the medical provider and patient via the  provision of related health information.6–8 Additionally, because technologies are  designed to streamline the diagnosis and treatment processes, and big data analytics  offer novel perspectives regarding the contribution of health data to health care, PHRs correspondence: Younbyoung chae acupuncture and Meridian science  research center, college of Korean  Medicine, Kyung hee University,  1 hoegi-dong, Dongdaemun-gu, seoul  130-701, republic of Korea Tel +82 2 961 2208 Fax +82 2 963 2175 email ybchae@khu.ac.k r Journal name: Neuropsychiatric Disease and Treatment Article Designation: Original Research Y ear: 2017 Volume: 13 Running head verso: Lee et al Running head recto: The dynamic relationship between emotional and physical states DOI: http://dx.doi.org/10.2147/NDT.S120995",Non-OADS,/arxiv_data1/oa_pdf/02/61/ndt-13-411.PMC5308597.pdf
"Neuropsychiatric Disease and Treatment Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/neuropsychiatric-disease-and-treatment-journa lNeuropsychiatric Disease and Treatment is an international, peer- reviewed journal of clinical therapeutics and pharmacology focusing   on concise rapid reporting of clinical or pre-clinical studies on a   range of neuropsychiatric and neurological disorders.",Non-OADS,/arxiv_data1/oa_pdf/02/61/ndt-13-411.PMC5308597.pdf
Visit http://www.dovepress.com/testimonials.ph p to  read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/02/61/ndt-13-411.PMC5308597.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/0f/4e/ott-10-745.PMC5308598.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).OncoTargets and Therapy 2017:10 745–752OncoTargets and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  745Original researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/OTT .S11197 1 T wo snPs in the promoter region of T oll-like  receptor 4 gene are not associated with smoking  in saudi arabia Muhammad Kohailan1 Mohammad alanazi1 Mahmoud rouabhia2 abdullah al amri1 narasimha reddy Parine1 abdelhabib semlali1 1Department of Biochemistry,   college of science, King saud  University, riyadh, Kingdom of saudi  arabia; 2groupe de recherche en  Écologie Buccale, Département de  stomatologie, Faculté de Médecine  Dentaire, Université laval, Québec,   Qc, canadaAbstract:  Defects in the innate immune system, particularly in Toll-like receptors (TLRs),  have been reported in several cigarette smoke-promoted diseases.",Non-OADS,/arxiv_data1/oa_pdf/0f/4e/ott-10-745.PMC5308598.pdf
"Keywords:  Toll-like receptor 4, polymorphism, genetic variation, smoking Introduction Innate immunity, which is considered to be the first line of defense against diseases,  is well studied, and its role has been clarified through study of mutations in innate  immunity genes as well as of patients with various diseases such as cystic fibrosis.1 In  addition to induction of autoimmune diseases,2 defects in the innate immune system have  been reported in several other diseases such as types of cancer,3 asthma,4 psoriasis,5 and  Alzheimer’s and other neurodegenerative diseases.6,7 The innate immune system initially  recognizes microorganisms through pattern recognition receptors, in particular Toll-like  receptors (TLRs).8 TLRs are a family of at least 13 transmembrane receptors that are  expressed on immune cells as well as on gingival epithelial cells and are involved in  the initiation of inflammatory processes.9–11 Upon induction by certain ligands, TLRs  activate intracellular signaling pathways that promote the production of multiple  immune mediators that contribute to host defense.12,13 Several polymorphisms have  been reported at different positions in TLR genes14,15 and were found to be associated  with inflammatory diseases.16,17 Single-nucleotide polymorphisms (SNPs) are a class  of polymorphisms involving single-base substitutions.18 SNPs are thought to constitute  the majority of sequence variants in human beings,19 and they occur approximately once  every 300 bases.20 Several reports have demonstrated the role of TLR SNPs in the devel - opment of cancer.21,22 TLR4 , which is located on chromosome  9, encodes a protein that  plays a critical role in the immune system through recognition of lipopolysaccharides  found in Gram-negative bacteria.23,24 TLR4  polymorphisms have been reported to be correspondence: abdelhabib semlali Department of Biochemistry, college  of science, King saud University,  PO Box 2454, riyadh 11451,   Kingdom of saudi arabia Tel +966 11 467 6035 Fax +966 11 467 5802 email asemlali@ksu.edu.s aJournal name: OncoTargets and Therapy Article Designation: Original Research Y ear: 2017 Volume: 10 Running head verso: Kohailan et al Running head recto: TLR4  polymorphisms in smokers in a Saudi Arabian population DOI: http://dx.doi.org/10.2147/OTT.S111971",Non-OADS,/arxiv_data1/oa_pdf/0f/4e/ott-10-745.PMC5308598.pdf
"Additionally,  we  constructed linkage disequilibrium plots for both the TLR4  rs2770150 and rs10759931 SNPs using SNP Annotation  and Proxy Search (SNAP; http://www.broadinstitute.org/ mpg/snap/ldplot.ph p; Figures 1 and  2).",OADS,/arxiv_data1/oa_pdf/0f/4e/ott-10-745.PMC5308598.pdf
"OncoTargets and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/oncotargets-and-therapy-journa lOncoTargets and Therapy is an international, peer-reviewed, open  access journal focusing on the pathological basis of all cancers, potential  targets for therapy and treatment protocols employed to improve the  management of cancer patients.",Non-OADS,/arxiv_data1/oa_pdf/0f/4e/ott-10-745.PMC5308598.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/0f/4e/ott-10-745.PMC5308598.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/cd/24/dddt-11-365.PMC5308599.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).Drug Design, Development and Therapy 2017:11 365–370Drug Design, Development and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  365Reviewopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/DDDT .S12197 9 effect of dexmedetomidine in preventing  etomidate-induced myoclonus: a meta-analysis Xueke Du1 Chengmao Zhou2 Linghui Pan1 Changlong Li1 1Department of Anesthesiology,   Affiliated Tumor Hospital of Guangxi  Medical University, Nanning,   2Department of Surgery, Zhaoqing  Medical College, Zhaoqing Shi,   Guangdong Sheng, People’s Republic  of ChinaObjective:  To investigate the effect of dexmedetomidine in the prevention of etomidate-induced  myoclonus.",Non-OADS,/arxiv_data1/oa_pdf/cd/24/dddt-11-365.PMC5308599.pdf
"Its mechanism is Correspondence: Linghui Pan Department of Anesthesiology, Affiliated  Tumor Hospital of Guangxi Medical  University, Nanning 530021, People’s  Republic of China Tel +86 771 533 3550 Fax +86 771 531 2000 email panlinghui187@163.co m Journal name: Drug Design, Development and Therapy Article Designation: Review Y ear: 2017 Volume: 11 Running head verso: Du et al Running head recto: Effect of dexmedetomidine in preventing etomidate-induced myoclonus DOI: http://dx.doi.org/10.2147/DDDT.S121979",Non-OADS,/arxiv_data1/oa_pdf/cd/24/dddt-11-365.PMC5308599.pdf
"Drug Design, Development and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/drug-design-development-and-therapy-journa lDrug Design, Development and Therapy is an international, peer- reviewed open-access journal that spans the spectrum of drug design  and development through to clinical applications.",Non-OADS,/arxiv_data1/oa_pdf/cd/24/dddt-11-365.PMC5308599.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/cd/24/dddt-11-365.PMC5308599.pdf
"https://doi.org/10.1177/2333794X16685190Global Pediatric Health Volume 4: 1 –8  © The Author(s) 2017Reprints and permissions: sagepub.com/journalsPermissions.nav  DOI: 10.1177/2333794X16685190 journals.sagepub.com/home/gph Creative Commons Non Commercial CC-BY-NC: This article is distributed under the terms of the Creative Commons  Attribution-NonCommercial 3.0 License (http://www.creativecommons.org/licenses/by-nc/3.0/) which permits non- commercial use, reproduction and distribution of the work without further permission provided the original work is attributed as specified  on the SAGE and Open Access pages (https://us.sagepub.com/en-us/nam/open-access-at-sage).Original Article Childhood overweight and obesity are pervasive and costly  public health problems.1 Pediatric primary care is an impor - tant opportunity to assess and treat these conditions, because school-age children are seen regularly in primary care.",Non-OADS,/arxiv_data1/oa_pdf/00/95/10.1177_2333794X16685190.PMC5308601.pdf
https://brightfutures.aap.org/Bright%20Futures%20 Documents/5-Promoting_Healthy_Weight.pdf.,Non-OADS,/arxiv_data1/oa_pdf/00/95/10.1177_2333794X16685190.PMC5308601.pdf
https://www.cen- sus.gov/prod/2013pubs/acs-22.pdf.,Non-OADS,/arxiv_data1/oa_pdf/00/95/10.1177_2333794X16685190.PMC5308601.pdf
"https://doi.org/10.1177/2333794X16689011Global Pediatric Health Volume 4: 1 –5  © The Author(s) 2017Reprints and permissions: sagepub.com/journalsPermissions.nav  DOI: 10.1177/2333794X16689011 journals.sagepub.com/home/gph Creative Commons Non Commercial CC-BY-NC: This article is distributed under the terms of the Creative Commons  Attribution-NonCommercial 3.0 License (http://www.creativecommons.org/licenses/by-nc/3.0/) which permits non- commercial use, reproduction and distribution of the work without further permission provided the original work is attributed as specified  on the SAGE and Open Access pages (https://us.sagepub.com/en-us/nam/open-access-at-sage).Brief Report Case Report A 1-month-old girl was transferred to our hospital with  marked abdominal distension.",Non-OADS,/arxiv_data1/oa_pdf/fc/6b/10.1177_2333794X16689011.PMC5308602.pdf
"creativecommons.org/licenses/by-nc/3.0/) which permits non-commercial use, reproduction and distribution of the work without further permiss ion provided the original work is attributed as specified on the SAGE and Open Access pages (https://us.sagepub.com/en-us/nam/open-access-at-sage).T rends in Hearing Volume 21: 1–14!The Author(s) 2017 Reprints and permissions:sagepub.co.uk/journalsPermissions.nav DOI: 10.1177/2331216516686786 journals.sagepub.com/home/tia",Non-OADS,/arxiv_data1/oa_pdf/b4/82/10.1177_2331216516686786.PMC5308603.pdf
doi:http://dx.doi.org/10.1017/ S1355617714000241.,Non-OADS,/arxiv_data1/oa_pdf/b4/82/10.1177_2331216516686786.PMC5308603.pdf
http://doi.org/10.109 7/AUD.0b013e31806dc265.,Non-OADS,/arxiv_data1/oa_pdf/b4/82/10.1177_2331216516686786.PMC5308603.pdf
"Baltimore, Maryland, July 19–20, 2010.Available at: http://www.who.int/blindness/publications/ get2020/en/.",Non-OADS,/arxiv_data1/oa_pdf/6c/f9/i1552-5783-58-2-997.PMC5308676.pdf
"Primers were designed by Exon Primer (provided in thepublic domain by the Institute for Human Genetics, TechnicalUniversity of Munich, Germany (http://ihg.gsf.de/ihg/ Exon-Primer.html/) and by Primer3 online program.",OADS,/arxiv_data1/oa_pdf/4a/e9/i1552-5783-58-2-1028.PMC5308768.pdf
The FreeSurfer (v5.1) toolkit (http://surfer.nmr.mgh.,OADS,/arxiv_data1/oa_pdf/cd/ba/i1552-5783-58-2-959.PMC5308769.pdf
"28 Each diffusion-weighted volume was skull stripped and coregistered to the ﬁrst b¼0 volume using a rigid afﬁne transformation to correct for distortion caused by eddy-current effects and simple head motion using FMRIB’s software library and diffusion toolbox v2.0 (FSL, http://www.fmrib.ox.ac.uk/fsl/; in the public domain).",Non-OADS,/arxiv_data1/oa_pdf/cd/ba/i1552-5783-58-2-959.PMC5308769.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/45/bd/main.PMC5308793.pdf
Contents lists available at ScienceDirect Contemporary Clinical Trials Communications journal homepage: www.elsevier.com /locate/conctc http://dx.doi.org/10.1016/j.conctc.2017.01.002 2451-8654/ ©2017 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/45/bd/main.PMC5308793.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).Contemporary Clinical Trials Communications 5 (2017) 116 e122,Non-OADS,/arxiv_data1/oa_pdf/45/bd/main.PMC5308793.pdf
"Wiley Encyclopedia of Clinical Trials, 2007, http://dx.doi.org/10.1002/9780471462422.eoct342/abstract (Accessed 30 November 2015).",Non-OADS,/arxiv_data1/oa_pdf/45/bd/main.PMC5308793.pdf
"Grimshaw, An Adaptive Bayesian Approach to Continuous Dose-response Modeling, 2010 (Accessed 09 December 2015), https://stat.duke.edu/~tjl13/papers/TJL_MSthesis.pdf .",OADS,/arxiv_data1/oa_pdf/45/bd/main.PMC5308793.pdf
" Annals of Surgical Treatment and Research 105pISSN 2288-6575  • eISSN 2288-6796 https://doi.org/10.4174/astr.2017.92.2.105 Annals of Surgical Treatment and ResearchORIGINAL ARTICLE Cerebral monitoring during carotid endarterectomy by  transcranial Doppler ultrasonography Woo-Sung Yun Division of Transplantation and Vascular Surgery, Department of Surgery, Yeungnam University Medical Center, Yeungnam  University College of Medicine, Daegu, Korea INTRODUCTION Based on the results of large ­scale clinical studies [1 ­5], carotid  endarterectomy (CEA) has been recommended for symptomatic  and asymptomatic patients with high ­grade carotid artery  stenosis [6].",Non-OADS,/arxiv_data1/oa_pdf/51/e8/astr-92-105.PMC5309175.pdf
"All  articles are distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/51/e8/astr-92-105.PMC5309175.pdf
"110pISSN 2288-6575  • eISSN 2288-6796 https://doi.org/10.4174/astr.2017.92.2.110 Annals of Surgical Treatment and ResearchCASE REPORT Fulminant course in a case of malignant phyllodes tumor Young Woo Chang, Hwan Soo Kim, Deok Woo Kim1, Gil Soo Son Department of Breast Endocrine Surgery, Korea University College of Medicine, Seoul, 1Department of Plastic and Reconstructive  Surgery, Korea University College of Medicine, Seoul, Korea INTRODUCTION Phyllodes tumors are rare and account for 0.3 to 1% of all  breast malignancies [1].",Non-OADS,/arxiv_data1/oa_pdf/b6/ac/astr-92-110.PMC5309176.pdf
"All  articles are distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/b6/ac/astr-92-110.PMC5309176.pdf
" Annals of Surgical Treatment and Research 113pISSN 2288-6575  • eISSN 2288-6796 https://doi.org/10.4174/astr.2017.92.2.113 Annals of Surgical Treatment and ResearchCASE REPORT Spontaneous reduction of small bowel herniation  through the foramen of Winslow: importance of a   timely approach Hyung-Gyo Cho, Jeonghyun Kang1 Yonsei University College of Medicine, Seoul, 1Department of Surgery, Yonsei University College of Medicine, Seoul, Korea INTRODUCTION The foramen of Winslow is the normal window between the  greater and lesser peritoneal cavities.",Non-OADS,/arxiv_data1/oa_pdf/5b/41/astr-92-113.PMC5309177.pdf
"All  articles are distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/5b/41/astr-92-113.PMC5309177.pdf
https://doi.org/10.1093/jscr/rjs016.,Non-OADS,/arxiv_data1/oa_pdf/5b/41/astr-92-113.PMC5309177.pdf
https://doi.org/10.1093/jscr/rju065.,Non-OADS,/arxiv_data1/oa_pdf/5b/41/astr-92-113.PMC5309177.pdf
" Annals of Surgical Treatment and Research 55pISSN 2288-6575  • eISSN 2288-6796 https://doi.org/10.4174/astr.2017.92.2.55 Annals of Surgical Treatment and ResearchORIGINAL ARTICLE A novel panel of serum miR-21/miR-155/miR-365 as a  potential diagnostic biomarker for breast cancer Ji-Guang Han*, Yong-Dong Jiang*, Chun-Hui Zhang1, Yan-Mei Yang2, Da Pang, Yan-Ni Song, Guo-Qiang Zhang Departments of Breast Surgery and 1Oncology, The Third Affiliated Hospital of Harbin Medical University, Harbin,   2Institute of Cancer Prevention and Treatment, Harbin Medical University, Harbin, China INTRODUCTION Breast cancer, one of the most common types of female can­ cers, is a highly heterogeneous disease that has multiple sub­ types with distinct clinical outcomes and a high fatality rate globally [1].",Non-OADS,/arxiv_data1/oa_pdf/33/e6/astr-92-55.PMC5309178.pdf
"All  articles are distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/33/e6/astr-92-55.PMC5309178.pdf
" Annals of Surgical Treatment and Research 67pISSN 2288-6575  • eISSN 2288-6796 https://doi.org/10.4174/astr.2017.92.2.67 Annals of Surgical Treatment and ResearchORIGINAL ARTICLE Three-dimensional (3D) printing of mouse primary  hepatocytes to generate 3D hepatic structure Yohan Kim1,2,3,*, Kyojin Kang1,2,3,*, Jaemin Jeong1,3,*, Seung Sam Paik4, Ji Sook Kim4, Su A Park5, Wan Doo Kim5,  Jisun Park5, Dongho Choi1,2,3 1Department of Surgery, Hanyang University College of Medicine, Seoul, 2Department of Translational Medicine, Graduate School  of Biomedical Science and Engineering, Hanyang University, 3HY Indang Center of Regenerative Medicine and Stem Cell  Research, Hanyang University, Seoul, 4Department of Pathology, Hanyang University College of Medicine, Seoul, 5Department of  Nature-Inspired Nanoconvergence Systems, Korea Institute of Machinery and Materials, Daejeon, Korea INTRODUCTION Many patients have been suffering from severe liver diseases  such as hepatocellular carcinoma, liver cirrhosis from chronic  viral hepatitis and alcoholic liver disease.",Non-OADS,/arxiv_data1/oa_pdf/84/73/astr-92-67.PMC5309179.pdf
"All  articles are distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/84/73/astr-92-67.PMC5309179.pdf
" Annals of Surgical Treatment and Research 73pISSN 2288-6575  • eISSN 2288-6796 https://doi.org/10.4174/astr.2017.92.2.73 Annals of Surgical Treatment and ResearchORIGINAL ARTICLE The 13-year experience of performing  pancreaticoduodenectomy in a mid-volume municipal  hospital Hongbeom Kim*, Jung Kee Chung*, Young Joon Ahn, Hae Won Lee, In Mok Jung Department of Surgery, Seoul Metropolitan Government - Seoul National University Boramae Medical Center, Seoul National  University College of Medicine, Seoul, Korea INTRODUCTION Pancreaticoduodenectomy (PD) is a complex surgery asso­ ciated with high morbidity, mortality, and cost.",Non-OADS,/arxiv_data1/oa_pdf/31/e8/astr-92-73.PMC5309180.pdf
"All  articles are distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/31/e8/astr-92-73.PMC5309180.pdf
1  (http://www.nhis.or.kr).,Non-OADS,/arxiv_data1/oa_pdf/31/e8/astr-92-73.PMC5309180.pdf
"To specifically compare the hospital costs of PD with those of other hospitals, the overall costs for the patients with pancreatic head cancer were selectively analyzed using the data extracted from the database of the NHIS (http://www.nhis.or.kr) and the open database at the website of HIRA (http://www.hira.or.kr).",OADS,/arxiv_data1/oa_pdf/31/e8/astr-92-73.PMC5309180.pdf
National Health Insurance Operation System (NHIS) of Korea (http://www.nhis.or.kr).,Non-OADS,/arxiv_data1/oa_pdf/31/e8/astr-92-73.PMC5309180.pdf
"82pISSN 2288-6575  • eISSN 2288-6796 https://doi.org/10.4174/astr.2017.92.2.82 Annals of Surgical Treatment and ResearchORIGINAL ARTICLE Surgical resection of synchronous and metachronous  lung and liver metastases of colorectal cancers Shinseok Jeong, Jin Seok Heo, Jin Young Park, Dong Wook Choi, Seong Ho Choi Department of General Surgery, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea INTRODUCTION Colorectal cancer (CRC) is one of the most common cancers.",Non-OADS,/arxiv_data1/oa_pdf/34/08/astr-92-82.PMC5309181.pdf
"All  articles are distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/34/08/astr-92-82.PMC5309181.pdf
"90pISSN 2288-6575  • eISSN 2288-6796 https://doi.org/10.4174/astr.2017.92.2.90 Annals of Surgical Treatment and ResearchORIGINAL ARTICLE Complete mesocolic excision in right hemicolectomy:  comparison between hand-assisted laparoscopic and  open approaches Qin-Song Sheng, Zhe Pan, Jin Chai1, Xiao-Bin Cheng, Fan-Long Liu, Jin-Hai Wang, Wen-Bin Chen, Jian-Jiang Lin Department of Colorectal and Anal Surgery, The First Affiliated Hospital of College of Medicine, Zhejiang University, Hangzhou,  1Department of Colorectal and Anal Surgery, Yinzhou No.3 Hospital, Ningbo, China INTRODUCTION Total mesorectal excision (TME) is now considered the  ‘standard’ surgical approach for rectal cancers, which requires  appropriate surgical technique and leads to an improved recurrence rate and 5 ­year survival [1,2].",Non-OADS,/arxiv_data1/oa_pdf/56/16/astr-92-90.PMC5309182.pdf
"All  articles are distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/56/16/astr-92-90.PMC5309182.pdf
" Annals of Surgical Treatment and Research 97pISSN 2288-6575  • eISSN 2288-6796 https://doi.org/10.4174/astr.2017.92.2.97 Annals of Surgical Treatment and ResearchORIGINAL ARTICLE Inhibitory effect of sustained perivascular delivery of  paclitaxel on neointimal hyperplasia in the jugular vein  after open cutdown central venous catheter placement   in rats Seongyup Kim*, Younglim Kim1,*, Ji Woong Hwang2, Suk-Bae Moon1 Department of General Surgery, Wonju Severance Christian Hospital, Yonsei University Wonju College of Medicine, Wonju,  1Department of Surgery, Kangwon National University School of Medicine, Chuncheon, 2Department of Surgery, Eulji University  Hospital, Daejeon, Korea INTRODUCTION Central venous catheter (CVC) placement in pediatric patients  is performed for a variety of clinical indications.",Non-OADS,/arxiv_data1/oa_pdf/46/54/astr-92-97.PMC5309183.pdf
"All  articles are distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/46/54/astr-92-97.PMC5309183.pdf
"Method W e recruited a non-representative sampleof US-adult cigarette users (18 –50 years), via Amazon Mechanical T urk (http://www.mturk.com), to take a brief survey(N=403).",Non-OADS,/arxiv_data1/oa_pdf/b8/aa/tobaccocontrol-2016-053006.PMC5309205.pdf
"2016. https://ris.govspace.gov.au/ ﬁles/2016/02/ Tobacco-Plain-Packaging-PIR.pdf 2 Strong D, Pierce J.",Non-OADS,/arxiv_data1/oa_pdf/b8/aa/tobaccocontrol-2016-053006.PMC5309205.pdf
2011. http://www.health.gov.au/internet/main/ publishing.nsf/Content/C5E90158113E0DC6CA257D 120011725C/ (accessed 4 Nov 2015).,Non-OADS,/arxiv_data1/oa_pdf/b8/aa/tobaccocontrol-2016-053006.PMC5309205.pdf
"1 https://doi.org/10.3345/kjp.2017.60.1.1Korean J Pediatr 2017;60(1):1-9 Malformations of cortical development: genetic  mechanisms and diagnostic approach Jeehun Lee, MD, PhD Department of Pediatrics, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea Malformations of cortical development are rare congenital anomalies of the cerebral cortex, wherein  patients present with intractable epilepsy and various degrees of developmental delay.",Non-OADS,/arxiv_data1/oa_pdf/de/60/kjped-60-1.PMC5309318.pdf
"In the Corresponding author: Jeehun Lee, MD, PhD Department of Pediatrics, Samsung Medical Cen - ter, Sungkyunkwan University, School of Medicine, 81 Irwon-ro, Gangnam-gu, Seoul 06351, KoreaTel: +82-2-3410-0910Fax: +82-2-3410-0043E-mail: jhlee0101@skku.edu Received: 29 May, 2015 Revised: 20 November, 2015Accepted: 16 December, 2015 Copyright © 2017 by The Korean Pediatric Society This is an open-access article distributed under the  terms of the Creative Commons Attribution Non- Commercial License (http://creativecommons.org/ licenses/by-nc/4.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any  medium, provided the original work is properly cited.Review article Korean J Pediatr 2017;60(1):1-9 https://doi.org/10.3345/kjp.2017.60.1.1pISSN 1738-1061•eISSN 2092-7258 Korean J Pediatr",Non-OADS,/arxiv_data1/oa_pdf/de/60/kjped-60-1.PMC5309318.pdf
"https://doi.org/10.3345/kjp.2017.60.1.1Lee J, et al.",OADS,/arxiv_data1/oa_pdf/de/60/kjped-60-1.PMC5309318.pdf
3 https://doi.org/10.3345/kjp.2017.60.1.1Korean J Pediatr 2017;60(1):1-9 standard deviations below the average.,OADS,/arxiv_data1/oa_pdf/de/60/kjped-60-1.PMC5309318.pdf
"https://doi.org/10.3345/kjp.2017.60.1.1Lee J, et al.",OADS,/arxiv_data1/oa_pdf/de/60/kjped-60-1.PMC5309318.pdf
"5 https://doi.org/10.3345/kjp.2017.60.1.1Korean J Pediatr 2017;60(1):1-9 (FLNA mutation) or acquired (infection, injury, or radiation).",Non-OADS,/arxiv_data1/oa_pdf/de/60/kjped-60-1.PMC5309318.pdf
"https://doi.org/10.3345/kjp.2017.60.1.1Lee J, et al.",OADS,/arxiv_data1/oa_pdf/de/60/kjped-60-1.PMC5309318.pdf
7 https://doi.org/10.3345/kjp.2017.60.1.1Korean J Pediatr 2017;60(1):1-9 able focal epilepsy and is frequently considered a candidate for  epilepsy surgery.,Non-OADS,/arxiv_data1/oa_pdf/de/60/kjped-60-1.PMC5309318.pdf
"https://doi.org/10.3345/kjp.2017.60.1.1Lee J, et al.",OADS,/arxiv_data1/oa_pdf/de/60/kjped-60-1.PMC5309318.pdf
9 https://doi.org/10.3345/kjp.2017.60.1.1Korean J Pediatr 2017;60(1):1-9 Genotype­phenotype analysis of human frontoparietal polymicro ­ gyria syndromes.,Non-OADS,/arxiv_data1/oa_pdf/de/60/kjped-60-1.PMC5309318.pdf
"https://doi.org/10.3345/kjp.2017.60.1.10Lee J, et al.",OADS,/arxiv_data1/oa_pdf/51/53/kjped-60-10.PMC5309319.pdf
"PCT has ashort half-life Corresponding author: Eun Hee Lee, MD Department of Pediatrics, Korea University Anam  Hospital, 123 Jeokgeum-ro, Danwon-gu, Ansan  15355, Korea  Tel: +82-2-920-6287 Fax: +82-2-922-7476 E-mail: frinky@hanmail.net Received: 6 September, 2016 Revised: 6 October, 2016 Accepted: 18 October, 2016 Copyright © 2017 by The Korean Pediatric Society This is an open-access article distributed under the  terms of the Creative Commons Attribution Non- Commercial License (http://creativecommons.org/ licenses/by-nc/4.0/) which permits unrestricted non- commercial use, distribution, and reproduction in any  medium, provided the original work is properly cited.Original article Korean J Pediatr 2017;60(1):10-16 https://doi.org/10.3345/kjp.2017.60.1.10 pISSN 1738-1061•eISSN 2092-7258 Korean J Pediatr",Non-OADS,/arxiv_data1/oa_pdf/51/53/kjped-60-10.PMC5309319.pdf
11 https://doi.org/10.3345/kjp.2017.60.1.10Korean J Pediatr 2017;60(1):10-16 and is known to be a specific marker for bacterial infections4).,Non-OADS,/arxiv_data1/oa_pdf/51/53/kjped-60-10.PMC5309319.pdf
"https://doi.org/10.3345/kjp.2017.60.1.10Lee J, et al.",OADS,/arxiv_data1/oa_pdf/51/53/kjped-60-10.PMC5309319.pdf
13 https://doi.org/10.3345/kjp.2017.60.1.10Korean J Pediatr 2017;60(1):10-16 invasive ventilator use (Table 6).,Non-OADS,/arxiv_data1/oa_pdf/51/53/kjped-60-10.PMC5309319.pdf
"https://doi.org/10.3345/kjp.2017.60.1.10Lee J, et al.",OADS,/arxiv_data1/oa_pdf/51/53/kjped-60-10.PMC5309319.pdf
"15 https://doi.org/10.3345/kjp.2017.60.1.10Korean J Pediatr 2017;60(1):10-16 cation, also affected the increased PCT level.",Non-OADS,/arxiv_data1/oa_pdf/51/53/kjped-60-10.PMC5309319.pdf
"https://doi.org/10.3345/kjp.2017.60.1.10Lee J, et al.",OADS,/arxiv_data1/oa_pdf/51/53/kjped-60-10.PMC5309319.pdf
"17 https://doi.org/10.3345/kjp.2017.60.1.17Korean J Pediatr 2017;60(1):17-23 The correlation of depression with Internet use  and body image in Korean adolescents Chang Hoon Lim, MD, Eun Ji Kim, MD, Jong Hyun Kim, MD, Jue Seong Lee, MD, Yoon Lee, MD, Sang Hee Park, MD, PhD  Department of Pediatrics, Korea University College of Medicine, Seoul, Korea Purpose: To examine the correlation of depression with Internet use and body image perception, and to  analyze the risk factors of depression in a total of 920 students in Seoul, Korea.",Non-OADS,/arxiv_data1/oa_pdf/34/cc/kjped-60-17.PMC5309320.pdf
"In 2005, about 97.3% of South Korean adolescents between 6 and 19 years of age Corresponding author: Sang Hee Park, MD, PhD  Department of Pediatrics, Korea University College of Medicine, 73 Inchon-ro, Seongbuk-gu, Seoul 02841, KoreaTel: +82-2-920-5090Fax: +82-2-922-7476E-mail: shepark0313@gmail.com Received: 6 September, 2016 Revised: 6 October, 2016Accepted: 18 October, 2016 Copyright © 2017 by The Korean Pediatric Society This is an open-access article distributed under the  terms of the Creative Commons Attribution Non- Commercial License (http://creativecommons.org/ licenses/by-nc/4.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any  medium, provided the original work is properly cited.Original article Korean J Pediatr 2017;60(1):17-23 https://doi.org/10.3345/kjp.2017.60.1.17pISSN 1738-1061•eISSN 2092-7258 Korean J Pediatr",Non-OADS,/arxiv_data1/oa_pdf/34/cc/kjped-60-17.PMC5309320.pdf
"https://doi.org/10.3345/kjp.2017.60.1.17Lim CH, et al.",OADS,/arxiv_data1/oa_pdf/34/cc/kjped-60-17.PMC5309320.pdf
19 https://doi.org/10.3345/kjp.2017.60.1.17Korean J Pediatr 2017;60(1):17-23 Results 1.,Non-OADS,/arxiv_data1/oa_pdf/34/cc/kjped-60-17.PMC5309320.pdf
"https://doi.org/10.3345/kjp.2017.60.1.17Lim CH, et al.",OADS,/arxiv_data1/oa_pdf/34/cc/kjped-60-17.PMC5309320.pdf
"21 https://doi.org/10.3345/kjp.2017.60.1.17Korean J Pediatr 2017;60(1):17-23 aggravate a negative body image and cause it to become persis - tent, as qualifying additional information or neutral and positive  body information are not attended to and are thus neglected.",Non-OADS,/arxiv_data1/oa_pdf/34/cc/kjped-60-17.PMC5309320.pdf
"https://doi.org/10.3345/kjp.2017.60.1.17Lim CH, et al.",OADS,/arxiv_data1/oa_pdf/34/cc/kjped-60-17.PMC5309320.pdf
23 https://doi.org/10.3345/kjp.2017.60.1.17Korean J Pediatr 2017;60(1):17-23 but also a positive perception of their body image in order to pre - vent depression.,Non-OADS,/arxiv_data1/oa_pdf/34/cc/kjped-60-17.PMC5309320.pdf
Supplementary materials Supplementary material can be found via http://kjp.or.kr/ upload/kjp-60-17-s001.pdf.,Non-OADS,/arxiv_data1/oa_pdf/34/cc/kjped-60-17.PMC5309320.pdf
"https://doi.org/10.3345/kjp.2017.60.1.24Yoo JW, et al.",OADS,/arxiv_data1/oa_pdf/b2/c1/kjped-60-24.PMC5309321.pdf
"The endothelial cell dysfunction can last from Corresponding author: Hong Ryang Kil, MD, PhD Department of Pediatrics, Chungnam National University Hospital, Chungnam National University School of Medicine, 282 Munhwa-ro, Jung-gu, Daejeon 35015, KoreaTel: +82-42-280-7251Fax: +82-42-255-3158E-mail: gilhongr@gmail.com Received: 8 September, 2016 Revised: 17 October, 2016Accepted: 21 October, 2016 Copyright © 2017 by The Korean Pediatric Society This is an open-access article distributed under the  terms of the Creative Commons Attribution Non- Commercial License (http://creativecommons.org/ licenses/by-nc/4.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any  medium, provided the original work is properly cited.Original article Korean J Pediatr 2017;60(1):24-29 https://doi.org/10.3345/kjp.2017.60.1.24pISSN 1738-1061•eISSN 2092-7258 Korean J Pediatr",Non-OADS,/arxiv_data1/oa_pdf/b2/c1/kjped-60-24.PMC5309321.pdf
25 https://doi.org/10.3345/kjp.2017.60.1.24Korean J Pediatr 2017;60(1):24-29 several months to several years7).,Non-OADS,/arxiv_data1/oa_pdf/b2/c1/kjped-60-24.PMC5309321.pdf
"https://doi.org/10.3345/kjp.2017.60.1.24Yoo JW, et al.",OADS,/arxiv_data1/oa_pdf/b2/c1/kjped-60-24.PMC5309321.pdf
"27 https://doi.org/10.3345/kjp.2017.60.1.24Korean J Pediatr 2017;60(1):24-29 the morphology of the coronary arteries appears normal on echo - cardiography, vascular endothelial injury and dysfunction may  persist after the convalescent phase9).",Non-OADS,/arxiv_data1/oa_pdf/b2/c1/kjped-60-24.PMC5309321.pdf
"https://doi.org/10.3345/kjp.2017.60.1.24Yoo JW, et al.",OADS,/arxiv_data1/oa_pdf/b2/c1/kjped-60-24.PMC5309321.pdf
29 https://doi.org/10.3345/kjp.2017.60.1.24Korean J Pediatr 2017;60(1):24-29 uation by intracoronary injection of acetylcholine.,Non-OADS,/arxiv_data1/oa_pdf/b2/c1/kjped-60-24.PMC5309321.pdf
"In order to ﬁnd the differentially expressed genes, statistical analyses exploiting Bayesian analysis of variance for microarrays (BAMarray; http://www.bamarray.com) were accomplished bycomparing day 2, 4 and 13 versus day 0, the undifferentiated preadipocytes.",OADS,/arxiv_data1/oa_pdf/7a/88/ijo2016189a.PMC5309343.pdf
"( c) lnc-U90926 expression was calculated with Bayesian analysis of variance for microarrays (BAMarray; http://www.bamarray.com) by comparing day 2, 4 and 13 versus day 0 undifferentiated preadipocytes.",OADS,/arxiv_data1/oa_pdf/7a/88/ijo2016189a.PMC5309343.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/4.0/ © The Author(s) 2017LncRNA U90926 negatively regulates adipogenesis J Chen et al 308 International Journal of Obesity (2017) 299 –308",Non-OADS,/arxiv_data1/oa_pdf/7a/88/ijo2016189a.PMC5309343.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/4.0/ © The Author(s) 2017 Supplementary Information accompanies this paper on International Journal of Obesity website (http://www.nature.com/ijo)Role of Epac2a in obesity and leptin signaling M Hwang et al 288 International Journal of Obesity (2017) 279 –288",Non-OADS,/arxiv_data1/oa_pdf/14/28/ijo2016208a.PMC5309344.pdf
"© 2017 Surgical Neurology International | Published by Wolters Kluwer - MedknowEditor: James I. Ausman, MD, PhD   University of California, Los  Angeles, CA, USAOPEN ACCESS For entire Editorial Board visit :    http://www.surgicalneurologyint.comCase Report Delayed and isolated oculomotor nerve palsy following minor  head trauma Yu Nakagawa, Masahiro Toda, Shunsuke Shibao, Kazunari Y oshida Department of Neurosurgery, School of Medicine, Keio University, T okyo, Japan E‑mail:  Yu Nakagawa ‑ fi020202naka2510027yu@gmail.com; *Masahiro T oda ‑ todam@z2.keio.jp; Shunsuke Shibao ‑ shibarc@yahoo.co.jp;   Kazunari Yoshida ‑ kazrmky@keio.jp   *Corresponding author Received: 02 August 16  Accepted: 05 December 16  Published: 06 February 17 Abstract Background:  The purpose of this study was to consider the mechanism of isolated  oculomotor nerve palsy after minor head trauma.",Non-OADS,/arxiv_data1/oa_pdf/76/49/SNI-8-20.PMC5309438.pdf
"Surg Neurol Int  2017;8:20. http://surgicalneurologyint.com/Delayed-and-isolated-oculomotor-nerve-palsy- following-minor-head-trauma/This is an open access article distributed under the terms of the Creative Commons  Attribution-NonCommercial-ShareAlike 3.0 License, which allows others to remix,  tweak, and build upon the work non-commercially, as long as the author is credited and  the new creations are licensed under the identical terms.",Non-OADS,/arxiv_data1/oa_pdf/76/49/SNI-8-20.PMC5309438.pdf
"Surgical Neurology International 2017, 8:20  http://www.surgicalneurologyint.com/content/8/1/20injury.",Non-OADS,/arxiv_data1/oa_pdf/76/49/SNI-8-20.PMC5309438.pdf
"Surgical Neurology International 2017, 8:20  http://www.surgicalneurologyint.com/content/8/1/20petroclinoid ligament.",Non-OADS,/arxiv_data1/oa_pdf/76/49/SNI-8-20.PMC5309438.pdf
"Surgical Neurology International 2017, 8:20  http://www.surgicalneurologyint.com/content/8/1/204.",Non-OADS,/arxiv_data1/oa_pdf/76/49/SNI-8-20.PMC5309438.pdf
"© 2017 Surgical Neurology International | Published by Wolters Kluwer - MedknowEditor: James I. Ausman, MD, PhD   University of California, Los  Angeles, CA, USAOPEN ACCESS For entire Editorial Board visit :    http://www.surgicalneurologyint.comSNI: NeurovascularCase Report A5 segment aneurysm of the anterior cerebral artery, imbedded  into the body of the corpus callosum: A  case report Fransua Sharafeddin, Ahmad Hafez, Martin Lehecka, Rahul Raj, Roberto Colasanti,  Ahmadreza Rafiei, Joham Choque, Behnam R. Jahromi, Mika Niemelä, Juha Hernesniemi Department of Neurosurgery, Helsinki University Central Hospital, Helsinki, Finland E‑mail: *Fransua Sharafeddin ‑ fransua.sharafeddin@gmail.com; Ahmad Hafez ‑ ext‑ahmad.hafez@hus.fi; Martin Lehecka ‑ martin.lehecka@hus.fi;   Rahul Raj ‑ rahul.raj@hus.fi; Roberto Colasanti ‑ roberto.colasanti@gmail.com; Ahmadreza Rafiei ‑ ahmadreza.raf@gmail.com;   Joham Choque ‑ johchove@hotmail.com; Behnam R. Jahromi ‑ behnam.rezai@gmail.com; Mika Niemelä ‑ mika.niemela@hus.fi;   Juha Hernesniemi ‑ juha.hernesniemi@hus.fi   *Corresponding author Received: 09 October 16  Accepted: 07 December 16  Published: 06 February 17 Abstract Background: The A5 segment aneurysms of the anterior cerebral artery are rare,  approximately 0.5% of all intracranial aneurysms.",Non-OADS,/arxiv_data1/oa_pdf/15/ec/SNI-8-18.PMC5309442.pdf
"Surg Neurol Int 2017;8:18. http://surgicalneurologyint.com/A5-segment-aneurysm-of-the-anterior-cerebral- artery,-imbedded-into-the-body-of-the-corpus-callosum:-A case-reportThis is an open access article distributed under the terms of the Creative Commons  Attribution-NonCommercial-ShareAlike 3.0 License, which allows others to remix,  tweak, and build upon the work non-commercially, as long as the author is credited and  the new creations are licensed under the identical terms.",Non-OADS,/arxiv_data1/oa_pdf/15/ec/SNI-8-18.PMC5309442.pdf
"Surgical Neurology International 2017, 8:18  http://www.surgicalneurologyint.com/content/8/1/18CLINICAL PRESENTATION A 41‑year‑old healthy non‑smoking Caucasian female  was admitted to the neurology department to be  investigated for possible multiple sclerosis, vertigo,  coordination problems, tingling, and numbness in her  left arm.",Non-OADS,/arxiv_data1/oa_pdf/15/ec/SNI-8-18.PMC5309442.pdf
"Surgical Neurology International 2017, 8:18  http://www.surgicalneurologyint.com/content/8/1/18callosum.",Non-OADS,/arxiv_data1/oa_pdf/15/ec/SNI-8-18.PMC5309442.pdf
"Surgical Neurology International 2017, 8:18  http://www.surgicalneurologyint.com/content/8/1/18anterior cerebral artery aneurysms: Microsurgical anatomy.",Non-OADS,/arxiv_data1/oa_pdf/15/ec/SNI-8-18.PMC5309442.pdf
"© 2017 Surgical Neurology International | Published by Wolters Kluwer - MedknowEditor: Nancy E. Epstein, MD Winthrop University Hospital, Mineola, NY, USAOPEN ACCESS For entire Editorial Board visit :    http://www.surgicalneurologyint.comSNI: SpineOriginal Article Comparison of intubation success and glottic visualization using  King Vision and C‑MAC videolaryngoscopes in patients with  cervical spine injuries with cervical immobilization: A  randomized  clinical trial Dhanyasi Shravanalakshmi, Prasanna U. Bidkar, K. Narmadalakshmi, Suman Lata,  Sandeep K. Mishra, S. Adinarayanan Department of Anaesthesiology and Critical Care, Jawaharlal Institute of Postgraduate Medical Education and Research (JIPMER), Pondicherry, India E‑mail:  Dhanyasi Shravanalakshmi ‑ sharoo.karoo@gmail.com; *Prasanna U. Bidkar ‑ drprasannabidkar@gmail.com; K. Narmadalakshmi ‑ nammukannan@yahoo.com;  Suman Lata ‑ sumanlata13@yahoo.com; Sandeep K. Mishra ‑ jipmermishra@gmail.com; S. Adinarayanan ‑ adinarayanans@gmail.com   *Corresponding author Received: 14 October 16  Accepted: 14 December 16  Published: 06 February 17 Abstract Background:  Glottic visualization can be difficult with cervical immobilization  in patients with cervical spine injury.",Non-OADS,/arxiv_data1/oa_pdf/5d/a8/SNI-8-19.PMC5309444.pdf
"Surg Neurol Int 2017;8:19. http://surgicalneurologyint.com/Comparison-of-intubation-success-and-glottic-visualization-using-King-Vision-and-C-MAC-videolaryngoscopes-in-patients-with-cervical-spine- injuries-with-cervical-immobilization:-A randomized-clinical-trial/This is an open access article distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 3.0 License, which allows others to remix, tweak, and  build upon the work non-commercially, as long as the author is credited and the new creations are licensed under the identical terms.",Non-OADS,/arxiv_data1/oa_pdf/5d/a8/SNI-8-19.PMC5309444.pdf
"Surgical Neurology International 2017, 8:19  http://www.surgicalneurologyint.com/content/8/1/19INTRODUCTION Although direct laryngoscopy has been used with  variable success, it has the potential to cause greater  cervical spine movement.",Non-OADS,/arxiv_data1/oa_pdf/5d/a8/SNI-8-19.PMC5309444.pdf
"Surgical Neurology International 2017, 8:19  http://www.surgicalneurologyint.com/content/8/1/19RESULTS All three groups were comparable with respect to age  [Table 2].",Non-OADS,/arxiv_data1/oa_pdf/5d/a8/SNI-8-19.PMC5309444.pdf
"Surgical Neurology International 2017, 8:19  http://www.surgicalneurologyint.com/content/8/1/19Success of intubation Intubation was successful in all patients (100%), using  all three devices [ Table  4].",Non-OADS,/arxiv_data1/oa_pdf/5d/a8/SNI-8-19.PMC5309444.pdf
"Surgical Neurology International 2017, 8:19  http://www.surgicalneurologyint.com/content/8/1/19In a study of Alvis et al.",Non-OADS,/arxiv_data1/oa_pdf/5d/a8/SNI-8-19.PMC5309444.pdf
"Surgical Neurology International 2017, 8:19  http://www.surgicalneurologyint.com/content/8/1/19• All the three videolaryngoscopes provided good grade  glottic visualization • The ease of insertion of laryngoscope blade is graded  as conventional C‑ MAC > King Vision > D blade  C‑MAC videolaryngoscopes.",Non-OADS,/arxiv_data1/oa_pdf/5d/a8/SNI-8-19.PMC5309444.pdf
"© 2017 Surgical Neurology International | Published by Wolters Kluwer - MedknowSNI: Neuroscience NursingEditor: Mona Stecker,   Winthrop University Hospital,   Mineola, NY 11501, USAOPEN ACCESS For entire Editorial Board visit :    http://www.surgicalneurologyint.com Original Article Predictive model of length of stay and discharge destination in  neuroscience admissions M. M. Stecker, M. Stecker, J. Falotico1 Winthrop University Hospital, Mineola, New York, 1Colgate University, Hamilton, NY , USA E‑mail: *M. M. Stecker ‑ mmstecker@gmail.com; M. Stecker ‑ mona.stecker@gmail.com; J. Falotico ‑ jfalotico@colgate.edu   *Corresponding author Received: 02 September 16  Accepted: 15 November 16  Published: 06 February 17 Abstract Background:  The purpose of this study was to try and determine the best  predictors of hospital length of stay and discharge destination in patients admitted  to a neuroscience service.",Non-OADS,/arxiv_data1/oa_pdf/fc/d2/SNI-8-17.PMC5309446.pdf
"Surg Neurol Int  2017;8:17. http://surgicalneurologyint.com/Predictive-model-of-length-of-stay-and-discharge- destination-in-neuroscience-admissions/This is an open access article distributed under the terms of the Creative Commons  Attribution-NonCommercial-ShareAlike 3.0 License, which allows others to remix,  tweak, and build upon the work non-commercially, as long as the author is credited and  the new creations are licensed under the identical terms.",Non-OADS,/arxiv_data1/oa_pdf/fc/d2/SNI-8-17.PMC5309446.pdf
"Surgical Neurology International 2017, 8:17  http://www.surgicalneurologyint.com/content/8/1/17first‑ever stroke patients.",Non-OADS,/arxiv_data1/oa_pdf/fc/d2/SNI-8-17.PMC5309446.pdf
"Surgical Neurology International 2017, 8:17  http://www.surgicalneurologyint.com/content/8/1/17RESULTS Table  1 shows the results of t‑tests applied to each of the  binary pre‑admission risk factors and clearly demonstrates  that the largest effect is a significantly shorter length of  stay in patients admitted from an outpatient setting.",Non-OADS,/arxiv_data1/oa_pdf/fc/d2/SNI-8-17.PMC5309446.pdf
"Surgical Neurology International 2017, 8:17  http://www.surgicalneurologyint.com/content/8/1/17Deep venous thrombosis, Cauti, feeding tube  placement, intubation, admission to intensive  care unit, and shunt insertion These factors were all determined to have an effect on  LOS, and the current literature supports these findings.",Non-OADS,/arxiv_data1/oa_pdf/fc/d2/SNI-8-17.PMC5309446.pdf
"Surgical Neurology International 2017, 8:17  http://www.surgicalneurologyint.com/content/8/1/17Table 6: Results of forward stepwise linear regression with  LOS as the dependent variable and drug abuse, admit from  outpatient, mRS, systolic blood pressure at admission and  hemoglobin at admission as independent factors Slope Standard  errort (114) P Admit from Outpatient −10.8305 2.387645 −4.53607 0.000014 MRS at admission 2.4972 0.699373 3.57067 0.00052 Systolic BP −0.0899 0.036757 −2.44633 0.016 R²=0.28,  F (3, 114)=15.111tPA with a pre‑stroke mRS of > or = 2 had a prolonged  LOS.",Non-OADS,/arxiv_data1/oa_pdf/fc/d2/SNI-8-17.PMC5309446.pdf
"Surgical Neurology International 2017, 8:17  http://www.surgicalneurologyint.com/content/8/1/17on patients’ hospital stays.",Non-OADS,/arxiv_data1/oa_pdf/fc/d2/SNI-8-17.PMC5309446.pdf
"Surgical Neurology International 2017, 8:17  http://www.surgicalneurologyint.com/content/8/1/17Full Name:_________________________________________________ Date of Admission:_________________ Gender: □ Male □ Female Age:_______________ MRN#:______________________ Height:_______________________ Weight:______________________Comfort Measures Only?",Non-OADS,/arxiv_data1/oa_pdf/fc/d2/SNI-8-17.PMC5309446.pdf
"Surgical Neurology International 2017, 8:17  http://www.surgicalneurologyint.com/content/8/1/17Insurance: □ Medicaid □ Medicare □ Commercial □ None U.S. Citizen: □ Yes □ No Activities of Daily Living (prior to admission): Does the patient have home assistance?",Non-OADS,/arxiv_data1/oa_pdf/fc/d2/SNI-8-17.PMC5309446.pdf
Available from: http://www.ispd.org/guidelines/ quality/shower.doc.,Non-OADS,/arxiv_data1/oa_pdf/a8/78/ABR-6-5.PMC5309448.pdf
"© 2017 Surgical Neurology International | Published by Wolters Kluwer ‑ MedknowEditor: James I. Ausman, MD, PhD   University of California, Los  Angeles, CA, USAOPEN ACCESS For entire Editorial Board visit :    http://www.surgicalneurologyint.comCase Report Rare association of secondary superficial siderosis caused  by a fourth ventricle hemorrhagic ependymoma mimicking a  cavernoma: Case report and literature review Eduardo E. Espinosa Rodríguez, Rodrigo Carrasco Moro, Juan S. Martínez San Millán1,  Héctor G. Pian Arias2 Departments of Neurosurgery, 1Radiology and 2Pathology, Hospital Universitario Ramón y Cajal, Madrid, Spain E‑mail: *Eduardo E. Espinosa Rodríguez ‑ dreeer84@hotmail.com; Rodrigo Carrasco Moro ‑ rocamo@gmail.com;   Juan S. Martínez San Millán ‑ jsamami@hotmail.com; Héctor G. Pian Arias ‑ hectorpian@yahoo.es   *Corresponding author Received: 23 May 16  Accepted: 17 November 16  Published: 06 February 17 Abstract Background:  The association of a hemorrhagic tumor with secondary superficial  siderosis (SS) is a relatively rare although well described phenomenon.",Non-OADS,/arxiv_data1/oa_pdf/64/22/SNI-8-14.PMC5309449.pdf
"Surg Neurol Int 2017;8:14. http://surgicalneurologyint.com/Rare-association-of-secondary-superficial-siderosis- caused-by-a-fourth-ventricle-hemorrhagic-ependymoma-mimicking-a-cavernoma:- Case-report-and-literature-review/This is an open access article distributed under the terms of the Creative Commons  Attribution-NonCommercial-ShareAlike 3.0 License, which allows others to remix,  tweak, and build upon the work non-commercially, as long as the author is credited and  the new creations are licensed under the identical terms.",Non-OADS,/arxiv_data1/oa_pdf/64/22/SNI-8-14.PMC5309449.pdf
"Surgical Neurology International 2017, 8:14  http://www.surgicalneurologyint.com/content/8/1/14leptomeninges and superficial CNS parenchyma, as well  as the subependymal lining throughout the neuroaxis,  present a dark, brownish discoloration.",Non-OADS,/arxiv_data1/oa_pdf/64/22/SNI-8-14.PMC5309449.pdf
"Surgical Neurology International 2017, 8:14  http://www.surgicalneurologyint.com/content/8/1/14and/or subarachnoid, 33%) and mixed intra and  extratumoral hemorrhage (13%).",Non-OADS,/arxiv_data1/oa_pdf/64/22/SNI-8-14.PMC5309449.pdf
"Surgical Neurology International 2017, 8:14  http://www.surgicalneurologyint.com/content/8/1/14Table 1: Published reports of current, nonoperated CNS tumors presenting with superficial siderosis Reference Age/ SexPresentation HCP/ TreatmentSOB/Location Management Follow‑up/Outcome SS Other 1Noetzel 1940 47/M Deafness,  dementiaNo NA Metastasis*/CxMen NA NA 2Rosenthal 1958 27/M NA NA NA Oligodendroglioma/NA NA NA 3McGee 1962 54/M Deafness,  myelopathyIncontinence NA Ependymoma/Lum NA NA 4Dastur 1962 26/M Meningismus H/A, N/V, papilledema,  ataxiaObstructive/ VPPinealoma STR 1d/Died 5Tomlinson 1964 16/F Deafness, ataxia,  dementia,  incontinenceH/A, dysarthria Yes/No Ependymoma/LV Not treated 2y/Died 6Brahman 1965 NA/F NA NA NA Astrocytoma/NA NA NA 7Kott 1966 29/F Deafness,  myelopathy,  meningismusH/A, N/V, papilledema, seizures, bilateral VIcp  palsyNo Ependymoma/LV SR 1m/Died 8Sherwin 1972 31/M NA NA NA Meningioma/NA NA NA 9Gomori 1985 32/M Deafness, tinnitus,  nystagmusSciatica Yes/No Myx ependymoma/ LumSR NA/Sciatica,  sphincter  dysfunction 10Koeppen 1988 59/M Deafness, ataxia,  myelopathyNo No Ependymoma/Lum GTR + IChA NA 11Parnes 1992 59/M Deafness, ataxia,  myelopathy,  tinnitusNo NA Ependymoma/Lum NA NA 12Willeit 1992 59/M Deafness, ataxia,  myelopathyIncontinence No Ependymoma/Lum GTR NA 13Shen 1993 16/F Meningismus No No Myx Ependymoma/ LumGTR NA 14Mamourian  199372/F Deafness Incontinence No Paraganglioma/Lum GTR NA 15Grunshaw 1993 29/F Loss of taste/ smell, deafness,  ataxia,  myelopathy,  nystagmusNo Obstructive/ NoUnknown****/IVv Nottreated NA 16Offenbacher  199648/M No No NA Neurinoma/FS NA NA 17Castelli 1997 48/M Deafness, ataxia H/A, N/V Obstructive/ NoEpendymoma/IVv SR NA 18Friedman 1998 21/M Absent Incontinence, low back  painNo Myx Ependymoma/ LumB NA/Sphincter  dysfunction,  paraparesis;  dissemination 19Matsumoto  199848/M Deafness, tinnitus,  ataxia, myelopathy,  sphincter  dysfunctionNo Yes/No Melanocytoma/T GTR 1y/Unchanged 20Kato 1998 24/M Absent Polydipsia, vertigo No Metastasis**/ SuprasellarGTR + Rt 7m/Dissemination 21Lemmerling  199850/M Deafness, ataxia No No Ependymoma/Lum GTR NA 22Sharma 1998 60/M Deafness, ataxia Low back pain No Paraganglioma/Lum GTR NA 23Durieux 1999 66/M Deafness, ataxia No No Adenoma/Sellar SRx 2+ Rt NA Contd...",Non-OADS,/arxiv_data1/oa_pdf/64/22/SNI-8-14.PMC5309449.pdf
"Surgical Neurology International 2017, 8:14  http://www.surgicalneurologyint.com/content/8/1/14Table 1: Contd... Reference Age/ SexPresentation HCP/ TreatmentSOB/Location Management Follow‑up/Outcome SS Other 24Bostantjopoulou  200061/F Deafness, ataxia,  myelopathyNo No Pilocytic astrocytoma/ TLGTR NA 25Straube 2001 55/F Deafness, ataxia,  polyradiculopathy,  sphincter  dysfunctionNo No Pilocytic astrocytoma/ ParasellarSTR + Rs NA 26Das 2001 50/M H/A, N/V,  meningismus,  papilledemaMyelopathy Arreabsortive/ VPSMelanocytoma/TL GTR + Rt 30m/Died;  Dissemination (8m) 27Yoshida 2002 54/F Deafness, ataxia No No Teratoma/C GTR NA 28Salem 2002 44/F Deafness, ataxia H/A, N/V, cervical pain No Ependymoma/IVv GTR NA 29Elalaoui 2003 44/F Deafness, ataxia No No Ependymoma/IVv STR + Rt 4m/Unchanged 30Kitis 2003 46/M Absent Impaired consciousness  hemianopsiaObstructive/ NoAdenoma/Sellar STR NA 31Kitis 2003 36/M Deafness,  nystagmusLow back pain No Myx Ependymoma/ LumGTR NA 32Vibert 2004 55/F Deafness, ataxia Deep hypoestesia No Ependymoma/Lum STR 4y/Progression of  SS symptoms 33Messori 2004 65/M Deafness, ataxia,  myelopathy,  nystagmusDeep hypoestesia No Myx Ependymoma/ LumGTR 2m/NA*** 34Kumar 2006 19/M Incontinence,  ataxiaSeizures, hemianopsia,  hemiparesisNo Germ cell tumor/ BBGGB x 2 (Non Diagnostic)6y/Died 35Konya 2006 49/F No H/A No PGNT/FL GTR 1y/Asymptomatic 36Spengos 2007 63/M Deafness, ataxia,  myelopathyNo No Ependymoma/Lum GTR NA/Unchanged 37Léveque 2009 23/M H/A, N/V,  dysphagia,  dysarthria, left VI  nerve palsySphincter dysfunction No Myx Ependymoma/ LumGTR 3m/Improvement 38Vreto 2011 47/M Tinnitus H/A, VIIcp palsy, left  RombergNo Melanocytoma/CPA SR NA 39Vyas 2011 40/M Deafness, ataxia,  dementiaNo No Adenoma/Sellar SR NA 40Steinberg 2013 43/M No Hemianopsia No Pituitary apoplexy/ SellarMT NA/Decrease in size  of the lesion 41Grech 2013 64/F Deafness, ataxia Low back pain No Myx Ependymoma/ LumGTR + CI NA/Improved 42Al‑Najar 2013 70/M Ataxia H/A, N/V, hemiparesis No Hemangioblastoma/LV B + GTR NA 43Tosaka 2014 69/M Deafness, ataxia,  dementiaH/A, vision loss No Craneopharyngioma/ IIIvSTR 1y/Progression of  SS symptoms 44Pikis 2014 33/M Deafness Low back pain No Myx Ependymoma/ LumGTR 2y/Unchanged 45Present case 35/M Deafness,  nystagmus,  cervical painDrop attacks,  drowsiness, ataxia,  papilledemaYes/EVD Ependymoma/IVv GTR 1.5y/No progression  of SS symptoms Including the present case, there are 45 published case reports of superficial siderosis secondary to nonoperated CNS tumors.",Non-OADS,/arxiv_data1/oa_pdf/64/22/SNI-8-14.PMC5309449.pdf
"Surgical Neurology International 2017, 8:14  http://www.surgicalneurologyint.com/content/8/1/14all 8 cases secondary to myxopapillary ependymoma  had an intraspinal location;[12‑14,20,30,38,45,52] thus, it would  seem that our differential diagnosis was statistically  improbable.",Non-OADS,/arxiv_data1/oa_pdf/64/22/SNI-8-14.PMC5309449.pdf
"Surgical Neurology International 2017, 8:14  http://www.surgicalneurologyint.com/content/8/1/1420.",Non-OADS,/arxiv_data1/oa_pdf/64/22/SNI-8-14.PMC5309449.pdf
"Surgical Neurology International 2017, 8:14  http://www.surgicalneurologyint.com/content/8/1/14Commentary Re: Rare association of  secondary superficial siderosis  caused by a fourth ventricle  hemorrhagic ependymoma  mimicking a cavernoma: Case  report and literature review Secondary superficial siderosis (SS) is a rare condition  in which there is iron staining of the cortical surface  or ventricles depending on the location of the causative  lesion.",Non-OADS,/arxiv_data1/oa_pdf/64/22/SNI-8-14.PMC5309449.pdf
"© 2017 Surgical Neurology International | Published by Wolters Kluwer - MedknowOPEN ACCESS For entire Editorial Board visit :    http://www.surgicalneurologyint.com SNI: Skull BaseEditor: James I. Ausman, MD, PhD   University of California, Los  Angeles, CA, USAReview Article The impact of surgical timing on visual outcome in pituitary  apoplexy: Literature review and case illustration Arif Abdulbaki1,2, Imad Kanaan1,2 1Department of Neurosciences, Division of Neurosurgery, King Faisal Specialist Hospital and Research Center, Riyadh 11211, 2Alfaisal University, College of  Medicine, Riyadh 11533, Saudi Arabia E‑mail:  Arif Abdulbaki ‑ a.abdulbaki@hotmail.com; *Imad Kanaan ‑ dr.imad.kanaan@gmail.com   *Corresponding author Received: 29 August 16  Accepted: 16 November 16  Published: 06 February 17 Abstract Background:  Neuro‑ophthalmologic signs are common clinical manifestations  of pituitary apoplexy.",Non-OADS,/arxiv_data1/oa_pdf/38/c8/SNI-8-16.PMC5309450.pdf
"Surg  Neurol Int 2017;8:16. http://surgicalneurologyint.com/The-impact-of-surgical-timing-on-visual-outcome-in- pituitary-apoplexy:-Literature-review-and-case-illustration/This is an open access article distributed under the terms of the Creative Commons  Attribution-NonCommercial-ShareAlike 3.0 License, which allows others to remix,  tweak, and build upon the work non-commercially, as long as the author is credited and  the new creations are licensed under the identical terms.",Non-OADS,/arxiv_data1/oa_pdf/38/c8/SNI-8-16.PMC5309450.pdf
"Surgical Neurology International 2017, 8:16  http://www.surgicalneurologyint.com/content/8/1/16deterioration of vision is a serious condition because the  tolerance of optic nerve to ischemia is unpredictable.",Non-OADS,/arxiv_data1/oa_pdf/38/c8/SNI-8-16.PMC5309450.pdf
"Surgical Neurology International 2017, 8:16  http://www.surgicalneurologyint.com/content/8/1/16term apoplexy was first used by Brougham et al.",Non-OADS,/arxiv_data1/oa_pdf/38/c8/SNI-8-16.PMC5309450.pdf
"Surgical Neurology International 2017, 8:16  http://www.surgicalneurologyint.com/content/8/1/16It is crucial to understand the pathophysiology of these  visual disorders.",Non-OADS,/arxiv_data1/oa_pdf/38/c8/SNI-8-16.PMC5309450.pdf
"Surgical Neurology International 2017, 8:16  http://www.surgicalneurologyint.com/content/8/1/16demyelinization are reversible functional mechanisms.",Non-OADS,/arxiv_data1/oa_pdf/38/c8/SNI-8-16.PMC5309450.pdf
"© 2017 Surgical Neurology International | Published by Wolters Kluwer - MedknowEditor: James I. Ausman, MD, PhD   University of California, Los  Angeles, CA, USAOPEN ACCESS For entire Editorial Board visit :    http://www.surgicalneurologyint.comSNI: NeurovascularT echnical Note Technical nuances of subtemporal approach for the treatment of  basilar tip aneurysm Vladimir S. Nakov , Toma Y. Spiriev , Ivan T .",Non-OADS,/arxiv_data1/oa_pdf/94/f8/SNI-8-15.PMC5309464.pdf
"Surg  Neurol Int 2017;8:15. http://surgicalneurologyint.com/T echnical-nuances-of-subtemporal-approach-for- the-treatment-of-basilar-tip-aneurysm/This is an open access article distributed under the terms of the Creative Commons  Attribution-NonCommercial-ShareAlike 3.0 License, which allows others to remix,  tweak, and build upon the work non-commercially, as long as the author is credited and  the new creations are licensed under the identical terms.",Non-OADS,/arxiv_data1/oa_pdf/94/f8/SNI-8-15.PMC5309464.pdf
"Surgical Neurology International 2017, 8:15  http://www.surgicalneurologyint.com/content/8/1/15subtemporal, anterior and petrosectomy.",Non-OADS,/arxiv_data1/oa_pdf/94/f8/SNI-8-15.PMC5309464.pdf
"Surgical Neurology International 2017, 8:15  http://www.surgicalneurologyint.com/content/8/1/15aneurysm might not be suitable for subtemporal approach  and may require pterional, OZ or pretemporal approach;  on the contrary, very low riding aneurysms might require  anterior petrosectomy technique in order to reach the  lesions [ Table  1].",Non-OADS,/arxiv_data1/oa_pdf/94/f8/SNI-8-15.PMC5309464.pdf
The Digital Imaging and Communications in  Medicine (DICOM) files of 1 mm thickness and  non‑overlapping CTA slices are imported into OsiriX  open‑source imaging software (Version 5.8.1; free  download from http://www.osirix‑viewer.com/) on a mid.,Non-OADS,/arxiv_data1/oa_pdf/94/f8/SNI-8-15.PMC5309464.pdf
"Surgical Neurology International 2017, 8:15  http://www.surgicalneurologyint.com/content/8/1/15base.",Non-OADS,/arxiv_data1/oa_pdf/94/f8/SNI-8-15.PMC5309464.pdf
"Surgical Neurology International 2017, 8:15  http://www.surgicalneurologyint.com/content/8/1/15the direction of the aneurysmal sac.",Non-OADS,/arxiv_data1/oa_pdf/94/f8/SNI-8-15.PMC5309464.pdf
"Surgical Neurology International 2017, 8:15  http://www.surgicalneurologyint.com/content/8/1/15increase of the systolic pressure to at least 20 Torr above  the normal systolic pressure of the patient.",Non-OADS,/arxiv_data1/oa_pdf/94/f8/SNI-8-15.PMC5309464.pdf
"Surgical Neurology International 2017, 8:15  http://www.surgicalneurologyint.com/content/8/1/1516.",Non-OADS,/arxiv_data1/oa_pdf/94/f8/SNI-8-15.PMC5309464.pdf
"See: http://creativecommons.org/ licenses/by-nc/4.0/ Manuscript source:  Invited manuscript Correspondence to: Talha Shaikh, MD,  Department of  Radiation Oncology, Fox Chase Cancer Center, 333 Cottman  Avenue, Philadelphia, PA 19111,  United States.",Non-OADS,/arxiv_data1/oa_pdf/ab/79/WJCO-8-1.PMC5309711.pdf
Third generation World Journal of Clinical Oncology WJCO Submit a Manuscript: http://www.wjgnet.com/esps/ Help Desk: http://www.wjgnet.com/esps/helpdesk.aspx DOI: 0.5306/wjco.v8.i.World J Clin Oncol  207 February 0; 8(): -20 ISSN 228-4333 (online) © 207 Baishideng Publishing Group Inc. All rights reserved.,Non-OADS,/arxiv_data1/oa_pdf/ab/79/WJCO-8-1.PMC5309711.pdf
wjgnet.com/ 2218-4333 /full/v8/i1/1.htm  DOI: http://dx.doi.,OADS,/arxiv_data1/oa_pdf/ab/79/WJCO-8-1.PMC5309711.pdf
"All rights reserved.Published by Baishideng Publishing Group Inc 8226 Regency Drive, Pleasanton, CA 94588, USA Telephone: +1-925-223-8242 Fax: +1-925-223-8243 E-mail: bpgoffice@wjgnet.com Help Desk: http://www.wjgnet.com/esps/helpdesk.aspx http://www.wjgnet.com",Non-OADS,/arxiv_data1/oa_pdf/ab/79/WJCO-8-1.PMC5309711.pdf
"See: http://creativecommons.org/ licenses/by-nc/4.0/ Manuscript source:  Invited manuscript Correspondence to:  Dr. Murtaza M Tambuwala, PhD, School  of Pharmacy and Pharmaceutical Science, University of Ulster,  Coleraine, County Londonderry, Coleraine, Northern Ireland  BT52 1SA, United Kingdom.",Non-OADS,/arxiv_data1/oa_pdf/9d/7d/WJCO-8-21.PMC5309712.pdf
wjgnet.com/ 2218-4333 /full/v8 /i1/21.htm  DOI: http://dx.doi.,OADS,/arxiv_data1/oa_pdf/9d/7d/WJCO-8-21.PMC5309712.pdf
org/10.5306/wjco.v8.i1.21World Journal of Clinical Oncology WJCO Submit a Manuscript: http://www.wjgnet.com/esps/ Help Desk: http://www.wjgnet.com/esps/helpdesk.aspx DOI: 10.5306/wjco.v8.i1.21World J Clin Oncol  2017 February 10; 8(1): 21-36 ISSN 2218-4333 (online) © 2017 Baishideng Publishing Group Inc. All rights reserved.,Non-OADS,/arxiv_data1/oa_pdf/9d/7d/WJCO-8-21.PMC5309712.pdf
"All rights reserved.Published by Baishideng Publishing Group Inc 8226 Regency Drive, Pleasanton, CA 94588, USA Telephone: +1-925-223-8242 Fax: +1-925-223-8243 E-mail: bpgoffice@wjgnet.com Help Desk: http://www.wjgnet.com/esps/helpdesk.aspx http://www.wjgnet.com",Non-OADS,/arxiv_data1/oa_pdf/9d/7d/WJCO-8-21.PMC5309712.pdf
"See: http://creativecommons.org/ licenses/by-nc/4.0/ Manuscript source: Invited manuscript Correspondence to:  Sebastiano Buti, MD, PhD, Medical  Oncology Unit, University Hospital of Parma, Via Gramsci 14,  43126 Parma, Italy.",Non-OADS,/arxiv_data1/oa_pdf/44/41/WJCO-8-37.PMC5309713.pdf
"Bersanelli M, Buti S. From targeting the tumor to targeting  the immune system: Tra nsversal c hallenges in oncology with World Journal of Clinical Oncology WJCO Submit a Manuscript: http://www.wjgnet.com/esps/ Help Desk: http://www.wjgnet.com/esps/helpdesk.aspx DOI: 10.5306/wjco.v8.i1.37World J Clin Oncol  2017 February 10; 8(1): 37-53 ISSN 2218-4333 (online) © 2017 Baishideng Publishing Group Inc. All rights reserved.",Non-OADS,/arxiv_data1/oa_pdf/44/41/WJCO-8-37.PMC5309713.pdf
World J Clin Oncol   2017; 8(1): 37-53  Available from: URL:  http://www.wjgnet.,Non-OADS,/arxiv_data1/oa_pdf/44/41/WJCO-8-37.PMC5309713.pdf
com/ 2218-4333 /full/v8/i1/37.htm  DOI: http://dx.doi.org/ 10.5306/wjco.v8.,Non-OADS,/arxiv_data1/oa_pdf/44/41/WJCO-8-37.PMC5309713.pdf
Available from: URL:https://clinicaltrials.gov/ct2/show/ NCT02791334 4 Bristol-Myers Squibb .,Non-OADS,/arxiv_data1/oa_pdf/44/41/WJCO-8-37.PMC5309713.pdf
Available from:  URL: https://clinicaltrials.gov/ct2/show/NCT02534506 5 Pardoll DM .,Non-OADS,/arxiv_data1/oa_pdf/44/41/WJCO-8-37.PMC5309713.pdf
Available  from: URL: https://clinicaltrials.gov/ct2/show/NCT02821013 16 Incyte Corporation .,Non-OADS,/arxiv_data1/oa_pdf/44/41/WJCO-8-37.PMC5309713.pdf
Available from: URL: https://clinicaltrials.gov/ ct2/show/NCT02752074 17 Amgen .,Non-OADS,/arxiv_data1/oa_pdf/44/41/WJCO-8-37.PMC5309713.pdf
Available from: URL:  https://clinicaltrials.gov/ct2/show/NCT02263508 18 National Cancer Institute (NCI) .,Non-OADS,/arxiv_data1/oa_pdf/44/41/WJCO-8-37.PMC5309713.pdf
Available from: URL: https://clinicaltrials.gov/ct2/show/ NCT02362594 21 National Cancer Institute (NCI) .,Non-OADS,/arxiv_data1/oa_pdf/44/41/WJCO-8-37.PMC5309713.pdf
Available from: URL:  https://clinicaltrials.gov/ct2/show/NCT02506153 22 Merck Sharp & Dohme Corp .,Non-OADS,/arxiv_data1/oa_pdf/44/41/WJCO-8-37.PMC5309713.pdf
Available from: URL: https://clinicaltrials.gov/ct2/show/ NCT02504372 23 Hoffmann-La Roche .,Non-OADS,/arxiv_data1/oa_pdf/44/41/WJCO-8-37.PMC5309713.pdf
Available  from: URL: https://clinicaltrials.gov/ct2/show/NCT02450331 24 Hoffmann-La Roche .,Non-OADS,/arxiv_data1/oa_pdf/44/41/WJCO-8-37.PMC5309713.pdf
Available from: URL: https://clinicaltrials.gov/ ct2/show/NCT02768558 26 National Cancer Institute (NCI) .,Non-OADS,/arxiv_data1/oa_pdf/44/41/WJCO-8-37.PMC5309713.pdf
Available  from: URL: https://clinicaltrials.gov/ct2/show/NCT02595944 27 Bristol-Myers Squibb .,Non-OADS,/arxiv_data1/oa_pdf/44/41/WJCO-8-37.PMC5309713.pdf
Available from: URL: https://clinicaltrials.gov/ct2/ show/NCT02632409 29 Bristol-Myers Squibb .,Non-OADS,/arxiv_data1/oa_pdf/44/41/WJCO-8-37.PMC5309713.pdf
Available from: URL:  https://clinicaltrials.gov/ct2/show/NCT02743494 30 AstraZeneca .,Non-OADS,/arxiv_data1/oa_pdf/44/41/WJCO-8-37.PMC5309713.pdf
Available from: URL: https://clinicaltrials.gov/ct2/ show/NCT02125461 31 Canadian Cancer Trials Group .,Non-OADS,/arxiv_data1/oa_pdf/44/41/WJCO-8-37.PMC5309713.pdf
"Available from: URL: https://www.esmo.org 36 Reck M , Rodríguez-Abreu D, Robinson AG, Hui R, Csőszi T,  Fülöp A, Gottfried M, Peled N, Tafreshi A, Cuffe S, O’Brien M,  Rao S, Hotta K, Leiby MA, Lubiniecki GM, Shentu Y , Rangwala  R, Brahmer JR. Pembrolizumab versus Chemotherapy for PD-L1- Positive Non-Small-Cell Lung Cancer.",Non-OADS,/arxiv_data1/oa_pdf/44/41/WJCO-8-37.PMC5309713.pdf
Available  from: URL: https://clinicaltrials.gov/ct2/show/NCT02041533  38 Merck Sharp & Dohme Corp .,Non-OADS,/arxiv_data1/oa_pdf/44/41/WJCO-8-37.PMC5309713.pdf
Available  from: URL: https://clinicaltrials.gov/ct2/show/NCT02702401 43 Merck Sharp & Dohme Corp .,Non-OADS,/arxiv_data1/oa_pdf/44/41/WJCO-8-37.PMC5309713.pdf
Available from: URL: https://clinicaltrials.gov/ct2/show/ NCT02578680 44 Merck Sharp & Dohme Corp .,Non-OADS,/arxiv_data1/oa_pdf/44/41/WJCO-8-37.PMC5309713.pdf
Available from: URL: https://clinicaltrials.gov/ct2/ show/NCT02775435 45 Merck Sharp & Dohme Corp .,Non-OADS,/arxiv_data1/oa_pdf/44/41/WJCO-8-37.PMC5309713.pdf
Available from: URL: https://clinicaltrials.gov/ct2/show/ NCT02220894 46 Merck Sharp & Dohme Corp .,Non-OADS,/arxiv_data1/oa_pdf/44/41/WJCO-8-37.PMC5309713.pdf
Available from: URL: https://clinicaltrials.gov/ ct2/show/NCT02819518 49 Merck Sharp & Dohme Corp .,Non-OADS,/arxiv_data1/oa_pdf/44/41/WJCO-8-37.PMC5309713.pdf
Available from: URL: https://clinicaltrials.gov/ ct2/show/NCT02563002 50 Merck Sharp & Dohme Corp .,Non-OADS,/arxiv_data1/oa_pdf/44/41/WJCO-8-37.PMC5309713.pdf
Available  from: URL: https://clinicaltrials.gov/ct2/show/NCT02564263 51 Merck Sharp & Dohme Corp .,Non-OADS,/arxiv_data1/oa_pdf/44/41/WJCO-8-37.PMC5309713.pdf
Available  from: URL: https://clinicaltrials.gov/ct2/show/NCT02370498 52 Merck Sharp & Dohme Corp .,Non-OADS,/arxiv_data1/oa_pdf/44/41/WJCO-8-37.PMC5309713.pdf
Available from:  URL: https://clinicaltrials.gov/ct2/show/NCT02494583 53 Pfizer .,Non-OADS,/arxiv_data1/oa_pdf/44/41/WJCO-8-37.PMC5309713.pdf
Available from: URL: https://clinicaltrials.gov/ct2/show/ NCT02580058  54 Pfizer .,Non-OADS,/arxiv_data1/oa_pdf/44/41/WJCO-8-37.PMC5309713.pdf
Available from: URL: https://clinicaltrials.gov/ct2/show/ NCT02718417 55 Pfizer .,Non-OADS,/arxiv_data1/oa_pdf/44/41/WJCO-8-37.PMC5309713.pdf
Available from: URL: https://clinicaltrials.gov/ct2/ show/NCT02684006 56 Pfizer .,Non-OADS,/arxiv_data1/oa_pdf/44/41/WJCO-8-37.PMC5309713.pdf
"Available from: URL: https://clinicaltrials.gov/ct2/ show/NCT02603432 57 EMD Serono Research & Development Institute, Inc .",Non-OADS,/arxiv_data1/oa_pdf/44/41/WJCO-8-37.PMC5309713.pdf
"Available from: URL: https://clinicaltrials.gov/ct2/ show/NCT02625610 58 EMD Serono Research & Development Institute, Inc .",Non-OADS,/arxiv_data1/oa_pdf/44/41/WJCO-8-37.PMC5309713.pdf
"Available from: URL: https://clinicaltrials.gov/ct2/ show/NCT02625623 59 EMD Serono Research & Development Institute, Inc .",Non-OADS,/arxiv_data1/oa_pdf/44/41/WJCO-8-37.PMC5309713.pdf
"Available from: URL: https://clinicaltrials.gov/ct2/ show/NCT02576574 60 EMD Serono Research & Development Institute, Inc .",Non-OADS,/arxiv_data1/oa_pdf/44/41/WJCO-8-37.PMC5309713.pdf
Available from: URL: https://clinicaltrials.gov/ct2/show/ NCT02302807 63 Hoffmann-La Roche .,Non-OADS,/arxiv_data1/oa_pdf/44/41/WJCO-8-37.PMC5309713.pdf
Available from: URL:  https://clinicaltrials.gov/ct2/show/NCT02807636  64 Hoffmann-La Roche .,Non-OADS,/arxiv_data1/oa_pdf/44/41/WJCO-8-37.PMC5309713.pdf
Available from: URL: https://clinicaltrials.gov/ct2/ show/NCT02813785  68 Hoffmann-La Roche .,Non-OADS,/arxiv_data1/oa_pdf/44/41/WJCO-8-37.PMC5309713.pdf
Available  from: URL: https://clinicaltrials.gov/ct2/show/NCT02367781  69 Hoffmann-La Roche .,Non-OADS,/arxiv_data1/oa_pdf/44/41/WJCO-8-37.PMC5309713.pdf
Available from: URL: https://clinicaltrials.gov/ ct2/show/NCT02366143  70 Hoffmann-La Roche .,Non-OADS,/arxiv_data1/oa_pdf/44/41/WJCO-8-37.PMC5309713.pdf
Available from: URL: https://clinicaltrials.gov/ct2/ show/NCT02425891  71 Hoffmann-La Roche .,Non-OADS,/arxiv_data1/oa_pdf/44/41/WJCO-8-37.PMC5309713.pdf
Available from: URL: https://clinicaltrials.gov/ct2/ show/NCT02420821 72 Hoffmann-La Roche .,Non-OADS,/arxiv_data1/oa_pdf/44/41/WJCO-8-37.PMC5309713.pdf
Available from: URL: https://clinicaltrials.gov/ct2/show/ NCT02763579  73 Hoffmann-La Roche .,Non-OADS,/arxiv_data1/oa_pdf/44/41/WJCO-8-37.PMC5309713.pdf
Available from: URL: https://clinicaltrials.gov/ct2/ show/NCT02551159  75 AstraZeneca .,Non-OADS,/arxiv_data1/oa_pdf/44/41/WJCO-8-37.PMC5309713.pdf
Available from: URL: https://clinicaltrials.gov/ct2/show/ NCT02453282 76 AstraZeneca .,Non-OADS,/arxiv_data1/oa_pdf/44/41/WJCO-8-37.PMC5309713.pdf
Available from: URL: https://clinicaltrials.gov/ct2/ show/NCT02516241 77 Southwest Oncology Group .,Non-OADS,/arxiv_data1/oa_pdf/44/41/WJCO-8-37.PMC5309713.pdf
Available  from: URL: https://clinicaltrials.gov/ct2/show/NCT02154490  78 AstraZeneca .,Non-OADS,/arxiv_data1/oa_pdf/44/41/WJCO-8-37.PMC5309713.pdf
Available from: URL: https://clinicaltrials.gov/ct2/show/ NCT02454933 79 AstraZeneca .,Non-OADS,/arxiv_data1/oa_pdf/44/41/WJCO-8-37.PMC5309713.pdf
Available from:  URL: https://clinicaltrials.gov/ct2/show/N CT02369874 80 AstraZeneca .,Non-OADS,/arxiv_data1/oa_pdf/44/41/WJCO-8-37.PMC5309713.pdf
Available from: URL:  https://clinicaltrials.gov/ct2/show/NCT02542293  81 AstraZeneca .,Non-OADS,/arxiv_data1/oa_pdf/44/41/WJCO-8-37.PMC5309713.pdf
Available from: URL: https://clinicaltrials.gov/ct2/show/ NCT02576509 86 Ono Pharmaceutical Co. Ltd .,Non-OADS,/arxiv_data1/oa_pdf/44/41/WJCO-8-37.PMC5309713.pdf
Available from: URL: https://clinicaltrials.gov/ct2/show/ NCT02569242 87 Bristol-Myers Squibb .,Non-OADS,/arxiv_data1/oa_pdf/44/41/WJCO-8-37.PMC5309713.pdf
Available from: URL: https://clinicaltrials.gov/ct2/show/ NCT02231749  88 Bristol-Myers Squibb .,Non-OADS,/arxiv_data1/oa_pdf/44/41/WJCO-8-37.PMC5309713.pdf
Available from: URL: https://clinicaltrials.gov/ct2/ show/NCT02017717  89 Bristol-Myers Squibb .,Non-OADS,/arxiv_data1/oa_pdf/44/41/WJCO-8-37.PMC5309713.pdf
Available from: URL: https://clinicaltrials.gov/ ct2/show/NCT02477826 91 Bristol-Myers Squibb .,Non-OADS,/arxiv_data1/oa_pdf/44/41/WJCO-8-37.PMC5309713.pdf
Available from: URL: https://clinicaltrials.gov/ct2/ show/NCT02538666 92 Bristol-Myers Squibb .,Non-OADS,/arxiv_data1/oa_pdf/44/41/WJCO-8-37.PMC5309713.pdf
Available  from: URL: https://clinicaltrials.gov/ct2/show/NCT02617589  93 Bristol-Myers Squibb .,Non-OADS,/arxiv_data1/oa_pdf/44/41/WJCO-8-37.PMC5309713.pdf
Available  from: URL: https://clinicaltrials.gov/ct2/show/NCT02481830  94 Bristol-Myers Squibb .,Non-OADS,/arxiv_data1/oa_pdf/44/41/WJCO-8-37.PMC5309713.pdf
Available from: URL: https://clinicaltrials.gov/ct2/ show/NCT02613507 95 National Cancer Institute (NCI) .,Non-OADS,/arxiv_data1/oa_pdf/44/41/WJCO-8-37.PMC5309713.pdf
Available from: URL: https://clinicaltrials.gov/ct2/ show/NCT02339571 96 Bristol-Myers Squibb .,Non-OADS,/arxiv_data1/oa_pdf/44/41/WJCO-8-37.PMC5309713.pdf
"Available from: URL: https://clinicaltrials.gov/ct2/ show/NCT02599402 97 Buti S , Bersanelli M. The ‘nivolution’ in renal cell carcinoma: behind the scenes of clinical trials.",Non-OADS,/arxiv_data1/oa_pdf/44/41/WJCO-8-37.PMC5309713.pdf
"All rights reserved.Published by Baishideng Publishing Group Inc 8226 Regency Drive, Pleasanton, CA 94588, USA Telephone: +1-925-223-8242 Fax: +1-925-223-8243 E-mail: bpgoffice@wjgnet.com Help Desk: http://www.wjgnet.com/esps/helpdesk.aspx http://www.wjgnet.com",Non-OADS,/arxiv_data1/oa_pdf/44/41/WJCO-8-37.PMC5309713.pdf
"See: http://creativecommons.org/ licenses/by ­nc/4.0/Manuscript source: Invited manuscript Correspondence to:  Ruben R Gonzalez-Perez, PhD,  Department of Microbiology, Biochemistry, and Immunology,  Morehouse School of Medicine, 720 Westview Drive, Hugh  Gloster Suite 329, Atlanta, GA 30310,  United States.",Non-OADS,/arxiv_data1/oa_pdf/55/c4/WJCO-8-54.PMC5309714.pdf
Doses of the chemotherapeutics [cisplatin World Journal of Clinical Oncology WJCO Submit a Manuscript: http://www.wjgnet.com/esps/ Help Desk: http://www.wjgnet.com/esps/helpdesk.aspx DOI: 10.5306/wjco.v8.i1.54World J Clin Oncol  2017 February 10; 8(1): 54-66 ISSN 2218-4333 (online) © 2017 Baishideng Publishing Group Inc. All rights reserved.,Non-OADS,/arxiv_data1/oa_pdf/55/c4/WJCO-8-54.PMC5309714.pdf
wjgnet.com/ 2218 ­4333 /full/v8/i1/54.htm  DOI: http://dx.doi.,OADS,/arxiv_data1/oa_pdf/55/c4/WJCO-8-54.PMC5309714.pdf
"Available from: URL:  http://www.cancer.org/Cancer/BreastCancer/DetailedGuide/breast ­ cancer ­key­statistics 2 Chavez KJ , Garimella SV , Lipkowitz S. Triple negative breast cancer  cell lines: one tool in the search for better treatment of triple negative  breast cancer.",Non-OADS,/arxiv_data1/oa_pdf/55/c4/WJCO-8-54.PMC5309714.pdf
"All rights reserved.Published by Baishideng Publishing Group Inc 8226 Regency Drive, Pleasanton, CA 94588, USA Telephone: +1-925-223-8242 Fax: +1-925-223-8243 E-mail: bpgoffice@wjgnet.com Help Desk: http://www.wjgnet.com/esps/helpdesk.aspx http://www.wjgnet.com",Non-OADS,/arxiv_data1/oa_pdf/55/c4/WJCO-8-54.PMC5309714.pdf
"See: http://creativecommons.org/ licenses/by-nc/4.0/ Manuscript source:  Invited manuscript Correspondence to: Cathy Mitchelmore, PhD, Associate  Professor, Department of Science and Environment, Roskilde  University, Universitetsvej 1, Postbox 260, 4000 Roskilde,  Denmark.",Non-OADS,/arxiv_data1/oa_pdf/5e/fe/WJCO-8-67.PMC5309715.pdf
"In contrast, the MYC  gene was amplified in one cell line and in more than  40% of the CRC cas es.World Journal of Clinical Oncology WJCO Submit a Manuscript: http://www.wjgnet.com/esps/ Help Desk: http://www.wjgnet.com/esps/helpdesk.aspx DOI: 10.5306/wjco.v8.i1.67World J Clin Oncol  2017 February 10; 8(1): 67-74 ISSN 2218-4333 (online) © 2017 Baishideng Publishing Group Inc. All rights reserved.",Non-OADS,/arxiv_data1/oa_pdf/5e/fe/WJCO-8-67.PMC5309715.pdf
World J Clin Oncol   2017; 8(1): 67-74  Available from: URL:  http://www.wjgnet.,Non-OADS,/arxiv_data1/oa_pdf/5e/fe/WJCO-8-67.PMC5309715.pdf
com/ 2218-4333 /full/v8/i1/67.htm  DOI: http://dx.doi.org/ 10.5306/wjco.v8.i1.67 INTRODUCTION N-myc downstream regulated gene 2 ( NDRG2 )  is one of four genes belonging to the NDRG  gene  family.,Non-OADS,/arxiv_data1/oa_pdf/5e/fe/WJCO-8-67.PMC5309715.pdf
"All rights reserved.Published by Baishideng Publishing Group Inc 8226 Regency Drive, Pleasanton, CA 94588, USA Telephone: +1-925-223-8242 Fax: +1-925-223-8243 E-mail: bpgoffice@wjgnet.com Help Desk: http://www.wjgnet.com/esps/helpdesk.aspx http://www.wjgnet.com",Non-OADS,/arxiv_data1/oa_pdf/5e/fe/WJCO-8-67.PMC5309715.pdf
"See: http://creativecommons.org/ licenses/by-nc/4.0/ Manuscript source: Invited manuscript Correspondence to: Salimah H Meghani, PhD, MBE, RN,  FAAN, Associate Professor, Department of Biobehavioral Health Sciences, NewCourtland Center for Transitions and  Health, Leonard Davis Institute of Health Economics, University  of Pennsylvania, Claire M. Fagin Hall 418 Curie Boulevard,  Room 337, Philadelphia, PA 19104-4217,  United States.",Non-OADS,/arxiv_data1/oa_pdf/0d/d7/WJCO-8-75.PMC5309716.pdf
Multiple logistic  regression was used to identify predictors of cluster World Journal of Clinical Oncology WJCO Submit a Manuscript: http://www.wjgnet.com/esps/ Help Desk: http://www.wjgnet.com/esps/helpdesk.aspx DOI: 10.5306/wjco.v8.i1.75World J Clin Oncol  2017 February 10; 8(1): 75-85 ISSN 2218-4333 (online) © 2017 Baishideng Publishing Group Inc. All rights reserved.,Non-OADS,/arxiv_data1/oa_pdf/0d/d7/WJCO-8-75.PMC5309716.pdf
wjgnet.com/ 2218-4333 /full/v8/i1/75.htm  DOI: http://dx.doi.,OADS,/arxiv_data1/oa_pdf/0d/d7/WJCO-8-75.PMC5309716.pdf
"Available  from: URL: https://www.asco.org/advocacy-policy/asco-in-action/ asco-releases-principles-balancing-appropriate-patient-access 3 Paice JA , Lacchetti C, Bruera E. Management of Chronic Pain  in Survivors of Adult Cancers: ASCO Clinical Practice Guideline  Summary.",Non-OADS,/arxiv_data1/oa_pdf/0d/d7/WJCO-8-75.PMC5309716.pdf
"All rights reserved.Published by Baishideng Publishing Group Inc 8226 Regency Drive, Pleasanton, CA 94588, USA Telephone: +1-925-223-8242 Fax: +1-925-223-8243 E-mail: bpgoffice@wjgnet.com Help Desk: http://www.wjgnet.com/esps/helpdesk.aspx http://www.wjgnet.com",Non-OADS,/arxiv_data1/oa_pdf/0d/d7/WJCO-8-75.PMC5309716.pdf
"See: http://creativecommons.org/ licenses/by-nc/4.0/ Manuscript source: Invited manuscript Correspondence to: Rosalie A Machado, Research Associate,  Thyroid Head and Neck Cancer Foundation, 10 Union Square E,  New York, NY 10003,  United States.",Non-OADS,/arxiv_data1/oa_pdf/f1/79/WJCO-8-86.PMC5309717.pdf
Hemifacial spasm has not been  reported in association with a malignant parotid tumor  but must be considered in the differential diagnosis of World Journal of Clinical Oncology WJCO Submit a Manuscript: http://www.wjgnet.com/esps/ Help Desk: http://www.wjgnet.com/esps/helpdesk.aspx DOI: 10.5306/wjco.v8.i1.86World J Clin Oncol  2017 February 10; 8(1): 86-90 ISSN 2218-4333 (online) © 2017 Baishideng Publishing Group Inc. All rights reserved.,Non-OADS,/arxiv_data1/oa_pdf/f1/79/WJCO-8-86.PMC5309717.pdf
wjgnet.com/ 2218-4333 /full/v8/i1/86.htm  DOI: http://dx.doi.,OADS,/arxiv_data1/oa_pdf/f1/79/WJCO-8-86.PMC5309717.pdf
"All rights reserved.Published by Baishideng Publishing Group Inc 8226 Regency Drive, Pleasanton, CA 94588, USA Telephone: +1-925-223-8242 Fax: +1-925-223-8243 E-mail: bpgoffice@wjgnet.com Help Desk: http://www.wjgnet.com/esps/helpdesk.aspx http://www.wjgnet.com",Non-OADS,/arxiv_data1/oa_pdf/f1/79/WJCO-8-86.PMC5309717.pdf
"See: http://creativecommons.org/ licenses/by-nc/4.0/ Manuscript source:  Invited manuscript Correspondence to:  Dr. Nicolas Williet, MD, Department of  Gastroenterology, University Hospital of Saint Etienne, Avenue  Albert Raimond, 4 2270 Saint-Priest en Jarez,  France.",Non-OADS,/arxiv_data1/oa_pdf/b6/b8/WJCO-8-91.PMC5309718.pdf
"In order to document the  difficulty of this diagnosis, characteristics of 63 patients  suffering from this condition  and diagnosis were World Journal of Clinical Oncology WJCO Submit a Manuscript: http://www.wjgnet.com/esps/ Help Desk: http://www.wjgnet.com/esps/helpdesk.aspx DOI: 10.5306/wjco.v8.i1.91World J Clin Oncol  2017 February 10; 8(1): 91-95 ISSN 2218-4333 (online) © 2017 Baishideng Publishing Group Inc. All rights reserved.",Non-OADS,/arxiv_data1/oa_pdf/b6/b8/WJCO-8-91.PMC5309718.pdf
World J Clin Oncol  2017; 8(1): 91-95  Available  from: URL:  http://www.wjgnet.com/ 2218-4333 /full/v8/i1/91.htm   DOI: http://dx.doi.org/10.5306/wjco.v8.i1.91 INTRODUCTION Here we describe the case of a pancreatic plasma­ cytoma and difficulties to establish the diagnosis.,Non-OADS,/arxiv_data1/oa_pdf/b6/b8/WJCO-8-91.PMC5309718.pdf
"All rights reserved.Published by Baishideng Publishing Group Inc 8226 Regency Drive, Pleasanton, CA 94588, USA Telephone: +1-925-223-8242 Fax: +1-925-223-8243 E-mail: bpgoffice@wjgnet.com Help Desk: http://www.wjgnet.com/esps/helpdesk.aspx http://www.wjgnet.com",Non-OADS,/arxiv_data1/oa_pdf/b6/b8/WJCO-8-91.PMC5309718.pdf
"To view a copy  of this license, visit http://creativecommons.org/licenses/ by-nc-nd/3.0/ © The Author(s) 2017",Non-OADS,/arxiv_data1/oa_pdf/ad/c7/aps2016125a.PMC5309756.pdf
"This is an Open Access article distributed under the terms of th e Creative Commons Attribution-NonCommercial-NoDerivatives License (http://creativecommons.org/licenses/by-nc-nd/4.0/), which permits non-commercial re- use, distribution, and reproduction in any medium, provided the original work is properly cited, and is not altered, transformed, or built upon in any way.EUROPEAN JOURNAL OF PHYSIOTHERAPY, 2016 VOL.",Non-OADS,/arxiv_data1/oa_pdf/91/02/iejp-18-218.PMC5309865.pdf
"4, 218–225http://dx.doi.org/10.1080/21679169.2016.1181208",Non-OADS,/arxiv_data1/oa_pdf/91/02/iejp-18-218.PMC5309865.pdf
Available from http://www.va.gov/ health/NewsFeatures/20110321a.asp.,Non-OADS,/arxiv_data1/oa_pdf/70/fd/17.PMC5309901.pdf
Available from http://www.ncbi.nlm.nih.,Non-OADS,/arxiv_data1/oa_pdf/70/fd/17.PMC5309901.pdf
Available from http://www.idf.org/global-   guideline-type-2-diabetes-2012.,Non-OADS,/arxiv_data1/oa_pdf/70/fd/17.PMC5309901.pdf
Available from https://www.regulations.,Non-OADS,/arxiv_data1/oa_pdf/70/fd/17.PMC5309901.pdf
Resources  are available at http://www.obesity,Non-OADS,/arxiv_data1/oa_pdf/41/df/11.PMC5309902.pdf
Available from http://sixuntilme.com/wp.,Non-OADS,/arxiv_data1/oa_pdf/41/df/11.PMC5309902.pdf
Available  from http://diabetes.diabetesjournals.org/site/misc/ifora.xhtml.,Non-OADS,/arxiv_data1/oa_pdf/41/df/11.PMC5309902.pdf
Available  from http://www.sagepub.com/journals/ Journal201731/manuscriptSubmission.,Non-OADS,/arxiv_data1/oa_pdf/41/df/11.PMC5309902.pdf
Available from http://www.merriam-  webster.com/dictionary/control.,Non-OADS,/arxiv_data1/oa_pdf/41/df/11.PMC5309902.pdf
Available  from http://www.phac-aspc.gc.ca/cd-mc/diabetes-diabete/dic-dac-99/index-eng.php.,Non-OADS,/arxiv_data1/oa_pdf/a0/42/43.PMC5309903.pdf
Available from http://saxinstitute.org.au/wp-content/uploads/Guidelines-for-authors-regarding-technical-review-of-45-and-Up-Study-papers.pdf.,Non-OADS,/arxiv_data1/oa_pdf/a0/42/43.PMC5309903.pdf
Available  from https://www.saxinstitute.org.au/our-work/45-up-study/questionnaires.,Non-OADS,/arxiv_data1/oa_pdf/a0/42/43.PMC5309903.pdf
Available from  https://www.idf.org/sites/default/files/ EN_6E_Atlas_Full_0.pdf.,Non-OADS,/arxiv_data1/oa_pdf/cd/86/23.PMC5309904.pdf
Available from https://www.diabetes.org.,Non-OADS,/arxiv_data1/oa_pdf/cd/86/23.PMC5309904.pdf
Available from http://www.hscic.gov.uk/catalogue/PUB16496/nati-diab-audi-12-13-rep2.pdf.,Non-OADS,/arxiv_data1/oa_pdf/cd/86/23.PMC5309904.pdf
Available from https://www.diabetes.org.uk/About_us/News_Landing_Page/2007/April/Diabetes-services-still-failing-children-and- young-people.,Non-OADS,/arxiv_data1/oa_pdf/cd/86/23.PMC5309904.pdf
Available from http://www.yhpho.org.uk/resource/view.aspx?RID=8872.,Non-OADS,/arxiv_data1/oa_pdf/cd/86/23.PMC5309904.pdf
Available from https://www.nice.org.uk/guidance/ng18/resources/diabetes-type-1-and-type-2-in-children- and-young-people-diagnosis-and-manage - ment-1837278149317.,Non-OADS,/arxiv_data1/oa_pdf/cd/86/23.PMC5309904.pdf
"U.K., 2010 Available from http://webarchive.national   archives.gov.uk/20130107105354/http:/www.dh.gov.uk/prod_consum_dh/groups/ dh_digitalassets/@dh/@en/@ps/documents/ digitalasset/dh_112511.pdf.",OADS,/arxiv_data1/oa_pdf/cd/86/23.PMC5309904.pdf
Available from https://www.gov.uk/government/uploads/system/uploads/ attachment_data/file/198836/National_ Service_Framework_for_Diabetes.pdf.,Non-OADS,/arxiv_data1/oa_pdf/cd/86/23.PMC5309904.pdf
Available from  https://www.england.nhs.uk/wp-content/ uploads/2016/01/diabetes-transition-   service-specification.pdf.,Non-OADS,/arxiv_data1/oa_pdf/cd/86/23.PMC5309904.pdf
Available from http://www.apho.org.uk/resource/view.aspx?RID=50215   &SEARCH=sunderland&SPEAR.,Non-OADS,/arxiv_data1/oa_pdf/cd/86/23.PMC5309904.pdf
A webcast of this speech is available for viewing at the ADA  website (http://professional.diabetes.org/search/site?f%5B0%5D=im_field_ dbp_ct%3A7&f%5B1%5D=sm_field_wcast_mname%3Anode%3A120& retain-filters=1).,Non-OADS,/arxiv_data1/oa_pdf/41/2d/58.PMC5309906.pdf
Available from http://www.diabetes.org/collab/team-tackle.,Non-OADS,/arxiv_data1/oa_pdf/7d/3e/51.PMC5309907.pdf
Available from  http://www.healthindicators.gov/Indicators/ Diabetesmanagement-benefit-use-diabetic-older-adultspercent_1263/Profile/ClassicData.,Non-OADS,/arxiv_data1/oa_pdf/7d/3e/51.PMC5309907.pdf
Available from https://www.medicare.gov/coverage/   diabetes-self-mgmt-training.html.,Non-OADS,/arxiv_data1/oa_pdf/7d/3e/51.PMC5309907.pdf
Available   from https://www.medicare.gov/coverage/   nutrition-therapy-services.html.,Non-OADS,/arxiv_data1/oa_pdf/7d/3e/51.PMC5309907.pdf
See http://creativecommons.org/licenses/by-nc-nd/3.0 for details.■ ABSTRACT Risky behavior is often at its lifetime peak in adolescence.,Non-OADS,/arxiv_data1/oa_pdf/24/18/3.PMC5309908.pdf
Available from http://www.cdc.gov/healthyyouth/data/yrbs/index.htm.,OADS,/arxiv_data1/oa_pdf/24/18/3.PMC5309908.pdf
Foreign http://dx.doi.org/10.1016/j.gore.2017.01.005 2352-5789/© 2017 The Author(s).,Non-OADS,/arxiv_data1/oa_pdf/da/42/main.PMC5310111.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/da/42/main.PMC5310111.pdf
"The current pop- ulation of Liberia is approximately 4.6Million with almost 1.3M of its population residing in the capital Monrovia ( http://data.un.org/ CountryPro ﬁle.aspx?crName=liberia ).In 1961 the President of Liberia, William Tubman visited US Presi- dent John F. Kennedy.",Non-OADS,/arxiv_data1/oa_pdf/da/42/main.PMC5310111.pdf
"As of 2013 b25% of all births and b5% of deaths were registered in Liberia (http://data.un.org/CountryPro ﬁle.aspx?crName=liberia; Toivanen et al., 2011 ).",OADS,/arxiv_data1/oa_pdf/da/42/main.PMC5310111.pdf
"Beddoe AM, Trends in Cervical Cancer Presentation and Treatment in Liberia (unpub- lished data) http://data.un.org/CountryPro ﬁle.aspx?crName=liberia .",OADS,/arxiv_data1/oa_pdf/da/42/main.PMC5310111.pdf
"Note: Lane1-control DNA and Lane2-SNP+DNA.Saudi Pharmaceutical Journal (2017) 25, 148 King Saud University Saudi Pharmaceutical Journal www.ksu.edu.sa www.sciencedirect.com http://dx.doi.org/10.1016/j.jsps.2016.03.001 1319-0164 /C2112016 The Authors.",Non-OADS,/arxiv_data1/oa_pdf/1e/2c/main.PMC5310134.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/1e/2c/main.PMC5310134.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/2e/7e/main.PMC5310135.pdf
"Production and hosting by ElsevierSaudi Pharmaceutical Journal (2017) 25, 83–87 King Saud University Saudi Pharmaceutical Journal www.ksu.edu.sa www.sciencedirect.com http://dx.doi.org/10.1016/j.jsps.2016.01.001 1319-0164 /C2112016 The Authors.",Non-OADS,/arxiv_data1/oa_pdf/2e/7e/main.PMC5310135.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/2e/7e/main.PMC5310135.pdf
http://dx.doi.org/10.1177/ 1049909113489874 .,Non-OADS,/arxiv_data1/oa_pdf/2e/7e/main.PMC5310135.pdf
http://dx.doi.org/10.1093/annonc/mds094 .,Non-OADS,/arxiv_data1/oa_pdf/2e/7e/main.PMC5310135.pdf
"Malar J 8, 2. http://dx.doi.org/10.1186/1475-2875- 8-2.",Non-OADS,/arxiv_data1/oa_pdf/2e/7e/main.PMC5310135.pdf
http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/2e/7e/main.PMC5310135.pdf
Retrieved 14th May 2015 from < http://www.nhsq.info/strategy-goals-and-projects/national-cancer-strat- egy/national-cancer-strategy-home >.,Non-OADS,/arxiv_data1/oa_pdf/2e/7e/main.PMC5310135.pdf
Retrieved 14th May 2015 from < http://www.nhsq.info >.,Non-OADS,/arxiv_data1/oa_pdf/2e/7e/main.PMC5310135.pdf
http://dx.doi.org/10.1016/ j.clinepi.2004.10.012 .,OADS,/arxiv_data1/oa_pdf/2e/7e/main.PMC5310135.pdf
Retrieved 14th May from < http://apps.who.,Non-OADS,/arxiv_data1/oa_pdf/2e/7e/main.PMC5310135.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/3a/08/main.PMC5310136.pdf
"Production and hosting by ElsevierSaudi Pharmaceutical Journal (2017) 25, 136–140 King Saud University Saudi Pharmaceutical Journal www.ksu.edu.sa www.sciencedirect.com http://dx.doi.org/10.1016/j.jsps.2015.06.007 1319-0164 ª2015 The Authors.",Non-OADS,/arxiv_data1/oa_pdf/3a/08/main.PMC5310136.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/3a/08/main.PMC5310136.pdf
"Production and hosting by ElsevierSaudi Pharmaceutical Journal (2017) 25, 128–135 King Saud University Saudi Pharmaceutical Journal www.ksu.edu.sa www.sciencedirect.com http://dx.doi.org/10.1016/j.jsps.2016.05.008 1319-0164 /C2112016 The Authors.",Non-OADS,/arxiv_data1/oa_pdf/be/de/main.PMC5310137.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/be/de/main.PMC5310137.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/be/de/main.PMC5310137.pdf
"Production and hosting by ElsevierSaudi Pharmaceutical Journal (2017) 25, 52–58 King Saud University Saudi Pharmaceutical Journal www.ksu.edu.sa www.sciencedirect.com http://dx.doi.org/10.1016/j.jsps.2015.06.012 1319-0164 ª2015 The Authors.",Non-OADS,/arxiv_data1/oa_pdf/72/32/main.PMC5310138.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/72/32/main.PMC5310138.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/72/32/main.PMC5310138.pdf
Institute for Healthcare Improvement Available: < http://www.ihi.org/resources/ Pages/Tools/MedicationReconciliationReview.aspx > (accessed 25.02.15).Whose responsibility is medication reconciliation 57,Non-OADS,/arxiv_data1/oa_pdf/72/32/main.PMC5310138.pdf
Available: <http://www.ismp.org/survey/survey200604.asp > (accessed 09.12.13).,OADS,/arxiv_data1/oa_pdf/72/32/main.PMC5310138.pdf
Available: < http://www.jointcommission.org/assets/1/ 18/SEA_35.pdf > (accessed 25.02.15).,OADS,/arxiv_data1/oa_pdf/72/32/main.PMC5310138.pdf
< http://ezproxy.squ.edu.,Non-OADS,/arxiv_data1/oa_pdf/72/32/main.PMC5310138.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/73/d6/main.PMC5310139.pdf
"Production and hosting by ElsevierSaudi Pharmaceutical Journal (2017) 25, 141–143 King Saud University Saudi Pharmaceutical Journal www.ksu.edu.sa www.sciencedirect.com http://dx.doi.org/10.1016/j.jsps.2015.06.008 1319-0164 ª2015 The Authors.",Non-OADS,/arxiv_data1/oa_pdf/73/d6/main.PMC5310139.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/73/d6/main.PMC5310139.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/c1/73/main.PMC5310140.pdf
Contents lists available at ScienceDirect Annals of Medicine and Surgery journal homepage: www.annalsjournal.com http://dx.doi.org/10.1016/j.amsu.2017.02.002 2049-0801/ ©2017 The Author(s).,Non-OADS,/arxiv_data1/oa_pdf/c1/73/main.PMC5310140.pdf
"Today 42 (2012) 1165e1169, http://dx.doi.org/10.1007/s00595-012-0163-3 .",Non-OADS,/arxiv_data1/oa_pdf/c1/73/main.PMC5310140.pdf
"Today 46 (2016) 1318e1324, http://dx.doi.org/10.1007/s00595-016-1315-7 .",Non-OADS,/arxiv_data1/oa_pdf/c1/73/main.PMC5310140.pdf
"36 (Pt A) (2016) 319 e323, http://dx.doi.org/10.1016/j.ijsu.2016.10.025 .",OADS,/arxiv_data1/oa_pdf/c1/73/main.PMC5310140.pdf
"Today 46 (2016)1039e1044, http://dx.doi.org/10.1007/s00595-015-1273-5 .",Non-OADS,/arxiv_data1/oa_pdf/c1/73/main.PMC5310140.pdf
This  is  an  open access article  under  the  CC  BY-NC-ND  license  (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/22/25/main.PMC5310141.pdf
http://dx.doi.org/10.1016/j.ijscr.2017.01.062 2210-2612/© 2017  The  Authors.,Non-OADS,/arxiv_data1/oa_pdf/22/25/main.PMC5310141.pdf
"Production and hosting by ElsevierSaudi Pharmaceutical Journal (2017) 25, 88–92 King Saud University Saudi Pharmaceutical Journal www.ksu.edu.sa www.sciencedirect.com http://dx.doi.org/10.1016/j.jsps.2016.02.001 1319-0164 /C2112016 The Authors.",Non-OADS,/arxiv_data1/oa_pdf/8c/22/main.PMC5310142.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/8c/22/main.PMC5310142.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/8c/22/main.PMC5310142.pdf
"Production and hosting by ElsevierSaudi Pharmaceutical Journal (2017) 25, 93–98 King Saud University Saudi Pharmaceutical Journal www.ksu.edu.sa www.sciencedirect.com http://dx.doi.org/10.1016/j.jsps.2016.02.002 1319-0164 /C2112016 The Authors.",Non-OADS,/arxiv_data1/oa_pdf/b2/17/main.PMC5310143.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/b2/17/main.PMC5310143.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/b2/17/main.PMC5310143.pdf
Available from: < http://www.health.nsw.gov.au/sabs/Docu- ments/2014-sn-002.pdf >.,Non-OADS,/arxiv_data1/oa_pdf/b2/17/main.PMC5310143.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/13/e1/main.PMC5310145.pdf
"Production and hosting by ElsevierSaudi Pharmaceutical Journal (2017) 25, 25–31 King Saud University Saudi Pharmaceutical Journal www.ksu.edu.sa www.sciencedirect.com http://dx.doi.org/10.1016/j.jsps.2016.04.027 1319-0164 /C2112016 The Authors.",Non-OADS,/arxiv_data1/oa_pdf/13/e1/main.PMC5310145.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/13/e1/main.PMC5310145.pdf
"Up till now, more than 1165 types of salivary proteins have been identiﬁed and reported inhuman salivary proteome central depository ( http://www.skb.",Non-OADS,/arxiv_data1/oa_pdf/13/e1/main.PMC5310145.pdf
60. http://dx.doi.org/10.1016/j.jpor.2016.03.006 (E-pub ahead of print).,OADS,/arxiv_data1/oa_pdf/13/e1/main.PMC5310145.pdf
J.http://dx.doi.org/10.2174/1874210601610010060 (E-pub ahead of print).,Non-OADS,/arxiv_data1/oa_pdf/13/e1/main.PMC5310145.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/7d/a3/main.PMC5310147.pdf
"Production and hosting by ElsevierSaudi Pharmaceutical Journal (2017) 25, 32–43 King Saud University Saudi Pharmaceutical Journal www.ksu.edu.sa www.sciencedirect.com http://dx.doi.org/10.1016/j.jsps.2015.06.003 1319-0164 ª2015 The Authors.",Non-OADS,/arxiv_data1/oa_pdf/7d/a3/main.PMC5310147.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/7d/a3/main.PMC5310147.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/30/c1/main.PMC5310148.pdf
"Production and hosting by ElsevierSaudi Pharmaceutical Journal (2017) 25, 59–69 King Saud University Saudi Pharmaceutical Journal www.ksu.edu.sa www.sciencedirect.com http://dx.doi.org/10.1016/j.jsps.2015.07.001 1319-0164 ª2015 Production and hosting by Elsevier B.V. on behalf of King Saud University.",Non-OADS,/arxiv_data1/oa_pdf/30/c1/main.PMC5310148.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/30/c1/main.PMC5310148.pdf
"Production and hosting by ElsevierSaudi Pharmaceutical Journal (2017) 25, 76–82 King Saud University Saudi Pharmaceutical Journal www.ksu.edu.sa www.sciencedirect.com http://dx.doi.org/10.1016/j.jsps.2015.12.001 1319-0164 /C2112016 Production and hosting by Elsevier B.V. on behalf of King Saud University.",Non-OADS,/arxiv_data1/oa_pdf/7c/73/main.PMC5310150.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/7c/73/main.PMC5310150.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/7c/73/main.PMC5310150.pdf
< http://www.who.int/inﬂuen- za/vaccines/SAGE_information/en/ > (Accessed 20 March 2013).,Non-OADS,/arxiv_data1/oa_pdf/7c/73/main.PMC5310150.pdf
< http://www.who.int/immunization/sage/ 1_WHA56_19_Prevention_and_control_of_inﬂuenza_pandemics.pdf>.,Non-OADS,/arxiv_data1/oa_pdf/7c/73/main.PMC5310150.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/4d/a2/main.PMC5310151.pdf
"Production and hosting by ElsevierSaudi Pharmaceutical Journal (2017) 25, 104–109 King Saud University Saudi Pharmaceutical Journal www.ksu.edu.sa www.sciencedirect.com http://dx.doi.org/10.1016/j.jsps.2016.05.004 1319-0164 /C2112016 The Authors.",Non-OADS,/arxiv_data1/oa_pdf/4d/a2/main.PMC5310151.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/4d/a2/main.PMC5310151.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/81/f3/main.PMC5310152.pdf
"Production and hosting by ElsevierSaudi Pharmaceutical Journal (2017) 25, 120–127 King Saud University Saudi Pharmaceutical Journal www.ksu.edu.sa www.sciencedirect.com http://dx.doi.org/10.1016/j.jsps.2016.05.007 1319-0164 /C2112016 The Authors.",Non-OADS,/arxiv_data1/oa_pdf/81/f3/main.PMC5310152.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/81/f3/main.PMC5310152.pdf
924860. http://dx.doi.org/10.1155/2015/924860 .,Non-OADS,/arxiv_data1/oa_pdf/81/f3/main.PMC5310152.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/f5/3e/main.PMC5310153.pdf
"Production and hosting by Elsevier1Precedex /C210, Hospira Inc., Lake Forest, IL, USA.Saudi Pharmaceutical Journal (2017) 25, 144–147 King Saud University Saudi Pharmaceutical Journal www.ksu.edu.sa www.sciencedirect.com http://dx.doi.org/10.1016/j.jsps.2016.01.002 1319-0164 /C2112016 The Authors.",Non-OADS,/arxiv_data1/oa_pdf/f5/3e/main.PMC5310153.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/f5/3e/main.PMC5310153.pdf
"Production and hosting by ElsevierSaudi Pharmaceutical Journal (2017) 25, 44–51 King Saud University Saudi Pharmaceutical Journal www.ksu.edu.sa www.sciencedirect.com http://dx.doi.org/10.1016/j.jsps.2015.06.011 1319-0164 ª2015 The Authors.",Non-OADS,/arxiv_data1/oa_pdf/19/6a/main.PMC5310154.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/19/6a/main.PMC5310154.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/19/6a/main.PMC5310154.pdf
doi: http://dx.doi.org/10.1016/j.saa.,OADS,/arxiv_data1/oa_pdf/19/6a/main.PMC5310154.pdf
e00245 http://dx.doi.org/10.1016/j.heliyon.2017.e00245 2405-8440/© 2017 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/1a/23/main.PMC5310155.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/1a/23/main.PMC5310155.pdf
"In the post-HAART era, the frequency of Article No~e00245 2 http://dx.doi.org/10.1016/j.heliyon.2017.e00245 2405-8440/© 2017 The Authors.",Non-OADS,/arxiv_data1/oa_pdf/1a/23/main.PMC5310155.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/1a/23/main.PMC5310155.pdf
"Stimulated astrocytes specifically release large amounts of HMGB1, and in neuroblastoma cells stimulated with retinoic acid HMGB1 is accumulated in a Article No~e00245 3 http://dx.doi.org/10.1016/j.heliyon.2017.e00245 2405-8440/© 2017 The Authors.",Non-OADS,/arxiv_data1/oa_pdf/1a/23/main.PMC5310155.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/1a/23/main.PMC5310155.pdf
"According to the American Academy of Neurology (AAN) 2007 revised criteria [29], the two most frequent categories of impairment are ANI (asymptomatic neurocognitive impairment involving at least two cognitive domains without Article No~e00245 4 http://dx.doi.org/10.1016/j.heliyon.2017.e00245 2405-8440/© 2017 The Authors.",Non-OADS,/arxiv_data1/oa_pdf/1a/23/main.PMC5310155.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/1a/23/main.PMC5310155.pdf
Article No~e00245 5 http://dx.doi.org/10.1016/j.heliyon.2017.e00245 2405-8440/© 2017 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/1a/23/main.PMC5310155.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/1a/23/main.PMC5310155.pdf
HIV-1 DNA was determined by a modified version of the Amplicor HIV-1 Monitor test (version1.5 Roche Diagnostics) with an internalHIV-1 DNA standard provided by Roche Laboratories (limit detection of Article No~e00245 6 http://dx.doi.org/10.1016/j.heliyon.2017.e00245 2405-8440/© 2017 The Authors.,OADS,/arxiv_data1/oa_pdf/1a/23/main.PMC5310155.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/1a/23/main.PMC5310155.pdf
"Thus, CSF andserum samples were treated with 1.5 M Glycine and further diluted with 1.5 M Article No~e00245 7 http://dx.doi.org/10.1016/j.heliyon.2017.e00245 2405-8440/© 2017 The Authors.",Non-OADS,/arxiv_data1/oa_pdf/1a/23/main.PMC5310155.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/1a/23/main.PMC5310155.pdf
The 30 patients diagnosed Article No~e00245 8 http://dx.doi.org/10.1016/j.heliyon.2017.e00245 2405-8440/© 2017 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/1a/23/main.PMC5310155.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/1a/23/main.PMC5310155.pdf
Article No~e00245 9 http://dx.doi.org/10.1016/j.heliyon.2017.e00245 2405-8440/© 2017 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/1a/23/main.PMC5310155.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/1a/23/main.PMC5310155.pdf
None of the patients with Article No~e00245 10 http://dx.doi.org/10.1016/j.heliyon.2017.e00245 2405-8440/© 2017 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/1a/23/main.PMC5310155.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/1a/23/main.PMC5310155.pdf
Article No~e00245 11 http://dx.doi.org/10.1016/j.heliyon.2017.e00245 2405-8440/© 2017 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/1a/23/main.PMC5310155.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/1a/23/main.PMC5310155.pdf
Article No~e00245 12 http://dx.doi.org/10.1016/j.heliyon.2017.e00245 2405-8440/© 2017 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/1a/23/main.PMC5310155.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/1a/23/main.PMC5310155.pdf
Article No~e00245 13 http://dx.doi.org/10.1016/j.heliyon.2017.e00245 2405-8440/© 2017 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/1a/23/main.PMC5310155.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/1a/23/main.PMC5310155.pdf
Article No~e00245 14 http://dx.doi.org/10.1016/j.heliyon.2017.e00245 2405-8440/© 2017 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/1a/23/main.PMC5310155.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/1a/23/main.PMC5310155.pdf
Article No~e00245 15 http://dx.doi.org/10.1016/j.heliyon.2017.e00245 2405-8440/© 2017 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/1a/23/main.PMC5310155.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/1a/23/main.PMC5310155.pdf
Article No~e00245 16 http://dx.doi.org/10.1016/j.heliyon.2017.e00245 2405-8440/© 2017 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/1a/23/main.PMC5310155.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/1a/23/main.PMC5310155.pdf
"In HIV-infected patients, we found an inverse correlation between total circulating anti-HMGB1 IgG antibodies and HMGB1, Article No~e00245 17 http://dx.doi.org/10.1016/j.heliyon.2017.e00245 2405-8440/© 2017 The Authors.",Non-OADS,/arxiv_data1/oa_pdf/1a/23/main.PMC5310155.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/1a/23/main.PMC5310155.pdf
Article No~e00245 18 http://dx.doi.org/10.1016/j.heliyon.2017.e00245 2405-8440/© 2017 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/1a/23/main.PMC5310155.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/1a/23/main.PMC5310155.pdf
"Moreover, our data strongly suggest that circulating anti-HMGB1 IgG autoantibodies may beconsidered as an early clinical biomarker of the onset of HIV-associated Article No~e00245 19 http://dx.doi.org/10.1016/j.heliyon.2017.e00245 2405-8440/© 2017 The Authors.",Non-OADS,/arxiv_data1/oa_pdf/1a/23/main.PMC5310155.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/1a/23/main.PMC5310155.pdf
Article No~e00245 20 http://dx.doi.org/10.1016/j.heliyon.2017.e00245 2405-8440/© 2017 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/1a/23/main.PMC5310155.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/1a/23/main.PMC5310155.pdf
"Daar, et al., Plasma and cerebrospinal fluid biomarkers predict cerebral injury in Article No~e00245 21 http://dx.doi.org/10.1016/j.heliyon.2017.e00245 2405-8440/© 2017 The Authors.",Non-OADS,/arxiv_data1/oa_pdf/1a/23/main.PMC5310155.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/1a/23/main.PMC5310155.pdf
Article No~e00245 22 http://dx.doi.org/10.1016/j.heliyon.2017.e00245 2405-8440/© 2017 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/1a/23/main.PMC5310155.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/1a/23/main.PMC5310155.pdf
"Jarvik, et al., A multi-center 1H MRS study of the AIDS dementia complex: Article No~e00245 23 http://dx.doi.org/10.1016/j.heliyon.2017.e00245 2405-8440/© 2017 The Authors.",Non-OADS,/arxiv_data1/oa_pdf/1a/23/main.PMC5310155.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/1a/23/main.PMC5310155.pdf
Article No~e00245 24 http://dx.doi.org/10.1016/j.heliyon.2017.e00245 2405-8440/© 2017 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/1a/23/main.PMC5310155.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/1a/23/main.PMC5310155.pdf
Article No~e00245 25 http://dx.doi.org/10.1016/j.heliyon.2017.e00245 2405-8440/© 2017 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/1a/23/main.PMC5310155.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/1a/23/main.PMC5310155.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/68/b0/main.PMC5310156.pdf
"Production and hosting by ElsevierSaudi Pharmaceutical Journal (2017) 25, 70–75 King Saud University Saudi Pharmaceutical Journal www.ksu.edu.sa www.sciencedirect.com http://dx.doi.org/10.1016/j.jsps.2015.07.002 1319-0164 ª2015 Production and hosting by Elsevier B.V. on behalf of King Saud University.",Non-OADS,/arxiv_data1/oa_pdf/68/b0/main.PMC5310156.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/68/b0/main.PMC5310156.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/1d/eb/main.PMC5310157.pdf
"Production and hosting by ElsevierSaudi Pharmaceutical Journal (2017) 25,1–7 King Saud University Saudi Pharmaceutical Journal www.ksu.edu.sa www.sciencedirect.com http://dx.doi.org/10.1016/j.jsps.2015.06.009 1319-0164 ª2015 The Authors.",Non-OADS,/arxiv_data1/oa_pdf/1d/eb/main.PMC5310157.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/1d/eb/main.PMC5310157.pdf
http://dx.doi.org/10.2337/dc2309-0114 (2009 June 1).,Non-OADS,/arxiv_data1/oa_pdf/1d/eb/main.PMC5310157.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/bd/77/main.PMC5310159.pdf
"Production and hosting by ElsevierSaudi Pharmaceutical Journal (2017) 25, 99–103 King Saud University Saudi Pharmaceutical Journal www.ksu.edu.sa www.sciencedirect.com http://dx.doi.org/10.1016/j.jsps.2016.05.001 1319-0164 /C2112016 The Authors.",Non-OADS,/arxiv_data1/oa_pdf/bd/77/main.PMC5310159.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/bd/77/main.PMC5310159.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/fa/e5/main.PMC5310160.pdf
"Production and hosting by ElsevierSaudi Pharmaceutical Journal (2017) 25, 8–17 King Saud University Saudi Pharmaceutical Journal www.ksu.edu.sa www.sciencedirect.com http://dx.doi.org/10.1016/j.jsps.2015.06.010 1319-0164 ª2015 The Authors.",Non-OADS,/arxiv_data1/oa_pdf/fa/e5/main.PMC5310160.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/fa/e5/main.PMC5310160.pdf
"Production and hosting by ElsevierSaudi Pharmaceutical Journal (2017) 25, 110–119 King Saud University Saudi Pharmaceutical Journal www.ksu.edu.sa www.sciencedirect.com http://dx.doi.org/10.1016/j.jsps.2016.05.006 1319-0164 /C2112016 The Authors.",Non-OADS,/arxiv_data1/oa_pdf/77/74/main.PMC5310161.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/77/74/main.PMC5310161.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/77/74/main.PMC5310161.pdf
http://dx.doi.org/10.1016/j.gore.2016.12.011 2352-5789/© 2017 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/ae/c0/main.PMC5310162.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/ae/c0/main.PMC5310162.pdf
http://www.htt.org.za/ .,Non-OADS,/arxiv_data1/oa_pdf/ae/c0/main.PMC5310162.pdf
http://apps.who.int/iris/bitstream/10665/44776/1/ 9789241502856_eng.pdf .,Non-OADS,/arxiv_data1/oa_pdf/ae/c0/main.PMC5310162.pdf
http://apps.who.int/iris/bitstream/ 10665/94830/1/9789241548694_eng.pdf .Fig.,OADS,/arxiv_data1/oa_pdf/ae/c0/main.PMC5310162.pdf
"Lactobacilli adhere to epithe- lial cells and thus cause steric prevention of infection with undesirable http://dx.doi.org/10.1016/j.redox.2017.01.015 Received 15 January 2017; Accepted 23 January 2017⁎Correspondence to: Institut für Virologie, Department für Medizinische Mikrobiologie und Hygiene, Hermann-Herder Strasse 11, D-79104 Freiburg, Germany.",Non-OADS,/arxiv_data1/oa_pdf/f9/94/main.PMC5310163.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/BY-NC-ND/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/f9/94/main.PMC5310163.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/79/b6/main.PMC5310164.pdf
"Production and hosting by ElsevierSaudi Pharmaceutical Journal (2017) 25, 18–24 King Saud University Saudi Pharmaceutical Journal www.ksu.edu.sa www.sciencedirect.com http://dx.doi.org/10.1016/j.jsps.2016.04.024 1319-0164 /C2112016 The Author.",Non-OADS,/arxiv_data1/oa_pdf/79/b6/main.PMC5310164.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/79/b6/main.PMC5310164.pdf
"Evidence levels,based on those suggested by the Oxford Centre for Evidence- Based Medicine (Table 1 )(http://www.cebm.net/index.aspx?",Non-OADS,/arxiv_data1/oa_pdf/79/b6/main.PMC5310164.pdf
The full reference isavailable in the following website: < http://www.cebm.net/index.,Non-OADS,/arxiv_data1/oa_pdf/79/b6/main.PMC5310164.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/00/9f/main.PMC5310165.pdf
Contents lists available at ScienceDirect Annals of Medicine and Surgery journal homepage: www.annalsjournal.com http://dx.doi.org/10.1016/j.amsu.2017.01.022 2049-0801/ ©2017 The Author(s).,Non-OADS,/arxiv_data1/oa_pdf/00/9f/main.PMC5310165.pdf
This  is  an  open access article  under  the  CC  BY-NC-ND  license  (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/5a/65/main.PMC5310168.pdf
http://dx.doi.org/10.1016/j.ijscr.2017.01.065 2210-2612/© 2017  The  Authors.,Non-OADS,/arxiv_data1/oa_pdf/5a/65/main.PMC5310168.pdf
http://dx.doi.org/10.1016/j.pmedr.2017.01.011 2211-3355/© 2017 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/50/3f/main.PMC5310169.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/50/3f/main.PMC5310169.pdf
Contents lists available at ScienceDirect Preventive Medicine Reports journal homepage: http://ees.elsevier.com/pmedr,Non-OADS,/arxiv_data1/oa_pdf/50/3f/main.PMC5310169.pdf
This is a n open access article under the CC BY-NC-ND license (http://creativecommons.org /licenses/by-nc-nd/4.0/ ).Keywords: Social phobiaBottom-upTop-downCorrelation analysis Amygdala 1.,Non-OADS,/arxiv_data1/oa_pdf/22/5a/main.PMC5310170.pdf
http://dx.doi.org/10.1016/j.nicl.2017.01.020 2213-1582/© 2017 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/22/5a/main.PMC5310170.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/22/5a/main.PMC5310170.pdf
"HC were selected from a volun- teer database of the Collaborative Research Center “Fear, Anxiety, Anx- iety Disorders ” (TRR SFB 58; http://sfbtrr58.uni-muenster.de /) or wererecruited by means of ﬂyers and newspaper ads.",Non-OADS,/arxiv_data1/oa_pdf/22/5a/main.PMC5310170.pdf
"To increase signal discriminability (Dale, 1999 ), the random stimulus sequence was optimized using the “optimal sequencing ”(optseq) algorithm ( http://www.surfer.nmr.",OADS,/arxiv_data1/oa_pdf/22/5a/main.PMC5310170.pdf
http://dx.doi.org/10.1016/S1364- 6613(00)01501-1 .,OADS,/arxiv_data1/oa_pdf/22/5a/main.PMC5310170.pdf
http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/22/5a/main.PMC5310170.pdf
http://dx.doi.org/10.1177/1073858407299288 .,Non-OADS,/arxiv_data1/oa_pdf/22/5a/main.PMC5310170.pdf
133 (1):1 –24.http://dx.doi.org/10.1037/0033- 2909.133.1.1 .,Non-OADS,/arxiv_data1/oa_pdf/22/5a/main.PMC5310170.pdf
http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/22/5a/main.PMC5310170.pdf
http://dx.doi.org/10.1196/annals.1417.016 .,Non-OADS,/arxiv_data1/oa_pdf/22/5a/main.PMC5310170.pdf
"12 (1):92 –98.http://dx.doi.org/10.1038/nn.2242 .Bishop, S.J., Duncan, J., Brett, M., Lawrence, A.D., 2004a.",Non-OADS,/arxiv_data1/oa_pdf/22/5a/main.PMC5310170.pdf
http://dx.doi.org/10.1038/nn1173 .,Non-OADS,/arxiv_data1/oa_pdf/22/5a/main.PMC5310170.pdf
http://dx.doi.org/10.1523/JNEUROSCI.2550-04.2004 .,Non-OADS,/arxiv_data1/oa_pdf/22/5a/main.PMC5310170.pdf
http://dx.doi.org/10.1093/cercor/bhl070 .,Non-OADS,/arxiv_data1/oa_pdf/22/5a/main.PMC5310170.pdf
http://dx.doi.org/10.1001/ archpsyc.65.10.1176 .,Non-OADS,/arxiv_data1/oa_pdf/22/5a/main.PMC5310170.pdf
http://dx.doi.org/10.1176/appi.ajp.2008.07071060 .,Non-OADS,/arxiv_data1/oa_pdf/22/5a/main.PMC5310170.pdf
4:6.http://dx.doi.org/10.1186/2045-5380- 4-6.,Non-OADS,/arxiv_data1/oa_pdf/22/5a/main.PMC5310170.pdf
http://dx.doi.org/10.1371/journal.pone.0128608 .,Non-OADS,/arxiv_data1/oa_pdf/22/5a/main.PMC5310170.pdf
http://dx.doi.org/10.1016/j.neubiorev.2014.,OADS,/arxiv_data1/oa_pdf/22/5a/main.PMC5310170.pdf
http://dx.doi.org/10.1016/j.pscychresns.2012.05.006 .,OADS,/arxiv_data1/oa_pdf/22/5a/main.PMC5310170.pdf
http://dx.doi.org/10.3758/s13415-014- 0270-2 .,Non-OADS,/arxiv_data1/oa_pdf/22/5a/main.PMC5310170.pdf
http://dx.doi.org/10.1093/ brain/awl004 .,Non-OADS,/arxiv_data1/oa_pdf/22/5a/main.PMC5310170.pdf
http://dx.doi.org/10.1038/74783 .,Non-OADS,/arxiv_data1/oa_pdf/22/5a/main.PMC5310170.pdf
http://dx.doi.org/10.1016/j.cub.2004.09.041 .,OADS,/arxiv_data1/oa_pdf/22/5a/main.PMC5310170.pdf
http://dx.doi.org/10.1016/S0896-6273(00)80593-0 .,OADS,/arxiv_data1/oa_pdf/22/5a/main.PMC5310170.pdf
http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/22/5a/main.PMC5310170.pdf
http://dx.doi.org/10.1162/jocn.2006.18.5.766 .,Non-OADS,/arxiv_data1/oa_pdf/22/5a/main.PMC5310170.pdf
http://dx.doi.org/10.1016/j.tics.,OADS,/arxiv_data1/oa_pdf/22/5a/main.PMC5310170.pdf
http://dx.doi.org/10.1176/appi.ajp.2007.07030504 .,Non-OADS,/arxiv_data1/oa_pdf/22/5a/main.PMC5310170.pdf
http://dx.doi.org/10.1016/j.paid.2010.08.,OADS,/arxiv_data1/oa_pdf/22/5a/main.PMC5310170.pdf
http://dx.doi.org/10.1016/j.pnpbp.2010.02.028 .,OADS,/arxiv_data1/oa_pdf/22/5a/main.PMC5310170.pdf
105 (2):84 –93.http://dx.doi.org/10.1034/j.1600-0447.2002.1r103.x .,Non-OADS,/arxiv_data1/oa_pdf/22/5a/main.PMC5310170.pdf
"Med., 1535370215603514 http://dx.doi.org/10.1177/ 1535370215603514 .",Non-OADS,/arxiv_data1/oa_pdf/22/5a/main.PMC5310170.pdf
http://dx.doi.org/10.1016/j.brainresbull.2008.08.003 .,OADS,/arxiv_data1/oa_pdf/22/5a/main.PMC5310170.pdf
http://dx.doi.org/ 10.1016/j.pscychresns.2015.03.005 .,OADS,/arxiv_data1/oa_pdf/22/5a/main.PMC5310170.pdf
http://dx.doi.org/10.1002/hbm.20249 .,Non-OADS,/arxiv_data1/oa_pdf/22/5a/main.PMC5310170.pdf
http://dx.doi.org/10.1001/ archgenpsychiatry.2008.525 .,Non-OADS,/arxiv_data1/oa_pdf/22/5a/main.PMC5310170.pdf
http://dx.doi.org/10.1162/jocn.2008.20148 .,Non-OADS,/arxiv_data1/oa_pdf/22/5a/main.PMC5310170.pdf
http://dx.doi.org/10.1002/hbm.23120 .,Non-OADS,/arxiv_data1/oa_pdf/22/5a/main.PMC5310170.pdf
http://dx.doi.org/10.1038/ 72999 .,Non-OADS,/arxiv_data1/oa_pdf/22/5a/main.PMC5310170.pdf
http://dx.doi.org/10.1038/nature14188 .,Non-OADS,/arxiv_data1/oa_pdf/22/5a/main.PMC5310170.pdf
http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/22/5a/main.PMC5310170.pdf
http://dx.doi.org/10.1093/cercor/bhq237 .,Non-OADS,/arxiv_data1/oa_pdf/22/5a/main.PMC5310170.pdf
http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/22/5a/main.PMC5310170.pdf
http://ediss.sub.uni-hamburg.de/ volltexte/2008/3642/ .,Non-OADS,/arxiv_data1/oa_pdf/22/5a/main.PMC5310170.pdf
http://dx.doi.org/10.1002/(SICI)1097-0193(1997)5:4 b238::AID-HBM6 N3.0.CO;2-4 .,Non-OADS,/arxiv_data1/oa_pdf/22/5a/main.PMC5310170.pdf
http://dx.doi.org/10.1002/ hbm.20345 .,Non-OADS,/arxiv_data1/oa_pdf/22/5a/main.PMC5310170.pdf
http://dx.doi.org/10.1016/ j.cub.2007.08.005 .,OADS,/arxiv_data1/oa_pdf/22/5a/main.PMC5310170.pdf
http://dx.doi.org/10.1126/science.288.5472.1835 .,Non-OADS,/arxiv_data1/oa_pdf/22/5a/main.PMC5310170.pdf
http://dx.doi.org/10.1016/S1053- 8119(03)00169-1 .,OADS,/arxiv_data1/oa_pdf/22/5a/main.PMC5310170.pdf
http://dx.doi.org/10.1093/scan/nsq103 .,OADS,/arxiv_data1/oa_pdf/22/5a/main.PMC5310170.pdf
"http://dx.doi.org/10.1007/ s00429-010-0262-0 .Miskovic, V., Schmidt, L.A., 2012.",Non-OADS,/arxiv_data1/oa_pdf/22/5a/main.PMC5310170.pdf
http://dx.doi.org/10.1016/j.neubiorev.2011.08.002 .,OADS,/arxiv_data1/oa_pdf/22/5a/main.PMC5310170.pdf
476 (2):84 –88.http://dx.doi.org/10.1016/j.neulet.2010.04.,OADS,/arxiv_data1/oa_pdf/22/5a/main.PMC5310170.pdf
http://dx.doi.org/10.1037/0033-2909.132.2.297 .,Non-OADS,/arxiv_data1/oa_pdf/22/5a/main.PMC5310170.pdf
http://dx.doi.org/10.1080/17470910802250519 .,Non-OADS,/arxiv_data1/oa_pdf/22/5a/main.PMC5310170.pdf
http://dx.doi.org/10.1146/annurev-clinpsy-050212- 185631 .,Non-OADS,/arxiv_data1/oa_pdf/22/5a/main.PMC5310170.pdf
http://dx.doi.org/10.1016/S0926-6410(01)00053-2 .,OADS,/arxiv_data1/oa_pdf/22/5a/main.PMC5310170.pdf
http://dx.doi.org/10.1016/j.neuroimage.2005.12.,OADS,/arxiv_data1/oa_pdf/22/5a/main.PMC5310170.pdf
http://dx.doi.org/10.1016/j.tics.2005.03.010 .,OADS,/arxiv_data1/oa_pdf/22/5a/main.PMC5310170.pdf
http://dx.doi.org/10.1016/j.psyneuen.,OADS,/arxiv_data1/oa_pdf/22/5a/main.PMC5310170.pdf
http://dx.doi.org/10.,Non-OADS,/arxiv_data1/oa_pdf/22/5a/main.PMC5310170.pdf
http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/22/5a/main.PMC5310170.pdf
http://dx.doi.org/10.1016/S0005- 7967(97)00022-3 .,OADS,/arxiv_data1/oa_pdf/22/5a/main.PMC5310170.pdf
http://dx.doi.org/10.1097/WNR.,Non-OADS,/arxiv_data1/oa_pdf/22/5a/main.PMC5310170.pdf
http://dx.doi.org/10.1016/j.neubiorev.2007.12.002 .,OADS,/arxiv_data1/oa_pdf/22/5a/main.PMC5310170.pdf
http://dx.doi.org/10.1001/archpsyc.59.11.1027 .,Non-OADS,/arxiv_data1/oa_pdf/22/5a/main.PMC5310170.pdf
http://dx.doi.org/10.1348/014466508X368856 .,Non-OADS,/arxiv_data1/oa_pdf/22/5a/main.PMC5310170.pdf
http://dx.doi.org/10.1159/000087987 .,Non-OADS,/arxiv_data1/oa_pdf/22/5a/main.PMC5310170.pdf
http://dx.doi.org/10.1523/ JNEUROSCI.2859-10.2011 .,Non-OADS,/arxiv_data1/oa_pdf/22/5a/main.PMC5310170.pdf
"http://dx.doi.org/10.1016/j.neuropsychologia.2014.09.015 .Tzourio-Mazoyer, N., Landeau, B., Papathanassiou, D., Crivello, F., Etard, O., Delcroix, N., ... Joliot, M., 2002.",Non-OADS,/arxiv_data1/oa_pdf/22/5a/main.PMC5310170.pdf
http://dx.doi.org/10.1006/nimg.2001.0978 .,OADS,/arxiv_data1/oa_pdf/22/5a/main.PMC5310170.pdf
http://dx.doi.org/10.3758/s13415- 011-0072-8 .,Non-OADS,/arxiv_data1/oa_pdf/22/5a/main.PMC5310170.pdf
http://dx.doi.org/10.1016/j.neulet.2011.03.042 .,OADS,/arxiv_data1/oa_pdf/22/5a/main.PMC5310170.pdf
http://dx.doi.org/10.1026/0084-5345.28.1.68 .,Non-OADS,/arxiv_data1/oa_pdf/22/5a/main.PMC5310170.pdf
3:20.http://dx.doi.org/10.1186/2045-5380-3-20 .333 C.Y.,Non-OADS,/arxiv_data1/oa_pdf/22/5a/main.PMC5310170.pdf
This  is  an  open access article under the CC BY-NC-ND  license  (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/5b/b1/main.PMC5310171.pdf
"Preoperative  chemotherapy  was  administered,  and http://dx.doi.org/10.1016/j.ijscr.2017.01.063 2210-2612/© 2017  The  Author(s).",Non-OADS,/arxiv_data1/oa_pdf/5b/b1/main.PMC5310171.pdf
"[4]  T.  Akiyama,  S.  Kanda,  A.  Maeda,  M.  Endo,  K.  Saita,  Patella  dislocation  following distal  femoral  replacement  after  bone  tumour  resection,  BMJ  Case  Rep.  2014 (2014),  http://dx.doi.org/10.1136/bcr-2014-205006  (29/Jul/2014).",Non-OADS,/arxiv_data1/oa_pdf/5b/b1/main.PMC5310171.pdf
"7  (2013)  272–274,  http://dx.doi.",Non-OADS,/arxiv_data1/oa_pdf/5b/b1/main.PMC5310171.pdf
"These bacteria could not be identi ﬁed by matrix-assisted laser desorption/ionization mass spectrometry (MALDI-TOF MS; http://www.mediterranee- infection.com/article.php?laref=256&titre=urms-database (last access 01/30/17)) on a Micro ﬂex spectrometer (Bruker Dal- tonics, Bremen, Germany) [1,2] .",OADS,/arxiv_data1/oa_pdf/be/47/main.PMC5310172.pdf
Published by Elsevier Ltd on behalf of European Society of Clinical Microbiology and Infectious DiseasesThis is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ) http://dx.doi.org/10.1016/j.nmni.2017.01.005,Non-OADS,/arxiv_data1/oa_pdf/be/47/main.PMC5310172.pdf
"Published by Elsevier Ltd on behalf of European Society of Clinical Microbiology and Infectious Diseases, NMNI ,16,6 0 –62 This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).",Non-OADS,/arxiv_data1/oa_pdf/be/47/main.PMC5310172.pdf
"Published by Elsevier Ltd on behalf of European Society of Clinical Microbiology and Infectious Diseases, NMNI ,16,6 0 –62 This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).",Non-OADS,/arxiv_data1/oa_pdf/be/47/main.PMC5310172.pdf
"At a later time point amplitude-integrated (aEEG) or multichannel electroencephalography(mchEEG) and brain magnetic resonance imaging (MRI) further http://dx.doi.org/10.1016/j.redox.2017.02.002 Received 13 January 2017; Received in revised form 1 February 2017; Accepted 4 February 2017⁎Corresponding author at: Division of Neonatology, University & Polytechnic Hospital La Fe, Avenida Fernando Abril Martorell 106, Valencia, Spain.",Non-OADS,/arxiv_data1/oa_pdf/7d/a8/main.PMC5310173.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/BY-NC-ND/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/7d/a8/main.PMC5310173.pdf
57 (Suppl 3) (2015) 8 –16.http://dx.doi.org/10.1111/dmcn.12726.,Non-OADS,/arxiv_data1/oa_pdf/7d/a8/main.PMC5310173.pdf
169 (2015) 397– 403. http://dx.doi.org/10.1001/ jamapediatrics.2014.3269 .,Non-OADS,/arxiv_data1/oa_pdf/7d/a8/main.PMC5310173.pdf
86 (2010) 329– 338. http://dx.doi.org/10.1016/j.earlhumdev.2010.05.010 .,OADS,/arxiv_data1/oa_pdf/7d/a8/main.PMC5310173.pdf
91 (2002) 17 –19.http://dx.doi.org/10.1111/j.1651- 2227.2002.tb01633.x .,Non-OADS,/arxiv_data1/oa_pdf/7d/a8/main.PMC5310173.pdf
74 (2016) 35–61.http://dx.doi.org/10.1016/bs.acc.2015.12.006 .,Non-OADS,/arxiv_data1/oa_pdf/7d/a8/main.PMC5310173.pdf
http://dx.doi.org/10.1371/ journal.pone.0050520 .,Non-OADS,/arxiv_data1/oa_pdf/7d/a8/main.PMC5310173.pdf
http://dx.doi.org/10.1021/pr400617m .,Non-OADS,/arxiv_data1/oa_pdf/7d/a8/main.PMC5310173.pdf
"Murray, Early cord metabolite index and outcome in perinatal asphyxia and hypoxic-ischaemic encephalopathy, Neonatology 110(2016) 296– 302. http://dx.doi.org/10.1159/000446556 .",Non-OADS,/arxiv_data1/oa_pdf/7d/a8/main.PMC5310173.pdf
http://dx.doi.org/10.1371/ journal.pone.0009606 .,Non-OADS,/arxiv_data1/oa_pdf/7d/a8/main.PMC5310173.pdf
76 (2014)127– 134. http://dx.doi.org/10.1038/pr.2014.70 .,Non-OADS,/arxiv_data1/oa_pdf/7d/a8/main.PMC5310173.pdf
http://dx.doi.org/10.1371/journal.pone.0066540.,Non-OADS,/arxiv_data1/oa_pdf/7d/a8/main.PMC5310173.pdf
http://dx.doi.org/10.1002/iub.337 .,Non-OADS,/arxiv_data1/oa_pdf/7d/a8/main.PMC5310173.pdf
http://dx.doi.org/10.1038/pr.2016.66 .,Non-OADS,/arxiv_data1/oa_pdf/7d/a8/main.PMC5310173.pdf
22 (2009) 161– 168. http://dx.doi.org/10.1080/ 14767050802663186 .,Non-OADS,/arxiv_data1/oa_pdf/7d/a8/main.PMC5310173.pdf
78 (2006) 779– 787. http://dx.doi.org/ 10.1021/ac051437y.,Non-OADS,/arxiv_data1/oa_pdf/7d/a8/main.PMC5310173.pdf
http://dx.doi.org/ 10.1093/nar/gkv380 .,Non-OADS,/arxiv_data1/oa_pdf/7d/a8/main.PMC5310173.pdf
9 (2015) 267– 275. http://dx.doi.org/10.2217/bmm.14.116 .,Non-OADS,/arxiv_data1/oa_pdf/7d/a8/main.PMC5310173.pdf
40 (2009) 215– 226. http://dx.doi.org/10.1016/j.pediatrneur- ol.2008.09.026 .,OADS,/arxiv_data1/oa_pdf/7d/a8/main.PMC5310173.pdf
9 (1975) 158– 161. http://dx.doi.org/10.1203/00006450-197504000-00002 .,Non-OADS,/arxiv_data1/oa_pdf/7d/a8/main.PMC5310173.pdf
74 (2013) 170– 179. http://dx.doi.org/ 10.1038/pr.2013.88.,Non-OADS,/arxiv_data1/oa_pdf/7d/a8/main.PMC5310173.pdf
35 (2015) 794– 805. http://dx.doi.org/10.1038/jcbfm.2014.253 .,Non-OADS,/arxiv_data1/oa_pdf/7d/a8/main.PMC5310173.pdf
31 (2011) 547– 559. http://dx.doi.org/10.1038/jcbfm.2010.125 .,Non-OADS,/arxiv_data1/oa_pdf/7d/a8/main.PMC5310173.pdf
http://dx.doi.org/ 10.3389/fphys.2012.00424 .,Non-OADS,/arxiv_data1/oa_pdf/7d/a8/main.PMC5310173.pdf
72 (1983) 231– 237. http://dx.doi.org/10.1111/j.1651- 2227.1983.tb09703.x .J.,Non-OADS,/arxiv_data1/oa_pdf/7d/a8/main.PMC5310173.pdf
http://dx.doi.org/ 10.1016/j.ygyno.2009.07.016 .,OADS,/arxiv_data1/oa_pdf/e3/1b/main.PMC5310174.pdf
http://dx.doi.org/10.,Non-OADS,/arxiv_data1/oa_pdf/e3/1b/main.PMC5310174.pdf
http://dx.doi.org/10.1016/j.ygyno.2016.03.031 .,OADS,/arxiv_data1/oa_pdf/e3/1b/main.PMC5310174.pdf
http://dx.doi.org/10.1002/jso.24174 (Apr).,OADS,/arxiv_data1/oa_pdf/e3/1b/main.PMC5310174.pdf
Rep. 16:24. http://dx.doi.org/ 10.1016/j.gore.2016.03.004 (Mar).,OADS,/arxiv_data1/oa_pdf/e3/1b/main.PMC5310174.pdf
http://dx.doi.org/10.1016/j.gore.2017.02.003 2352-5789/© 2017 The Author(s).,Non-OADS,/arxiv_data1/oa_pdf/e3/1b/main.PMC5310174.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/e3/1b/main.PMC5310174.pdf
132 (1):38 –43.http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/e3/1b/main.PMC5310174.pdf
"http://dx.doi.org/10.1097/ COC.0000000000000302 .Z a h lE r i k s s o n ,A .",Non-OADS,/arxiv_data1/oa_pdf/e3/1b/main.PMC5310174.pdf
http://dx.doi.org/10.10 16/j.ygyno.2015.12.028 .23 R. Kimmig et al.,OADS,/arxiv_data1/oa_pdf/e3/1b/main.PMC5310174.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/90/15/main.PMC5310175.pdf
Contents lists available at ScienceDirect Respiratory Medicine Case Reports journal homepage: www.elsevier.com/locate/rmcr http://dx.doi.org/10.1016/j.rmcr.2017.02.004 2213-0071/ ©2017 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/90/15/main.PMC5310175.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).Respiratory Medicine Case Reports 20 (2017) 145 e149,Non-OADS,/arxiv_data1/oa_pdf/90/15/main.PMC5310175.pdf
"Matthay, Negative pressure pulmonary edema, Chest (2016), http://dx.doi.org/10.1016/ j.chest.2016.03.043 .",Non-OADS,/arxiv_data1/oa_pdf/90/15/main.PMC5310175.pdf
This  is  an  open  access  article under the  CC  BY-NC-ND  license  (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/36/b7/main.PMC5310176.pdf
http://dx.doi.org/10.1016/j.ijscr.2016.12.019 2210-2612/© 2016  Published  by  Elsevier  Ltd  on  behalf  of  IJS  Publishing  Group  Ltd.,Non-OADS,/arxiv_data1/oa_pdf/36/b7/main.PMC5310176.pdf
This  is  an  open access article under the CC BY-NC-ND  license  (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/30/3a/main.PMC5310177.pdf
Plain  erect  X  ray  of the  abdomen  revealed  gas  underdiaphragm  at  the  5th  postpartum http://dx.doi.org/10.1016/j.ijscr.2017.01.053 2210-2612/© 2017  The  Author(s).,Non-OADS,/arxiv_data1/oa_pdf/30/3a/main.PMC5310177.pdf
This  is  an  open access article  under  the  CC  BY-NC-ND  license  (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/91/26/main.PMC5310178.pdf
"A  full  physical  exam  showed vital  signs  within  normal  limited:  blood  pressure,  130/85  mmHg; http://dx.doi.org/10.1016/j.ijscr.2017.01.010 2210-2612/© 2017  The  Author(s).",Non-OADS,/arxiv_data1/oa_pdf/91/26/main.PMC5310178.pdf
"Cancer  14  (2007)  13–28,  http://dx.doi.",Non-OADS,/arxiv_data1/oa_pdf/91/26/main.PMC5310178.pdf
"25  (2001)  914–926,  http://dx.doi.org/10.1007/s00268-001-0030-7 [PubMed][CrossRef].",Non-OADS,/arxiv_data1/oa_pdf/91/26/main.PMC5310178.pdf
"18  (May–June  (3)) (2012) e37–42, http://dx.doi.org/10.4158/EP11222 ,  CR.",Non-OADS,/arxiv_data1/oa_pdf/91/26/main.PMC5310178.pdf
"[7] N.  Michalopoulos,  K.  Pazaitou-Panayiotou,  M.  Boudina,  T.  Papavramidis,  G. Karayannopoulou,  S.  Papavramidis,  Mixed  corticomedullary  adrenal carcinoma,  Surg  Today  43  (November  (11))  (2013)  1232–1239,  http://dx.doi.",Non-OADS,/arxiv_data1/oa_pdf/91/26/main.PMC5310178.pdf
"91  (6)  (2006)  2027–2037,  http://dx.doi.org/ 10.1210/jc.2005-2639 [PubMed][CrossRef].",Non-OADS,/arxiv_data1/oa_pdf/91/26/main.PMC5310178.pdf
This  is  an  open access article under  the  CC  BY-NC-ND  license  (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/65/8d/main.PMC5310179.pdf
"An  ultrasound  scan  of  her  neck  revealed  a  normal  sized  thy- roid  gland,  while  an  enlarged  parathyroid  was  located  on  the  left lower  side  of  her  cervical  region,  with  its  dimensions  approximately http://dx.doi.org/10.1016/j.ijscr.2017.01.064 2210-2612/© 2017  The  Authors.",Non-OADS,/arxiv_data1/oa_pdf/65/8d/main.PMC5310179.pdf
Published by Elsevier Ltd on behalf of European Society of Clinical Microbiology and Infectious Diseases This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ) http://dx.doi.org/10.1016/j.nmni.2017.01.004,Non-OADS,/arxiv_data1/oa_pdf/4a/82/main.PMC5310180.pdf
The tests of antibiotic susceptibility were realized using the disk diffusion method according to the European Committee on Antimicrobial Susceptibility Testing (EUCAST) 2015 recom- mendations ( http://www.eucast.org/ ).,Non-OADS,/arxiv_data1/oa_pdf/4a/82/main.PMC5310180.pdf
"Published by Elsevier Ltd on behalf of European Society of Clinical Microbiology and Infectious Diseases, NMNI ,16,6 3–72 This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).",Non-OADS,/arxiv_data1/oa_pdf/4a/82/main.PMC5310180.pdf
"Published by Elsevier Ltd on behalf of European Society of Clinical Microbiology and Infectious Diseases, NMNI ,16,6 3–72 This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).",Non-OADS,/arxiv_data1/oa_pdf/4a/82/main.PMC5310180.pdf
"Published by Elsevier Ltd on behalf of European Society of Clinical Microbiology and Infectious Diseases, NMNI ,16,6 3–72 This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).",Non-OADS,/arxiv_data1/oa_pdf/4a/82/main.PMC5310180.pdf
"Published by Elsevier Ltd on behalf of European Society of Clinical Microbiology and Infectious Diseases, NMNI ,16,6 3–72 This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).",Non-OADS,/arxiv_data1/oa_pdf/4a/82/main.PMC5310180.pdf
"Published by Elsevier Ltd on behalf of European Society of Clinical Microbiology and Infectious Diseases, NMNI ,16,6 3–72 This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).",Non-OADS,/arxiv_data1/oa_pdf/4a/82/main.PMC5310180.pdf
"Published by Elsevier Ltd on behalf of European Society of Clinical Microbiology and Infectious Diseases, NMNI ,16,6 3–72 This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).",Non-OADS,/arxiv_data1/oa_pdf/4a/82/main.PMC5310180.pdf
"Published by Elsevier Ltd on behalf of European Society of Clinical Microbiology and Infectious Diseases, NMNI ,16,6 3–72 This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).",Non-OADS,/arxiv_data1/oa_pdf/4a/82/main.PMC5310180.pdf
"Published by Elsevier Ltd on behalf of European Society of Clinical Microbiology and Infectious Diseases, NMNI ,16,6 3–72 This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).",Non-OADS,/arxiv_data1/oa_pdf/4a/82/main.PMC5310180.pdf
"Published by Elsevier Ltd on behalf of European Society of Clinical Microbiology and Infectious Diseases, NMNI ,16,6 3–72 This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).",Non-OADS,/arxiv_data1/oa_pdf/4a/82/main.PMC5310180.pdf
This is an open access articleunder the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/21/fa/main.PMC5310181.pdf
1936-5233/17http://dx.doi.org/10.1016/j.tranon.2017.01.008,OADS,/arxiv_data1/oa_pdf/21/fa/main.PMC5310181.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/9e/17/main.PMC5310200.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/9e/17/main.PMC5310200.pdf
http://dx.doi.org/10.1016/j.eucr.2016.11.016Urology Case Reports 12 (2017) 1 e3,Non-OADS,/arxiv_data1/oa_pdf/9e/17/main.PMC5310200.pdf
http://dx.doi.org/10.1007/s002240-011-0409-3 .,Non-OADS,/arxiv_data1/oa_pdf/9e/17/main.PMC5310200.pdf
http://dx.doi.org/10.1089/end.2011.0385 .,Non-OADS,/arxiv_data1/oa_pdf/9e/17/main.PMC5310200.pdf
http://dx.doi.org/10.1590/S 1677-5538.IBJU.2014.0536 .G.,Non-OADS,/arxiv_data1/oa_pdf/9e/17/main.PMC5310200.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/8b/f6/main.PMC5310202.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/8b/f6/main.PMC5310202.pdf
http://dx.doi.org/10.1016/j.eucr.2017.01.006Urology Case Reports 11 (2017) 76 e78,Non-OADS,/arxiv_data1/oa_pdf/8b/f6/main.PMC5310202.pdf
Available online at www.sciencedirect.com ScienceDirect journal homepage: http://Elsevier.com/locate/radcr Radiology Case Reports 12 (2017) 120 e123 http://dx.doi.org/10.1016/j.radcr.2016.10.012 1930-0433/ ©2016 the Authors.,Non-OADS,/arxiv_data1/oa_pdf/21/cc/main.PMC5310238.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/21/cc/main.PMC5310238.pdf
Available online at www.sciencedirect.com ScienceDirect journal homepage: http://Elsevier.com/locate/radcr Radiology Case Reports 12 (2017) 84 e86 http://dx.doi.org/10.1016/j.radcr.2016.10.010 1930-0433/ ©2016 Published by Elsevier Inc. on behalf of under copyright license from the University of Washington.,Non-OADS,/arxiv_data1/oa_pdf/53/ed/main.PMC5310239.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/53/ed/main.PMC5310239.pdf
Retrieved 5/ 9/2016 from http://emedicine.medscape.com/article/185777- overview .,Non-OADS,/arxiv_data1/oa_pdf/53/ed/main.PMC5310239.pdf
Available online at www.sciencedirect.com ScienceDirect journal homepage: http://Elsevier.com/locate/radcr Radiology Case Reports 12 (2017) 196 e199 http://dx.doi.org/10.1016/j.radcr.2016.10.008 1930-0433/Published by Elsevier Inc. on behalf of under copyright license from the University of Washington.,Non-OADS,/arxiv_data1/oa_pdf/6a/6b/main.PMC5310240.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/6a/6b/main.PMC5310240.pdf
Available online at www.sciencedirect.com ScienceDirect journal homepage: http://Elsevier.com/locate/radcr Radiology Case Reports 12 (2017) 34 e38 http://dx.doi.org/10.1016/j.radcr.2016.10.005 1930-0433/ ©2016 the Authors.,Non-OADS,/arxiv_data1/oa_pdf/58/aa/main.PMC5310242.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/58/aa/main.PMC5310242.pdf
Available online at www.sciencedirect.com ScienceDirect journal homepage: http://Elsevier.com/locate/radcr Radiology Case Reports 12 (2017) 191 e195 http://dx.doi.org/10.1016/j.radcr.2016.08.019 1930-0433/ ©2016 the Authors.,Non-OADS,/arxiv_data1/oa_pdf/d3/d7/main.PMC5310243.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/d3/d7/main.PMC5310243.pdf
Available online at www.sciencedirect.com ScienceDirect journal homepage: http://Elsevier.com/locate/radcr Radiology Case Reports 12 (2017) 31 e33 http://dx.doi.org/10.1016/j.radcr.2016.10.009 1930-0433/ ©2016 the Authors.,Non-OADS,/arxiv_data1/oa_pdf/66/bb/main.PMC5310244.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/66/bb/main.PMC5310244.pdf
"Supplementary data Supplementary data associated with this article can be foundin the online version, at http://dx.doi.org/10.1016/j.radcr.2 016.10.009 .",OADS,/arxiv_data1/oa_pdf/66/bb/main.PMC5310244.pdf
Available online at www.sciencedirect.com ScienceDirect journal homepage: http://Elsevier.com/locate/radcr Radiology Case Reports 12 (2017) 87 e91 http://dx.doi.org/10.1016/j.radcr.2016.10.013 1930-0433/ ©2016 Published by Elsevier Inc. on behalf of under copyright license from the University of Washington.,Non-OADS,/arxiv_data1/oa_pdf/68/ce/main.PMC5310245.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/68/ce/main.PMC5310245.pdf
Available online at www.sciencedirect.com ScienceDirect journal homepage: http://Elsevier.com/locate/radcr Radiology Case Reports 12 (2017) 54 e58 http://dx.doi.org/10.1016/j.radcr.2016.10.007 1930-0433/ ©2016 the Authors.,Non-OADS,/arxiv_data1/oa_pdf/14/ce/main.PMC5310246.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/14/ce/main.PMC5310246.pdf
"Available online at www.sciencedirect.com ScienceDirect journal homepage: http://Elsevier.com/locate/radcr Radiology Case Reports 12 (2017) 42 e44 http://dx.doi.org/10.1016/j.radcr.2016.07.003 1930-0433/Copyright ©2016, the Authors.",Non-OADS,/arxiv_data1/oa_pdf/9a/db/main.PMC5310247.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/9a/db/main.PMC5310247.pdf
Available online at www.sciencedirect.com ScienceDirect journal homepage: http://Elsevier.com/locate/radcr Radiology Case Reports 12 (2017) 200 e203 http://dx.doi.org/10.1016/j.radcr.2016.10.017 1930-0433/ ©2016 the Authors.,Non-OADS,/arxiv_data1/oa_pdf/af/39/main.PMC5310253.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/af/39/main.PMC5310253.pdf
Available online at www.sciencedirect.com ScienceDirect journal homepage: http://Elsevier.com/locate/radcr Radiology Case Reports 12 (2017) 59 e64 http://dx.doi.org/10.1016/j.radcr.2016.10.016 1930-0433/ ©2016 the Authors.,Non-OADS,/arxiv_data1/oa_pdf/e6/5c/main.PMC5310254.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/e6/5c/main.PMC5310254.pdf
Available online at www.sciencedirect.com ScienceDirect journal homepage: http://Elsevier.com/locate/radcr Radiology Case Reports 12 (2017) 133 e135 http://dx.doi.org/10.1016/j.radcr.2016.10.021 1930-0433/ ©2016 the Authors.,Non-OADS,/arxiv_data1/oa_pdf/bb/73/main.PMC5310255.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/bb/73/main.PMC5310255.pdf
Available online at www.sciencedirect.com ScienceDirect journal homepage: http://Elsevier.com/locate/radcr Radiology Case Reports 12 (2017) 65 e69 http://dx.doi.org/10.1016/j.radcr.2016.10.019 1930-0433/ ©2016 Published by Elsevier Inc. on behalf of under copyright license from the University of Washington.,Non-OADS,/arxiv_data1/oa_pdf/38/01/main.PMC5310256.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/38/01/main.PMC5310256.pdf
Available online at www.sciencedirect.com ScienceDirect journal homepage: http://Elsevier.com/locate/radcr Radiology Case Reports 12 (2017) 136 e140 http://dx.doi.org/10.1016/j.radcr.2016.11.001 1930-0433/ ©2016 the Authors.,Non-OADS,/arxiv_data1/oa_pdf/aa/32/main.PMC5310257.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/aa/32/main.PMC5310257.pdf
https://www.nccn.org/professionals/physician_gls/pdf/sarcoma.pdf; [accessed on 10.07.16].,Non-OADS,/arxiv_data1/oa_pdf/aa/32/main.PMC5310257.pdf
Available online at www.sciencedirect.com ScienceDirect journal homepage: http://Elsevier.com/locate/radcr Radiology Case Reports 12 (2017) 146 e149 http://dx.doi.org/10.1016/j.radcr.2016.10.024 1930-0433/ ©2016 the Authors.,Non-OADS,/arxiv_data1/oa_pdf/5e/20/main.PMC5310258.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/5e/20/main.PMC5310258.pdf
Available online at www.sciencedirect.com ScienceDirect journal homepage: http://Elsevier.com/locate/radcr Radiology Case Reports 12 (2017) 130 e132 http://dx.doi.org/10.1016/j.radcr.2016.10.020 1930-0433/ ©2016 the Authors.,Non-OADS,/arxiv_data1/oa_pdf/f4/35/main.PMC5310260.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/f4/35/main.PMC5310260.pdf
Available online at www.sciencedirect.com ScienceDirect journal homepage: http://Elsevier.com/locate/radcr Radiology Case Reports 12 (2017) 73 e77 http://dx.doi.org/10.1016/j.radcr.2016.10.023 1930-0433/ ©2016 the Authors.,Non-OADS,/arxiv_data1/oa_pdf/45/b8/main.PMC5310261.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/45/b8/main.PMC5310261.pdf
Available online at www.sciencedirect.com ScienceDirect journal homepage: http://Elsevier.com/locate/radcr Radiology Case Reports 12 (2017) 81 e83 http://dx.doi.org/10.1016/j.radcr.2016.10.022 1930-0433/ ©2016 the Authors.,Non-OADS,/arxiv_data1/oa_pdf/d4/1a/main.PMC5310262.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/d4/1a/main.PMC5310262.pdf
Available online at www.sciencedirect.com ScienceDirect journal homepage: http://Elsevier.com/locate/radcr Radiology Case Reports 12 (2017) 161 e167 http://dx.doi.org/10.1016/j.radcr.2016.10.018 1930-0433/ ©2016 the Authors.,Non-OADS,/arxiv_data1/oa_pdf/33/df/main.PMC5310263.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/33/df/main.PMC5310263.pdf
Available online at www.sciencedirect.com ScienceDirect journal homepage: http://Elsevier.com/locate/radcr Radiology Case Reports 12 (2017) 124 e129 http://dx.doi.org/10.1016/j.radcr.2016.10.015 1930-0433/ ©2016 the Authors.,Non-OADS,/arxiv_data1/oa_pdf/68/f4/main.PMC5310264.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/68/f4/main.PMC5310264.pdf
Available online at www.sciencedirect.com ScienceDirect journal homepage: http://Elsevier.com/locate/radcr Radiology Case Reports 12 (2017) 113 e119 http://dx.doi.org/10.1016/j.radcr.2016.10.014 1930-0433/ ©2016 the Authors.,Non-OADS,/arxiv_data1/oa_pdf/5a/11/main.PMC5310265.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/5a/11/main.PMC5310265.pdf
Available online at www.sciencedirect.com ScienceDirect journal homepage: http://Elsevier.com/locate/radcr Radiology Case Reports 12 (2017) 13 e18 http://dx.doi.org/10.1016/j.radcr.2016.11.005 1930-0433/ ©2016 the Authors.,Non-OADS,/arxiv_data1/oa_pdf/76/f1/main.PMC5310370.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/76/f1/main.PMC5310370.pdf
Available online at www.sciencedirect.com ScienceDirect journal homepage: http://Elsevier.com/locate/radcr Radiology Case Reports 12 (2017) 92 e96 http://dx.doi.org/10.1016/j.radcr.2016.11.002 1930-0433/ ©2016 the Authors.,Non-OADS,/arxiv_data1/oa_pdf/3f/b0/main.PMC5310371.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/3f/b0/main.PMC5310371.pdf
Available online at www.sciencedirect.com ScienceDirect journal homepage: http://Elsevier.com/locate/radcr Radiology Case Reports 12 (2017) 39 e41 http://dx.doi.org/10.1016/j.radcr.2016.11.015 1930-0433/ ©2016 the Authors.,Non-OADS,/arxiv_data1/oa_pdf/87/fd/main.PMC5310372.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/87/fd/main.PMC5310372.pdf
Available online at www.sciencedirect.com ScienceDirect journal homepage: http://Elsevier.com/locate/radcr Radiology Case Reports 12 (2017) 179 e184 http://dx.doi.org/10.1016/j.radcr.2016.11.006 1930-0433/ ©2016 the Authors.,Non-OADS,/arxiv_data1/oa_pdf/5a/6f/main.PMC5310373.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/5a/6f/main.PMC5310373.pdf
Available online at www.sciencedirect.com ScienceDirect journal homepage: http://Elsevier.com/locate/radcr Radiology Case Reports 12 (2017) 50 e53 http://dx.doi.org/10.1016/j.radcr.2016.11.019 1930-0433/ ©2016 the Authors.,Non-OADS,/arxiv_data1/oa_pdf/4d/ec/main.PMC5310374.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/4d/ec/main.PMC5310374.pdf
Available online at www.sciencedirect.com ScienceDirect journal homepage: http://Elsevier.com/locate/radcr Radiology Case Reports 12 (2017) 45 e49 http://dx.doi.org/10.1016/j.radcr.2016.11.013 1930-0433/ ©2016 the Authors.,Non-OADS,/arxiv_data1/oa_pdf/c9/60/main.PMC5310377.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/c9/60/main.PMC5310377.pdf
Available online at www.sciencedirect.com ScienceDirect journal homepage: http://Elsevier.com/locate/radcr Radiology Case Reports 12 (2017) 168 e174 http://dx.doi.org/10.1016/j.radcr.2016.11.009 1930-0433/ ©2016 the Authors.,Non-OADS,/arxiv_data1/oa_pdf/fb/bc/main.PMC5310380.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/fb/bc/main.PMC5310380.pdf
Available online at www.sciencedirect.com ScienceDirect journal homepage: http://Elsevier.com/locate/radcr Radiology Case Reports 12 (2017) 102 e107 http://dx.doi.org/10.1016/j.radcr.2016.11.012 1930-0433/Published by Elsevier Inc. on behalf of under copyright license from the University of Washington.,Non-OADS,/arxiv_data1/oa_pdf/b6/ad/main.PMC5310381.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/b6/ad/main.PMC5310381.pdf
Available online at www.sciencedirect.com ScienceDirect journal homepage: http://Elsevier.com/locate/radcr Radiology Case Reports 12 (2017) 108 e112 http://dx.doi.org/10.1016/j.radcr.2016.11.014 1930-0433/ ©2016 the Authors.,Non-OADS,/arxiv_data1/oa_pdf/9e/f3/main.PMC5310382.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/9e/f3/main.PMC5310382.pdf
"Supplementary data Supplementary data associated with this article can be foundin the online version, at http://dx.doi.org/10.1016/j.radcr.2 016.11.014 .",OADS,/arxiv_data1/oa_pdf/9e/f3/main.PMC5310382.pdf
"3 |  USING THE COMPENDIUM The Compendium’s homepage (http://srhr.org/postpartumfp) consists of two sections: (1) dropdown menus that allow the user to select characteristics of a woman in the postpartum period needing family planning services, and (2) a chart of family planning methods arranged by timing eligibility in the postpartum period (Fig.",Non-OADS,/arxiv_data1/oa_pdf/5b/01/IJGO-136-2.PMC5310387.pdf
Navigate to http://srhr.org/postpartumfp.,Non-OADS,/arxiv_data1/oa_pdf/5b/01/IJGO-136-2.PMC5310387.pdf
Available online at www.sciencedirect.com ScienceDirect journal homepage: http://Elsevier.com/locate/radcr Radiology Case Reports 12 (2017) 97 e101 http://dx.doi.org/10.1016/j.radcr.2016.11.008 1930-0433/ ©2016 the Authors.,Non-OADS,/arxiv_data1/oa_pdf/a4/a4/main.PMC5310388.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/a4/a4/main.PMC5310388.pdf
Available online at www.sciencedirect.com ScienceDirect journal homepage: http://Elsevier.com/locate/radcr Radiology Case Reports 12 (2017) 141 e145 http://dx.doi.org/10.1016/j.radcr.2016.11.017 1930-0433/ ©2016 the Authors.,Non-OADS,/arxiv_data1/oa_pdf/6b/bc/main.PMC5310389.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/6b/bc/main.PMC5310389.pdf
Available online at www.sciencedirect.com ScienceDirect journal homepage: http://Elsevier.com/locate/radcr Radiology Case Reports 12 (2017) 78 e80 http://dx.doi.org/10.1016/j.radcr.2016.11.007 1930-0433/ ©2016 the Authors.,Non-OADS,/arxiv_data1/oa_pdf/57/ea/main.PMC5310390.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/57/ea/main.PMC5310390.pdf
Available online at www.sciencedirect.com ScienceDirect journal homepage: http://Elsevier.com/locate/radcr Radiology Case Reports 12 (2017) 207 e209 http://dx.doi.org/10.1016/j.radcr.2016.11.003 1930-0433/ ©2016 the Authors.,Non-OADS,/arxiv_data1/oa_pdf/9f/eb/main.PMC5310391.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/9f/eb/main.PMC5310391.pdf
Available online at www.sciencedirect.com ScienceDirect journal homepage: http://Elsevier.com/locate/radcr Radiology Case Reports 12 (2017) 70 e72 http://dx.doi.org/10.1016/j.radcr.2016.11.016 1930-0433/ ©2016 the Authors.,Non-OADS,/arxiv_data1/oa_pdf/1b/69/main.PMC5310393.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/1b/69/main.PMC5310393.pdf
Available online at www.sciencedirect.com ScienceDirect journal homepage: http://Elsevier.com/locate/radcr Radiology Case Reports 12 (2017) 19 e24 http://dx.doi.org/10.1016/j.radcr.2016.11.011 1930-0433/ ©2016 the Authors.,Non-OADS,/arxiv_data1/oa_pdf/62/31/main.PMC5310394.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/62/31/main.PMC5310394.pdf
Available online at www.sciencedirect.com ScienceDirect journal homepage: http://Elsevier.com/locate/radcr Radiology Case Reports 12 (2017) 154 e158 http://dx.doi.org/10.1016/j.radcr.2016.12.002 1930-0433/ ©2016 the Authors.,Non-OADS,/arxiv_data1/oa_pdf/a7/b2/main.PMC5310533.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/a7/b2/main.PMC5310533.pdf
Available online at www.sciencedirect.com ScienceDirect journal homepage: http://Elsevier.com/locate/radcr Radiology Case Reports 12 (2017) 25 e28 http://dx.doi.org/10.1016/j.radcr.2016.11.023 1930-0433/ ©2016 the Authors.,Non-OADS,/arxiv_data1/oa_pdf/3b/bb/main.PMC5310534.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/3b/bb/main.PMC5310534.pdf
Available online at www.sciencedirect.com ScienceDirect journal homepage: http://Elsevier.com/locate/radcr Radiology Case Reports 12 (2017) 204 e206 http://dx.doi.org/10.1016/j.radcr.2016.11.022 1930-0433/ ©2016 the Authors.,Non-OADS,/arxiv_data1/oa_pdf/89/2f/main.PMC5310535.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/89/2f/main.PMC5310535.pdf
Available online at www.sciencedirect.com ScienceDirect journal homepage: http://Elsevier.com/locate/radcr Radiology Case Reports 12 (2017) 1 e12 http://dx.doi.org/10.1016/j.radcr.2016.12.001 1930-0433/ ©2016 the Authors.,Non-OADS,/arxiv_data1/oa_pdf/5e/dd/main.PMC5310536.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/5e/dd/main.PMC5310536.pdf
Available online at www.sciencedirect.com ScienceDirect journal homepage: http://Elsevier.com/locate/radcr Radiology Case Reports 12 (2017) 150 e153 http://dx.doi.org/10.1016/j.radcr.2016.11.025 1930-0433/ ©2016 the Authors.,Non-OADS,/arxiv_data1/oa_pdf/24/78/main.PMC5310537.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/24/78/main.PMC5310537.pdf
Available online at www.sciencedirect.com ScienceDirect journal homepage: http://Elsevier.com/locate/radcr Radiology Case Reports 12 (2017) 159 e160 http://dx.doi.org/10.1016/j.radcr.2016.11.021 1930-0433/ ©2016 the Authors.,Non-OADS,/arxiv_data1/oa_pdf/c7/aa/main.PMC5310538.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/c7/aa/main.PMC5310538.pdf
Available online at www.sciencedirect.com ScienceDirect journal homepage: http://Elsevier.com/locate/radcr Radiology Case Reports 12 (2017) 29 e30 http://dx.doi.org/10.1016/j.radcr.2016.11.024 1930-0433/ ©2016 the Authors.,Non-OADS,/arxiv_data1/oa_pdf/ce/89/main.PMC5310539.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/ce/89/main.PMC5310539.pdf
Available online at www.sciencedirect.com ScienceDirect journal homepage: http://Elsevier.com/locate/radcr Radiology Case Reports 12 (2017) 175 e178 http://dx.doi.org/10.1016/j.radcr.2016.11.027 1930-0433/ ©2016 the Authors.,Non-OADS,/arxiv_data1/oa_pdf/07/10/main.PMC5310540.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/07/10/main.PMC5310540.pdf
Available online at www.sciencedirect.com ScienceDirect journal homepage: http://Elsevier.com/locate/radcr Radiology Case Reports 12 (2017) 185 e190 http://dx.doi.org/10.1016/j.radcr.2016.11.020 1930-0433/ ©2016 the Authors.,Non-OADS,/arxiv_data1/oa_pdf/01/8f/main.PMC5310541.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/01/8f/main.PMC5310541.pdf
This is a n open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).Keywords: Comparative genomic analysis Gene annotations Molecular evolutionPhylogenetic analysisRRID:SCR_014401 1.,Non-OADS,/arxiv_data1/oa_pdf/a4/a1/main.PMC5310593.pdf
"The public eutherian geno- mic sequence assemblies used in gene identi ﬁcations of potential KLN coding sequences were downloaded from National Center for Biotech- nology Information (NCBI) GenBank ( ftp://ftp.ncbi.nlm.nih.gov/ genomes/genbank/vertebrate_mammalian/ ), as well as NCBI's BLAST programs ( ftp://ftp.ncbi.nlm.nih.gov/blast/ ).",OADS,/arxiv_data1/oa_pdf/a4/a1/main.PMC5310593.pdf
"In addition, the public eu- therian genomic sequences were downloaded from Ensembl genome browser ( http://www.ensembl.org ).",OADS,/arxiv_data1/oa_pdf/a4/a1/main.PMC5310593.pdf
"The analyses of KLNgene features included direct evidence of gene annotations deposited in NCBI's nr, est_human, est_mouse and est_others databases ( https://www.ncbi.",OADS,/arxiv_data1/oa_pdf/a4/a1/main.PMC5310593.pdf
http://dx.doi.org/10.1016/j.ymgmr.2017.01.009 2214-4269/© 2017 The Author.,Non-OADS,/arxiv_data1/oa_pdf/a4/a1/main.PMC5310593.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/a4/a1/main.PMC5310593.pdf
"Under accession numbers LT631550 –LT631670, the eutherian KLNgene data set was deposited in European Nucleotide Archive ( https://www.ebi.ac.uk/ena/data/view/LT631550-LT631670 ).",OADS,/arxiv_data1/oa_pdf/a4/a1/main.PMC5310593.pdf
"In KLNphylogenetic tree calculations, the MEGA 6.06 pro- gram was used ( http://www.megasoftware.net ), using neighbour- joining method (default settings, except gaps/missing data treatment = pairwise deletion), minimum evolution method (default settings, ex- cept gaps/missing data treatment = pairwise deletion), maximum par- simony method (default settings, except gaps/missing data treatment = use all sites) and unweighted pair group method with ar- ithmetic mean method (default settings, except gaps/missing data = pairwise deletion).",OADS,/arxiv_data1/oa_pdf/a4/a1/main.PMC5310593.pdf
"In KLN protein primary structures, the SignalP 4.1 server was used in predictions of N-terminal signal peptides using default set- tings ( http://www.cbs.dtu.dk/services/SignalP/ ).",OADS,/arxiv_data1/oa_pdf/a4/a1/main.PMC5310593.pdf
This is a n open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).Keywords: Inborn errors of metabolismAdulthoodClinical characteristics 1.,Non-OADS,/arxiv_data1/oa_pdf/d5/f1/main.PMC5310594.pdf
http://dx.doi.org/10.1016/j.ymgmr.2017.01.011 2214-4269/© 2017 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/d5/f1/main.PMC5310594.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/d5/f1/main.PMC5310594.pdf
The full terms of this license are available at https://www.dovepress.com/terms.,Non-OADS,/arxiv_data1/oa_pdf/e5/57/jpr-10-349.PMC5310634.pdf
"php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/).",OADS,/arxiv_data1/oa_pdf/e5/57/jpr-10-349.PMC5310634.pdf
"For  permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).Journal of Pain Research 2017:10 349–357Journal of Pain Research Dovepress submit your manuscript | www.dovepress.com Dovepress  349 ORIGINAL RESEARCH open access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/JPR.S120092Neuronal plasticity of trigeminal ganglia in mice  following nerve injury Randi Lynds1,2,*  Chuang Lyu3,*  Gong-Wei Lyu4  Xie-Qi Shi1,2  Annika Rosén5,6  Kamal Mustafa6  Tie-Jun Sten Shi7 1Department of Dental Medicine,   Karolinska Institutet, Huddinge,   Sweden; 2Division of Oral and  Maxillofacial Radiology, Department of Clinical Dentistry, Faculty of Medicine and Dentistry, University of Bergen, Bergen, Norway;  3State  Key Laboratory of Veterinary Biotechnology, Harbin Veterinary Research Institute of Chinese Academy of Agricultural Sciences,   4Department of Neurology, The First  Hospital of Harbin Medical University,  Harbin, People’s Republic of China;     5Division for Oral and Maxillofacial  Surgery, 6Tissue Engineering Group,   Department of Clinical Dentistry,  Faculty of Medicine and Dentistry,   7Department of Biomedicine,   University of Bergen, Bergen, Norway *These authors contributed equally to  this workBackground: Nerve injury may induce neuropathic pain.",Non-OADS,/arxiv_data1/oa_pdf/e5/57/jpr-10-349.PMC5310634.pdf
"Keywords: infraorbital nerve, orofacial pain, sensory neurons, neuropeptides, animal model Introduction Trigeminal neuralgia is regarded as being one of the most painful diseases known.1  Pain resulting from this disease impairs patients’ mood, quality of life, daily life activi- ties, and work performance.2 Known factors that can cause trigeminal neuralgia are  injury, inflammation, and vascular compression of the trigeminal nerve.3,4 However,  the mechanisms of trigeminal neuralgia are still poorly understood.Correspondence: Tie-Jun Sten Shi   Department of Clinical Dentistry,  University of Bergen, Årstadveien 19, PO Box 7804, 5020 Bergen, Norway   Tel +47 4539 2855 Email tjstenshi@gmail.comJournal name: Journal of Pain Research  Article Designation: ORIGINAL RESEARCHY ear: 2017V olume: 10Running head verso: Lynds et alRunning head recto: Neuronal plasticity of TGs in mice following nerve injuryDOI: http://dx.doi.org/10.2147/JPR.S120092",Non-OADS,/arxiv_data1/oa_pdf/e5/57/jpr-10-349.PMC5310634.pdf
"Journal of Pain Research 2017:10submit your manuscript | www.dovepress.com Dovepress Dovepress Journal of Pain Research Publish your work in this journal Submit your manuscript here:  https://www.dovepress.com/journal-of-pain-research-journal The Journal of Pain Research is an international, peer reviewed, open  access, online journal that welcomes laboratory and clinical findings   in the fields of pain research and the prevention and management of pain.",Non-OADS,/arxiv_data1/oa_pdf/e5/57/jpr-10-349.PMC5310634.pdf
Visit http://www.dovepress.com/testimonials.php to read real quotes from published authors.Dovepress 357 Neuronal plasticity of TGs in mice following nerve injury 53.,Non-OADS,/arxiv_data1/oa_pdf/e5/57/jpr-10-349.PMC5310634.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/cd/c7/ijn-12-1171.PMC5310635.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).International Journal of Nanomedicine 2017:12 1171–1182International Journal of Nanomedicine Dove press submit your manuscript | www.dovepress.co m Dove press  1171RevIewopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/IJN.S12615 4 Harnessing supramolecular peptide  nanotechnology in biomedical applications Kiat Hwa Chan1 wei Hao Lee2 Shuangmu Zhuo3 Ming Ni3 1Division of Science, Yale-NUS  College, Singapore; 2Department  of Chemistry, Krieger School of  Arts & Sciences, Johns Hopkins  University, Baltimore, MD, USA;   3Fujian Provincial Key Laboratory  for Photonics Technology, Key  Laboratory of Opto electronic  Science and Technology for  Medicine of Ministry of education,   Fujian Normal University, Fuzhou,   People’s Republic of ChinaAbstract:  The harnessing of peptides in biomedical applications is a recent hot topic.",Non-OADS,/arxiv_data1/oa_pdf/cd/c7/ijn-12-1171.PMC5310635.pdf
"This feature has been  extensively exploited in the design of artificial proteins, in which hydrophobic residues Correspondence: Shuangmu Zhuo;  Ming Ni College of Photonic and electronic  engineering, Fujian Normal University,  Shangsan Road, Cangshan District,  Fuzhou City, Fujian Province, 350007,  People’s Republic of China email shuangmuzhuo@gmail.co m;   mingni.sg@gmail.co m Journal name: International Journal of Nanomedicine Article Designation: Review Y ear: 2017 Volume: 12 Running head verso: Chan et al Running head recto: Harnessing supramolecular peptide nanotechnology DOI: http://dx.doi.org/10.2147/IJN.S126154",Non-OADS,/arxiv_data1/oa_pdf/cd/c7/ijn-12-1171.PMC5310635.pdf
"Creative Commons license and disclaimer available from: http://creativecommons.org/licenses/by/4.0/legalcod e.56 are used for polypeptides, whereas solid-phase peptide  synthesis can be utilized for oligopeptides.",Non-OADS,/arxiv_data1/oa_pdf/cd/c7/ijn-12-1171.PMC5310635.pdf
Creative Commons license  and disclaimer available from: http://creativecommons.org/licenses/by/4.0/legalcod e.36 The sequences are from N– .C.,Non-OADS,/arxiv_data1/oa_pdf/cd/c7/ijn-12-1171.PMC5310635.pdf
"International Journal of Nanomedicine Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-nanomedicine-journa lThe International Journal of Nanomedicine is an international, peer- reviewed journal focusing on the application of nanotechnology   in diagnostics, therapeutics, and drug delivery systems throughout   the biomedical field.",Non-OADS,/arxiv_data1/oa_pdf/cd/c7/ijn-12-1171.PMC5310635.pdf
Visit http://www.dovepress.com/ testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/cd/c7/ijn-12-1171.PMC5310635.pdf
The full terms of this license are available at https://www.dovepress.com/terms.,Non-OADS,/arxiv_data1/oa_pdf/74/7e/jpr-10-341.PMC5310636.pdf
"php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/).",OADS,/arxiv_data1/oa_pdf/74/7e/jpr-10-341.PMC5310636.pdf
"For  permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).Journal of Pain Research 2017:10 341–348Journal of Pain Research Dovepress submit your manuscript | www.dovepress.com Dovepress  341 PERSPECTIVES open access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/JPR.S121920The use of rotation to fentanyl in cancer-related  pain Delia Dima1 Ciprian T omuleasa1 Ioana Frinc1 Sergiu Pasca2 Lorand Magdo2 Ioana Berindan-Neagoe2–4 Mihai Muresan5 Cosmin Lisencu5 Alexandru Irimie5,6 Mihnea Zdrenghea1,7 1Department of Hematology, Ion  Chiricuta Oncology Institute, 2Faculty  of Medicine, Research Center for  Functional Genomics and Translational Medicine, Iuliu Hatieganu University of Medicine and Pharmacy, Iuliu Hatieganu,  3Department of Functional  Genomics, The Oncology Institute Ion Chiricuta,  4Medfuture Research  Center for Advanced Medicine,  University of Medicine and Pharmacy,  Iuliu Hatieganu,  5Department of  Surgery, Ion Chiricuta Oncology Institute,  6Department of Oncology,   University of Medicine and Pharmacy,  Iuliu Hatieganu,  7Department  of Hematology, Iuliu Hatieganu University of Medicine and Pharmacy,  Cluj Napoca, RomaniaAbstract: Pain is commonly diagnosed with respect to cancer and heart diseases, being a major  symptom in most neoplastic diseases.",Non-OADS,/arxiv_data1/oa_pdf/74/7e/jpr-10-341.PMC5310636.pdf
"7,8 A proper risk evaluation must be undertaken when prescribing opioids, Correspondence: Ciprian Tomuleasa Department of Hematology, Ion Chiricuta Oncology Institute/Research Center for Functional Genomics and Translational Medicine, Iuliu Hatieganu University of Medicine and Pharmacy, Strada Gheorghe Marinescu No 23, Cluj Napoca 400124, RomaniaTel +40 264 74133 7480Email ciprian.tomuleasa@umfcluj.roJournal name: Journal of Pain Research  Article Designation: PERSPECTIVESY ear: 2017V olume: 10Running head verso: Dima et alRunning head recto: Use of rotation to fentanyl in cancer-related painDOI: http://dx.doi.org/10.2147/JPR.S121920",Non-OADS,/arxiv_data1/oa_pdf/74/7e/jpr-10-341.PMC5310636.pdf
"Journal of Pain Research 2017:10submit your manuscript | www.dovepress.com Dovepress Dovepress Journal of Pain Research Publish your work in this journal Submit your manuscript here:  https://www.dovepress.com/journal-of-pain-research-journal The Journal of Pain Research is an international, peer reviewed, open  access, online journal that welcomes laboratory and clinical findings   in the fields of pain research and the prevention and management of pain.",Non-OADS,/arxiv_data1/oa_pdf/74/7e/jpr-10-341.PMC5310636.pdf
Visit http://www.dovepress.com/testimonials.php to read real quotes from published authors.Dovepress 348 Dima et al 48.,Non-OADS,/arxiv_data1/oa_pdf/74/7e/jpr-10-341.PMC5310636.pdf
The full terms of this license are available at https://www.dovepress.com/terms.,Non-OADS,/arxiv_data1/oa_pdf/7b/5e/jpr-10-311.PMC5310637.pdf
"php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/).",OADS,/arxiv_data1/oa_pdf/7b/5e/jpr-10-311.PMC5310637.pdf
"For  permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).Journal of Pain Research  2017:10 311–317Journal of Pain Research Dovepress submit your manuscript | www.dovepress.com Dovepress  311 ORIGINAL RESEARCH open access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/JPR.S123487Benzodiazepine use in patients with chronic pain  in an interdisciplinary pain rehabilitation program Julie L Cunningham1 Julia R Craner2,3 Michele M Evans2 W Michael Hooten4 1Department of Pharmacy, Mayo  Clinic College of Medicine, Rochester,   MN, 2Department of Psychiatry and  Psychology, Mayo Clinic, Mayo Clinic College of Medicine, Rochester,  MN,  3Department of Psychiatry  and Behavioral Medicine, Spectrum Health System, Grand Rapids, MI,   4Department of Anesthesiology, Mayo  Clinic, and Mayo Clinic College of Medicine, Rochester, MN, USAObjectives:  In the context of widespread opioid use, increased emphasis has been placed on  the potentially deleterious effects of concurrent benzodiazepine (BZD) and opioid use.",Non-OADS,/arxiv_data1/oa_pdf/7b/5e/jpr-10-311.PMC5310637.pdf
"When administered concurrently,  BZD-related inhibitory effects can be synergistic with the inhibitory effects of opioids.Correspondence: Julie L Cunningham Department of Pharmacy and Mayo Clinic College of Medicine, 200 First Street SW, Rochester, MN 55905, USATel +1 507 255 0415Fax +1 507 255 7556Email cunningham.julie2@mayo.eduJournal name: Journal of Pain Research  Article Designation: ORIGINAL RESEARCHY ear: 2017V olume: 10Running head verso: Cunningham et alRunning head recto: Benzodiazepines in chronic painDOI: http://dx.doi.org/10.2147/JPR.S123487",Non-OADS,/arxiv_data1/oa_pdf/7b/5e/jpr-10-311.PMC5310637.pdf
"Journal of Pain Research  2017:10submit your manuscript | www.dovepress.com Dovepress Dovepress Journal of Pain Research  Publish your work in this journal Submit your manuscript here:  https://www.dovepress.com/journal-of-pain-research-journal The Journal of Pain Research is an international, peer reviewed, open  access, online journal that welcomes laboratory and clinical findings   in the fields of pain research and the prevention and management of pain.",Non-OADS,/arxiv_data1/oa_pdf/7b/5e/jpr-10-311.PMC5310637.pdf
Visit http://www.dovepress.com/testimonials.php to read real quotes from published authors.Dovepress 317 Benzodiazepines in chronic pain 36.,Non-OADS,/arxiv_data1/oa_pdf/7b/5e/jpr-10-311.PMC5310637.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/52/2a/ijn-12-1143.PMC5310638.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).International Journal of Nanomedicine 2017:12 1143–1160International Journal of Nanomedicine Dove press submit your manuscript | www.dovepress.co m Dove press  1143OrIg INal researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/IJN.S12129 9 Protein nanocoatings on synthetic polymeric  nanofibrous membranes designed as carriers  for skin cells Marketa Bacakova1,2 Julia Pajorova1,2 Denisa stranska3 Daniel Hadraba1,4 Frantisek lopot4 T omas riedel5 eduard Brynda5 Margit Zaloudkova6 lucie Bacakova1 1Department of Biomaterials  and Tissue engineering, Institute  of Physiology, czech academy  of sciences, 2second Faculty of  Medicine,  charles University,   Prague, 3Instar T echnologies,   Liberec, 4Department of anatomy  and Biomechanics, Faculty of  Physical education and sport,   charles University, 5Department  of chemistry and Physics of  surfaces and Biointerfaces, Institute  of Macromolecular chemistry,   6Department of composites and  Carbon Materials, Institute of Rock  structure and Mechanics, czech  academy of sciences, Prague,   Czech RepublicAbstract:  Protein-coated resorbable synthetic polymeric nanofibrous membranes are promising  for the fabrication of advanced skin substitutes.",Non-OADS,/arxiv_data1/oa_pdf/52/2a/ijn-12-1143.PMC5310638.pdf
"Moreover, the pores can ensure the supply of cells with active biological molecules,  mainly with nutrients and growth factors from the cell culture medium or from the correspondence: Marketa Bacakova Department of Biomaterials and  Tissue engineering, Institute of  Physiology, czech academy of sciences,  1083 Vídeňská, Prague 4 14220,  Czech Republic Tel +420 296 443 765 email marketa.bacakova@fgu.cas.c z Journal name: International Journal of Nanomedicine Article Designation: Original Research Y ear: 2017 Volume: 12 Running head verso: Bacakova et al Running head recto: Protein-coated nanofibers for skin cells DOI: http://dx.doi.org/10.2147/IJN.S121299",Non-OADS,/arxiv_data1/oa_pdf/52/2a/ijn-12-1143.PMC5310638.pdf
"International Journal of Nanomedicine Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-nanomedicine-journa lThe International Journal of Nanomedicine is an international, peer- reviewed journal focusing on the application of nanotechnology   in diagnostics, therapeutics, and drug delivery systems throughout   the biomedical field.",Non-OADS,/arxiv_data1/oa_pdf/52/2a/ijn-12-1143.PMC5310638.pdf
Visit http://www.dovepress.com/ testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/52/2a/ijn-12-1143.PMC5310638.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/72/85/ijn-12-1113.PMC5310639.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).International Journal of Nanomedicine 2017:12 1113–1126International Journal of Nanomedicine Dove press submit your manuscript | www.dovepress.co m Dove press  1113OrIg INal researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/IJN.S12322 8 Fe3O4-based Plga nanoparticles as Mr contrast  agents for the detection of thrombosis Jia liu1 Jie Xu1 Jun Zhou1 Yu Zhang1 Dajing guo1 Zhigang Wang2 1Department of radiology,   2Department of Ultrasound, Institute  of Ultrasound Imaging, The second  affiliated hospital of chongqing  Medical University, Yuzhong,   chongqing, People’s republic of chinaAbstract:  Thrombotic disease is a great threat to human health, and early detection is particularly  important.",Non-OADS,/arxiv_data1/oa_pdf/72/85/ijn-12-1113.PMC5310639.pdf
"A variety of particles have been  reported in the literature for thrombosis detection.4–17 Compared with ultrasound,4–8  nuclear medicine,9,10,18 and computed tomography (CT),11 the advantages of magnetic  resonance imaging (MRI) that are particularly relevant in the context of cardiovascular  diseases are its high temporal and spatial imaging resolution, high soft tissue contrast, correspondence: Dajing guo Department of radiology, The second  Affiliated Hospital of Chongqing Medical  University, No 74 linjiang rd, Yuzhong  District, 400010 chongqing, People’s  republic of china Tel +86 23 6369 3781 email guodaj@163.co m Journal name: International Journal of Nanomedicine Article Designation: Original Research Y ear: 2017 Volume: 12 Running head verso: Liu et al Running head recto: Fe3O4-based PLGA nanoparticles for the detection of thrombus DOI: http://dx.doi.org/10.2147/IJN.S123228",Non-OADS,/arxiv_data1/oa_pdf/72/85/ijn-12-1113.PMC5310639.pdf
"International Journal of Nanomedicine Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-nanomedicine-journa lThe International Journal of Nanomedicine is an international, peer- reviewed journal focusing on the application of nanotechnology   in diagnostics, therapeutics, and drug delivery systems throughout   the biomedical field.",Non-OADS,/arxiv_data1/oa_pdf/72/85/ijn-12-1113.PMC5310639.pdf
Visit http://www.dovepress.com/ testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/72/85/ijn-12-1113.PMC5310639.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/42/6b/ijn-12-1161.PMC5310640.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).International Journal of Nanomedicine 2017:12 1161–1169International Journal of Nanomedicine Dove press submit your manuscript | www.dovepress.co m Dove press  1161OrIg INal researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/IJN.S11975 0 Decreased bacterial growth on titanium  nanoscale topographies created by ion beam  assisted evaporation Michelle stolzoff1 Jason e Burns2 arash aslani2 eric J T obin2 congtin Nguyen1 Nicholas De la T orre3 Negar h golshan3 Katherine s Ziemer3 Thomas J Webster1,3,4 1Department of Bioengineering,   Northeastern University, Boston,   2N2 Biomedical, Bedford, M a,   3Department of chemical engineering,   Northeastern University, Boston,   Ma, Usa; 4center of excellence  for advanced Materials research,   University of King abdulaziz, Jeddah,   saudi arabiaAbstract:  Titanium is one of the most widely used materials for orthopedic implants, yet it  has exhibited significant complications in the short and long term, largely resulting from poor  cell–material interactions.",Non-OADS,/arxiv_data1/oa_pdf/42/6b/ijn-12-1161.PMC5310640.pdf
"Insect wings, for example, employ correspondence: Thomas J Webster Department of chemical engineering,  Northeastern University, 360 huntington  ave, Boston, Ma 02115, Usa email th.webster@neu.ed u Journal name: International Journal of Nanomedicine Article Designation: Original Research Y ear: 2017 Volume: 12 Running head verso: Stolzoff et al Running head recto: Decreased bacterial growth on titanium nanoscale topographies DOI: http://dx.doi.org/10.2147/IJN.S119750",Non-OADS,/arxiv_data1/oa_pdf/42/6b/ijn-12-1161.PMC5310640.pdf
"International Journal of Nanomedicine Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-nanomedicine-journa lThe International Journal of Nanomedicine is an international, peer- reviewed journal focusing on the application of nanotechnology   in diagnostics, therapeutics, and drug delivery systems throughout   the biomedical field.",Non-OADS,/arxiv_data1/oa_pdf/42/6b/ijn-12-1161.PMC5310640.pdf
Visit http://www.dovepress.com/ testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/42/6b/ijn-12-1161.PMC5310640.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/a1/05/ijn-12-1097.PMC5310641.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).International Journal of Nanomedicine 2017:12 1097–1111International Journal of Nanomedicine Dove press submit your manuscript | www.dovepress.co m Dove press  1097RevIewopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/IJN.S12460 1 Phytobioactive compound-based nanodelivery  systems for the treatment of type 2 diabetes  mellitus – current status Palanivel Ganesan1,2 Palanisamy Arulselvan3 Dong-Kug Choi1,2 1Nanotechnology Research Center  and Department of Applied  Life Science, 2Department of  Biotechnology, College of Biomedical  and Health Science, Konkuk  University, Chungju, Republic of  Korea; 3Laboratory of vaccines and  Immunotherapeutics, Institute of  Bioscience, Universiti Putra Malaysia,   Serdang, MalaysiaAbstract:  Type 2 diabetes mellitus (T2DM) is a major chronic disease that is prevalent world - wide, and it is characterized by an increase in blood glucose, disturbances in the metabolism,  and alteration in insulin secretion.",Non-OADS,/arxiv_data1/oa_pdf/a1/05/ijn-12-1097.PMC5310641.pdf
"Many factors related to this disease can be  controlled through a change in lifestyle and activities.3,4 Inflammation for this disease,  and the associated complications, can be effectively reduced by taking certain drugs,  and recently, the consumption of phytobioactive compounds – such as polyphenols,  flavanones, curcumin, terpenoids, and quercetin rich foods – has shown potential  antidiabetic effects without any other complications.5,6 Many researchers have  orally administered phytobioactive compounds to show its beneficial effect on T2DM  and its complications.7–15 However, many food grade bioactive compounds taken  through oral means undergo a substantial loss in bioactivity, and thereby, the antidi - abetic activity of the phytobioactive compounds is diminished.Correspondence: Dong-Kug Choi Nanotechnology Research Center and  Department of Applied Life Science,  College of Biomedical and Health Science,  Konkuk University, 268 Chungwon- daero, Chungju-si, Chungcheongbuk-do,  Republic of Korea Tel +82 43 840 3610 Fax +82 43 840 3872 email choidk@kku.ac.k r Journal name: International Journal of Nanomedicine Article Designation: Review Y ear: 2017 Volume: 12 Running head verso: Ganesan et al Running head recto: Nanodelivery systems for type 2 diabetes mellitus DOI: http://dx.doi.org/10.2147/IJN.S124601",Non-OADS,/arxiv_data1/oa_pdf/a1/05/ijn-12-1097.PMC5310641.pdf
"International Journal of Nanomedicine Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-nanomedicine-journa lThe International Journal of Nanomedicine is an international, peer- reviewed journal focusing on the application of nanotechnology   in diagnostics, therapeutics, and drug delivery systems throughout   the biomedical field.",Non-OADS,/arxiv_data1/oa_pdf/a1/05/ijn-12-1097.PMC5310641.pdf
Visit http://www.dovepress.com/ testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/a1/05/ijn-12-1097.PMC5310641.pdf
"The full terms of this license are available at https://www.dovepress.com/ terms.php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/e1/23/lctt-7-063.PMC5310692.pdf
"For  permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).Modern management of malignant pleural  mesothelioma Shivani C Patel1 Jonathan E Dowell1,2 1Division of Hematology and Oncology,  University of T exas Southwestern,  2Section of Hematology and Oncology,  Veterans Affairs North Texas  Healthcare System, Dallas, TX, USA Correspondence: Jonathan E Dowell   Division of Hematology and Oncology,  University of T exas Southwestern,  5323 Harry Hines Boulevard, Dallas,  TX 75390-8852, USA   Email jonathan.dowell@utsouthwestern.",Non-OADS,/arxiv_data1/oa_pdf/e1/23/lctt-7-063.PMC5310692.pdf
"Available  from: http://seer.cancer.gov/archive/csr/1975_2010/results_merged/ sect_17_mesothelioma.pd f. Accessed September 15, 2015.",OADS,/arxiv_data1/oa_pdf/e1/23/lctt-7-063.PMC5310692.pdf
"Lung Cancer: Targets and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/lung-cancer-targets--therapy-journa lLung Cancer: Targets and Therapy is an international, peer-reviewed, open access  journal focusing on lung cancer research, identification of therapeutic targets and  the optimal use of preventative and integrated treatment interventions to achieve  improved outcomes, enhanced survival and quality of life for the cancer patient.",Non-OADS,/arxiv_data1/oa_pdf/e1/23/lctt-7-063.PMC5310692.pdf
Visit http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/e1/23/lctt-7-063.PMC5310692.pdf
The full terms of this license are available at https://www.dovepress.com/terms.,Non-OADS,/arxiv_data1/oa_pdf/78/7a/lctt-7-073.PMC5310693.pdf
"php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",OADS,/arxiv_data1/oa_pdf/78/7a/lctt-7-073.PMC5310693.pdf
"For  permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).Fatigue in lung cancer patients: symptom burden  and management of challenges Simona Carnio Rosario Francesco Di  Stefano Silvia Novello Oncology Department, University of  T urin, AOU San Luigi, Orbassano, Italy Correspondence: Silvia Novello   Oncology Department, University  of T urin, AOU San Luigi, Regione  Gonzole 10, Orbassano, T urin 10043, Italy   Email silvia.novello@unito.i tAbstract:  Lung cancer (LC) remains the most common cause of cancer death in several countries  across the world.",Non-OADS,/arxiv_data1/oa_pdf/78/7a/lctt-7-073.PMC5310693.pdf
"Available from: http://www.nccn.org/professionals/ physician_gls/pdf/fatigue.pd f. Accessed March 16, 2016.",Non-OADS,/arxiv_data1/oa_pdf/78/7a/lctt-7-073.PMC5310693.pdf
Available  from: http://www.nccn.org/professionals/physician_gls/f_guidelines.,Non-OADS,/arxiv_data1/oa_pdf/78/7a/lctt-7-073.PMC5310693.pdf
"Available from: http://www.cancer.org/ healthy/eathealthygetactive/csguidelinesonnutritionphysicalactivity - forcancerprevention/acsguidelines-on-nutrition-and-physical-activity- for-cancer prevention-summar y. Accessed August 14, 2014.",Non-OADS,/arxiv_data1/oa_pdf/78/7a/lctt-7-073.PMC5310693.pdf
Available  from: http://www.who.int/cancer/palliative/definition /en/ 2011.,Non-OADS,/arxiv_data1/oa_pdf/78/7a/lctt-7-073.PMC5310693.pdf
"Lung Cancer: Targets and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/lung-cancer-targets--therapy-journa lLung Cancer: Targets and Therapy is an international, peer-reviewed, open access  journal focusing on lung cancer research, identification of therapeutic targets and  the optimal use of preventative and integrated treatment interventions to achieve  improved outcomes, enhanced survival and quality of life for the cancer patient.",Non-OADS,/arxiv_data1/oa_pdf/78/7a/lctt-7-073.PMC5310693.pdf
Visit http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/78/7a/lctt-7-073.PMC5310693.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p and  incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/fe/39/lctt-7-001.PMC5310694.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).Lung Cancer: Targets and Therapy 2016:7 1–9Lung Cancer: Targets and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  1Reviewopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/LCTT .S8534 7Nutrition support and dietary interventions for  patients with lung cancer: current insights Nicole Kiss1,2 1Nutrition and Speech Pathology  Department, Peter MacCallum Cancer  Centre, east Melbourne, viC, Australia;   2Department of Cancer experiences  Research, Peter MacCallum Cancer  Centre, east Melbourne, viC, Australia Correspondence: Nicole Kiss   Nutrition and Speech Pathology  Department, Locked Bag  1,   A’Beckett Street, east Melbourne,   viC 3002, Australia   Tel +61 3 9656 1002  Fax +61 3 9656 1402  email n icole.kiss@petermac.or gAbstract:  Malnutrition and weight loss are prevalent in patients with lung cancer.",Non-OADS,/arxiv_data1/oa_pdf/fe/39/lctt-7-001.PMC5310694.pdf
Available from: http://globocan.iarc.fr/Pages/fact_sheets_population.,OADS,/arxiv_data1/oa_pdf/fe/39/lctt-7-001.PMC5310694.pdf
Available from: http://www.cancer.,Non-OADS,/arxiv_data1/oa_pdf/fe/39/lctt-7-001.PMC5310694.pdf
Available from: http://www.cancer.,Non-OADS,/arxiv_data1/oa_pdf/fe/39/lctt-7-001.PMC5310694.pdf
Available from: https://www.nhmrc.gov.au/guidelines-publications/ cp97.,Non-OADS,/arxiv_data1/oa_pdf/fe/39/lctt-7-001.PMC5310694.pdf
Available  from: http://www.andeal.org/topic.cfm?menu =2819&cat =5066.,Non-OADS,/arxiv_data1/oa_pdf/fe/39/lctt-7-001.PMC5310694.pdf
Visit http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/fe/39/lctt-7-001.PMC5310694.pdf
"Submit your manuscript here:  http://www.dovepress.com/lung-cancer-targets--therapy-journa l Lung Cancer: Targets and Therapy 2016:7submit your manuscript | www.dovepress.co m Dove press Dove press Dove pres s 9Nutrition support and dietary interventions  52. van der Meij BS, Phernambucq EC, Fieten GM, et  al.",Non-OADS,/arxiv_data1/oa_pdf/fe/39/lctt-7-001.PMC5310694.pdf
"The full terms of this license are available at https://www.dovepress.com/ terms.php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/95/00/lctt-7-011.PMC5310695.pdf
"For  permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).Lung Cancer: Targets and Therapy 2016:7 11–17Lung Cancer: Targets and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  11Reviewopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/LCTT .S6034 4HSP90 as a novel molecular target in non-small- cell lung cancer Khashayar esfahani victor Cohen Segal Cancer Center, Jewish General  Hospital, McGill University, Montreal,   QC, Canada Correspondence: victor Cohen   Segal Cancer Center, Jewish General  Hospital, McGill University, 3755 Chemin  de la Côte-Sainte-Catherine, Montreal,  QC, H3T 1e2, Canada   email v cohen@jgh.mcgill.c aAbstract:  Lung cancer remains the most lethal cancer, with over 160,000 annual deaths in the  USA alone.",Non-OADS,/arxiv_data1/oa_pdf/95/00/lctt-7-011.PMC5310695.pdf
Visit http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/95/00/lctt-7-011.PMC5310695.pdf
Submit your manuscript here:  http://www.dovepress.com/lung-cancer-targets--therapy-journa l Lung Cancer: Targets and Therapy 2016:7submit your manuscript | www.dovepress.co m Dove press Dove press Dove pres s 17HSP90 inhibitors in NSCLC,Non-OADS,/arxiv_data1/oa_pdf/95/00/lctt-7-011.PMC5310695.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/86/bd/lctt-7-019.PMC5310696.pdf
"Information on how to  request permission may be found at: http://www.dovepress.com/permissions.ph pLung Cancer: Targets and Therapy 2016:7 19–27Lung Cancer: Targets and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  19Reviewopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/LCTT .S6034 1miRNA-21 as a novel therapeutic target   in lung cancer Athina Markou Martha Zavridou evi S Lianidou Analysis of Circulating T umor Cells,   Laboratory of Analytical Chemistry,   Department of Chemistry, University  of Athens, Athens, Greece Correspondence: evi S Lianidou   Analysis of Circulating Tumor Cells,  Laboratory of Analytical Chemistry,  Department of Chemistry, University   of Athens, Athens 15771, Greece   Tel +30 21 0727 4319   Fax +30 21 0727 4750   email lianidou@chem.uoa.g rAbstract:  Lung cancer is a leading cause of cancer death, and late diagnosis is one of the most  important reasons for the high mortality rate.",Non-OADS,/arxiv_data1/oa_pdf/86/bd/lctt-7-019.PMC5310696.pdf
Visit http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/86/bd/lctt-7-019.PMC5310696.pdf
Submit your manuscript here:  http://www.dovepress.com/lung-cancer-targets--therapy-journa l Lung Cancer: Targets and Therapy 2016:7submit your manuscript | www.dovepress.co m Dove press Dove press Dove pres s 27miRNA-21 as a novel therapeutic target in lung cancer  80.,Non-OADS,/arxiv_data1/oa_pdf/86/bd/lctt-7-019.PMC5310696.pdf
The full terms of this license are available at https://www.dovepress.com/terms.,Non-OADS,/arxiv_data1/oa_pdf/7d/ac/lctt-7-035.PMC5310697.pdf
"php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",OADS,/arxiv_data1/oa_pdf/7d/ac/lctt-7-035.PMC5310697.pdf
"For  permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).Lung Cancer: Targets and Therapy Lung Cancer: Targets and Therapy 2016:7 35–44Dove press submit your manuscript | www.dovepress.co m Dove press  OriginaL  researChopen access to scientific and medical research Open access Full T ext article 35 http: //dx.doi.org/10.2147/LCTT .S10018 4retrospective analysis of outcomes and  prognostic factors of chemotherapy for small-cell  lung cancer seigo Minami Y oshitaka Ogata shouichi ihara suguru Yamamoto Kiyoshi Komuta Department of respiratory Medicine,   Osaka Police hospital, Osaka, Japan Correspondence: seigo Minami   Department of respiratory Medicine,  Osaka Police hospital, 10-31 Kitayama-cho,   T ennoji-ku, Osaka 543-0035, Japan   T el +81 6 6771 6051   Fax +81 6 6771 2838   email seigominami@oph.gr.j pBackground:  Small-cell lung cancer (SCLC) is responsive to initial chemotherapy but  becomes resistant to cytotoxic drugs.",Non-OADS,/arxiv_data1/oa_pdf/7d/ac/lctt-7-035.PMC5310697.pdf
"National Cancer Institute, Cancer Therapy Evaluation Program [homep - age on the Internet], Common Toxicity Criteria, Version 2.0 [published  1999 April 30] Available from: http://ctep.cancer.gov/protocolDeve- lopment/electronic_applications/docs/ctcv20_4-30-992.pd f. Accessed  March 12, 2016.",Non-OADS,/arxiv_data1/oa_pdf/7d/ac/lctt-7-035.PMC5310697.pdf
"Lung Cancer: Targets and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/lung-cancer-targets--therapy-journa lLung Cancer: Targets and Therapy is an international, peer-reviewed, open access  journal focusing on lung cancer research, identification of therapeutic targets and  the optimal use of preventative and integrated treatment interventions to achieve  improved outcomes, enhanced survival and quality of life for the cancer patient.",Non-OADS,/arxiv_data1/oa_pdf/7d/ac/lctt-7-035.PMC5310697.pdf
Visit http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/7d/ac/lctt-7-035.PMC5310697.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p  and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/ab/c6/lctt-7-029.PMC5310698.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).Lung Cancer: Targets and Therapy 2016:7 29–34submit your manuscript | www.dovepress.co m Dove press  29 http: //dx.doi.org/10.2147/LCTT .S8511 2Optimal delivery of follow-up care following  pulmonary lobectomy for lung cancer Ying-Yi Chen Tsai-w ang Huang Hung Chang Shih-Chun Lee Division of Thoracic Surgery,   Department of Surgery, Tri-Service  General Hospital, National Defense  Medical Center, Taipei, Taiwan Correspondence: Shih-Chun Lee   Division of Thoracic Surgery, Department  of Surgery, Tri-Service General Hospital,  325, Section 2, Cheng-Kung Road,   Taipei 114, Taiwan, Republic of China   T el +886 2 8792 7167   Fax +886 2 8792 7403   email leesc001@yahoo.com.t wIntroduction:  The rationale for oncologic surveillance following pulmonary lobectomy is to  detect recurrent disease or a second primary lung cancer early enough so that an intervention  can increase survival and/or improve quality of life.",Non-OADS,/arxiv_data1/oa_pdf/ab/c6/lctt-7-029.PMC5310698.pdf
"Lung Cancer: Targets and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/lung-cancer-targets--therapy-journa lLung Cancer: Targets and Therapy is an international, peer-reviewed, open access  journal focusing on lung cancer research, identification of therapeutic targets and  the optimal use of preventative and integrated treatment interventions to achieve  improved outcomes, enhanced survival and quality of life for the cancer patient.",Non-OADS,/arxiv_data1/oa_pdf/ab/c6/lctt-7-029.PMC5310698.pdf
Visit http://www.dovepress.com/testimonials.php to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/ab/c6/lctt-7-029.PMC5310698.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/bf/ad/lctt-7-053.PMC5310699.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.ph pLung Cancer: Targets and Therapy 2016:7 53–61Lung Cancer: Targets and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  53OriginaL  researChopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/LCTT .S9069 4high expression of aKr1C1 is associated with  proliferation and migration of small-cell lung  cancer cells he Tian1 Xing Li2 Wenli Jiang3 Cuiting Lv3 Weizhang sun4 Caiguo huang3 ruohua Chen5 1Department of Pediatrics of  Changhai hospital, second Military  Medical University, shanghai, People’s  republic of China; 2Department  of gynecology and Obstetrics of  Changhai hospital, second Military  Medical University, shanghai, People’s  republic of China; 3Department of  Biochemistry and Molecular Biology,   second Military Medical University,   shanghai, People’s republic of China;   4PeT Center, Chengdu Military  Command region general hospital,   Chengdu, People’s republic of China;   5ViP Clinic of Changhai hospital,   second Military Medical University,   shanghai, People’s republic of China  Correspondence: Caiguo huang   Department of Biochemistry and  Molecular Biology, second Military  Medical University, shanghai, 200433,  People’s republic of China   T el +86 130 0315 8543   email huangcaig@hotmail.co m    ruohua Chen   ViP Clinic of Changhai hospital, second  Military Medical University, shanghai,  200433, People’s republic of China   T el +86 136 0166 6610   email crhkbl@yeah.ne tAbstract:  AKR1C1 is a member of the AKR1C family, which not only plays an important role  in hormone metabolism but is believed to be involved in carcinogen metabolism.",Non-OADS,/arxiv_data1/oa_pdf/bf/ad/lctt-7-053.PMC5310699.pdf
Visit http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/bf/ad/lctt-7-053.PMC5310699.pdf
Submit your manuscript here:  http://www.dovepress.com/lung-cancer-targets--therapy-journa l Lung Cancer: Targets and Therapy 2016:7submit your manuscript | www.dovepress.co m Dove press Dove press Dove pres s 61The expression and function of aKr1C1 in sCLC  26.,Non-OADS,/arxiv_data1/oa_pdf/bf/ad/lctt-7-053.PMC5310699.pdf
The full terms of this license are available at https://www.dovepress.com/terms.,Non-OADS,/arxiv_data1/oa_pdf/46/e4/lctt-7-045.PMC5310700.pdf
"php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/).",OADS,/arxiv_data1/oa_pdf/46/e4/lctt-7-045.PMC5310700.pdf
"For  permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).Monitoring and management of lung cancer patients  following curative-intent treatment: clinical utility of  2-deoxy-2-[fluorine-18]fluoro-d-glucose positron  emission tomography/computed tomography Shigeki Sawada Hiroshi Suehisa Tsuyoshi Ueno Ryujiro Sugimoto Motohiro Yamashita Department of Thoracic Surgery,   National Hospital Organization  Shikoku Cancer Center, Matsuyama,   Japan Correspondence: Shigeki Sawada   Department of Thoracic Surgery,  Shikoku Cancer Center, 160 Kou,  Minamiumemoto-cho, Matsuyama, Ehime  791-0280, Japan   T el +81 89 999 1111   Fax +81 89 999 1100   Email ssawada@shikoku-cc.go.j pAbstract:  A large number of studies have demonstrated that 2-deoxy-2-[fluorine-18]fluoro- d-glucose positron emission tomography/computed tomography (FDG-PET/CT) is superior  to conventional modalities for the diagnosis of lung cancer and the evaluation of the extent  of the disease.",Non-OADS,/arxiv_data1/oa_pdf/46/e4/lctt-7-045.PMC5310700.pdf
"Available from: http://www.oecd.org/els/health-systems/ List-of-variables-OECD-Health-Statistics-2014.pd f. Accessed April 1,  2016.",OADS,/arxiv_data1/oa_pdf/46/e4/lctt-7-045.PMC5310700.pdf
Visit http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/46/e4/lctt-7-045.PMC5310700.pdf
Submit your manuscript here:  http://www.dovepress.com/lung-cancer-targets--therapy-journa l Lung Cancer: Targets and Therapy 2016:7submit your manuscript | www.dovepress.co m Dove press Dove press Dove pres s 51Follow-up surveillance with PET/CT for lung cancer,Non-OADS,/arxiv_data1/oa_pdf/46/e4/lctt-7-045.PMC5310700.pdf
The full terms of this license are available at https://www.dovepress.com/terms.,Non-OADS,/arxiv_data1/oa_pdf/c6/24/lctt-7-083.PMC5310701.pdf
"php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/).",OADS,/arxiv_data1/oa_pdf/c6/24/lctt-7-083.PMC5310701.pdf
"For  permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).Lung Cancer: Targets and Therapy 2016:7 83–90Lung Cancer: Targets and Therapy Dovepress submit your manuscript | www.dovepress.com Dovepress  83 Review open access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/LCTT .S99303Spotlight on crizotinib in the first-line treatment  of ALK-positive advanced non-small-cell lung  cancer: patients selection and perspectives etienne Giroux Leprieur1,2 vincent Fallet3,4 Jacques Cadranel3,4 Marie wislez3,4 1Respiratory Diseases and Thoracic  Oncology Department, APHP- Ambroise Paré Hospital, Boulogne-Billancourt, France;  2eA4340  Laboratory, UVSQ, Paris-Saclay University, France;  3Respiratory  Diseases Department, APHP – T enon Hospital, Paris, France;  4Sorbonne  University, GRC 04, UPMC Univ   Paris 06, FranceAbstract:  Around 4% of advanced non-small-cell lung cancers (NSCLCs) have an ALK rear - rangement at the time of diagnosis.",Non-OADS,/arxiv_data1/oa_pdf/c6/24/lctt-7-083.PMC5310701.pdf
"3 These drugs are currently authorized Correspondence: Marie wislez Respiratory Diseases Department,   APHP – Tenon Hospital, 4 rue de la Chine, 75970 Paris, FranceTel +33 1 5601 6838Fax +33 1 5601 7248email marie.wislez@tnn.aphp.frJournal name: Lung Cancer: Targets and Therapy Article Designation: ReviewY ear: 2016V olume: 7Running head verso: Giroux Leprieur et alRunning head recto: Crizotinib in the first-line treatment of ALK-positive advanced NSCLCDOI: http://dx.doi.org/10.2147/LCTT.S99303",Non-OADS,/arxiv_data1/oa_pdf/c6/24/lctt-7-083.PMC5310701.pdf
"Lung Cancer: Targets and Therapy 2016:7submit your manuscript | www.dovepress.com Dovepress Dovepress Lung Cancer: Targets and Therapy Publish your work in this journal Submit your manuscript here: https://www.dovepress.com/lung-cancer-targets--therapy-journalLung Cancer: Targets and Therapy is an international, peer-reviewed, open access  journal focusing on lung cancer research, identification of therapeutic targets and the optimal use of preventative and integrated treatment interventions to achieve improved outcomes, enhanced survival and quality of life for the cancer patient.",Non-OADS,/arxiv_data1/oa_pdf/c6/24/lctt-7-083.PMC5310701.pdf
Visit http://www.dovepress.com/testimonials.php to read real quotes from   published authors.Dovepress 90 Giroux Leprieur et al,Non-OADS,/arxiv_data1/oa_pdf/c6/24/lctt-7-083.PMC5310701.pdf
The full terms of this license are available at https://www.dovepress.com/terms.,Non-OADS,/arxiv_data1/oa_pdf/c7/4d/lctt-7-091.PMC5310702.pdf
"php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/).",OADS,/arxiv_data1/oa_pdf/c7/4d/lctt-7-091.PMC5310702.pdf
"For  permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).Lung Cancer: Targets and Therapy 2016:7 91–97Lung Cancer: Targets and Therapy Dovepress submit your manuscript | www.dovepress.com Dovepress  91 REVIEW open access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/LCTT .S94337Profile of rociletinib and its potential in the  treatment of non-small-cell lung cancer Phu N Tran1 Samuel J Klempner2,3 1Division of Hematology/Oncology,   University of California Irvine, Irvine,   CA, 2Angeles Clinic and Research  Institute, 3Cedars-Sinai Medical  Center, Los Angeles, CA, USAAbstract: Patients with non-small-cell lung cancer (NSCLC) harboring activating muta- tions in EGFR benefit from treatment with EGFR small-molecule tyrosine-kinase inhibitors.",Non-OADS,/arxiv_data1/oa_pdf/c7/4d/lctt-7-091.PMC5310702.pdf
"6–8Correspondence: Samuel J Klempner Precision Medicine Program, Angeles Clinic and Research Institute, 11818 Wilshire Boulevard, Los Angeles, CA 90025, USATel +1 310 231 2154Fax +1 310 231 2172Email sklempner@theangelesclinic.orgJournal name: Lung Cancer: Targets and Therapy Article Designation: REVIEWY ear: 2016V olume: 7Running head verso: Tran and KlempnerRunning head recto: Rociletinib for EGFR-mutant NSCLCDOI: http://dx.doi.org/10.2147/LCTT.S94337",Non-OADS,/arxiv_data1/oa_pdf/c7/4d/lctt-7-091.PMC5310702.pdf
"Lung Cancer: Targets and Therapy 2016:7submit your manuscript | www.dovepress.com Dovepress Dovepress Lung Cancer: Targets and Therapy Publish your work in this journal Submit your manuscript here: https://www.dovepress.com/lung-cancer-targets--therapy-journalLung Cancer: Targets and Therapy is an international, peer-reviewed, open access  journal focusing on lung cancer research, identification of therapeutic targets and the optimal use of preventative and integrated treatment interventions to achieve improved outcomes, enhanced survival and quality of life for the cancer patient.",Non-OADS,/arxiv_data1/oa_pdf/c7/4d/lctt-7-091.PMC5310702.pdf
Visit http://www.dovepress.com/testimonials.php to read real quotes from   published authors.Dovepress 97 Rociletinib for EGFR -mutant NSCLC 32.,Non-OADS,/arxiv_data1/oa_pdf/c7/4d/lctt-7-091.PMC5310702.pdf
Available from: http://www.fda.gov/down-loads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/OncologicDrugsAdvisoryCommittee/UCM494782.pdf.,Non-OADS,/arxiv_data1/oa_pdf/c7/4d/lctt-7-091.PMC5310702.pdf
Available from: http://www.businesswire.com/news/home/20151116005513/en.,Non-OADS,/arxiv_data1/oa_pdf/c7/4d/lctt-7-091.PMC5310702.pdf
The full terms of this license are available at https://www.dovepress.com/terms.,Non-OADS,/arxiv_data1/oa_pdf/7e/24/lctt-7-141.PMC5310703.pdf
"php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/).",OADS,/arxiv_data1/oa_pdf/7e/24/lctt-7-141.PMC5310703.pdf
"For  permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).Lung Cancer: Targets and Therapy 2016:7 141–148Lung Cancer: Targets and Therapy Dovepress submit your manuscript | www.dovepress.com Dovepress  141 REVIEW open access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/LCTT .S93604Lung cancer in Brazil: epidemiology and  treatment challenges Vanessa Karen de Sá1,2  Juliano C Coelho3  Vera Luiza Capelozzi1  Sergio Jobim de Azevedo3 1Department of Pathology,   Faculty of Medicine, University  of São Paulo, 2Department of  Genomics and Molecular Biology,  International Research Center,  A.C. Camargo Cancer Center, São Paulo,  3Department of Oncology,   Clinical Research – UPCO, Hospital de Clínicas de Porto Alegre, Porto Alegre, Rio Grande do Sul, BrazilAbstract: Lung cancer persists throughout the world as a major cause of death.",Non-OADS,/arxiv_data1/oa_pdf/7e/24/lctt-7-141.PMC5310703.pdf
"Since lung cancer has a long latency period from exposure to tobacco  to the development of the disease, the real impact of the anti-tobacco campaign Correspondence: Vanessa Karen de Sá Department of Genomics and Molecular Biology, International Research Center, A.C. Camargo Cancer Center, Rua Taguá, 440, First Floor, CEP 01508-010, São Paulo, BrazilTel +55 11 2189 5023Fax +55 11 2189 5025Email vanessa.karen@cipe.accamargo.org.brJournal name: Lung Cancer: Targets and Therapy Article Designation: REVIEWY ear: 2016V olume: 7Running head verso: de Sá et alRunning head recto: Lung cancer in BrazilDOI: http://dx.doi.org/10.2147/LCTT.S93604",Non-OADS,/arxiv_data1/oa_pdf/7e/24/lctt-7-141.PMC5310703.pdf
Available from: http://www.inca.gov.br/vigescola/docs/vigescolafim1.pdf.,Non-OADS,/arxiv_data1/oa_pdf/7e/24/lctt-7-141.PMC5310703.pdf
"Lung Cancer: Targets and Therapy 2016:7submit your manuscript | www.dovepress.com Dovepress Dovepress Lung Cancer: Targets and Therapy Publish your work in this journal Submit your manuscript here: https://www.dovepress.com/lung-cancer-targets--therapy-journalLung Cancer: Targets and Therapy is an international, peer-reviewed, open access  journal focusing on lung cancer research, identification of therapeutic targets and the optimal use of preventative and integrated treatment interventions to achieve improved outcomes, enhanced survival and quality of life for the cancer patient.",Non-OADS,/arxiv_data1/oa_pdf/7e/24/lctt-7-141.PMC5310703.pdf
Visit http://www.dovepress.com/testimonials.php to read real quotes from   published authors.Dovepress 148 de Sá et al 36.,Non-OADS,/arxiv_data1/oa_pdf/7e/24/lctt-7-141.PMC5310703.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by/4.0/.,Non-OADS,/arxiv_data1/oa_pdf/28/8f/lctt-7-099.PMC5310705.pdf
The full terms of this license are available at https://www.dovepress.com/terms.,Non-OADS,/arxiv_data1/oa_pdf/28/8f/lctt-7-099.PMC5310705.pdf
"php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/).",OADS,/arxiv_data1/oa_pdf/28/8f/lctt-7-099.PMC5310705.pdf
"For  permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).Lung Cancer: Targets and Therapy 2016:7 99–110Lung Cancer: Targets and Therapy Dovepress submit your manuscript | www.dovepress.com Dovepress  99 OriginaL  researCh open access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/LCTT .S107560Outcomes and prognostic factors of  chemotherapy for patients with locally advanced  or metastatic pulmonary squamous cell carcinoma seigo Minami Y oshitaka Ogata shouichi ihara suguru Yamamoto Kiyoshi Komuta Department of respiratory Medicine,   Osaka Police hospital, Osaka, JapanBackground: Pulmonary squamous cell carcinoma has not benefited from improvements in  chemotherapy over the past decade, compared with non-squamous non-small-cell lung cancer.",Non-OADS,/arxiv_data1/oa_pdf/28/8f/lctt-7-099.PMC5310705.pdf
"In contrast, squamous cell carcinoma has been left behind in terms of new  Correspondence: seigo Minami Department of respiratory Medicine, Osaka Police hospital, 10-31 Kitayama-cho, Tennoji-ku, Osaka 543-0035, Osaka, JapanTel +81 6 6771 6051Fax +81 6 6771 2838email seigominami@oph.gr.jpJournal name: Lung Cancer: Targets and Therapy Article Designation: Original ResearchY ear: 2016V olume: 7Running head verso: Chemotherapy for advanced pulmonary squamous cell carcinomaRunning head recto: Minami et alDOI: http://dx.doi.org/10.2147/LCTT.S107560",Non-OADS,/arxiv_data1/oa_pdf/28/8f/lctt-7-099.PMC5310705.pdf
"Lung Cancer: Targets and Therapy 2016:7submit your manuscript | www.dovepress.com Dovepress Dovepress Lung Cancer: Targets and Therapy Publish your work in this journal Submit your manuscript here: https://www.dovepress.com/lung-cancer-targets--therapy-journalLung Cancer: Targets and Therapy is an international, peer-reviewed, open access  journal focusing on lung cancer research, identification of therapeutic targets and the optimal use of preventative and integrated treatment interventions to achieve improved outcomes, enhanced survival and quality of life for the cancer patient.",Non-OADS,/arxiv_data1/oa_pdf/28/8f/lctt-7-099.PMC5310705.pdf
Visit http://www.dovepress.com/testimonials.php to read real quotes from   published authors.Dovepress 110 Minami et al Table S4  regimens Regimens First-line Second-line Third-line n 103 63 32 Platinum-based 92 4 4  Platinum    Cisplatin-based 1 0 1    Carboplatin-based 91 4 3  Partner agent    Paclitaxel 52 2 2    nab-Paclitaxel 16 1 0    s-1 18 1 1    gemcitabine 3 0 0    Docetaxel 3 0 0    Vinorelbine 0 0 1 non-platinum doublets  Docetaxel + s-1 0 6 0  gemcitabine + vinorelbine 0 2 9 non-platinum monotherapy  Docetaxel 0 33 6  egFr-TKi 0 12 7  s-1 10 6 6  gemcitabine 1 0 0 Concurrent thoracic radiotherapy 8 0 1 Note: Data are presented as number of patients.,Non-OADS,/arxiv_data1/oa_pdf/28/8f/lctt-7-099.PMC5310705.pdf
The full terms of this license are available at https://www.dovepress.com/terms.,Non-OADS,/arxiv_data1/oa_pdf/ee/f4/lctt-7-119.PMC5310706.pdf
"php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/).",OADS,/arxiv_data1/oa_pdf/ee/f4/lctt-7-119.PMC5310706.pdf
"For  permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).Lung Cancer: Targets and Therapy 2016:7 119–127Lung Cancer: Targets and Therapy Dovepress submit your manuscript | www.dovepress.com Dovepress  119 REVIEW open access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/LCTT .S96443Radiation-induced esophagitis in lung cancer Sarah Baker Alysa Fairchild Department of Radiation Oncology,   Cross Cancer Institute, University of Alberta, Edmonton, AB, CanadaAbstract:  Radiation-induced esophagitis is the most common local acute toxicity of radio- therapy (RT) delivered for the curative or palliative intent treatment of lung cancer.",Non-OADS,/arxiv_data1/oa_pdf/ee/f4/lctt-7-119.PMC5310706.pdf
"1  By definition, “late” refers to > 3 months after the completion of RT; median time of  onset of late esophageal injury is 6 months,5 with some instances diagnosed at 1 year  or later.1 Late side effects more often require invasive management such as surgical  intervention, and even then may not be reversible.1 Although RT dose schedules are  generally chosen to limit the risk of long-term side effects to ≤ 5%, prevalence depends  on the proportion of patients alive and at risk after treatment, and whether they are Correspondence: Alysa Fairchild Department of Radiation Oncology, Cross Cancer Institute, University of Alberta, 11560 University Avenue, Edmonton, AB, T6G 1Z2, CanadaTel +1 780 432 8783Fax +1 780 432 8380Email alysa.fairchild@albertahealthservices.caJournal name: Lung Cancer: Targets and Therapy Article Designation: REVIEWY ear: 2016V olume: 7Running head verso: Baker and FairchildRunning head recto: Radiation-induced esophagitisDOI: http://dx.doi.org/10.2147/LCTT.S96443",Non-OADS,/arxiv_data1/oa_pdf/ee/f4/lctt-7-119.PMC5310706.pdf
Available from: http://evs.nci.nih.gov/ftp1/ CTCAE/CTCAE_4.03_2010-06-14_QuickReference_5x7.pdf.,OADS,/arxiv_data1/oa_pdf/ee/f4/lctt-7-119.PMC5310706.pdf
Source: the website of  the National Cancer Institute (https://www.cancer.gov).,Non-OADS,/arxiv_data1/oa_pdf/ee/f4/lctt-7-119.PMC5310706.pdf
Available from: https://www.rtog.org/ResearchAssociates/ AdverseEventReporting/RTOGEORTCLateRadiationMorbidityScoringSchema.aspx.,OADS,/arxiv_data1/oa_pdf/ee/f4/lctt-7-119.PMC5310706.pdf
Available from: http://evs.nci.nih.gov/ftp1/CTCAE/CTCAE_4.03_2010-06-14_QuickReference_5x7.pdf.,OADS,/arxiv_data1/oa_pdf/ee/f4/lctt-7-119.PMC5310706.pdf
Available from: https://clinicaltrials.gov/ct2/show/NCT01952847 NML Identifier: NCT01952847.,Non-OADS,/arxiv_data1/oa_pdf/ee/f4/lctt-7-119.PMC5310706.pdf
"Lung Cancer: Targets and Therapy 2016:7submit your manuscript | www.dovepress.com Dovepress Dovepress Lung Cancer: Targets and Therapy Publish your work in this journal Submit your manuscript here: https://www.dovepress.com/lung-cancer-targets--therapy-journalLung Cancer: Targets and Therapy is an international, peer-reviewed, open access  journal focusing on lung cancer research, identification of therapeutic targets and the optimal use of preventative and integrated treatment interventions to achieve improved outcomes, enhanced survival and quality of life for the cancer patient.",Non-OADS,/arxiv_data1/oa_pdf/ee/f4/lctt-7-119.PMC5310706.pdf
Visit http://www.dovepress.com/testimonials.php to read real quotes from   published authors.Dovepress 127 Radiation-induced esophagitis  51.,Non-OADS,/arxiv_data1/oa_pdf/ee/f4/lctt-7-119.PMC5310706.pdf
Available from: https://www.rtog.org/ResearchAssociates/AdverseEventReporting/RTOGEORTCLateRadiationMorbidityScor - ingSchema.aspx.,OADS,/arxiv_data1/oa_pdf/ee/f4/lctt-7-119.PMC5310706.pdf
The full terms of this license are available at https://www.dovepress.com/terms.,Non-OADS,/arxiv_data1/oa_pdf/06/a8/lctt-7-111.PMC5310707.pdf
"php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/).",OADS,/arxiv_data1/oa_pdf/06/a8/lctt-7-111.PMC5310707.pdf
"For  permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).Lung Cancer: Targets and Therapy 2016:7 111–118Lung Cancer: Targets and Therapy Dovepress submit your manuscript | www.dovepress.com Dovepress  111 Review open access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/LCTT .S98643electromagnetic navigation bronchoscopy:   clinical utility in the diagnosis of lung cancer Luis M Seijo Pulmonary Department, instituto  de investigación Sanitaria-Fundación  Jimenez Díaz-Centro de investigación  Biomedica en Red enfermedades  Respiratorias, Madrid, SpainAbstract:  Electromagnetic navigation bronchoscopy (ENB) is one of several technological  advances which have broadened the indications for bronchoscopy in the diagnostic workup of  lung cancer.",Non-OADS,/arxiv_data1/oa_pdf/06/a8/lctt-7-111.PMC5310707.pdf
"4,5 An aggressive management strategy may lead to many invasive Correspondence: Luis M Seijo Pulmonary Department, iiS-Fundación Jimenez Díaz-CiBeReS, Avenida de los Reyes Católicos 2, Madrid 28040, SpainTel +34 91 550 4800 ext 2418email luis.seijo@fjd.esJournal name: Lung Cancer: Targets and Therapy Article Designation: REviEWY ear: 2016volume: 7 Running head verso: SeijoRunning head recto: Clinical utility of ENB in the diagnosis of lung cancerDOi: http://dx.doi.org/10.2147/LCTT.S98643",Non-OADS,/arxiv_data1/oa_pdf/06/a8/lctt-7-111.PMC5310707.pdf
"Lung Cancer: Targets and Therapy 2016:7submit your manuscript | www.dovepress.com Dovepress Dovepress Lung Cancer: Targets and Therapy Publish your work in this journal Submit your manuscript here: https://www.dovepress.com/lung-cancer-targets--therapy-journalLung Cancer: Targets and Therapy is an international, peer-reviewed, open access  journal focusing on lung cancer research, identification of therapeutic targets and the optimal use of preventative and integrated treatment interventions to achieve improved outcomes, enhanced survival and quality of life for the cancer patient.",Non-OADS,/arxiv_data1/oa_pdf/06/a8/lctt-7-111.PMC5310707.pdf
visit http://www.dovepress.com/testimonials.php to read real quotes from   published authors.Dovepress 118 Seijo  33.,Non-OADS,/arxiv_data1/oa_pdf/06/a8/lctt-7-111.PMC5310707.pdf
The full terms of this license are available at https://www.dovepress.com/terms.,Non-OADS,/arxiv_data1/oa_pdf/96/00/lctt-7-129.PMC5310708.pdf
"php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/).",OADS,/arxiv_data1/oa_pdf/96/00/lctt-7-129.PMC5310708.pdf
"For  permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).Lung Cancer: Targets and Therapy 2016:7 129–140Lung Cancer: Targets and Therapy Dovepress submit your manuscript | www.dovepress.com Dovepress  129 REVIEW open access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/LCTT .S101639Oligometastatic non-small-cell lung cancer:  current treatment strategies Patrick J Richard   Ramesh Rengan Department of Radiation Oncology,   University of Washington, Seattle, WA,  USAAbstract:  The oligometastatic disease theory was initially described in 1995 by Hellman and  Weichselbaum.",Non-OADS,/arxiv_data1/oa_pdf/96/00/lctt-7-129.PMC5310708.pdf
"If treated aggressively, Correspondence: Patrick J Richard Department of Radiation Oncology, University of Washington, 1959 NE Pacific Street, Box 356043, Seattle, WA 98195, USAEmail patrick.richard@usoncology.comJournal name: Lung Cancer: Targets and Therapy Article Designation: REVIEWY ear: 2016V olume: 7Running head verso: Richard and RenganRunning head recto: Oligometastatic non-small-cell lung cancerDOI: http://dx.doi.org/10.2147/LCTT.S101639",Non-OADS,/arxiv_data1/oa_pdf/96/00/lctt-7-129.PMC5310708.pdf
"Lung Cancer: Targets and Therapy 2016:7submit your manuscript | www.dovepress.com Dovepress Dovepress Lung Cancer: Targets and Therapy Publish your work in this journal Submit your manuscript here: https://www.dovepress.com/lung-cancer-targets--therapy-journalLung Cancer: Targets and Therapy is an international, peer-reviewed, open access  journal focusing on lung cancer research, identification of therapeutic targets and the optimal use of preventative and integrated treatment interventions to achieve improved outcomes, enhanced survival and quality of life for the cancer patient.",Non-OADS,/arxiv_data1/oa_pdf/96/00/lctt-7-129.PMC5310708.pdf
Visit http://www.dovepress.com/testimonials.php to read real quotes from   published authors.Dovepress 140 Richard and Rengan 51.,Non-OADS,/arxiv_data1/oa_pdf/96/00/lctt-7-129.PMC5310708.pdf
The full terms of this license are available at https://www.dovepress.com/terms.,Non-OADS,/arxiv_data1/oa_pdf/47/40/lctt-7-149.PMC5310716.pdf
"php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/).",OADS,/arxiv_data1/oa_pdf/47/40/lctt-7-149.PMC5310716.pdf
"For  permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).Lung Cancer: Targets and Therapy 2016:7 149–152Lung Cancer: Targets and Therapy Dovepress submit your manuscript | www.dovepress.com Dovepress  149 ORIGINAL RESEARCH open access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/LCTT .S116762Driver oncogenes in Sub-Saharan African patients  with non-small cell lung cancer Barbara Legius1 Sandra Van Den Broecke1 Inge Muylle1 Vincent Ninane1,2 1Department of Pulmonology, Centre  Hospitalier Universitaire Saint Pierre,   2Faculty of Medicine, Université Libre  de Bruxelles, Brussels, BelgiumAbstract: Non-small cell lung cancer can exhibit driver oncogenes, including epidermal growth  factor receptor (EGFR) and anaplastic lymphoma kinase (ALK), that are possible targets for  therapy.",Non-OADS,/arxiv_data1/oa_pdf/47/40/lctt-7-149.PMC5310716.pdf
"As the latter is influenced by race and smoking habits that may differ from Afro-Americans; we have studied the prevalence of EGFR mutations and ALK trans-locations in a case series of patients of Sub-Saharan African ethnicity with NSCLC.Correspondence: Barbara Legius Centre Hospitalier Universitaire Saint Pierre, Rue Haute 322, Brussels 1000, BelgiumTel +32 2 535 4244Fax +32 2 535 4174Email b.legius@gmail.comJournal name: Lung Cancer: Targets and Therapy Article Designation: ORIGINAL RESEARCHY ear: 2016V olume: 7Running head verso: Legius et alRunning head recto: Driver oncogenes in Sub-Saharan African patientsDOI: http://dx.doi.org/10.2147/LCTT.S116762",Non-OADS,/arxiv_data1/oa_pdf/47/40/lctt-7-149.PMC5310716.pdf
"Lung Cancer: Targets and Therapy 2016:7submit your manuscript | www.dovepress.com Dovepress Dovepress Lung Cancer: Targets and Therapy Publish your work in this journal Submit your manuscript here: https://www.dovepress.com/lung-cancer-targets--therapy-journalLung Cancer: Targets and Therapy is an international, peer-reviewed, open access  journal focusing on lung cancer research, identification of therapeutic targets and the optimal use of preventative and integrated treatment interventions to achieve improved outcomes, enhanced survival and quality of life for the cancer patient.",Non-OADS,/arxiv_data1/oa_pdf/47/40/lctt-7-149.PMC5310716.pdf
Visit http://www.dovepress.com/testimonials.php to read real quotes from   published authors.Dovepress 152 Legius et al,Non-OADS,/arxiv_data1/oa_pdf/47/40/lctt-7-149.PMC5310716.pdf
http://dx.doi.org/10.1016/j.idcr.2017.01.003 2214-2509/©  2017  The  Authors.,Non-OADS,/arxiv_data1/oa_pdf/38/ae/main.PMC5310815.pdf
This  is  an  open  access  article  under  the  CC  BY-NC-ND  license  (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).IDCases  7  (2017)  53–55 Contents  lists  available  at  ScienceDirect IDCases journal  homepage:  www.elsevier.com/locate/idcr,Non-OADS,/arxiv_data1/oa_pdf/38/ae/main.PMC5310815.pdf
Published by Elsevier Ltd on behalf of European Society of Clinical Microbiology and Infectious Diseases This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ) http://dx.doi.org/10.1016/j.nmni.2017.01.008,Non-OADS,/arxiv_data1/oa_pdf/8c/c8/main.PMC5310817.pdf
MALDI-TOF MS spectrum MALDI-TOF MS spectra of ‘Lachnoclostridium urinimassiliense ’ strain Marseille-P2804Tand ‘Lachnoclostridium phocaeense ’strainMarseille-P3177Tare available online ( http://www.mediterranee- infection.com/article.php?laref=256&titre=urms-database ).,OADS,/arxiv_data1/oa_pdf/8c/c8/main.PMC5310817.pdf
"Published by Elsevier Ltd on behalf of European Society of Clinical Microbiology and Infectious Diseases, NMNI ,16,7 3 –75 This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).",Non-OADS,/arxiv_data1/oa_pdf/8c/c8/main.PMC5310817.pdf
"Published by Elsevier Ltd on behalf of European Society of Clinical Microbiology and Infectious Diseases, NMNI ,16,7 3 –75 This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).",Non-OADS,/arxiv_data1/oa_pdf/8c/c8/main.PMC5310817.pdf
"Production and hosting by ElsevierJournal of Advanced Research (2017) 8, 209–215 Cairo University Journal of Advanced Research http://dx.doi.org/10.1016/j.jare.2017.01.004 2090-1232 /C2112017 Production and hosting by Elsevier B.V. on behalf of Cairo University.",Non-OADS,/arxiv_data1/oa_pdf/0f/fd/main.PMC5310818.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/0f/fd/main.PMC5310818.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/ 4.0/).,Non-OADS,/arxiv_data1/oa_pdf/0f/fd/main.PMC5310818.pdf
SUPPLEMENTARY MATERIALS Supplementary material for this article is available at http://advances.sciencemag.org/cgi/ content/full/3/2/e1601966/DC1fig.,Non-OADS,/arxiv_data1/oa_pdf/60/2a/1601966.PMC5310823.pdf
The survey items for all three administrations can be viewed from the Cutting Edge Evaluation Summary Web page: http://serc.carleton.edu/NAGTWorkshops/about/evaluation.html.,OADS,/arxiv_data1/oa_pdf/37/58/1600193.PMC5310824.pdf
SUPPLEMENTARY MATERIALS Supplementary material for this article is available at http://advances.sciencemag.org/cgi/ content/full/3/2/e1600193/DC1fig.,Non-OADS,/arxiv_data1/oa_pdf/37/58/1600193.PMC5310824.pdf
"President ’s Council of Advisors on Science and Technology, “Engage to excel: Producing one million additional college graduates with degrees in science, technology,engineering, and mathematics ”(Executive Office of the President, 2012); http://files.eric.",Non-OADS,/arxiv_data1/oa_pdf/37/58/1600193.PMC5310824.pdf
"National Science Foundation (NSF), “Shaping the future: New expectations for undergraduate education in science, mathematics, engineering, and technology ” (nsf96139, NSF, 1996); http://nsf.gov/publications/pub_summ.jsp?ods_key=nsf96139.",Non-OADS,/arxiv_data1/oa_pdf/37/58/1600193.PMC5310824.pdf
An examination of teaching practices across stem and non-stem disciplines between 2004 and 2014 ”(2016): https://sloan.org/ storage/app/media/files/STEM_Higher_Ed/STEM_Faculty_Teaching_Practices.pdf.,Non-OADS,/arxiv_data1/oa_pdf/37/58/1600193.PMC5310824.pdf
"C. A. Manduca, D. W. Mogk, N. Stillings, “Bringing research on learning to the geosciences ”(SERC, 2004); http://serc.carleton.edu/files/research_on_learning/ ROL0304_2004.pdf.",Non-OADS,/arxiv_data1/oa_pdf/37/58/1600193.PMC5310824.pdf
"A. McLaughlin, E. Iverson, R. Kirkendall, C. Manduca, M. Bruckner, “On the Cutting Edge 2010 evaluation report ”(SERC, 2010); https://serc.carleton.edu/files/NAGTWorkshops/ 2009_cutting_edge_evaluation_1265409435.pdf.",Non-OADS,/arxiv_data1/oa_pdf/37/58/1600193.PMC5310824.pdf
"Rockman et al, “On The Cutting Edge Project: Year 3 independent evaluation report ” (SERC, 2013); http://serc.carleton.edu/files/NAGTWorkshops/about/ 2013_external_evaluation_repor.pdf.",OADS,/arxiv_data1/oa_pdf/37/58/1600193.PMC5310824.pdf
"SERC, “Classroom observation project: Understanding and improving our teaching ” (SERC, 2016); http://serc.carleton.edu/NAGTWorkshops/certop/index.html.",Non-OADS,/arxiv_data1/oa_pdf/37/58/1600193.PMC5310824.pdf
"American Association for the Advancement of Science (AAAS), “Describing and measuring undergraduate STEM teaching practice: A report from a national meetingon the measurement of undergraduate science, technology, engineering andmathematics (STEM) teaching ”(AAAS, 2013); http://ccliconference.org/files/2013/11/ Measuring-STEM-Teaching-Practices.pdf.",Non-OADS,/arxiv_data1/oa_pdf/37/58/1600193.PMC5310824.pdf
"E. Wenger-Trayner, B. Wenger-Trayner, “Communities of practice: A brief introduction ” (Wenger-Trayner, 2016); http://wenger-trayner.com/introduction-to-communities-of-practice.",Non-OADS,/arxiv_data1/oa_pdf/37/58/1600193.PMC5310824.pdf
"SERC, “On the Cutting Edge evaluation ”(SERC, 2015); http://serc.carleton.edu/ NAGTWorkshops/about/evaluation.html.",Non-OADS,/arxiv_data1/oa_pdf/37/58/1600193.PMC5310824.pdf
"SERC, “Activity design: Questions to consider when designing or reviewing an activity ” (SERC, 2012); http://serc.carleton.edu/NAGTWorkshops/servicelearning/workshop10/activity_design/index.html.",OADS,/arxiv_data1/oa_pdf/37/58/1600193.PMC5310824.pdf
"D. Siegle, “Educational research basics: Excel spreadsheet to calculate instrument reliability estimates, ”http://researchbasics.education.uconn.edu/excel-spreadsheet-to- calculate-instrument-reliability-estimates.",Non-OADS,/arxiv_data1/oa_pdf/37/58/1600193.PMC5310824.pdf
SUPPLEMENTARY MATERIALS Supplementary material for this article is available at http://advances.sciencemag.org/cgi/ content/full/3/2/e1602159/DC1Supplementary Text fig.,Non-OADS,/arxiv_data1/oa_pdf/22/db/1602159.PMC5310825.pdf
SUPPLEMENTARY MATERIALS Supplementary material for this article is available at http://advances.sciencemag.org/cgi/ content/full/3/2/e1602306/DC1Supplementary Resultsfig.,Non-OADS,/arxiv_data1/oa_pdf/3e/65/1602306.PMC5310827.pdf
"Parsing and analyses were carried out using custom Python(v3.4.5) scripts (available through https://github.com/pimbongaerts/radseq), unless otherwise indicated, w ith statistical analyses and plotting performed in R (v3.3.1) (electronic notebook available through https:// github.com/pimbongaerts/bermuda-rad).",OADS,/arxiv_data1/oa_pdf/15/d0/1602373.PMC5310828.pdf
SUPPLEMENTARY MATERIALS Supplementary material for this article is available at http://advances.sciencemag.org/cgi/ content/full/3/2/e1602373/DC1fig.,Non-OADS,/arxiv_data1/oa_pdf/15/d0/1602373.PMC5310828.pdf
"Data and materials availability: All data and analyses are available as an electronic notebook (https://github.com/pimbongaerts/bermuda-rad),with scripts available through https://github.com/pimbongaerts/radseq.",OADS,/arxiv_data1/oa_pdf/15/d0/1602373.PMC5310828.pdf
/C2^u→ i ð15Þ SUPPLEMENTARY MATERIALS Supplementary material for this article is available at http://advances.sciencemag.org/cgi/ content/full/3/2/e1601469/DC1movie S1.,Non-OADS,/arxiv_data1/oa_pdf/8c/68/1601469.PMC5310830.pdf
These tools are part of the FASTX-Toolkit suite (http://hannonlab.cshl.edu/fastx_toolkit/).,OADS,/arxiv_data1/oa_pdf/31/88/leu2016182a.PMC5310924.pdf
Their quality was evaluatedand con ﬁrmed using the FastQC application (http://www.bioinformatics.,OADS,/arxiv_data1/oa_pdf/31/88/leu2016182a.PMC5310924.pdf
Gene Expression Omnibus: NCBI gene expression and hybridization array data repository) and are accessible through GEO Series accession number GSE76192(http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc = GSE76192).CONFLICT OF INTEREST The authors declare no con ﬂict of interest.,OADS,/arxiv_data1/oa_pdf/31/88/leu2016182a.PMC5310924.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/4.0/ © The Author(s) 2017 Supplementary Information accompanies this paper on the Leukemia website (http://www.nature.com/leu)Transcriptional selectivity of JQ1 E Donato et al 490 Leukemia (2017) 479 –490",Non-OADS,/arxiv_data1/oa_pdf/31/88/leu2016182a.PMC5310924.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/14/14/main.PMC5310928.pdf
Contents lists available at ScienceDirect International Journal for Parasitology: Parasites and Wildlife journal homepage: www.elsevier.com /locate/ijppaw http://dx.doi.org/10.1016/j.ijppaw.2016.12.003 2213-2244/ ©2017 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/14/14/main.PMC5310928.pdf
This  is  an  open access article under the CC  BY-NC-ND  license  (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/6f/5b/main.PMC5310934.pdf
Open  appendectomy  was  subsequently  performed  by http://dx.doi.org/10.1016/j.ijscr.2017.01.066 2210-2612/© 2017  The  Authors.,Non-OADS,/arxiv_data1/oa_pdf/6f/5b/main.PMC5310934.pdf
"4  (2004),  http://dx.doi.org/10.1002/14651858.",Non-OADS,/arxiv_data1/oa_pdf/6f/5b/main.PMC5310934.pdf
This is a n open access article under the CC BY-NC-ND license (http://creativecommons.org /licenses/by-nc-nd/4.0/ ).Keywords: Grey matterMulti-centerPrimary progressive aphasiaSupport vector machine classi ﬁcation Whole brain approach 1.,Non-OADS,/arxiv_data1/oa_pdf/79/27/main.PMC5310935.pdf
http://dx.doi.org/10.1016/j.nicl.2017.02.003 2213-1582/© 2017 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/79/27/main.PMC5310935.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/79/27/main.PMC5310935.pdf
"Subjects Patients and healthy controls were recruited within seven centers (located in Ulm, Munich, Leipzig, Homburg, Erlangen, Bonn, and Goettingen) of the German consortium for FTLD ( http://www.ftld.de ).",Non-OADS,/arxiv_data1/oa_pdf/79/27/main.PMC5310935.pdf
Voxel-based morphometry Images were processed with the VBM toolbox ( http://dbm.neuro.,OADS,/arxiv_data1/oa_pdf/79/27/main.PMC5310935.pdf
"The group comparisons between the three variants of PPA and healthy controls as well as between PPA variants were performed in FSL (FMRIB Analysis Group, Oxford University, UK., http://fsl.fmrib.ox.ac.uk/fsl/fslwiki/FSL ) using permutation-based non- parametric testing (5000 permutations) with the Threshold-Free Clus- ter Enhancement (TFCE) method ( Smith and Nichols, 2009; Winkler et al., 2014 ).",OADS,/arxiv_data1/oa_pdf/79/27/main.PMC5310935.pdf
"SVM classi ﬁcation ( Vapnik, 1995; Vapnik, 1998 )w a sp e r f o r m e d using libsvm version 3.18 ( Chang and Lin, 2011 ;https://www.csie.ntu.",Non-OADS,/arxiv_data1/oa_pdf/79/27/main.PMC5310935.pdf
"The original meta-analytic clusters were coregistered to the Montreal Neurological Institute template of the VBM results using SPM 8 and dilated by two voxels using the 3D dilation function implemented in the WFU PickAtlas (Maldjian, http://www.nitrc.org/projects/wfu_pickatlas ).",OADS,/arxiv_data1/oa_pdf/79/27/main.PMC5310935.pdf
"The mutation p.G144D was predicted tobe disease-causing, as the probable damaging score according to the software PolyPhen-2 (http://genetics.bwh.harvard.edu/pph/) 1Department of Pediatrics, Faculty of Medicine, University of the Ryukyus, Nishihara, Japan;2Department of Clinical Nephroscience, Niigata University Graduate School of Medical and Dental Sciences, Niigata, Japan and3Department of Pediatrics, Graduate School of Medical Science, Kumamoto University, Kumamoto, Japan.",Non-OADS,/arxiv_data1/oa_pdf/77/8a/hgv20172.PMC5311055.pdf
was 1.000 and the probability value score according to Mutation Taster (http://www.mutationtaster.org) was 0.999.,OADS,/arxiv_data1/oa_pdf/77/8a/hgv20172.PMC5311055.pdf
HGV DATABASE The relevant data from this Data Report are hosted at the Human Genome Variation Database at http://dx.doi.org/10.6084/m9.,OADS,/arxiv_data1/oa_pdf/77/8a/hgv20172.PMC5311055.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/4.0/ © The Author(s) 2017 59 Y  CA, SH 1 Y 56 Y  CC 40 YDiabetes Heart  disease 3 Y 81 Y MI 73 Y  MI67 Y  1 2 3 4 512 3 4 5 67 12 312 *** 39 Y Figure 1.",Non-OADS,/arxiv_data1/oa_pdf/77/8a/hgv20172.PMC5311055.pdf
"hyq77615@163.com Telephone: +86-776-2853272 Fax: +86-776-2853272 Received: se  ptember 25, 2016 Peer-review started: se ptember 30, 2016 First decision: October 20, 2016 Revised: November 4, 2016 Accepted: November 23, 2016 Article in press: November 28, 2016 Published online: fe bruary 14, 2017 Abstract AIM To explore the induction effects and mechanism of   Solanum lyratum Thumb (ST) on human hepatocellular Submit a Manuscript: http://www.wjgnet.com/esps/ Help Desk: http://www.wjgnet.com/esps/helpdesk.aspxDOI: 10.3748/wjg.v23.i6.1010 1010 February 14, 2017|Volume 23 |Issue 6| WJG|www.wjgnet.comWorld J Gastroenterol  2017 February 14; 23(6): 1010-1017  ISSN 1007-9327 (print)  ISSN 2219-2840 (online) © 2017 Baishideng Publishing Group Inc. All rights reserved.",Non-OADS,/arxiv_data1/oa_pdf/bd/83/WJG-23-1010.PMC5311089.pdf
"World J Gastroenterol 2017; 23(6): 1010-1017  Available from:  URL: http://www.wjgnet.com/1007-9327/full/v23/i6/1010.htm   DOI: http://dx.doi.org/10.3748/wjg.v23.i6.1010 Introduct Ion Solanum lyratum Thumb  (ST), belonging to Solan­ aceae , is generally used to treat tumors[1­3], including  liver, gastric, esophageal and bladder cancers, with  exact curative effects, and it is a commonly used anticancer drug.",Non-OADS,/arxiv_data1/oa_pdf/bd/83/WJG-23-1010.PMC5311089.pdf
"All rights reserved.Published by Baishideng Publishing Group Inc 8226 Regency Drive, Pleasanton, CA 94588, USA Telephone: +1-925-223-8242 Fax: +1-925-223-8243 E-mail: bpgoffice@wjgnet.com Help Desk: http://www.wjgnet.com/esps/helpdesk.aspx http://www.wjgnet.com I S S N  1 0  0 7  -   9  3 2  7 9    7 7 1 0  07   9 3 2 0 450  6",Non-OADS,/arxiv_data1/oa_pdf/bd/83/WJG-23-1010.PMC5311089.pdf
"See: http://creativecommons.org/licenses/by-nc/4.0/ Manuscript source: Unsolicited manuscript Correspondence to: Dr. Sanne van Erp , Department of  Gastroenterology and Hepatology, Leiden University Medical  Center, Albinusdreef 2, Leiden 2333 ZA,  the Netherlands.",Non-OADS,/arxiv_data1/oa_pdf/87/0e/WJG-23-1018.PMC5311090.pdf
"s.j.h.van_erp@lumc.nlSubmit a Manuscript: http://www.wjgnet.com/esps/ Help Desk: http://www.wjgnet.com/esps/helpdesk.aspxDOI: 10.3748/wjg.v23.i6.1018 1018 February 14, 2017|Volume 23 |Issue 6 | WJG|www.wjgnet.comWorld J Gastroenterol  2017 February 14; 23(6): 1018-1029  ISSN 1007-9327 (print)  ISSN 2219-2840 (online) © 2017 Baishideng Publishing Group Inc. All rights reserved.",Non-OADS,/arxiv_data1/oa_pdf/87/0e/WJG-23-1018.PMC5311090.pdf
"World J  Gastroenterol 2017; 23(6): 1018-1029  Available from: URL:  http://www.wjgnet.com/1007-9327/full/v23/i6/1018.htm  DOI:  http://dx.doi.org/10.3748/wjg.v23.i6.1018 INTRODUCTION Crohn’s disease (CD) is a relapsing inflammatory bowel  disease (IBD)[1], characterized by segmental transmural  lesions that can affect any part of the gastrointestinal  tract[2].",Non-OADS,/arxiv_data1/oa_pdf/87/0e/WJG-23-1018.PMC5311090.pdf
Post-processing and data analysis T1-weighted image analysis: Brain extraction tool  (BET) of FMRIB Software Library (FSL) (http://www.fmrib.ox.ac.uk/fsl) was used to extract the brain  tissue from T 1-weighted images[15].,OADS,/arxiv_data1/oa_pdf/87/0e/WJG-23-1018.PMC5311090.pdf
"All rights reserved.Published by Baishideng Publishing Group Inc 8226 Regency Drive, Pleasanton, CA 94588, USA Telephone: +1-925-223-8242 Fax: +1-925-223-8243 E-mail: bpgoffice@wjgnet.com Help Desk: http://www.wjgnet.com/esps/helpdesk.aspx http://www.wjgnet.com I S S N  1 0  0 7  -   9  3 2  7 9    7 7 1 0  07   9 3 2 0 450  6",Non-OADS,/arxiv_data1/oa_pdf/87/0e/WJG-23-1018.PMC5311090.pdf
"See: http://creativecommons.org/licenses/by-nc/4.0/Manuscript source: Unsolicited manuscript Correspondence to: Changhyun Lee, MD , Department of  Internal Medicine and Healthcare Research Institute, Healthcare  System Gangnam Center, Seoul National University Hospital, 737 Yeoksam-dong, Gangnam-Gu, Seoul 06236,  South Korea.",Non-OADS,/arxiv_data1/oa_pdf/19/74/WJG-23-1030.PMC5311091.pdf
"The adequacy of bowel preparation for the split-dose group  vs the non-split- dose group was 96.8% vs 85.2%, respectively, P <  0.001, and the compliance of the last meal restriction Submit a Manuscript: http://www.wjgnet.com/esps/ Help Desk: http://www.wjgnet.com/esps/helpdesk.aspxDOI: 10.3748/wjg.v23.i6.1030 1030 February 14, 2017|Volume 23 |Issue 6| WJG|www.wjgnet.comWorld J Gastroenterol  2017 February 14; 23(6): 1030-1037  ISSN 1007-9327 (print)  ISSN 2219-2840 (online) © 2017 Baishideng Publishing Group Inc. All rights reserved.",Non-OADS,/arxiv_data1/oa_pdf/19/74/WJG-23-1030.PMC5311091.pdf
World J Gastroenterol 2017; 23(6): 1030-1037  Available from:  URL: http://www.wjgnet.com/1007-9327/full/v23/i6/1030.htm  DOI: http://dx.doi.org/10.3748/wjg.v23.i6.1030 INTRODUCTION Bowel preparation is one of the most important factors  for a complete colonoscopy.,Non-OADS,/arxiv_data1/oa_pdf/19/74/WJG-23-1030.PMC5311091.pdf
"All rights reserved.Published by Baishideng Publishing Group Inc 8226 Regency Drive, Pleasanton, CA 94588, USA Telephone: +1-925-223-8242 Fax: +1-925-223-8243 E-mail: bpgoffice@wjgnet.com Help Desk: http://www.wjgnet.com/esps/helpdesk.aspx http://www.wjgnet.com I S S N  1 0  0 7  -   9  3 2  7 9    7 7 1 0  07   9 3 2 0 450  6",Non-OADS,/arxiv_data1/oa_pdf/19/74/WJG-23-1030.PMC5311091.pdf
"All	patients 	 with	evidence 	of	obstruction 	including 	oesophageal 	Submit a Manuscript: http://www.wjgnet.com/esps/ Help Desk: http://www.wjgnet.com/esps/helpdesk.aspx DOI: 10.3748/wjg.v23.i6.1038 1038 February 14, 2017 |Volume 23 |Issue 6 | WJG|www.wjgnet.comWorld J Gastroenterol   2017 February 14; 23(6): 1038-1043  ISSN 1007-9327 (print)  ISSN 2219-2840 (online) © 2017 Baishideng Publishing Group Inc. All rights reserved.",Non-OADS,/arxiv_data1/oa_pdf/69/33/WJG-23-1038.PMC5311092.pdf
"World J Gastroenterol  2017; 23(6): 1038-1043  Available from:  URL: http://www.wjgnet.com/1007-9327/full/v23/i6/1038.htm   DOI: http://dx.doi.org/10.3748/wjg.v23.i6.1038 INTRODUCTION For more than 40 years, it has been established that  a careful history can establish the diagnosis in up to  80% of patients presenting with dysphagia[1-3].",Non-OADS,/arxiv_data1/oa_pdf/69/33/WJG-23-1038.PMC5311092.pdf
"All rights reserved.Published by Baishideng Publishing Group Inc 8226 Regency Drive, Pleasanton, CA 94588, USA Telephone: +1-925-223-8242 Fax: +1-925-223-8243 E-mail: bpgoffice@wjgnet.com Help Desk: http://www.wjgnet.com/esps/helpdesk.aspx http://www.wjgnet.com I S S N  1 0  0 7  -   9  3 2  7 9    7 7 1 0  07   9 3 2 0 450  6",Non-OADS,/arxiv_data1/oa_pdf/69/33/WJG-23-1038.PMC5311092.pdf
"Tissue 	 samples 	of	patients 	without 	definite 	diagnosis 	after	 complete 	diagnostic 	work-up 	were	reviewed 	regarding 	Submit a Manuscript: http://www.wjgnet.com/esps/ Help Desk: http://www.wjgnet.com/esps/helpdesk.aspx DOI: 10.3748/wjg.v23.i6.1044 1044 February 14, 2017 |Volume 23 |Issue 6 | WJG|www.wjgnet.comWorld J Gastroenterol   2017 February 14; 23(6): 1044-1050  ISSN 1007-9327 (print)  ISSN 2219-2840 (online) © 2017 Baishideng Publishing Group Inc. All rights reserved.",Non-OADS,/arxiv_data1/oa_pdf/b1/6f/WJG-23-1044.PMC5311093.pdf
"World J Gastroenterol 2017; 23(6): 1044-1050  Available from:  URL: http://www.wjgnet.com/1007-9327/full/v23/i6/1044.htm   DOI: http://dx.doi.org/10.3748/wjg.v23.i6.1044INTRODUCTION Sclerosing cholangitis (SC) can arise from various  underlying diseases, such as infectious, immunological,  toxic or ischemic etiology as well as due to mechanical  obstruction.",Non-OADS,/arxiv_data1/oa_pdf/b1/6f/WJG-23-1044.PMC5311093.pdf
"All rights reserved.Published by Baishideng Publishing Group Inc 8226 Regency Drive, Pleasanton, CA 94588, USA Telephone: +1-925-223-8242 Fax: +1-925-223-8243 E-mail: bpgoffice@wjgnet.com Help Desk: http://www.wjgnet.com/esps/helpdesk.aspx http://www.wjgnet.com I S S N  1 0  0 7  -   9  3 2  7 9    7 7 1 0  07   9 3 2 0 450  6",Non-OADS,/arxiv_data1/oa_pdf/b1/6f/WJG-23-1044.PMC5311093.pdf
"METHODSSince 	2006, 	we	introduced 	the	surveillance 	for	HN	 region 	using 	NBI	for	all	patients 	with	ESCC 	before 	Submit a Manuscript: http://www.wjgnet.com/esps/ Help Desk: http://www.wjgnet.com/esps/helpdesk.aspx DOI: 10.3748/wjg.v23.i6.1051 1051 February 14, 2017 |Volume 23 |Issue 6 | WJG|www.wjgnet.comWorld J Gastroenterol   2017 February 14; 23(6): 1051-1058  ISSN 1007-9327 (print)  ISSN 2219-2840 (online) © 2017 Baishideng Publishing Group Inc. All rights reserved.",Non-OADS,/arxiv_data1/oa_pdf/5d/7a/WJG-23-1051.PMC5311094.pdf
World J Gastroenterol  2017; 23(6): 1051-1058  Available from:  URL: http://www.wjgnet.com/1007-9327/full/v23/i6/ 1051 .htm   DOI: http://dx.doi.org/10.3748/wjg.v23.i6.1051INTRODUCTION Most of patients with esophageal squamous cell car - cinoma (ESCC) have a high prevalence of second  primary head and neck squamous cell carcinoma  (HNSCC)[1].,Non-OADS,/arxiv_data1/oa_pdf/5d/7a/WJG-23-1051.PMC5311094.pdf
"All rights reserved.Published by Baishideng Publishing Group Inc 8226 Regency Drive, Pleasanton, CA 94588, USA Telephone: +1-925-223-8242 Fax: +1-925-223-8243 E-mail: bpgoffice@wjgnet.com Help Desk: http://www.wjgnet.com/esps/helpdesk.aspx http://www.wjgnet.com I S S N  1 0  0 7  -   9  3 2  7 9    7 7 1 0  07   9 3 2 0 450  6",Non-OADS,/arxiv_data1/oa_pdf/5d/7a/WJG-23-1051.PMC5311094.pdf
"A multivariate analysis showed that diabetes  mellitus (OR = 3.99, 95%CI: 1.56-10.20,  P = 0.004) Submit a Manuscript: http://www.wjgnet.com/esps/ Help Desk: http://www.wjgnet.com/esps/helpdesk.aspxDOI: 10.3748/wjg.v23.i6.1059 1059 February 14, 2017|Volume 23 |Issue 6| WJG|www.wjgnet.comWorld J Gastroenterol  2017 February 14; 23(6): 1059-1066  ISSN 1007-9327 (print)  ISSN 2219-2840 (online) © 2017 Baishideng Publishing Group Inc. All rights reserved.",Non-OADS,/arxiv_data1/oa_pdf/ef/4a/WJG-23-1059.PMC5311095.pdf
"World  J Gastroenterol 2017; 23(6): 1059-1066  Available from: URL:  http://www.wjgnet.com/1007-9327/full/v23/i6/1059.htm  DOI: http://dx.doi.org/10.3748/wjg.v23.i6.1059 INTRODUCTION Helicobacter pylori  (H. pylori ) is a global pathogen  that causes gastritis, peptic ulcers, mucosa-associated  lymphoid tissue (MALT) lymphoma, and gastric  cancer[1].",Non-OADS,/arxiv_data1/oa_pdf/ef/4a/WJG-23-1059.PMC5311095.pdf
"All rights reserved.Published by Baishideng Publishing Group Inc 8226 Regency Drive, Pleasanton, CA 94588, USA Telephone: +1-925-223-8242 Fax: +1-925-223-8243 E-mail: bpgoffice@wjgnet.com Help Desk: http://www.wjgnet.com/esps/helpdesk.aspx http://www.wjgnet.com I S S N  1 0  0 7  -   9  3 2  7 9    7 7 1 0  07   9 3 2 0 450  6",Non-OADS,/arxiv_data1/oa_pdf/ef/4a/WJG-23-1059.PMC5311095.pdf
"Submit a Manuscript: http://www.wjgnet.com/esps/ Help Desk: http://www.wjgnet.com/esps/helpdesk.aspx DOI: 10.3748/wjg.v23.i6.1067 1067 February 14, 2017 |Volume 23 |Issue 6 | WJG|www.wjgnet.comWorld J Gastroenterol   2017 February 14; 23(6): 1067-1075  ISSN 1007-9327 (print)  ISSN 2219-2840 (online) © 2017 Baishideng Publishing Group Inc. All rights reserved.",Non-OADS,/arxiv_data1/oa_pdf/88/cf/WJG-23-1067.PMC5311096.pdf
wjgnet.com/1007-9327/full/v23/i6/1067.htm  DOI: http://dx.doi.,OADS,/arxiv_data1/oa_pdf/88/cf/WJG-23-1067.PMC5311096.pdf
"All rights reserved.Published by Baishideng Publishing Group Inc 8226 Regency Drive, Pleasanton, CA 94588, USA Telephone: +1-925-223-8242 Fax: +1-925-223-8243 E-mail: bpgoffice@wjgnet.com Help Desk: http://www.wjgnet.com/esps/helpdesk.aspx http://www.wjgnet.com I S S N  1 0  0 7  -   9  3 2  7 9    7 7 1 0  07   9 3 2 0 450  6",Non-OADS,/arxiv_data1/oa_pdf/88/cf/WJG-23-1067.PMC5311096.pdf
"Pain sub-scales in P-HBI, SF-36 and SIBDQ measures were recoded into  4 identical scores for univariate and multinomial logistic  regression analysis of associations with psycho-social  variables.Submit a Manuscript: http://www.wjgnet.com/esps/ Help Desk: http://www.wjgnet.com/esps/helpdesk.aspxDOI: 10.3748/wjg.v23.i6.1076 1076 February 14, 2017|Volume 23 |Issue 6| WJG|www.wjgnet.comWorld J Gastroenterol  2017 February 14; 23(6): 1076-1089  ISSN 1007-9327 (print)  ISSN 2219-2840 (online) © 2017 Baishideng Publishing Group Inc. All rights reserved.",Non-OADS,/arxiv_data1/oa_pdf/a9/af/WJG-23-1076.PMC5311097.pdf
wjgnet.com/1007-9327/full/v23/i6/ 1076.htm  DOI: http://dx.doi.,OADS,/arxiv_data1/oa_pdf/a9/af/WJG-23-1076.PMC5311097.pdf
"All rights reserved.Published by Baishideng Publishing Group Inc 8226 Regency Drive, Pleasanton, CA 94588, USA Telephone: +1-925-223-8242 Fax: +1-925-223-8243 E-mail: bpgoffice@wjgnet.com Help Desk: http://www.wjgnet.com/esps/helpdesk.aspx http://www.wjgnet.com I S S N  1 0  0 7  -   9  3 2  7 9    7 7 1 0  07   9 3 2 0 450  6",Non-OADS,/arxiv_data1/oa_pdf/a9/af/WJG-23-1076.PMC5311097.pdf
"maeda-o@med.nagoya-u.ac.jp Telephone: 	+81-52-7441903 Fax:	+81-52-7441903 Received: 	October 20, 2016 Peer-review 	started: 	October 24, 2016 First	decision: 	October 28, 2016 Revised:  December 19, 2016 Accepted:  January 17, 2017 Article 	in	press: 	January 17, 2017 Published 	online: 	February 14, 2017 Abstract AIM To	evaluate 	the	feasibility 	of	chemotherapy 	including 	 fluoropyrimidine, 	platinum 	and	taxane 	with	modified 	 dosages 	for	unresectable 	gastric 	cancer 	in	Japanese 	 patients.Submit a Manuscript: http://www.wjgnet.com/esps/ Help Desk: http://www.wjgnet.com/esps/helpdesk.aspx DOI: 10.3748/wjg.v23.i6.1090 1090 February 14, 2017 |Volume 23 |Issue 6 | WJG|www.wjgnet.comWorld J Gastroenterol   2017 February 14; 23(6): 1090-1097  ISSN 1007-9327 (print)  ISSN 2219-2840 (online) © 2017 Baishideng Publishing Group Inc. All rights reserved.",Non-OADS,/arxiv_data1/oa_pdf/0e/f5/WJG-23-1090.PMC5311098.pdf
wjgnet.com/1007-9327/full/v23/i6/1090.htm  DOI: http://dx.doi.,OADS,/arxiv_data1/oa_pdf/0e/f5/WJG-23-1090.PMC5311098.pdf
"All rights reserved.Published by Baishideng Publishing Group Inc 8226 Regency Drive, Pleasanton, CA 94588, USA Telephone: +1-925-223-8242 Fax: +1-925-223-8243 E-mail: bpgoffice@wjgnet.com Help Desk: http://www.wjgnet.com/esps/helpdesk.aspx http://www.wjgnet.com I S S N  1 0  0 7  -   9  3 2  7 9    7 7 1 0  07   9 3 2 0 450  6",Non-OADS,/arxiv_data1/oa_pdf/0e/f5/WJG-23-1090.PMC5311098.pdf
"RESULTSThe	study 	cohort 	included 	167	(36.6%) 	patients 	who	Submit a Manuscript: http://www.wjgnet.com/esps/ Help Desk: http://www.wjgnet.com/esps/helpdesk.aspx DOI: 10.3748/wjg.v23.i6.1098 1098 February 14, 2017 |Volume 23 |Issue 6 | WJG|www.wjgnet.comWorld J Gastroenterol   2017 February 14; 23(6): 1098-1105  ISSN 1007-9327 (print)  ISSN 2219-2840 (online) © 2017 Baishideng Publishing Group Inc. All rights reserved.",Non-OADS,/arxiv_data1/oa_pdf/52/a3/WJG-23-1098.PMC5311099.pdf
"World J  Gastroenterol  2017; 23(6): 1098-1105  Available from: URL :  http://www.wjgnet.com/1007-9327/full/v23/i6/ 1098 .htm  DOI:  http://dx.doi.org/10.3748/wjg.v23.i6.1098 INTRODUCTION Esophagogastroduodenoscopy (EGD) and colonoscopy  are important examinations for screening, diagnosing,  and treating a variety of gastrointestinal diseases.",Non-OADS,/arxiv_data1/oa_pdf/52/a3/WJG-23-1098.PMC5311099.pdf
"All rights reserved.Published by Baishideng Publishing Group Inc 8226 Regency Drive, Pleasanton, CA 94588, USA Telephone: +1-925-223-8242 Fax: +1-925-223-8243 E-mail: bpgoffice@wjgnet.com Help Desk: http://www.wjgnet.com/esps/helpdesk.aspx http://www.wjgnet.com I S S N  1 0  0 7  -   9  3 2  7 9    7 7 1 0  07   9 3 2 0 450  6",Non-OADS,/arxiv_data1/oa_pdf/52/a3/WJG-23-1098.PMC5311099.pdf
"In conclusion, the co-existence of TA with high grade-NEC in our case allowed early identification CASE REPORTSubmit a Manuscript: http://www.wjgnet.com/esps/ Help Desk: http://www.wjgnet.com/esps/helpdesk.aspxDOI: 10.3748/wjg.v23.i6.1106 1106 February 14, 2017|Volume 23 |Issue 6| WJG|www.wjgnet.comWorld J Gastroenterol  2017 February 14; 23(6): 1106-1112  ISSN 1007-9327 (print)  ISSN 2219-2840 (online) © 2017 Baishideng Publishing Group Inc. All rights reserved.",Non-OADS,/arxiv_data1/oa_pdf/35/66/WJG-23-1106.PMC5311100.pdf
World J  Gastroenterol  2017; 23(6): 1106-1112  Available from: URL:  http://www.wjgnet.com/1007-9327/full/v23/i6/1106.htm  DOI: http://dx.doi.org/10.3748/wjg.v23.i6.1106 INTRODUCTION Neuroendocrine tumors (NET) is a distinct group  of neoplasms that arises from enterochromaffin/ neuroendocrine cells throughout the body and display  unique histomorphology.,Non-OADS,/arxiv_data1/oa_pdf/35/66/WJG-23-1106.PMC5311100.pdf
"All rights reserved.Published by Baishideng Publishing Group Inc 8226 Regency Drive, Pleasanton, CA 94588, USA Telephone: +1-925-223-8242 Fax: +1-925-223-8243 E-mail: bpgoffice@wjgnet.com Help Desk: http://www.wjgnet.com/esps/helpdesk.aspx http://www.wjgnet.com I S S N  1 0  0 7  -   9  3 2  7 9    7 7 1 0  07   9 3 2 0 450  6",Non-OADS,/arxiv_data1/oa_pdf/35/66/WJG-23-1106.PMC5311100.pdf
"Key words: Pancreatic 	cyst;	Pancreatic 	endometrial 	 cyst;	Endometriosis; 	Mucinous 	cystic 	neoplasm 	of	the	Submit a Manuscript: http://www.wjgnet.com/esps/ Help Desk: http://www.wjgnet.com/esps/helpdesk.aspx DOI: 10.3748/wjg.v23.i6.1113 1113 February 14, 2017 |Volume 23 |Issue 6 | WJG|www.wjgnet.comWorld J Gastroenterol   2017 February 14; 23(6): 1113-1118  ISSN 1007-9327 (print)  ISSN 2219-2840 (online) © 2017 Baishideng Publishing Group Inc. All rights reserved.",Non-OADS,/arxiv_data1/oa_pdf/ae/27/WJG-23-1113.PMC5311101.pdf
wjgnet.com/1007-9327/full/v23/i6/1113.htm  DOI: http://dx.doi.,OADS,/arxiv_data1/oa_pdf/ae/27/WJG-23-1113.PMC5311101.pdf
"All rights reserved.Published by Baishideng Publishing Group Inc 8226 Regency Drive, Pleasanton, CA 94588, USA Telephone: +1-925-223-8242 Fax: +1-925-223-8243 E-mail: bpgoffice@wjgnet.com Help Desk: http://www.wjgnet.com/esps/helpdesk.aspx http://www.wjgnet.com I S S N  1 0  0 7  -   9  3 2  7 9    7 7 1 0  07   9 3 2 0 450  6",Non-OADS,/arxiv_data1/oa_pdf/ae/27/WJG-23-1113.PMC5311101.pdf
"Randomized 	controlled 	trials	with	long-term 	follow-up 	 periods 	and	cost-effective 	studies 	are	required 	before 	 prophylactic 	stenting 	could	be	considered 	a	valid	option 	 to	prevent 	post-endoscopic 	submucosal 	dissection 	 stricture.Submit a Manuscript: http://www.wjgnet.com/esps/ Help Desk: http://www.wjgnet.com/esps/helpdesk.aspx DOI: 10.3748/wjg.v23.i6.931 931 February 14, 2017 |Volume 23 |Issue 6 | WJG|www.wjgnet.comWorld J Gastroenterol   2017 February 14; 23(6): 931-934 ISSN 1007-9327 (print)  ISSN 2219-2840 (online) © 2016 Baishideng Publishing Group Inc. All rights reserved.",Non-OADS,/arxiv_data1/oa_pdf/62/8d/WJG-23-931.PMC5311102.pdf
"All rights reserved.Published by Baishideng Publishing Group Inc 8226 Regency Drive, Pleasanton, CA 94588, USA Telephone: +1-925-223-8242 Fax: +1-925-223-8243 E-mail: bpgoffice@wjgnet.com Help Desk: http://www.wjgnet.com/esps/helpdesk.aspx http://www.wjgnet.com I S S N  1 0  0 7  -   9  3 2  7 9    7 7 1 0  07   9 3 2 0 450  6",Non-OADS,/arxiv_data1/oa_pdf/62/8d/WJG-23-931.PMC5311102.pdf
"Hiroyuki 	Matsubayashi,  Division of Endoscopy, Shizuoka  Cancer Center, Shizuoka 411-8777, Japan Hiroyuki 	Matsubayashi, 	Yoshimi 	Kiyozumi,  Clinic of Genetic  Medicine, Shizuoka Cancer Center, Shizuoka 411-8777, JapanKyoichi 	Takaori,  Department of Surgery, Kyoto University  Graduate School of Medicine, Sakyo, Kyoto 606-8397, JapanChigusa 	Morizane, 	Hiroko 	Hosoi,  Division of Hepatobiliary  and Pancreatic Oncology, National Cancer Center Hospital,  Chuoku, Tokyo 104-0045, JapanHiroyuki 	Maguchi, 	 Center for Gastroenterology, Teine-Keijinkai  Hospital, Sapporo, Hokkaido 006-0811, JapanMasamichi 	Mizuma, 	 Department of Surgery, Tohoku University  Graduate School of Medicine, Sendai, Miyagi 980-8574, JapanHideaki 	Takahashi,  Department of Hepatobiliary and Pancreatic  Oncology, National Cancer Center Hospital East, Kashiwa, Chiba  277-8577, JapanKeita	Wada,  Department of Surgery, Teikyo University School  of Medicine, Itabashi, Tokyo 173-8606, JapanShinichi 	Yachida, 	Masami 	Suzuki, 	Risa	Usui,	 Division of  Cancer Genomics, National Cancer Center Research Institute,  Chuoku, Tokyo 104-0045, JapanToru	Furukawa,  Institute for Integrated Medical Sciences,  Tokyo Women’s Medical University, Shinjuku, Tokyo 162-8666,  JapanJunji	Furuse,  Department of Internal Medicine, Kyorin  University School of Medicine, Mitaka, Tokyo 181-8611, JapanTakamitsu 	Sato,	 Division of Gastroenterology, Yokohama City  University Graduate School of Medicine, Yokohama, Kanagawa 236-0004, JapanMakoto 	Ueno, 	 Division of Hepatobiliary and Pancreatic Medical  Oncology, Kanagawa Cancer Center, Yokohama, Kanagawa  241-8515, JapanSusumu 	Hijioka, 	Nobumasa 	Mizuno,  Department of Gastroen - terology, Aichi Cancer Center Hospital, Nagoya, Aichi 464-8681,  JapanTakeshi 	Terashima,  Department of Gastroenterology, Kanazawa  University Graduate School of Medicine, Kanazawa, Ishikawa  920-8641, JapanMasaki 	Mizumoto, 	 Department of Surgery, Japan Bapist  Hospital, Kyotoshi, Kyoto 606-8273, JapanYuzo	Kodama,  Department of Gastroenterology and Hepatology,  Kyoto University Graduate School of Medicine, Sakyo, Kyoto  606-8397, JapanMasako 	Torishima,  Clinical Genetics Unit, Kyoto University  Graduate School of Medicine, Sakyo, Kyoto 606-8397, JapanTakahisa 	Kawaguchi,  Center for Genomic Medicine, Kyoto  University Graduate School of Medicine, Sakyo, Kyoto  606-8397, JapanReiko 	Ashida, 	 Osaka Medical Center for Cancer and  Cardiovascular Diseases, Higashinari, Osaka 537-8511, JapanMasayuki 	Kitano,  Second Department of Internal Medicine,  Wakayama Medical University, Wakayamashi, Wakayama  641-8509, JapanKeiji	Hanada,  Department of Gastroenterology, Onomichi  General Hospital, Onomichi, Hiroshima 722-8508, JapanMasayuki 	Furukawa,  Department of Gastroenterology, National Submit a Manuscript: http://www.wjgnet.com/esps/ Help Desk: http://www.wjgnet.com/esps/helpdesk.aspx DOI: 10.3748/wjg.v23.i6.935 935 February 14, 2017 |Volume 23 |Issue 6 | WJG|www.wjgnet.comWorld J Gastroenterol   2017 February 14; 23(6): 935-948  ISSN 1007-9327 (print)  ISSN 2219-2840 (online) © 2017 Baishideng Publishing Group Inc. All rights reserved.",Non-OADS,/arxiv_data1/oa_pdf/b3/cc/WJG-23-935.PMC5311103.pdf
wjgnet.com/1007-9327/full/v23/i6/935.htm  DOI: http://dx.doi.,OADS,/arxiv_data1/oa_pdf/b3/cc/WJG-23-935.PMC5311103.pdf
"The nationwide cancer deaths due to  PC is now total over 30000, so that PC ranks fourth  among all human cancers (http://ganjoho.jp/reg_stat/ 936 February 14, 2017 |Volume 23 |Issue 6 | WJG|www.wjgnet.comMatsubayashi	H 	et	al.",Non-OADS,/arxiv_data1/oa_pdf/b3/cc/WJG-23-935.PMC5311103.pdf
The National Familial Pancreas Tumor  Registry (NFPTR) (http://pathology.jhu.edu/pan - creas/nfptr/history.php) was founded in 1994 at Johns Figure 1  Worldwide mapping of the (familial) pancreatic cancer registries and genetic research institutions (1-24).,OADS,/arxiv_data1/oa_pdf/b3/cc/WJG-23-935.PMC5311103.pdf
"This  was followed by the European Registry of Hereditary  Pancreatitis and Familial Pancreas Cancer (EUROPAC:  http://www.europac-org.eu/)[30] (1997) at Liverpool  University (Liverpool, United Kingdom) and the  German National Case Collection for Familial Pancreatic  Carcinoma (FaPaCa: http://www.fapaca.de/)[49,50]  (1999) at Phillips University (Marburg, Germany).",Non-OADS,/arxiv_data1/oa_pdf/b3/cc/WJG-23-935.PMC5311103.pdf
A committee  was assembled in 2013 and the nationwide registry  of FPC (Japanese Familial Pancreatic Cancer Registry:  JFPCR: http://jfpcr.com) was officially established in  2014 by the Japan Pancreas Society.,Non-OADS,/arxiv_data1/oa_pdf/b3/cc/WJG-23-935.PMC5311103.pdf
"Available  from: URL: http://www.cancerorg/research/cancerfactsstatistics/2016 2 Egawa S , Toma H, Ohigashi H, Okusaka T, Nakao A, Hatori T,  Maguchi H, Yanagisawa A, Tanaka M. Japan Pancreatic Cancer  Registry; 30th year anniversary: Japan Pancreas Society.",Non-OADS,/arxiv_data1/oa_pdf/b3/cc/WJG-23-935.PMC5311103.pdf
"All rights reserved.Published by Baishideng Publishing Group Inc 8226 Regency Drive, Pleasanton, CA 94588, USA Telephone: +1-925-223-8242 Fax: +1-925-223-8243 E-mail: bpgoffice@wjgnet.com Help Desk: http://www.wjgnet.com/esps/helpdesk.aspx http://www.wjgnet.com I S S N  1 0  0 7  -   9  3 2  7 9    7 7 1 0  07   9 3 2 0 450  6",Non-OADS,/arxiv_data1/oa_pdf/b3/cc/WJG-23-935.PMC5311103.pdf
"Core tip: Lymphocytic 	esophagitis 	has	recently 	been	 described 	in	2006	and	subsequently, 	multiple 	groups 	 have	attempted 	to	describe 	its	clinical 	associations 	 and	risk	factors	 with	minimal 	information 	available	 on	Submit a Manuscript: http://www.wjgnet.com/esps/ Help Desk: http://www.wjgnet.com/esps/helpdesk.aspx DOI: 10.3748/wjg.v23.i6.949 949 February 14, 2017 |Volume 23 |Issue 6 | WJG|www.wjgnet.comWorld J Gastroenterol   2017 February 14; 23(6): 949-956  ISSN 1007-9327 (print)  ISSN 2219-2840 (online) © 2017 Baishideng Publishing Group Inc. All rights reserved.",Non-OADS,/arxiv_data1/oa_pdf/31/33/WJG-23-949.PMC5311104.pdf
World J Gastroenterol 2017;  23(6): 949-956  Available from: URL: http://www.wjgnet.,Non-OADS,/arxiv_data1/oa_pdf/31/33/WJG-23-949.PMC5311104.pdf
com/1007-9327/full/v23/i6/949.htm  DOI: http://dx.doi.,OADS,/arxiv_data1/oa_pdf/31/33/WJG-23-949.PMC5311104.pdf
"All rights reserved.Published by Baishideng Publishing Group Inc 8226 Regency Drive, Pleasanton, CA 94588, USA Telephone: +1-925-223-8242 Fax: +1-925-223-8243 E-mail: bpgoffice@wjgnet.com Help Desk: http://www.wjgnet.com/esps/helpdesk.aspx http://www.wjgnet.com I S S N  1 0  0 7  -   9  3 2  7 9    7 7 1 0  07   9 3 2 0 450  6",Non-OADS,/arxiv_data1/oa_pdf/31/33/WJG-23-949.PMC5311104.pdf
"See: http://creativecommons.org/licenses/by-nc/4.0/ Manuscript source: Invited manuscript Correspondence to: Andrea Párniczky, MD, Institute for  Translational Medicine, University of Pécs, Szigeti út 12., II.",Non-OADS,/arxiv_data1/oa_pdf/6c/6c/WJG-23-957.PMC5311105.pdf
"In this minireview, our aim was to  systematically analyse the literature on the treatment Submit a Manuscript: http://www.wjgnet.com/esps/ Help Desk: http://www.wjgnet.com/esps/helpdesk.aspxDOI: 10.3748/wjg.v23.i6.957 957 February 14, 2017|Volume 23 |Issue 6| WJG|www.wjgnet.comWorld J Gastroenterol  2017 February 14; 23(6): 957-963  ISSN 1007-9327 (print)  ISSN 2219-2840 (online) © 2017 Baishideng Publishing Group Inc. All rights reserved.",Non-OADS,/arxiv_data1/oa_pdf/6c/6c/WJG-23-957.PMC5311105.pdf
"World J Gastroenterol  2017;  23(6): 957-963  Available from: URL: http://www.wjgnet.com/1007-9327/full/v23/i6/957.htm  DOI: http://dx.doi.org/10.3748/wjg.v23.i6.957 INTRODUCTION Acute pancreatitis (AP) is a serious inflammatory dis­ ease with rising incidence both in adult and pediatric  populations[1,2].",Non-OADS,/arxiv_data1/oa_pdf/6c/6c/WJG-23-957.PMC5311105.pdf
"In February 2016, a literature search was per­ formed on the PubMed (http://www.ncbi.nlm.nih.gov/pubmed) and EMBASE (https://www.embase.",OADS,/arxiv_data1/oa_pdf/6c/6c/WJG-23-957.PMC5311105.pdf
"All rights reserved.Published by Baishideng Publishing Group Inc 8226 Regency Drive, Pleasanton, CA 94588, USA Telephone: +1-925-223-8242 Fax: +1-925-223-8243 E-mail: bpgoffice@wjgnet.com Help Desk: http://www.wjgnet.com/esps/helpdesk.aspx http://www.wjgnet.com I S S N  1 0  0 7  -   9  3 2  7 9    7 7 1 0  07   9 3 2 0 450  6",Non-OADS,/arxiv_data1/oa_pdf/6c/6c/WJG-23-957.PMC5311105.pdf
"For	Submit a Manuscript: http://www.wjgnet.com/esps/ Help Desk: http://www.wjgnet.com/esps/helpdesk.aspx DOI: 10.3748/wjg.v23.i6.964 964 February 14, 2017 |Volume 23 |Issue 6 | WJG|www.wjgnet.comWorld J Gastroenterol   2017 February 14; 23(6): 964-975  ISSN 1007-9327 (print)  ISSN 2219-2840 (online) © 2017 Baishideng Publishing Group Inc. All rights reserved.",Non-OADS,/arxiv_data1/oa_pdf/f8/3d/WJG-23-964.PMC5311106.pdf
"All rights reserved.Published by Baishideng Publishing Group Inc 8226 Regency Drive, Pleasanton, CA 94588, USA Telephone: +1-925-223-8242 Fax: +1-925-223-8243 E-mail: bpgoffice@wjgnet.com Help Desk: http://www.wjgnet.com/esps/helpdesk.aspx http://www.wjgnet.com I S S N  1 0  0 7  -   9  3 2  7 9    7 7 1 0  07   9 3 2 0 450  6",Non-OADS,/arxiv_data1/oa_pdf/f8/3d/WJG-23-964.PMC5311106.pdf
"See: http://creativecommons.org/licenses/by-nc/4.0/Manuscript 	source:  Invited manuscript Correspondence	 to:	Xing-Peng 	Wang, 	MD,	PhD,	Professor,   Department of Gastroenterology, Shanghai General Hospital,  Shanghai Jiao Tong University School of Medicine, No 100,  Haining Road, Shanghai 200080, China.",Non-OADS,/arxiv_data1/oa_pdf/e4/52/WJG-23-976.PMC5311107.pdf
"976 February 14, 2017 |Volume 23 |Issue 6 | WJG|www.wjgnet.comORIGINAL ARTICLE MicroRNA-155 promotes the pathogenesis of experimental  colitis by repressing SHIP-1 expressionBasic Study Zhan-Jun	Lu,	Jian-Jiong	Wu,	Wei-Liang	Jiang,	Jun-Hua	Xiao,	Kai-Zhong	Tao,	Lei	Ma,	Ping	Zheng,	Rong	Wan,	 Xing-Peng	WangSubmit a Manuscript: http://www.wjgnet.com/esps/ Help Desk: http://www.wjgnet.com/esps/helpdesk.aspx DOI: 10.3748/wjg.v23.i6.976World J Gastroenterol   2017 February 14; 23(6): 976-985  ISSN 1007-9327 (print)  ISSN 2219-2840 (online) © 2017 Baishideng Publishing Group Inc. All rights reserved.",Non-OADS,/arxiv_data1/oa_pdf/e4/52/WJG-23-976.PMC5311107.pdf
"All rights reserved.Published by Baishideng Publishing Group Inc 8226 Regency Drive, Pleasanton, CA 94588, USA Telephone: +1-925-223-8242 Fax: +1-925-223-8243 E-mail: bpgoffice@wjgnet.com Help Desk: http://www.wjgnet.com/esps/helpdesk.aspx http://www.wjgnet.com I S S N  1 0  0 7  -   9  3 2  7 9    7 7 1 0  07   9 3 2 0 450  6",Non-OADS,/arxiv_data1/oa_pdf/e4/52/WJG-23-976.PMC5311107.pdf
"See: http://creativecommons.org/licenses/by-nc/4.0/ Manuscript 	source: 	Unsolicited manuscript Correspondence 	to:	Dr.	Guo-Ping 	Sun,	Department of  Oncology, the First Affiliated Hospital of Anhui Medical  University, No.",Non-OADS,/arxiv_data1/oa_pdf/48/5f/WJG-23-986.PMC5311108.pdf
"RESULTSIn	the	present 	study, 	we	first	identified 	that	melatonin 	Submit a Manuscript: http://www.wjgnet.com/esps/ Help Desk: http://www.wjgnet.com/esps/helpdesk.aspx DOI: 10.3748/wjg.v23.i6.986 986 February 14, 2017 |Volume 23 |Issue 6 | WJG|www.wjgnet.comWorld J Gastroenterol   2017 February 14; 23(6):986-998  ISSN 1007-9327 (print)  ISSN 2219-2840 (online) © 2017 Baishideng Publishing Group Inc. All rights reserved.",Non-OADS,/arxiv_data1/oa_pdf/48/5f/WJG-23-986.PMC5311108.pdf
"World J Gastroenterol 2017; 23(6): 986-998   Available from: URL: http://www.wjgnet.com/1007-9327/full/ v23/i6/986.htm  DOI: http://dx.doi.org/10.3748/wjg.v23.i6.986 INTRODUCTION Hepatocellular carcinoma (HCC) was the fifth most  frequently diagnosed cancer worldwide and the third  cause of cancer-related death, responsible for approxi - mately 700000 human deaths annually worldwide[1,2].",Non-OADS,/arxiv_data1/oa_pdf/48/5f/WJG-23-986.PMC5311108.pdf
"All rights reserved.Published by Baishideng Publishing Group Inc 8226 Regency Drive, Pleasanton, CA 94588, USA Telephone: +1-925-223-8242 Fax: +1-925-223-8243 E-mail: bpgoffice@wjgnet.com Help Desk: http://www.wjgnet.com/esps/helpdesk.aspx http://www.wjgnet.com I S S N  1 0  0 7  -   9  3 2  7 9    7 7 1 0  07   9 3 2 0 450  6",Non-OADS,/arxiv_data1/oa_pdf/48/5f/WJG-23-986.PMC5311108.pdf
"hongweizhao788@163.com Telephone: 	+86-13303039680 Fax:	+86-311-85988449 Received: 	August 17, 2016 Peer-review 	started: 	August 19, 2016 First	decision: 	September 6, 2016 Revised: 	September 26, 2016 Accepted: 	October 30, 2016Submit a Manuscript: http://www.wjgnet.com/esps/ Help Desk: http://www.wjgnet.com/esps/helpdesk.aspx DOI: 10.3748/wjg.v23.i6.999 999 February 14, 2017 |Volume 23 |Issue 6 | WJG|www.wjgnet.comWorld J Gastroenterol   2017 February 14; 23(6): 999-1009  ISSN 1007-9327 (print)  ISSN 2219-2840 (online) © 2017 Baishideng Publishing Group Inc. All rights reserved.",Non-OADS,/arxiv_data1/oa_pdf/33/11/WJG-23-999.PMC5311109.pdf
"World J  Gastroenterol 2017; 23(6): 999-1009  Available from: URL:  http://www.wjgnet.com/1007-9327/full/v23/i6/999.htm  DOI:  http://dx.doi.org/10.3748/wjg.v23.i6.999 INTRODUCTION Inflammatory bowel disease (IBD), including Crohn’s  disease (CD) and ulcerative colitis (UC), are common  chronic diseases that are characterized by abnormal  mucosal immune response to luminal bacteria[1,2].",Non-OADS,/arxiv_data1/oa_pdf/33/11/WJG-23-999.PMC5311109.pdf
"All rights reserved.Published by Baishideng Publishing Group Inc 8226 Regency Drive, Pleasanton, CA 94588, USA Telephone: +1-925-223-8242 Fax: +1-925-223-8243 E-mail: bpgoffice@wjgnet.com Help Desk: http://www.wjgnet.com/esps/helpdesk.aspx http://www.wjgnet.com I S S N  1 0  0 7  -   9  3 2  7 9    7 7 1 0  07   9 3 2 0 450  6",Non-OADS,/arxiv_data1/oa_pdf/33/11/WJG-23-999.PMC5311109.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/ 4.0/).,Non-OADS,/arxiv_data1/oa_pdf/bb/da/main.PMC5311248.pdf
http://dx.doi.org/10.1016/j.jdcr.2016.11.001 64,OADS,/arxiv_data1/oa_pdf/bb/da/main.PMC5311248.pdf
"To view a copy of this license, visit http:// creativecommons.org/licenses/by-nc-sa/4.0/ © The Author(s) 2017 Supplementary Information accompanies this paper on the Oncogene website (http://www.nature.com/onc)ROCKs activation by FOXM1D promotes EMT and metastasis X Zhang et al 819 Oncogene (2017) 807 –819",Non-OADS,/arxiv_data1/oa_pdf/90/df/onc2016249a.PMC5311249.pdf
4Heatmaps re ﬂecting normalized expression data were generated using Gene-E (https://www.broadinstitute.org/cancer/soft ware/GENE-E/).,OADS,/arxiv_data1/oa_pdf/45/72/onc2016251a.PMC5311251.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/4.0/ © The Author(s) 2017 Supplementary Information accompanies this paper on the Oncogene website (http://www.nature.com/onc)Atypical E2Fs function as tumor suppressors I Thurlings et al 839 Oncogene (2017) 829 –839",Non-OADS,/arxiv_data1/oa_pdf/45/72/onc2016251a.PMC5311251.pdf
We used an online database of potential breast cancer biomarkers(http://www.kmplot.com) to assess the prognostic implications ofCXCL12 and CXCR7 expression in breast cancer patients.,OADS,/arxiv_data1/oa_pdf/b3/6b/onc2016252a.PMC5311419.pdf
"Plasmids and lentivirus particles The sequence of dn-TGFBR2 was ampli ﬁed from the genomic DNA of TGF β receptor 2-dn transgenic mice and inserted into pLVX-IRES-zsGreen vector.CXCL12 sequence was cloned and inserted into pLVX-IRES-zsGreen vector.CXCL12-speci ﬁc (sh-CXCL12), CXCR7-speci ﬁc (sh-CXCR7) and control (sh-control) short hairpin RNA (shRNA) lentivirus particles were prepared by GenePharma (Shanghai, China, http://www.genepharma.com/).Reagents Recombinant human TGF β, CXCL12, anti-mouse TGFBR2-PE, anti-mouse CXCL12-APC, anti-mouse/human CXCR7-APC were purchased from R&D Systems (Minneapolis, MN, USA).",OADS,/arxiv_data1/oa_pdf/b3/6b/onc2016252a.PMC5311419.pdf
"For intracellular staining of CXCL12, after permeabilization, cells were stained with ﬂuorochrome- conjugated antibodies and analyzed on a FACS Calibur (Becton Dickinson,SanJose, CA, USA, http://www.bd.com) according to the manufacturer ’s instruction.",Non-OADS,/arxiv_data1/oa_pdf/b3/6b/onc2016252a.PMC5311419.pdf
"To view a copy of this license, visit http:// creativecommons.org/licenses/by-nc-sa/4.0/ © The Author(s) 2017 Supplementary Information accompanies this paper on the Oncogene website (http://www.nature.com/onc)MSCs promote tumour metastasis via regulating CXCL12 PF Yu et al 849 Oncogene (2017) 840 –849",Non-OADS,/arxiv_data1/oa_pdf/b3/6b/onc2016252a.PMC5311419.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc- nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/16/8b/main.PMC5311424.pdf
http://dx.doi.org/10.1016/j.jdcr.2016.11.010 55,OADS,/arxiv_data1/oa_pdf/16/8b/main.PMC5311424.pdf
This is an open access article under the CC BY- NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/ 4.0/).,Non-OADS,/arxiv_data1/oa_pdf/62/45/main.PMC5311425.pdf
http://dx.doi.org/10.1016/j.jdcr.2016.11.004 61,OADS,/arxiv_data1/oa_pdf/62/45/main.PMC5311425.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/ 4.0/).,Non-OADS,/arxiv_data1/oa_pdf/6c/15/main.PMC5311427.pdf
http://dx.doi.org/10.1016/j.jdcr.2016.11.005 58,OADS,/arxiv_data1/oa_pdf/6c/15/main.PMC5311427.pdf
Available from: URL:http://www.hrsa.gov/hansensdisease/ .,OADS,/arxiv_data1/oa_pdf/6c/15/main.PMC5311427.pdf
Available from: URL: http://www.fda.gov/Safety/ MedWatch/SafetyInformation/ucm266123.htm .,Non-OADS,/arxiv_data1/oa_pdf/6c/15/main.PMC5311427.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc- nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/a3/b7/main.PMC5311428.pdf
http://dx.doi.org/10.1016/j.jdcr.2016.12.005 67,OADS,/arxiv_data1/oa_pdf/a3/b7/main.PMC5311428.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/ 4.0/).,Non-OADS,/arxiv_data1/oa_pdf/20/88/main.PMC5311429.pdf
http://dx.doi.org/10.1016/j.jdcr.2016.12.001 53,OADS,/arxiv_data1/oa_pdf/20/88/main.PMC5311429.pdf
"Stem Cell Reports Article In Vivo Maturation of Human Induced Pluripotent Stem Cell-Derived Cardiomyocytes in Neonatal and Adult Rat Hearts Shin Kadota,1,2,3Lil Pabon,1,2,3Hans Reinecke,1,2,3and Charles E. Murry1,2,3,4,5,* 1Department of Pathology, University of Washington, 850 Republican Street, Brotman Building Room 453, Seattle, WA 98109, USA 2Institute for Stem Cell and Regenerative Medicine 3Center for Cardiovascular Biology 4Department of Bioengineering 5Department of Medicine/Cardiology University of Washington, Seattle, WA 98109, USA*Correspondence: murry@uw.edu http://dx.doi.org/10.1016/j.stemcr.2016.10.009 SUMMARY We hypothesized that the neonatal rat heart would bring transplanted human induced pluripotent stem cell-derived cardiomyocytes (hiPSC-CMs) to maturity as it grows to adult size.",Non-OADS,/arxiv_data1/oa_pdf/d2/61/main.PMC5311430.pdf
This is an open access article under the CC BY -NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/d2/61/main.PMC5311430.pdf
SUPPLEMENTAL INFORMATION Supplemental Information includes ﬁve ﬁgures and two tables and can be found with this article online at http://dx.doi.org/10.1016/ j.stemcr.2016.10.009 .,OADS,/arxiv_data1/oa_pdf/d2/61/main.PMC5311430.pdf
"Stem Cell Reports Article Mesenchymal to Epithelial T ransition Mediated by CDH1 Promotes Spontaneous Reprogramming of Male Germline Stem Cells to Pluripotency Junhui An,1Yu Zheng,1and Christina Tenenhaus Dann1,* 1Department of Chemistry, Indiana University, Chemistry A025, 800 E. Kirkwood Avenue, Bloomington, IN 47405-7102, USA *Correspondence: ctdann@indiana.edu http://dx.doi.org/10.1016/j.stemcr.2016.12.006 SUMMARY Cultured spermatogonial stem cells (GSCs) can spontaneously form pluripotent cells in certain culture conditions.",Non-OADS,/arxiv_data1/oa_pdf/06/c0/main.PMC5311464.pdf
This is an open access article under the CC BY -NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/06/c0/main.PMC5311464.pdf
"SUPPLEMENTAL INFORMATION Supplemental Information includes Supplemental ExperimentalProcedures, seven ﬁgures, and four tables and can be foundwith this article online at http://dx.doi.org/10.1016/j.stemcr.",OADS,/arxiv_data1/oa_pdf/06/c0/main.PMC5311464.pdf
http://dx.doi.org/10.1016/j.stemcr.2016.12.009 SUMMARY Acquired genomic instability is one of the major concerns for the clinical use of induced pluripotent stem cells (iPSCs).,Non-OADS,/arxiv_data1/oa_pdf/14/f2/main.PMC5311465.pdf
This is an open access article under the CC BY -NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/14/f2/main.PMC5311465.pdf
"SUPPLEMENTAL INFORMATION Supplemental Information includes Supplemental ExperimentalProcedures, ﬁve ﬁgures, and three tables and can be found with this article online at http://dx.doi.org/10.1016/j.stemcr.",OADS,/arxiv_data1/oa_pdf/14/f2/main.PMC5311465.pdf
"See: http://creativecommons.org/ licenses/by-nc/4.0/ Manuscript source:  Invited manuscript Correspondence to:  Xiaofa Qin, MD, PhD,  GI Biopharma Inc,  918 Willow Grove Road, Westfield, NJ 07090,  United States.",Non-OADS,/arxiv_data1/oa_pdf/bd/67/WJGP-8-1.PMC5311466.pdf
wjgnet.com/2150-5330/full/v8/i1/ 1.htm  DOI: http://dx.doi.,OADS,/arxiv_data1/oa_pdf/bd/67/WJGP-8-1.PMC5311466.pdf
"That paper discussed  the interaction among gut bacteria, immune cells, and  epithelial cells through inflammatory mediators, cyto - kines, bioactive molecules, receptors, ligands, tran -World J Gastrointest Pathophysiol   207 February 5; 8(): -2 ISSN 250-5330 (online)  © 207 Baishideng Publishing Group Inc. All rights reserved.Submit a Manuscript: http://www.wjgnet.com/esps/ Help Desk: http://www.wjgnet.com/esps/helpdesk.aspx DOI: 0.429/wjgp.v8.i.",Non-OADS,/arxiv_data1/oa_pdf/bd/67/WJGP-8-1.PMC5311466.pdf
"Available  from: URL: http://www.ncbi.nlm.nih.gov/pubmed/?term=xiaofa qin P- Reviewer : Matowicka-Karna J, Yang CH, Zhu YL    S- Editor : Qi Y     L- Editor : A    E- Editor : Li D",Non-OADS,/arxiv_data1/oa_pdf/bd/67/WJGP-8-1.PMC5311466.pdf
"All rights reserved.Published by Baishideng Publishing Group Inc 8226 Regency Drive, Pleasanton, CA 94588, USA Telephone: +1-925-223-8242 Fax: +1-925-223-8243 E-mail: bpgoffice@wjgnet.com Help Desk: http://www.wjgnet.com/esps/helpdesk.aspx http://www.wjgnet.com",Non-OADS,/arxiv_data1/oa_pdf/bd/67/WJGP-8-1.PMC5311466.pdf
"See: http://creativecommons.org/ licenses/by-nc/4.0/ Manuscript source:  Invited manuscript Correspondence to:  Sara Ashtari, MSc  of Epidemiology  in Research Institute of Gastroenterology and Liver Diseases,  Gastroenterology and Liver Diseases Research Center, Research  Institute for Gastroenterology and Liver Diseases, Shahid  Beheshti University of Medical Sciences, Tabnak St, Yaman Ave,  Velenjak, Tehran 19835-178, Iran.",Non-OADS,/arxiv_data1/oa_pdf/81/dd/WJGP-8-3.PMC5311467.pdf
"sara_ashtari@yahoo.co m Telephone:  +98-21-22432515 Fax:  +98-21-22432517 Received:  September 13, 2016   Peer-review started:  September 14, 2016   First decision:  October 21, 2016   Revised:  November 23, 2016   Accepted:  December 7, 2016 Article in press:  December 9, 2016 Published online:  February 15, 2017 Abstract AIM To identify the prevalence, and clinical and pathologic  characteristic of colonic polyps among Iranian patients  undergoing a comprehensive colonoscopy, and deter - mine the polyp detection rate (PDR) and adenoma  detection rate (ADR).World J Gastrointest Pathophysiol   2017 February 15; 8(1): -10 ISSN 2150-50 (online)  © 2017 Baishideng Publishing Group Inc. All rights reserved.Submit a Manuscript: http://www.wjgnet.com/esps/ Help Desk: http://www.wjgnet.com/esps/helpdesk.aspx DOI: 10.4291/wjgp.v8.i1.",Non-OADS,/arxiv_data1/oa_pdf/81/dd/WJGP-8-3.PMC5311467.pdf
World J  Gastrointest Pathophysiol  2017; 8(1): 3-10  Available from:  URL:  http://www.wjgnet.com/2150-5330/full/v8/i1/ 3.htm  DOI: http://dx.doi.org/10.4291/wjgp.v8.i1.,Non-OADS,/arxiv_data1/oa_pdf/81/dd/WJGP-8-3.PMC5311467.pdf
"All rights reserved.Published by Baishideng Publishing Group Inc 8226 Regency Drive, Pleasanton, CA 94588, USA Telephone: +1-925-223-8242 Fax: +1-925-223-8243 E-mail: bpgoffice@wjgnet.com Help Desk: http://www.wjgnet.com/esps/helpdesk.aspx http://www.wjgnet.com",Non-OADS,/arxiv_data1/oa_pdf/81/dd/WJGP-8-3.PMC5311467.pdf
"Stem Cell Reports Article PDGFR a+Cells in Embryonic Stem Cell Cultures Represent the In Vitro Equivalent of the Pre-implantation Primitive Endoderm Precursors Antonio Lo Nigro,1,7,8,*Anchel de Jaime-Soguero,1,8Rita Khoueiry,1Dong Seong Cho,2 Giorgia Maria Ferlazzo,1Ilaria Perini,1Vanesa Abon Escalona,3,4Xabier Lopez Aranguren,5 Susana M. Chuva de Sousa Lopes,6Kian Peng Koh,1Pier Giulio Conaldi,7Wei-Shou Hu,2An Zwijsen,3,4 Frederic Lluis,1,9and Catherine M. Verfaillie1,9 1Department of Development and Regeneration, Stem Cell Biology and Embryology, KU Leuven Stem Cell Institute, Herestraat 49, Onderwijs en Navorsing 4, Box 804, 3000 Leuven, Belgium 2Department of Chemical Engineering and Materials Science, University of Minnesota, 421 Washington Avenue Southeast, Minneapolis, MN 55455, USA 3VIB Center for the Biology of Disease, 3000 Leuven, Belgium 4KU Leuven Department of Human Genetics, 3000 Leuven, Belgium 5Cell Therapy Program, Foundation for Applied Medical Research, University of Navarra, 31008 Pamplona, Spain 6Department of Anatomy and Embryology, Leiden University Medical Center, Einthovenweg 20, 2333 ZC Leiden, the Netherlands 7Ri.Med Foundation, Department of Laboratory Medicine and Advanced Biotechnologies, IRCCS-ISMETT (Istituto Mediterraneo per i Trapianti e Terapi ea d Alta Specializzazione), Via Tricomi 5, 90127 Palermo, Italy 8Co-ﬁrst author 9Co-senior author *Correspondence: antoniolonigro83@gmail.com http://dx.doi.org/10.1016/j.stemcr.2016.12.010 SUMMARY In early mouse pre-implantation development, primitive endoderm (PrE) precursors are platelet-derived growth factor receptor alpha (PDGFR a) positive.",Non-OADS,/arxiv_data1/oa_pdf/7f/0d/main.PMC5311469.pdf
This is an open access article under the CC BY -NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/7f/0d/main.PMC5311469.pdf
At least 15 colonies for each sample were sequenced and analyzed using Quma software ( http://quma.cdb.riken.jp/ ).,OADS,/arxiv_data1/oa_pdf/7f/0d/main.PMC5311469.pdf
"SUPPLEMENTAL INFORMATION Supplemental Information includes Supplemental ExperimentalProcedures, seven ﬁgures, and six tables and can be found with this article online at http://dx.doi.org/10.1016/j.stemcr.2016.12.",OADS,/arxiv_data1/oa_pdf/7f/0d/main.PMC5311469.pdf
"Stem Cell Reports Article EBIO Does Not Induce Cardiomyogenesis in Human Pluripotent Stem Cells but Modulates Cardiac Subtype Enrichment by Lineage-Selective Survival Monica Jara-Avaca,1,5Henning Kempf,1,5Michael Ru ¨ckert,1Diana Robles-Diaz,1Annika Franke,1 Jeanne de la Roche,2Martin Fischer,2Daniela Malan,3Philipp Sasse,3Wladimir Solodenko,4Gerald Dra ¨ger,4 Andreas Kirschning,4Ulrich Martin,1,6and Robert Zweigerdt1,6,* 1Leibniz Research Laboratories for Biotechnology and Artiﬁcial Organs (LEBAO), Department of Cardiothoracic, Transplantation and Vascular Surge ry, REBIRTH-Cluster of Excellence, Hannover Medical School, Carl-Neuberg Straße 1, 30625 Hannover, Germany 2Institute for Neurophysiology, Hannover Medical School, Carl-Neuberg Straße, 30625 Hannover, Germany 3Institute of Physiology I, Life & Brain Center, University of Bonn, Sigmund-Freud-Straße 25, 53127 Bonn, Germany 4Center of Biomolecular Drug Research (BMWZ), Institute of Organic Chemistry, Leibniz University Hannover, Schneiderberg 38, 30167 Hannover, Germany 5Co-ﬁrst author 6Co-senior author *Correspondence: zweigerdt.robert@mh-hannover.de http://dx.doi.org/10.1016/j.stemcr.2016.12.012 SUMMARY Subtype-speciﬁc human cardiomyocytes (CMs) are valuable for basic and applied research.",Non-OADS,/arxiv_data1/oa_pdf/33/c4/main.PMC5311470.pdf
305 This is an open access article under the CC BY -NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/33/c4/main.PMC5311470.pdf
"SUPPLEMENTAL INFORMATION Supplemental Information includes Supplemental ExperimentalProcedures, four ﬁgures, two tables, and three movies and can be found with this article online at http://dx.doi.org/10.1016/j.",Non-OADS,/arxiv_data1/oa_pdf/33/c4/main.PMC5311470.pdf
http://dx.doi.org/10.1093/toxsci/kfw1171 .,Non-OADS,/arxiv_data1/oa_pdf/33/c4/main.PMC5311470.pdf
"), nori@ucla.edu (N.Y.) http://dx.doi.org/10.1016/j.stemcr.2016.12.011 SUMMARY A method to maintain and rebuild ureteric bud (UB)-like structures from UB cells in vitro could provide a useful tool for kidney regen- eration.",Non-OADS,/arxiv_data1/oa_pdf/62/a1/main.PMC5311471.pdf
401 This is an open access article under the CC BY -NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/62/a1/main.PMC5311471.pdf
"SUPPLEMENTAL INFORMATION Supplemental Information includes Supplemental ExperimentalProcedures, six ﬁgures, and one table and can be found with thisarticle online at http://dx.doi.org/10.1016/j.stemcr.2016.12.011 .",OADS,/arxiv_data1/oa_pdf/62/a1/main.PMC5311471.pdf
"See: http://creativecommons.org/ licenses/by-nc/4.0/ Manuscript source:  Invited manuscript Correspondence to:  Gabriele Capurso, MD, PhD,  Digestive  and Liver Disease Unit, S.Andrea Hospital, University Sapienza,  Via di Grottarossa 1035, 00199 Rome,  Italy.",Non-OADS,/arxiv_data1/oa_pdf/d8/fe/WJGE-9-41.PMC5311472.pdf
"gabriele.capurso@gmail.co m Telephone:  +39-06-33775691 Fax:  +39-06-33775526 Received:  August 30, 2016 Peer-review started:  September 2, 2016 First decision:  September 29, 2016 Revised:  October 19, 2016 Accepted:  December 7, 2016Submit a Manuscript: http://www.wjgnet.com/esps/ DOI: 10.4253/wjge.v9.i2.41World J Gastrointest Endosc   2017 February 16; 9(2): 41-54 ISSN 1948-5190 (online) Article in press:  December 9, 2016 Published online:  February 16, 2017 Abstract Endoscopic ultrasound (EUS) and endoscopic retrograde  cholangiopancreatography (ERCP)-guided ablation pro - cedures are emerging as a minimally invasive ther apeutic  alternative to radiological and surgical treatments for  locally advanced pancreatic cancer (LAPC), pancreatic  neuroendocrine tumours (PNETs), and pancreatic cystic  lesions (PCLs).",Non-OADS,/arxiv_data1/oa_pdf/d8/fe/WJGE-9-41.PMC5311472.pdf
wjgnet.com/1948-5190/full/v9/i2/41.htm  DOI: http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/d8/fe/WJGE-9-41.PMC5311472.pdf
"© 2017 Baishideng Publishing Group Inc. All rights reserved.Published by Baishideng Publishing Group Inc 8226 Regency Drive, Pleasanton, CA 94588, USA Telephone: +1-925-223-8242 Fax: +1-925-223-8243 E-mail: bpgoffice@wjgnet.com Help Desk: http://www.wjgnet.com/esps/helpdesk.aspx http://www.wjgnet.com",Non-OADS,/arxiv_data1/oa_pdf/d8/fe/WJGE-9-41.PMC5311472.pdf
"See: http://creativecommons.org/ licenses/by-nc/4.0/ Manuscript source:  Invited manuscript Correspondence to:  Dr. Chisato Hamashima,  Division of  Cancer Screening Assessment and Management, Center for Public  Health Science, National Cancer Center, 5-1-1 Tsukiji Chuo-ku,  Tokyo 104-0045, Japan.",Non-OADS,/arxiv_data1/oa_pdf/e2/1c/WJGE-9-55.PMC5311473.pdf
"chamashi@ncc.go.j p Telephone:  +81-3-35475305 Fax:  +81-3-35478587 Received:  August 19, 2016  Peer-review started:  August 21, 2016  First decision:  September 28, 2016 Revised:  November 22, 2016   Accepted:  December 7, 2016 Article in press:  December 9, 2016 Published online:  February 16, 2017 Abstract Gastric cancer screening using endoscopy has recently Submit a Manuscript: http://www.wjgnet.com/esps/ DOI: 10.4253/wjge.v9.i2.55World J Gastrointest Endosc   2017 February 16; 9(2): 55-60 ISSN 1948-5190 (online) spread in Eastern Asian countries showing increasing  evidence of its effectiveness.",Non-OADS,/arxiv_data1/oa_pdf/e2/1c/WJGE-9-55.PMC5311473.pdf
World J Gastrointest Endosc  2017; 9(2): 55-60   Available from: URL:  http://www.wjgnet.com/1948-5190/full/ v9/i2/55.htm  DOI: http://dx.doi.org/10.4253/wjge.v9.i2.55 INTRODUCTION Endoscopic examination has been increasingly performed  for gastric cancer screening in Eastern Asian countries[1].,Non-OADS,/arxiv_data1/oa_pdf/e2/1c/WJGE-9-55.PMC5311473.pdf
"Available from: URL:  http://www.choosingwisely.org / P- Reviewer : Chrom P, El-Tawil AM, Soriano-Ursua MA     S- Editor : Ji FF    L- Editor : A    E- Editor : Li D  Hamashima C .",Non-OADS,/arxiv_data1/oa_pdf/e2/1c/WJGE-9-55.PMC5311473.pdf
"© 2017 Baishideng Publishing Group Inc. All rights reserved.Published by Baishideng Publishing Group Inc 8226 Regency Drive, Pleasanton, CA 94588, USA Telephone: +1-925-223-8242 Fax: +1-925-223-8243 E-mail: bpgoffice@wjgnet.com Help Desk: http://www.wjgnet.com/esps/helpdesk.aspx http://www.wjgnet.com",Non-OADS,/arxiv_data1/oa_pdf/e2/1c/WJGE-9-55.PMC5311473.pdf
"See: http://creativecommons.org/ licenses/by-nc/4.0/ Manuscript source:  Invited manuscript Correspondence to:  Andrew Y Wang, MD, AGAF, FACG,  FASGE, Associate Professor  of Medicine, Section Chief of  Interventional Endoscopy, Division of Gastroenterology and  Hepatology, University of Virginia, PO Box 800708, Charlottesville,  V A 22908, United States.",Non-OADS,/arxiv_data1/oa_pdf/51/38/WJGE-9-61.PMC5311474.pdf
METHODS Pathology and endoscopy databases at an academic Submit a Manuscript: http://www.wjgnet.com/esps/ DOI: 10.4253/wjge.v9.i2.61World J Gastrointest Endosc   2017 February 16; 9(2): 61-69 ISSN 1948-5190 (online),Non-OADS,/arxiv_data1/oa_pdf/51/38/WJGE-9-61.PMC5311474.pdf
wjgnet.com/1948-5190/full/v9/i2/61.htm  DOI: http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/51/38/WJGE-9-61.PMC5311474.pdf
"Available  from: URL: http://globocan.iarc.fr 3 Frye JW , Sauer BG, Gomez JM, Shami VM, Northup PG, Wang  AY.",Non-OADS,/arxiv_data1/oa_pdf/51/38/WJGE-9-61.PMC5311474.pdf
"© 2017 Baishideng Publishing Group Inc. All rights reserved.Published by Baishideng Publishing Group Inc 8226 Regency Drive, Pleasanton, CA 94588, USA Telephone: +1-925-223-8242 Fax: +1-925-223-8243 E-mail: bpgoffice@wjgnet.com Help Desk: http://www.wjgnet.com/esps/helpdesk.aspx http://www.wjgnet.com",Non-OADS,/arxiv_data1/oa_pdf/51/38/WJGE-9-61.PMC5311474.pdf
"See: http://creativecommons.org/ licenses/by-nc/4.0/ Manuscript source:  Invited manuscriptCorrespondence to:  Hideaki Harada, MD, Director, De- partment of Gastroenterology, New Tokyo Hospital, 1271 Wana- gaya, Matsudo Chiba 270-2232,  Japan.",Non-OADS,/arxiv_data1/oa_pdf/b8/bb/WJGE-9-70.PMC5311475.pdf
Although the rate of complete endoscopic resection Submit a Manuscript: http://www.wjgnet.com/esps/ DOI: 10.4253/wjge.v9.i2.70World J Gastrointest Endosc   2017 February 16; 9(2): 70-76 ISSN 1948-5190 (online),Non-OADS,/arxiv_data1/oa_pdf/b8/bb/WJGE-9-70.PMC5311475.pdf
World J Gastrointest Endosc  2017; 9(2): 70-76  Available  from: URL:  http://www.wjgnet.com/1948-5190/full/v9/i2/70.htm   DOI: http://dx.doi.org/10.4253/wjge.v9.i2.70 INTRODUCTION Submucosal tumors (SMTs) consist of neoplastic lesions  covered by normal overlying mucosa.,Non-OADS,/arxiv_data1/oa_pdf/b8/bb/WJGE-9-70.PMC5311475.pdf
"© 2017 Baishideng Publishing Group Inc. All rights reserved.Published by Baishideng Publishing Group Inc 8226 Regency Drive, Pleasanton, CA 94588, USA Telephone: +1-925-223-8242 Fax: +1-925-223-8243 E-mail: bpgoffice@wjgnet.com Help Desk: http://www.wjgnet.com/esps/helpdesk.aspx http://www.wjgnet.com",Non-OADS,/arxiv_data1/oa_pdf/b8/bb/WJGE-9-70.PMC5311475.pdf
"See: http://creativecommons.org/ licenses/by-nc/4.0/ Manuscript source:  Invited manuscript Correspondence to:  Yuji Sakai, MD,  Department of Gastro- enterology and Nephrology, Graduate School of Medicine, Chiba  University, Inohana 1-8-1, Chuou-ku, Chiba 260-8670,  Japan.",Non-OADS,/arxiv_data1/oa_pdf/f5/86/WJGE-9-77.PMC5311476.pdf
Submit a Manuscript: http://www.wjgnet.com/esps/ DOI: 10.4253/wjge.v9.i2.77World J Gastrointest Endosc   2017 February 16; 9(2): 77-84 ISSN 1948-5190 (online),Non-OADS,/arxiv_data1/oa_pdf/f5/86/WJGE-9-77.PMC5311476.pdf
World  J Gastrointest Endosc  2017; 9(2): 77-84  Available from: URL:   http://www.wjgnet.com/1948-5190/full/v9/i2/77.htm  DOI: http:// dx.doi.org/10.4253/wjge.v9.i2.77 INTRODUCTION Endoscopic retrograde cholangiopancreatography (ERCP)- related procedures have played a very important role for  diagnosis/treatment of biliary and pancreatic disease.,Non-OADS,/arxiv_data1/oa_pdf/f5/86/WJGE-9-77.PMC5311476.pdf
"© 2017 Baishideng Publishing Group Inc. All rights reserved.Published by Baishideng Publishing Group Inc 8226 Regency Drive, Pleasanton, CA 94588, USA Telephone: +1-925-223-8242 Fax: +1-925-223-8243 E-mail: bpgoffice@wjgnet.com Help Desk: http://www.wjgnet.com/esps/helpdesk.aspx http://www.wjgnet.com",Non-OADS,/arxiv_data1/oa_pdf/f5/86/WJGE-9-77.PMC5311476.pdf
"See: http://creativecommons.org/ licenses/by-nc/4.0/ Manuscript source:  Unsolicited manuscript Correspondence to:  Christoph Gubler, MD,  Division of  Gastroenterology and Hepatology, University Hospital Zurich,  Raemistrasse 100, CH-8091 Zurich,  Switzerland.",Non-OADS,/arxiv_data1/oa_pdf/ff/d3/WJGE-9-85.PMC5311477.pdf
"christoph.gubler@icloud.co m  Telephone:  +41-44-2553642 Fax:  +41-44-2554474 Received:  July 5, 2016 Peer-review started:  July 12, 2016 First decision:  September 9, 2016Submit a Manuscript: http://www.wjgnet.com/esps/ DOI: 10.4253/wjge.v9.i2.85World J Gastrointest Endosc   2017 February 16; 9(2): 85-90 ISSN 1948-5190 (online) Revised:  October 8, 2016 Accepted:  November 21, 2016 Article in press:  November 22, 2016 Published online:  February 16, 2017 Abstract Over-the-scope-clips (OTSC®) have been shown to be  an effective and safe endoscopic treatment option for  the closure of gastrointestinal perforations, leakages and  fistulae.",Non-OADS,/arxiv_data1/oa_pdf/ff/d3/WJGE-9-85.PMC5311477.pdf
"World J Gastrointest Endosc  2017; 9(2):  85-90  Available from: URL:  http://www.wjgnet.com/1948-5190/ full/v9/i2/85.htm  DOI: http://dx.doi.org/10.4253/wjge.v9.i2.85 INTRODUCTION The application spectrum of the over-the-scope-clip  (OTSC®) has continually evolved from hemostasis to  closure of gastrointestinal perforations, leakages and  fistulae including anorectal lesions[1-7].",Non-OADS,/arxiv_data1/oa_pdf/ff/d3/WJGE-9-85.PMC5311477.pdf
"© 2017 Baishideng Publishing Group Inc. All rights reserved.Published by Baishideng Publishing Group Inc 8226 Regency Drive, Pleasanton, CA 94588, USA Telephone: +1-925-223-8242 Fax: +1-925-223-8243 E-mail: bpgoffice@wjgnet.com Help Desk: http://www.wjgnet.com/esps/helpdesk.aspx http://www.wjgnet.com",Non-OADS,/arxiv_data1/oa_pdf/ff/d3/WJGE-9-85.PMC5311477.pdf
"See: http://creativecommons.org/ licenses/by-nc/4.0/ Manuscript source:  Unsolicited manuscript Correspondence to:  Yasumasa Matsuo, MD,  Division  of Gastroenterology and Hepatology, Department of Internal  Medicine, St. Marianna University School of Medicine, 2-16-1  Sugao, Miyamae-ku, Kawasaki City, Kanagawa 216-8511,  Japan.",Non-OADS,/arxiv_data1/oa_pdf/40/f4/WJGE-9-91.PMC5311478.pdf
"yasumasa_matsuo@marianna-u.ac.jp Telephone:  +81-44-9778111 Fax:  +81-44-9750608 Received:  July 2, 2016Submit a Manuscript: http://www.wjgnet.com/esps/ DOI: 10.4253/wjge.v9.i2.91World J Gastrointest Endosc   2017 February 16; 9(2): 91-94 ISSN 1948-5190 (online) Peer-review started:  July 4, 2016 First decision:  August 22, 2016 Revised:  September 27, 2016 Accepted:  October 22, 2016  Article in press:  October 24, 2016 Published online:  February 16, 2017 Abstract We present a rare case of fecaloma, 7 cm in size, in  the setting of systemic scleroderma.",Non-OADS,/arxiv_data1/oa_pdf/40/f4/WJGE-9-91.PMC5311478.pdf
"World J Gastrointest Endosc  2017; 9(2):  91-94  Available from: URL:  http://www.wjgnet.com/1948-5190/ full/v9/i2/91.htm  DOI: http://dx.doi.org/10.4253/wjge.v9.i2.91 INTRODUCTION A fecaloma is a hardened mass of food, discarded gastro­ intestinal cells, and digestive juice, which can become  lodged in the gastrointestinal tract.",Non-OADS,/arxiv_data1/oa_pdf/40/f4/WJGE-9-91.PMC5311478.pdf
"© 2017 Baishideng Publishing Group Inc. All rights reserved.Published by Baishideng Publishing Group Inc 8226 Regency Drive, Pleasanton, CA 94588, USA Telephone: +1-925-223-8242 Fax: +1-925-223-8243 E-mail: bpgoffice@wjgnet.com Help Desk: http://www.wjgnet.com/esps/helpdesk.aspx http://www.wjgnet.com",Non-OADS,/arxiv_data1/oa_pdf/40/f4/WJGE-9-91.PMC5311478.pdf
"See: http://creativecommons.org/ licenses/by-nc/4.0/ Manuscript source:  Unsolicited manuscript Correspondence to:  Wei-Ming Zhu, PhD,  Institute of General  Surgery, Jinling Hospital, Medical School of Nanjing University,  #305 East Zhongshan Road, Nanjing 210002, Jiangsu Province,  China.",Non-OADS,/arxiv_data1/oa_pdf/1e/1d/WJGE-9-95.PMC5311479.pdf
"dr_zhuweimingvip@sina.co m Telephone:  +86-25-4803956 Received:  September 27, 2016 Peer-review started:  September 28, 2016 First decision:  October 26, 2016 Revised:  November 5, 2016 Accepted:  December 16, 2016 Article in press:  December 19, 2016 Published online:  February 16, 2017Submit a Manuscript: http://www.wjgnet.com/esps/ DOI: 10.4253/wjge.v9.i2.95World J Gastrointest Endosc   2017 February 16; 9(2): 95-98 ISSN 1948-5190 (online) Abstract An ileal pouch fistula is an uncommon complication  after an ileal pouch anal anastomosis.",Non-OADS,/arxiv_data1/oa_pdf/1e/1d/WJGE-9-95.PMC5311479.pdf
"World J Gastrointest Endosc  2017; 9(2): 95-98  Available from:  URL:  http://www.wjgnet.com/1948-5190/full/v9/i2/95.htm  DOI:  http://dx.doi.org/10.4253/wjge.v9.i2.95 INTRODUCTION A leak from the tip of the J-pouch was defined as a leak  from the blind limb of the J-pouch with an endoscopic  finding or imaging results, including a Gastrografin  enema, computed tomography scan, magnetic reso - nance imaging, or intraoperative diagnosis made during  reoperation[1-3].",Non-OADS,/arxiv_data1/oa_pdf/1e/1d/WJGE-9-95.PMC5311479.pdf
"© 2017 Baishideng Publishing Group Inc. All rights reserved.Published by Baishideng Publishing Group Inc 8226 Regency Drive, Pleasanton, CA 94588, USA Telephone: +1-925-223-8242 Fax: +1-925-223-8243 E-mail: bpgoffice@wjgnet.com Help Desk: http://www.wjgnet.com/esps/helpdesk.aspx http://www.wjgnet.com",Non-OADS,/arxiv_data1/oa_pdf/1e/1d/WJGE-9-95.PMC5311479.pdf
"See: http://creativecommons.org/ licenses/by-nc/4.0/ Manuscript source:  Unsolicited manuscript Correspondence to:  Dr. Sen-Lin Li,  Department of Gastro - enterology, Liaocheng People’s Hospital, No.",Non-OADS,/arxiv_data1/oa_pdf/4a/7b/WJGE-9-99.PMC5311480.pdf
"lisenlin6201@163.com Telephone:  +86-635-8277306 Fax:  +86-635-8277306 Received:  October 4, 2016Submit a Manuscript: http://www.wjgnet.com/esps/ DOI: 10.4253/wjge.v9.i2.99World J Gastrointest Endosc   2017 February 16; 9(2): 99-104 ISSN 1948-5190 (online) Peer-review started:  October 7, 2016 First decision:  November 10, 2016 Revised:  December 5, 2016 Accepted:  January 2, 2017 Article in press:  January 3, 2016 Published online:  February 16, 2017 Abstract Achalasia is generally accepted as a condition associated  with an increased risk for developing esophageal squa - mous cell carcinoma.",Non-OADS,/arxiv_data1/oa_pdf/4a/7b/WJGE-9-99.PMC5311480.pdf
World J Gastrointest Endosc  2017; 9(2): 99-104   Available from: URL:  http://www.wjgnet.com/1948-5190/full/v9/ i2/99.htm  DOI: http://dx.doi.org/10.4253/wjge.v9.i2.99 INTRODUCTION Peroral endoscopic myotomy (POEM) is used for treat­ ment of achalasia as Endoscopic submucosal dissection  (ESD) for treatment of early esophageal cancer .,Non-OADS,/arxiv_data1/oa_pdf/4a/7b/WJGE-9-99.PMC5311480.pdf
"© 2017 Baishideng Publishing Group Inc. All rights reserved.Published by Baishideng Publishing Group Inc 8226 Regency Drive, Pleasanton, CA 94588, USA Telephone: +1-925-223-8242 Fax: +1-925-223-8243 E-mail: bpgoffice@wjgnet.com Help Desk: http://www.wjgnet.com/esps/helpdesk.aspx http://www.wjgnet.com",Non-OADS,/arxiv_data1/oa_pdf/4a/7b/WJGE-9-99.PMC5311480.pdf
"In S. pombe , the Cid1 terminal uridyltransferase (TUTase) acts upon poly- adenylated mRNAs to stimulate decapping and substrate 5Present address: Université de Strasbourg, CNRS, Architecture et Réactivité de l ’ARN, UPR 9002, F-67000 Strasbourg, France Corresponding author: laie@mskcc.orgArticle is online at http://www.rnajournal.org/cgi/doi/10.1261/rna.",Non-OADS,/arxiv_data1/oa_pdf/9d/c9/284.PMC5311484.pdf
"After 12 months, it is availableunder a Creative Commons License (Attribution-NonCommercial 4.0 Inter-national), as described at http://creativecommons.org/licenses/by-nc/4.0/.REPORT 284 RNA 23:284 –296; Published by Cold Spring Harbor Laboratory Press for the RNA Society",Non-OADS,/arxiv_data1/oa_pdf/9d/c9/284.PMC5311484.pdf
http://www.bioconductor.org/packages/2.12/bioc/html/ topGO.html.,Non-OADS,/arxiv_data1/oa_pdf/9d/c9/284.PMC5311484.pdf
MVBs are formed during endosomal Corresponding author: andrea.hinas@icm.uu.se Article is online at http://www.rnajournal.org/cgi/doi/10.1261/rna.,Non-OADS,/arxiv_data1/oa_pdf/36/e9/297.PMC5311485.pdf
"This article, published in RNA, is available under a Creative Commons License (Attribution-NonCommercial 4.0 International),as described at http://creativecommons.org/licenses/by-nc/4.0/.REPORT RNA 23:297 –307; Published by Cold Spring Harbor Laboratory Press for the RNA Society 297",Non-OADS,/arxiv_data1/oa_pdf/36/e9/297.PMC5311485.pdf
"The founding member of the RBPMS family is couch po- tato from Drosophila , originally identified in a genetic screen Corresponding author: cameron.mackereth@inserm.fr Article is online at http://www.rnajournal.org/cgi/doi/10.1261/rna.059733.",Non-OADS,/arxiv_data1/oa_pdf/44/f2/308.PMC5311487.pdf
116.© 2017 Soufari and Mackereth This article is distributed exclusively by the RNA Society for the first 12 months after the full-issue publication date (see http://rnajournal.cshlp.org/site/misc/terms.xhtml).,Non-OADS,/arxiv_data1/oa_pdf/44/f2/308.PMC5311487.pdf
"After 12 months, it is available under a Creative Commons License (Attribution-NonCommercial4.0 International), as described at http://creativecommons.org/licenses/by-nc/4.0/.REPORT 308 RNA 23:308 –316; Published by Cold Spring Harbor Laboratory Press for the RNA Society",Non-OADS,/arxiv_data1/oa_pdf/44/f2/308.PMC5311487.pdf
"Corresponding authors: xmguo2005@ya hoo.com, lsslzr@m ail.sysu.edu.cn Article is online at http://www.rnajournal.org/cgi/doi/10.1261/rna.058651.",OADS,/arxiv_data1/oa_pdf/7f/40/333.PMC5311491.pdf
"After 12 months, it is available under aCreative Commons License (Attribution-NonCommercial 4.0 Inter-national), as described at http://creativecommons.org/licenses/by-nc/4.0/.",Non-OADS,/arxiv_data1/oa_pdf/7f/40/333.PMC5311491.pdf
"Hypomodification of yW in tRNA Pheis known to induce −1 frameshifting (Carlson 4Present address: Department of Cell Biology, Harvard Medical School, Boston, MA 02115, USA Corresponding author: jia@queensu.caArticle is online at http://www.rnajournal.org/cgi/doi/10.1261/rna.",Non-OADS,/arxiv_data1/oa_pdf/3b/d1/346.PMC5311493.pdf
This article is distributed exclusively by the RNA Society for the first 12 months after the full-issue publication date (see http://rnajournal.cshlp.org/site/misc/terms.xhtml).,Non-OADS,/arxiv_data1/oa_pdf/3b/d1/346.PMC5311493.pdf
"After 12 months, it is available under a Creative Commons License (Attribution-NonCommercial4.0 International), as described at http://creativecommons.org/licenses/by-nc/4.0/.",Non-OADS,/arxiv_data1/oa_pdf/3b/d1/346.PMC5311493.pdf
Corresponding author: adrian.ferre@nih.gov Article is online at http://www.rnajournal.org/cgi/doi/10.1261/rna.059824.,Non-OADS,/arxiv_data1/oa_pdf/ab/73/355.PMC5311495.pdf
116.This article is distributed exclusively by the RNA Society for the first 12 months after the full-issue publication date (see http://rnajournal.cshlp.org/site/misc/ terms.xhtml).,Non-OADS,/arxiv_data1/oa_pdf/ab/73/355.PMC5311495.pdf
"After 12 months, it is available under a Creative CommonsLicense (Attribution-NonCommercial 4.0 International), as described athttp://creativecommons.org/licenses/by-nc/4.0/.",Non-OADS,/arxiv_data1/oa_pdf/ab/73/355.PMC5311495.pdf
Since the FG domains Corresponding author: susan.wente@vanderbilt.edu Article is online at http://www.rnajournal.org/cgi/doi/10.1261/rna.057612.,Non-OADS,/arxiv_data1/oa_pdf/74/5b/365.PMC5311497.pdf
"After 12 months, it is availableunder a Creative Commons License (Attribution-NonCommercial 4.0International), as described at http://creativecommons.org/licenses/by-nc/4.0/.",Non-OADS,/arxiv_data1/oa_pdf/74/5b/365.PMC5311497.pdf
Traditional methods Corresponding author: sika.zheng@ucr.edu Article is online at http://www.rnajournal.org/cgi/doi/10.1261/rna.,Non-OADS,/arxiv_data1/oa_pdf/3c/4b/378.PMC5311500.pdf
"After 12 months, it is available under aCreative Commons License (Attribution-NonCommercial 4.0 Inter-national), as described at http://creativecommons.org/licenses/by-nc/4.0/.",Non-OADS,/arxiv_data1/oa_pdf/3c/4b/378.PMC5311500.pdf
Corresponding author: akiraono@umich.edu Article is online at http://www.rnajournal.org/cgi/doi/10.1261/rna.,Non-OADS,/arxiv_data1/oa_pdf/66/d2/395.PMC5311501.pdf
"After 12 months, it is availableunder a Creative Commons License (Attribution-NonCommercial 4.0 Inter-national), as described at http://creativecommons.org/licenses/by-nc/4.0/.",Non-OADS,/arxiv_data1/oa_pdf/66/d2/395.PMC5311501.pdf
Corresponding author: eric_phizicky@urmc.rochester.edu Article is online at http://www.rnajournal.org/cgi/doi/10.1261/rna.059667.,Non-OADS,/arxiv_data1/oa_pdf/84/cb/406.PMC5311504.pdf
"After 12 months, it is available under a Creative Commons License (Attribution-NonCommercial 4.0International), as described at http://creativecommons.org/licenses/by-nc/4.0/.",Non-OADS,/arxiv_data1/oa_pdf/84/cb/406.PMC5311504.pdf
mskcc.org Article is online at http://www.rnajournal.org/cgi/doi/10.1261/rna.,OADS,/arxiv_data1/oa_pdf/5c/d7/420.PMC5311505.pdf
This article is distributed exclusively by the RNA Society for the first 12 months after the full-issue publication date (see http://rnajournal.cshlp.org/site/misc/terms.xhtml).,Non-OADS,/arxiv_data1/oa_pdf/5c/d7/420.PMC5311505.pdf
"After 12 months, it is available under a Creative Commons License (Attribution-NonCommercial4.0 International), as described at http://creativecommons.org/licenses/by-nc/4.0/.",Non-OADS,/arxiv_data1/oa_pdf/5c/d7/420.PMC5311505.pdf
"To viewa copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/4.0/ rThe Author(s) 2017Gut microbiota and defense against pathogens CU b e d a et al 10 Clinical & Translational Immunology",Non-OADS,/arxiv_data1/oa_pdf/44/ca/cti20172a.PMC5311919.pdf
Clinicaltrials.gov identifier NCT01482221 https://clinicaltrials.gov/ct2/show/NCT01482221.,Non-OADS,/arxiv_data1/oa_pdf/7f/cd/npp2016224a.PMC5312066.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/4.0/ © The Author(s) 2017 Supplementary Information accompanies the paper on the Neuropsychopharmacology website (http://www.nature.com/npp)Lanicemine trial in major depressive disorder G Sanacora et al 853 Neuropsychopharmacology",Non-OADS,/arxiv_data1/oa_pdf/7f/cd/npp2016224a.PMC5312066.pdf
"Functional images were preprocessed using the SPM8 software (http://www.fil.ion.ucl.ac.uk/spm) run- ning under Matlab 7.1 (Math Works, Natick, MA).",OADS,/arxiv_data1/oa_pdf/13/c5/npp2016247a.PMC5312071.pdf
Subcortical Atlas toolbox in FMRIB Software Library View (http://fsl.fmrib.ox.ac.uk/fsl/fslwiki/).,OADS,/arxiv_data1/oa_pdf/13/c5/npp2016247a.PMC5312071.pdf
"Again, all reported regions were localized using the Harvard Cortical andSubcortical Atlas toolbox in the FMRIB Software Library View (http://fsl.fmrib.ox.ac.uk/fsl/fslwiki/).",OADS,/arxiv_data1/oa_pdf/13/c5/npp2016247a.PMC5312071.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/4.0/ © The Author(s) 2017 Supplementary Information accompanies the paper on the Neuropsychopharmacology website (http://www.nature.com/npp)Network-level dysconnectivity in psychosis Q Gong et al 940 Neuropsychopharmacology",Non-OADS,/arxiv_data1/oa_pdf/13/c5/npp2016247a.PMC5312071.pdf
http://dx.doi.org/10.1016/j.stemcr.2016.12.013 SUMMARY Cell therapy is a promising approach to generate an enteric nervous system (ENS) and treat enteric neuropathies.,Non-OADS,/arxiv_data1/oa_pdf/af/79/main.PMC5312076.pdf
This is an open access article under the CC BY -NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/af/79/main.PMC5312076.pdf
SUPPLEMENTAL INFORMATION Supplemental Information includes Supplemental Experimental Procedures and ﬁve ﬁgures and can be found with this article on-line at http://dx.doi.org/10.1016/j.stemcr.2016.12.013 .,Non-OADS,/arxiv_data1/oa_pdf/af/79/main.PMC5312076.pdf
Psychiatry http://dx.doi.org/10.1038/mp.,Non-OADS,/arxiv_data1/oa_pdf/af/79/main.PMC5312076.pdf
"Continuing  mediCAl  eduCAtion Diabetes mellitus and the skin* Adriana	Lucia	Mendes1	 Helio	Amante	Miot2 Vidal	Haddad	Junior2  DOI: http://dx.doi.org/10.1590/abd1806-4841.20175514 Abstract:	Several	dermatoses	 are	routinely	associated	 with	diabetes	mellitus,	especially	 in	patients	with	chronic	disease.",Non-OADS,/arxiv_data1/oa_pdf/34/d0/abd-92-01-0008.PMC5312172.pdf
Available from:  http://www.idf.org/diabetesatlas/update2014.,Non-OADS,/arxiv_data1/oa_pdf/34/d0/abd-92-01-0008.PMC5312172.pdf
2017;92(1):21-5.investigAtion Comparative microscopic analysis of nail clippings from patients with  cutaneous psoriasis and psoriatic arthritis* Gabriela Poglia Fonseca1 Betina Werner2 Gabriela Seidel3	 Henrique	Luiz	Staub4 DOI: http://dx.doi.org/10.1590/abd1806-4841.20175056 Abstract: Background : The nail involvement in psoriasis is related to psoriatic arthritis and may represent a predictor of the  disease.,Non-OADS,/arxiv_data1/oa_pdf/97/93/abd-92-01-0021.PMC5312173.pdf
©2017	by	Anais	Brasileiros	de	DermatologiaDOI: http://dx.doi.org/10.1590/abd1806-4841.20175605 Abstract:  Background : Basal cell carcinoma is the malignant tumor most often diagnosed in the National Campaign for Skin  Cancer	Prevention	 (NCSCP).,Non-OADS,/arxiv_data1/oa_pdf/a7/ab/abd-92-01-0026.PMC5312174.pdf
Available from: http://www.ibm.com/analytics/us/en/technology/ spss/spss.html 6.,OADS,/arxiv_data1/oa_pdf/a7/ab/abd-92-01-0026.PMC5312174.pdf
"investigAtion Drug reaction with eosinophilia and systemic symptoms (DRESS) and its  relation with autoimmunity in a reference center in Mexico* Juan	Manuel	Ruiz	Matta1	 Silvia	Méndez	Flores1 Judith	Domínguez	Cherit1 DOI: http://dx.doi.org/10.1590/abd1806-4841.20175190 Abstract:  Background :	Drug	reaction	with	eosinophilia	 and	systemic	symptoms	 is	a	severe	adverse	drug	reaction,	with	a	re- ported mortality of 10%.",Non-OADS,/arxiv_data1/oa_pdf/0a/29/abd-92-01-0030.PMC5312175.pdf
"InvestIgatIon Frequency, severity and related factors of androgenetic alopecia in  dermatology outpatient clinic: hospital-based cross-sectional   study in Turkey* Kubra Esen Salman1 Ilknur Kivanc Altunay1 Nihal Asli Kucukunal1 Asli Aksu Cerman1 DOI: http://dx.doi.org/10.1590/abd1806-4841.20175241 Abstract:  Background : Androgenetic alopecia (AGA) is a patterned hair loss occurring due to systemic androgen and genetic  factors.",Non-OADS,/arxiv_data1/oa_pdf/25/da/abd-92-01-0035.PMC5312176.pdf
"Samtsov1 Evgeny N. Imyanitov2,3 DOI: http://dx.doi.org/10.1590/abd1806-4841.20175765 s Received on 06.03.2016.",OADS,/arxiv_data1/oa_pdf/67/78/abd-92-01-0041.PMC5312177.pdf
©2017	by	 Anais	Brasileiros	de	DermatologiaDOI: http://dx.doi.org/10.1590/abd1806-4841.20175178 Abstract:  Background : Emerging epidemiological evidence suggests independent associations between psoriasis and meta- bolic	syndrome.,Non-OADS,/arxiv_data1/oa_pdf/09/6c/abd-92-01-0046.PMC5312178.pdf
13 The	objective	of	this	study	was	to	determine	 the	profile	of	 seroprevalence of Helicobacter pylori in patients with clinical diag-nosis	of	psoriasis	treated	in	a	period	of	six	months	at	Ambulatório	 Amélio	Marques	of	the	Federal	University	 of	Uberlândia	 and	to	 evaluate its association with the severity of the disease.DOI: http://dx.doi.org/10.1590/abd1806-4841.20174880 Abstract: Background : Psoriasis	is	a	chronic	inflammatory	 disease	that	affects	the	skin	and	joints	and	has	a	multifactorial 	 etiology.,Non-OADS,/arxiv_data1/oa_pdf/58/c8/abd-92-01-0052.PMC5312179.pdf
"3,5DOI: http://dx.doi.org/10.1590/abd1806-4841.20174867 Abstract:  Background :The best way to approach surgically removed basal cell carcinoma with positive histopathological mar - gins is a controversial issue.",Non-OADS,/arxiv_data1/oa_pdf/01/da/abd-92-01-0058.PMC5312180.pdf
"The	concept	that	focuses	on	the	skin	as	a	reflection	of	the	 mind	and	emotions	 and	at	the	same	time	influences	 these	two	 spheres	has	always	existed,	because	emotional	 states	such	as	fear,	 shame,	anger,	and	terror,	are	manifested	 by	changes	in	color,	tex- ture,	moisture	and	skin	attachments	 as	well	as	mental	states,	such	 as	depression,	 anxiety	and	distortion	 of	body	image,	are	created	by	 skin disorders.DOI: http://dx.doi.org/10.1590/abd1806-4841.20175493 Abstract: The mind-skin connection has been studied since the nineteenth century.",Non-OADS,/arxiv_data1/oa_pdf/00/9e/abd-92-01-0063.PMC5312181.pdf
©2017	by	 Anais	Brasileiros	de	DermatologiaDOI: http://dx.doi.org/10.1590/abd1806-4841.20175208 Abstract:	Autoinflammatory	 disorders	are	immune-mediated	 diseases	with	increased	production	 of	inflammatory	 cytokines	 and	absence	of	detectable	 autoantibodies.,Non-OADS,/arxiv_data1/oa_pdf/06/2d/abd-92-01-0072.PMC5312182.pdf
"81Dermatopathology Analysis of the histomorphologic profile of invasive cutaneous squamous  cell carcinoma from 2002 to 2011 in a pathology laboratory in the region  of Campos Gerais, Brazil* Fernanda Magri de Souza1 Eloina Do Rocio Valenga Baroni1,2 Mário Rodrigues Montemór Netto1,2 DOI: http://dx.doi.org/10.1590/abd1806-4841.20174691 Abstract:  Squamous cell carcinoma is the second most common type of malignant skin cancer.",Non-OADS,/arxiv_data1/oa_pdf/54/32/abd-92-01-0081.PMC5312183.pdf
Available on: http://www.inca.gov.br/estimativa/2014/.,Non-OADS,/arxiv_data1/oa_pdf/54/32/abd-92-01-0081.PMC5312183.pdf
Available on:  http://www.cap.org/apps/docs/ committees/cancer/cancer_protocols/2013/SkinSquamous_13protocol_3102.,Non-OADS,/arxiv_data1/oa_pdf/54/32/abd-92-01-0081.PMC5312183.pdf
"©2017 by Anais Brasileiros de DermatologiaDOI: http://dx.doi.org/10.1590/abd1806-4841.20174807 Abstract:  The classification of cutaneous lymphomas is multidisciplinary and requires the correlation between clinical, his- topathological, immunohistochemical, and molecular diagnostic elements.",Non-OADS,/arxiv_data1/oa_pdf/e1/db/abd-92-01-0086.PMC5312184.pdf
2017;92(1):92-4.92 Case report Hemosiderotic dermatofibroma* Delky Johanna Villarreal Villarreal1 Aline Tanus Luz1 Alice Mota Buçard1 Luciana de Abreu1 Tullia Cuzzi1  DOI: http://dx.doi.org/10.1590/abd1806-4841.20173563 Abstract:   We report a rare clinical case of hemosiderotic dermatofibroma in a 36-year-old female patient.,Non-OADS,/arxiv_data1/oa_pdf/13/b3/abd-92-01-0092.PMC5312185.pdf
©2017 by Anais Brasileiros de DermatologiaDOI: http://dx.doi.org/10.1590/abd1806-4841.20175009 Abstract:  The majority of penile carcinoma is squamous cell carcinoma.,Non-OADS,/arxiv_data1/oa_pdf/24/a1/abd-92-01-0095.PMC5312186.pdf
Available from: http://www.cancer.,Non-OADS,/arxiv_data1/oa_pdf/24/a1/abd-92-01-0095.PMC5312186.pdf
"©2017	by	 Anais	Brasileiros	de	DermatologiaDOI: http://dx.doi.org/10.1590/abd1806-4841.20175189 Abstract:	We	report	a	case	of	dermatomyofibroma	 that,	to	our	knowledge,	 is	the	second	case	reported	in	Brazil.",Non-OADS,/arxiv_data1/oa_pdf/b7/3e/abd-92-01-0101.PMC5312187.pdf
"2017;92(1):104-6.104 CAse report Chronic tophaceous gout in patients with psoriasis* Laís	Cruz	Lobato1	 Jéssica	Castiel	Coutinho1 Maria	Zeli	Moreira	Frota2	 Antonio	Pedro	Mendes	Schettini3 Mônica	Santos	4,5	 DOI: http://dx.doi.org/10.1590/abd1806-4841.20174895 Abstract: Psoriasis	is	a	chronic	inflammatory	 disease	of	multifactorial	 etiology	influenced	 by	genetic,	immunological,	 and	en- vironmental factors.",Non-OADS,/arxiv_data1/oa_pdf/d1/29/abd-92-01-0104.PMC5312188.pdf
* Luise Ribeiro Daltro1 Lygia Bertalha Yaegashi2 Rodrigo Abdalah Freitas2 Bruno de Carvalho Fantini1 Cacilda da Silva Souza1 DOI: http://dx.doi.org/10.1590/abd1806-4841.20174502 Abstract:  Blue nevus is a benign melanocytic lesion whose most frequent variants are dendritic (common) blue nevus and  cellular blue nevus.,Non-OADS,/arxiv_data1/oa_pdf/5b/4e/abd-92-01-0110.PMC5312190.pdf
"©2017 	 by 	Anais 	 Brasileiros 	 de 	 DermatologiaDOI: http://dx.doi.org/10.1590/abd1806-4841.20174871 Abstract:	Pyoderma 	gangr enosum 	is 	a 	rar e 	neutr ophilic 	dermatosis, 	which 	usually 	pr esents 	as 	ulcers 	with 	erythematous-vi - olaceous undermined edges and a rough base with purulent or sanguinous exudate.",Non-OADS,/arxiv_data1/oa_pdf/dc/5d/abd-92-01-0114.PMC5312191.pdf
©2017	by	 Anais	Brasileiros	de	DermatologiaDOI: http://dx.doi.org/10.1590/abd1806-4841.20175136 Abstract:	Trichotillomania	 is	a	psychodermatologic	 disorder	characterized	 by	uncontrollable	 urge	to	pull	one’s	own	hair.,Non-OADS,/arxiv_data1/oa_pdf/55/66/abd-92-01-0118.PMC5312192.pdf
©2017 	 by 	Anais 	 Brasileiros 	 de 	 DermatologiaDOI: http://dx.doi.org/10.1590/abd1806-4841.20175229 Abstract:	Giant 	cell 	tumor 	of 	the 	tendon 	sheath 	is 	a 	benign 	soft 	tissue 	tumor 	most 	fr equent 	between 	the 	thir d 	and 	fifth 	decades 	 of 	life.,Non-OADS,/arxiv_data1/oa_pdf/99/83/abd-92-01-0121.PMC5312193.pdf
2017;92(1):124-5.imAges  in dermAtology A case of pigmented Bowen’s disease* Márcia	Maria	Vivan1	 Sérgio	Henrique	Hirata1 Liliane Santos do Nascimento1 Milvia Maria Simões e Silva Enokihara2 DOI: http://dx.doi.org/10.1590/abd1806-4841.20175381 Abstract:	Pigmented	 Bowen´s	disease	is	a	rare	subtype	of	Bowen´s	disease.,Non-OADS,/arxiv_data1/oa_pdf/99/c4/abd-92-01-0124.PMC5312194.pdf
"©2017	by	 Anais	Brasileiros	de	DermatologiaDOI: http://dx.doi.org/10.1590/abd1806-4841.20174505127 CASE REPORT A	12-year-old	 dark-skinned	 male	patient	was	admitted	at	 the dermatology service with the following characteristics: hyper - telorism,	macroglossia,	 lentigines,	 hypospadias,	 cryptorchidism,	 subaortic	stenosis,	growth	retardation,	 and	about	50%	of	his	hearing	 compromised	 (Figure	1).",Non-OADS,/arxiv_data1/oa_pdf/3a/fd/abd-92-01-0127.PMC5312195.pdf
©2017	by	 Anais	Brasileiros	de	DermatologiaDOI: http://dx.doi.org/10.1590/abd1806-4841.20174602 CASE REPORT We report a 73-year-old woman under post-surgical chemo- therapy	(breast	ductal	carcinoma)	 who	presented	 with	transudation 	 and	pain	on	the	lower	limbs	20	days	after	the	first	cycle	with	doxoru- bicin and cyclophosphamide and no improvement with furosemide.,Non-OADS,/arxiv_data1/oa_pdf/dd/20/abd-92-01-0131.PMC5312196.pdf
2017;92(1):134-6.CommuniCAtion Descriptive analysis of mycological examination of patients with  onychomycosis treated in private practice* John	Verrinder	Veasey1 Flávio Nappi1 Clarisse	Zaitz1 Laura Hitomi Muramatu1 DOI: http://dx.doi.org/10.1590/abd1806-4841.20174874 Abstract:  This is a retrospective study of 160 patients treated in private practice in São Paulo from March 2003 to March 2015.,Non-OADS,/arxiv_data1/oa_pdf/3a/aa/abd-92-01-0134.PMC5312197.pdf
"Available  from: http://www.uptodate.com/contents/onychomycosis?source=search_ result&search=onicomicose&selectedTitle=1%7E23Mailing   address : John Verrinder Veasey Private officeRua Padre João Manuel, 1212 conjunto 113 01411000 São Paulo, SP - Brazil Mycology Laboratory:  Rua Dr. Cesario Mota Jr, 112 01221100 São Paulo, SP - BrazilE-mail: johnveasey@uol.com.br How to cite this article: Veasey	 JV,	Nappi	F,	Zaitz	C,	Muramatu	 LH.",Non-OADS,/arxiv_data1/oa_pdf/3a/aa/abd-92-01-0134.PMC5312197.pdf
"137CommunICatIon Erythema dyschromicum perstans in a child following an enteroviral  meningitis* Cláudia Raquel Ferrão de Melo1 Mário Correia de Sá2 Sónia Carvalho1  DOI: http://dx.doi.org/10.1590/abd1806-4841.201745144 Abstract:  A healthy 6-year-old boy presented with an erythematous macular exanthema, meningeal signs and fever, initially  diagnosed with probable bacterial meningitis and treated with antibiotic and anti-inflammatory drugs.",Non-OADS,/arxiv_data1/oa_pdf/98/5f/abd-92-01-0137.PMC5312198.pdf
"139CommuniCAtion Identifying the incidence of rash, Stevens-Johnson syndrome and toxic  epidermal necrolysis in patients taking lamotrigine: a systematic review  of 122 randomized controlled trials* Romi Bloom1	 Kyle	T.	Amber2 DOI: http://dx.doi.org/10.1590/abd1806-4841.20175070 Abstract:	Lamotrigine	 is	an	antiepileptic	 drug	used	for	the	treatment	 of	epilepsy,	bipolar	disorder	and	numerous	 off-label	 uses.",Non-OADS,/arxiv_data1/oa_pdf/a4/d4/abd-92-01-0139.PMC5312199.pdf
2017;92(1):142-4.142 CommuniCAtion Daylight photodynamic therapy - Experience and safety in treatment  of actinic keratoses of the face and scalp in low latitude and high  brightness region* Luiz	Eduardo	Garcia	Galvão1 Heitor de Sá Gonçalves1 Karine Paschoal Botelho1  Juliana Chagas Caldas1 DOI: http://dx.doi.org/10.1590/abd1806-4841.20175175 Abstract:  Daylight photodynamic therapy has been used in countries with high latitudes during the summer for actinic kera- toses	treatment	with	reports	of	similar	efficacy	to	conventional	 photodynamic	 therapy.,Non-OADS,/arxiv_data1/oa_pdf/17/f5/abd-92-01-0142.PMC5312200.pdf
"©2017	by	 Anais	Brasileiros	de	DermatologiaDOI: http://dx.doi.org/10.1590/abd1806-4841.20174970 Dear	Editor, Becker’s	nevus	is	a	relatively	 common,	 hyperpigmented	 patch,	frequently	 associated	 with	hypertrichosis.1 Males are more  commonly	 affected	than	females,	with	an	incidence	 of	around	 0.25%.2	Becker’s	nevus	may	be	associated	 with	various	cutaneous	 and	skeletal	anomalies.",Non-OADS,/arxiv_data1/oa_pdf/22/df/abd-92-01-0145.PMC5312201.pdf
"letters s Lívia	Montelo	 Araújo	Jorge1 Omar Lupi1 Adriana	Rego	Hozannah1 Fred Bernardes Filho2Lyme disease in a Brazilian traveler who returned from Germany* DOI: http://dx.doi.org/10.1590/abd1806-4841.20175584 Dear	Editor, Lyme	disease	(LD)	is	a	multisystem	 infectious	 disease	with	 prominent	 cutaneous	 findings.",Non-OADS,/arxiv_data1/oa_pdf/83/ec/abd-92-01-0148.PMC5312202.pdf
"©2017	by	 Anais	Brasileiros	de	DermatologiaDOI: http://dx.doi.org/10.1590/abd1806-4841.20175846 Dear	Editor, Acute	hemorrhagic	 edema	of	infancy	was	initially	described	 in	1913	by	Snow.",Non-OADS,/arxiv_data1/oa_pdf/26/f7/abd-92-01-0150.PMC5312203.pdf
"* DOI: http://dx.doi.org/10.1590/abd1806-4841.20176016 Dear Editor, Neurothekeomas are rare benign dermal tumors, which  originate from the peripheral nerve sheath.",Non-OADS,/arxiv_data1/oa_pdf/95/0b/abd-92-01-0153.PMC5312204.pdf
"©2017	by	 Anais	Brasileiros	de	DermatologiaDOI: http://dx.doi.org/10.1590/abd1806-4841.20176151 Dear	Editor, The introduction of tumor necrosis factor immunobiolog- ical	blocking	agents	(anti-TNF)	 has	brought	great	advances	in	the	 treatment	 of	autoimmune	 diseases.",Non-OADS,/arxiv_data1/oa_pdf/82/ed/abd-92-01-0156.PMC5312205.pdf
"©2017 by Anais Brasileiros de DermatologiaDOI: http://dx.doi.org/10.1590/abd1806-4841.20176234 Dear Editor,  A 30-year-old Caucasian woman with history of chronic  active systemic sarcoidosis for 14 years, presented at our dermatol-ogy department complaining of recurrent ulcerative papules and nodules that had begun four years ago.",Non-OADS,/arxiv_data1/oa_pdf/7e/5d/abd-92-01-0158.PMC5312206.pdf
"2017;92(1):160-1.letters s Karina Colossi Furlan1		 Priscila	Kakizaki1 Juliana Cabral Nunes Chartuni2	 Neusa	Yuriko	Sakai	Valente1,3Sycosiform tinea barbae caused by trichophyton rubrum  and its  association with autoinoculation* DOI: http://dx.doi.org/10.1590/abd1806-4841.20174802 Dear	Editor, Tinea barbae is a dermatophyte infection that affects pri- marily the bearded areas of the face.1 Sycosis is one type of clini-cal manifestation associated with deep folliculitis.",Non-OADS,/arxiv_data1/oa_pdf/a1/42/abd-92-01-0160.PMC5312207.pdf
"The data were analyzed  using Statistica 6.0  (StarSoft, Inc., Tulsa, OK, USA) and BioEstat  5.0 (http://mamiraua.org.br/pt-br/downloads/programas/) software  (Copyrigth 2015, Instituto de Desenvolvimento Sustentavel Mamirauá,  Tefé, AM, Brazil).",OADS,/arxiv_data1/oa_pdf/fa/b0/AJA-19-160.PMC5312212.pdf
http://uroweb.org/wp‑content/uploads/22‑Paediatric‑Urology_LR.pdf;  2015.,Non-OADS,/arxiv_data1/oa_pdf/53/a4/AJA-19-168.PMC5312213.pdf
Available from: http://www.dqr.de/.,Non-OADS,/arxiv_data1/oa_pdf/c8/95/AJA-19-173.PMC5312214.pdf
Available from: http://www.asahq.org/resources/clinical‑information/ asa‑physical‑status‑classification‑system.,Non-OADS,/arxiv_data1/oa_pdf/c8/95/AJA-19-173.PMC5312214.pdf
"Dietary assessment We used a validated33,34 101-food item semi-quantitative food  frequency questionnaire (FFQ) to assess the usual intake of foods  and nutrients  (available at: http://bibliodieta.umh.es/files/2011/07/ CFA101.pdf).",Non-OADS,/arxiv_data1/oa_pdf/1c/7c/AJA-19-184.PMC5312216.pdf
Available from: http://www.ars.usda.gov/ba/bhnrc/ndl.,Non-OADS,/arxiv_data1/oa_pdf/1c/7c/AJA-19-184.PMC5312216.pdf
Available  from: http://www.globocan.iarc.fr/Pages/fact_sheets_cancer.aspx.,Non-OADS,/arxiv_data1/oa_pdf/42/85/AJA-19-196.PMC5312218.pdf
Available from: http://www.cebm.net/index.,Non-OADS,/arxiv_data1/oa_pdf/42/85/AJA-19-196.PMC5312218.pdf
This study received ethics  committee approval with the written informed consent obtained  from each participant before enrollment and was registered in the  Chinese Clinical Trial Registry (http://www.chictr.org.cn/) (Identifier:  ChiCTR -IOR -15007561).,Non-OADS,/arxiv_data1/oa_pdf/94/7f/AJA-19-214.PMC5312221.pdf
Available from: http://www.uroweb.org/gls/ pdf/14_Male%20Sexual%20Dysfunction_LR.pdf.,Non-OADS,/arxiv_data1/oa_pdf/23/b0/AJA-19-219.PMC5312222.pdf
We obtained the AR sequence from the National Center  for Biotechnology Information website (http://www.ncbi.nlm.nih.,OADS,/arxiv_data1/oa_pdf/86/47/AJA-19-260.PMC5312231.pdf
"According to the AR mutation  database  (http://androgendb.mcgill.ca/), at least, 800 different  mutations have been found in most exons in the human AR throughout  its coding region.6 It is crucial to analyze these mutations, which can lead  to the dysfunction and then result in the changes in clinical phenotypes  that can clarify the pathogenesis and be helpful for clinical treatment  and in designing therapies for AIS.7 Here, we identified a homozygous  mutation in the AR of the proband and a heterozygous mutation in her  mother and sister at the same site in exon 7 (p.V867M).",Non-OADS,/arxiv_data1/oa_pdf/86/47/AJA-19-260.PMC5312231.pdf
"Stem Cell Reports Report Recapitulation of Clinical Individual Susceptibility to Drug-Induced QT Prolongation in Healthy Subjects Using iPSC-Derived Cardiomyocytes Tadahiro Shinozawa,1,*Koki Nakamura,2Masanobu Shoji,3Maya Morita,1Maya Kimura,1Hatsue Furukawa,1 Hiroki Ueda,5Masanari Shiramoto,6Kyoko Matsuguma,7Yoshikazu Kaji,8Ippei Ikushima,8Makoto Yono,9 Shyh-Yuh Liou,5Hirofumi Nagai,1Atsushi Nakanishi,3Keiji Yamamoto,3and Seigo Izumo4 1Drug Safety Research Laboratories, Pharmaceutical Research Division, Takeda Pharmaceutical Company Limited, 26-1 Muraoka-Higashi 2-chome, Fujisawa, Kanagawa 251-8555, Japan 2Global Medical Affairs-Japan, Takeda Pharmaceutical Company Limited, 12-10 Nihonbashi 2-chome, Chuo-ku, Tokyo 103-8668, Japan 3Integrated Technology Research Laboratories 4Regenerative Medicine Unit Pharmaceutical Research Division, Takeda Pharmaceutical Company Limited, 26-1 Muraoka-Higashi 2-chome, Fujisawa, Kanagawa 251-8555, Japan 5Development Operations Department, Takeda Development Center Japan, Pharmaceutical Development Division, Takeda Pharmaceutical Company Limited, 12-10 Nihonbashi 2-chome, Chuo-ku, Tokyo 103-8668, Japan 6Hakata Clinic, Souseikai, 6-18 Tenya-machi, Hakata-ku, Fukuoka 812-0025, Japan 7Sugioka Memorial Hospital (current Fukuoka Mirai Hospital), Souseikai, 5-1 Kashii-Teriha 3-chome, Higashi-ku, Fukuoka 813-0017, Japan 8Sumida Hospital, Souseikai, 1-29-1 Honjo, Sumida-ku, Tokyo 130-0004, Japan 9Nishi-Kumamoto Hospital, Souseikai, 1012 Koga, Tomiai-machi, Minami-ku, Kumamoto 861-4157, Japan *Correspondence: tadahiro.shinozawa@takeda.com http://dx.doi.org/10.1016/j.stemcr.2016.12.014 SUMMARY To predict drug-induced serious adverse events (SAE) in clinical trials, a model using a panel of cells derived from human induced plurip- otent stem cells (hiPSCs) of individuals with different susceptibilities could facilitate major advancements in translational research in terms of safety and pharmaco-economics.",Non-OADS,/arxiv_data1/oa_pdf/f7/a0/main.PMC5312248.pdf
This is an open access article under the CC BY -NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/f7/a0/main.PMC5312248.pdf
"SUPPLEMENTAL INFORMATION Supplemental Information includes Supplemental ExperimentalProcedures, two ﬁgures, six tables, and one movie and can be foundwith this article online at http://dx.doi.org/10.1016/j.stemcr.2016.",Non-OADS,/arxiv_data1/oa_pdf/f7/a0/main.PMC5312248.pdf
"Stem Cell Reports Article Preclinical Efﬁcacy Failure of Human CNS-Derived Stem Cells for Use in the Pathway Study of Cervical Spinal Cord Injury Aileen J. Anderson,1,2,3,4,*Katja M. Piltti,1,3Mitra J. Hooshmand,1,3Rebecca A. Nishi,1,3 and Brian J. Cummings1,2,3,4 1Sue & Bill Gross Stem Cell Center 2Physical & Medical Rehabilitation 3Institute for Memory Impairments & Neurological Disorders 4Anatomy & Neurobiology University of California-Irvine, Irvine, CA 92697, USA *Correspondence: aja@uci.edu http://dx.doi.org/10.1016/j.stemcr.2016.12.018 SUMMARY We previously showed the efﬁcacy of multiple research cell lines (RCLs) of human CNS neural stem cells (HuCNS-SCs) in mouse and rat models of thoracic spinal cord injury (SCI), supporting a thoracic SCI clinical trial.",OADS,/arxiv_data1/oa_pdf/5a/7f/main.PMC5312249.pdf
249 This is an open access article under the CC BY -NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/5a/7f/main.PMC5312249.pdf
"SUPPLEMENTAL INFORMATION Supplemental Information includes Supplemental ExperimentalProcedures, six ﬁgures, and two tables and can be found withthis article online at http://dx.doi.org/10.1016/j.stemcr.2016.12.",OADS,/arxiv_data1/oa_pdf/5a/7f/main.PMC5312249.pdf
https://www.christopherreeve.org/living-with-paralysis/ stats-about-paralysis .,Non-OADS,/arxiv_data1/oa_pdf/5a/7f/main.PMC5312249.pdf
"Stem Cell Reports Article C/EBP-Induced T ransdifferentiation Reveals Granulocyte-Macrophage Precursor-like Plasticity of B Cells Branko Cirovic,1,2Jo¨rg Scho ¨nheit,1Elisabeth Kowenz-Leutz,1Jelena Ivanovska,1Christine Klement,1 Nina Pronina,1Vale´rie Be ´gay,1and Achim Leutz1,2,* 1Department of Tumorigenesis and Cell Differentiation, Max-Delbrueck-Center for Molecular Medicine, Robert-Roessle-Straße10, 13125 Berlin, Ge rmany 2Humboldt-University of Berlin, Institute of Biology, 10115 Berlin, Germany *Correspondence: aleutz@mdc-berlin.de http://dx.doi.org/10.1016/j.stemcr.2016.12.015 SUMMARY The lymphoid-myeloid transdifferentiation potentials of members of the C/EBP family (C/EBP a,b,d, and ε) were compared in v-Abl- immortalized primary B cells.",OADS,/arxiv_data1/oa_pdf/b2/ba/main.PMC5312250.pdf
This is an open access article under the CC BY -NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/b2/ba/main.PMC5312250.pdf
SUPPLEMENTAL INFORMATION Supplemental Information includes ﬁve ﬁgures and two tables and can be found with this article online at http://dx.doi.org/10.1016/ j.stemcr.2016.12.015 .,OADS,/arxiv_data1/oa_pdf/b2/ba/main.PMC5312250.pdf
"Stem Cell Reports Article PC1/3 Deﬁciency Impacts Pro-opiomelanocortin Processing in Human Embryonic Stem Cell-Derived Hypothalamic Neurons Liheng Wang,1,2Lina Sui,1Sunil K. Panigrahi,2Kana Meece,2Yurong Xin,3Jinrang Kim,3Jesper Gromada,3 Claudia A. Doege,4Sharon L. Wardlaw,2Dieter Egli,1,5and Rudolph L. Leibel1,2,* 1Division of Molecular Genetics, Department of Pediatrics and Naomi Berrie Diabetes Center, College of Physicians and Surgeons, Columbia Universit y, 1150 St. Nicholas Avenue, Room 620A, New York, NY 10032, USA 2Department of Medicine and Naomi Berrie Diabetes Center, College of Physicians and Surgeons, Columbia University, New York, NY 10032, USA 3Regeneron Pharmaceuticals, Tarrytown, NY 10591, USA 4Department of Pathology and Cell Biology and Naomi Berrie Diabetes Center, College of Physicians and Surgeons, Columbia University, New York, NY 10032, USA 5New York Stem Cell Foundation Research Institute, 3960 Broadway, New York, NY 10032, USA *Correspondence: rl232@columbia.edu http://dx.doi.org/10.1016/j.stemcr.2016.12.021 SUMMARY We recently developed a technique for generating hypothalamic neurons from human pluripotent stem cells.",Non-OADS,/arxiv_data1/oa_pdf/93/f7/main.PMC5312251.pdf
This is an open access article under the CC BY -NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/93/f7/main.PMC5312251.pdf
Generation of PCSK1 Mutant hESC Lines with CRISPR The two PCSK1 gRNAs were designed using software from Zhang Feng’s laboratory at the Massachusetts Institute of Technology(http://crispr.mit.edu ).,OADS,/arxiv_data1/oa_pdf/93/f7/main.PMC5312251.pdf
"SUPPLEMENTAL INFORMATION Supplemental Information includes Supplemental Experimental Procedures, ﬁve ﬁgures, and three tables and can be foundwith this article online at http://dx.doi.org/10.1016/j.stemcr.",OADS,/arxiv_data1/oa_pdf/93/f7/main.PMC5312251.pdf
http://dx.doi.org/10.1172/JCI88648 .,Non-OADS,/arxiv_data1/oa_pdf/93/f7/main.PMC5312251.pdf
"Stem Cell Reports Article HuCNS-SC Human NSCs Fail to Differentiate, Form Ectopic Clusters, and Provide No Cognitive Beneﬁts in a T ransgenic Model of Alzheimer’s Disease Samuel E. Marsh,1,2,3Stephen T. Yeung,3Maria Torres,3Lydia Lau,3Joy L. Davis,3Edwin S. Monuki,2,3,4 Wayne W. Poon,3and Mathew Blurton-Jones1,2,3,* 1Department of Neurobiology & Behavior 2Sue & Bill Gross Stem Cell Research Center 3Institute for Memory Impairments & Neurological Disorders 4Department of Pathology & Laboratory Medicine University of California Irvine, 845 Health Sciences Road, 3200 Gross Hall, Irvine, CA 92697, USA *Correspondence: mblurton@uci.edu http://dx.doi.org/10.1016/j.stemcr.2016.12.019 SUMMARY Transplantation of neural stem cells (NSCs) can improve cognition in animal modelsof Alzheimer’s disease (AD).",Non-OADS,/arxiv_data1/oa_pdf/ec/40/main.PMC5312253.pdf
235 This is an open access article under the CC BY -NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/ec/40/main.PMC5312253.pdf
"SUPPLEMENTAL INFORMATION Supplemental Information includes Supplemental Experimental Procedures, two ﬁgures, and two movies and can be found withthis article online at http://dx.doi.org/10.1016/j.stemcr.2016.",Non-OADS,/arxiv_data1/oa_pdf/ec/40/main.PMC5312253.pdf
"Stem Cell Reports Report Differentiation of Human Induced Pluripotent Stem Cells to Mammary-like Organoids Ying Qu,1Bingchen Han,1Bowen Gao,1Shikha Bose,2Yiping Gong,3Kolja Wawrowsky,4 Armando E. Giuliano,1Dhruv Sareen,4,5,6and Xiaojiang Cui1,* 1Department of Surgery, Samuel Oschin Comprehensive Cancer Institute, Cedars-Sinai Medical Center, 8700 Beverly Boulevard, Davis Building 2065, Los Angeles, CA 90048, USA 2Department of Pathology, Samuel Oschin Comprehensive Cancer Institute, Cedars-Sinai Medical Center, Los Angeles, CA 90048, USA 3Department of Breast Surgery, Hubei Cancer Hospital, Wuhan 430079, China 4Department of Biomedical Sciences 5Board of Governors Regenerative Medicine Institute 6The David and Janet Polak Foundation Stem Cell Core Laboratory Cedars-Sinai Medical Center, Los Angeles, CA 90048, USA*Correspondence: xiaojiang.cui@cshs.org http://dx.doi.org/10.1016/j.stemcr.2016.12.023 SUMMARY Human induced pluripotent stem cells (iPSCs) can give rise to multiple cell types and hold great promise in regenerative medicine and disease-modeling applications.",Non-OADS,/arxiv_data1/oa_pdf/09/3b/main.PMC5312254.pdf
205 This is an open access article under the CC BY -NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/09/3b/main.PMC5312254.pdf
The differentiallyexpressed genes were subjected to ingenuity pathway anal-ysis (IPA) analysis ( http://www.ingenuity.com/products/ ipa) for exploring the molecular basis of mEB differentia- tion.,OADS,/arxiv_data1/oa_pdf/09/3b/main.PMC5312254.pdf
"ACCESSION NUMBERS The accession number for the microarray data on iPSCs, 5-day mEBs, and 10-day mEBs reported in this article is GEO: GSE92706.SUPPLEMENTAL INFORMATION Supplemental Information includes Supplemental ExperimentalProcedures and four ﬁgures and can be found with this articleonline at http://dx.doi.org/10.1016/j.stemcr.2016.12.023 .",Non-OADS,/arxiv_data1/oa_pdf/09/3b/main.PMC5312254.pdf
"Stem Cell Reports Article TP53 Modulates Oxidative Stress in Gata1+Erythroid Cells Ashley C. Kramer,1Jenna Weber,1Ying Zhang,2Jakub Tolar,1Ying Y. Gibbens,1Margaret Shevik,1 and Troy C. Lund1,* 1Division of Pediatric Blood and Marrow Transplantation, University of Minnesota, Minneapolis, MN 55455, USA 2Minnesota Supercomputing Institute, University of Minnesota, Minneapolis, MN 55455, USA *Correspondence: lundx072@umn.edu http://dx.doi.org/10.1016/j.stemcr.2016.12.025 SUMMARY Metabolism of oxidative stress is necessary for cellular survival.",Non-OADS,/arxiv_data1/oa_pdf/93/26/main.PMC5312256.pdf
This is an open access article under the CC BY -NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/93/26/main.PMC5312256.pdf
"RNA-Seq Analysis Raw paired-end RNA-seq reads in fastq format were assessedfor base call quality, cycle uniformity, and contamination using fastQC ( http://www.bioinformatics.bbsrc.ac.uk/projects/fastqc/ ).",OADS,/arxiv_data1/oa_pdf/93/26/main.PMC5312256.pdf
"Differentiallyexpressed genes were mapped to their human homologous genes using BioMart and HomoloGene ( http://www.ncbi.nlm.nih.gov/ homologene/ )(Smedley et al., 2015 ).",OADS,/arxiv_data1/oa_pdf/93/26/main.PMC5312256.pdf
SUPPLEMENTAL INFORMATION Supplemental Information includes three ﬁgures and two tables and can be found with this article online at http://dx.doi.org/10.,Non-OADS,/arxiv_data1/oa_pdf/93/26/main.PMC5312256.pdf
http://dx.doi.org/10.,Non-OADS,/arxiv_data1/oa_pdf/93/26/main.PMC5312256.pdf
"Stem Cell Reports Article SCA-1 Labels a Subset of Estrogen-Responsive Bipotential Repopulating Cells within the CD24+CD49fhiMammary Stem Cell-Enriched Compartment Genevieve V. Dall,1,2Jessica L. Vieusseux,1Kenneth S. Korach,3Yukitomo Arao,3Sylvia C. Hewitt,3 Katherine J. Hamilton,3Elaine Dzierzak,4Wah Chin Boon,5Evan R. Simpson,6Robert G. Ramsay,7 Torsten Stein,8Joanne S. Morris,9Robin L. Anderson,10,11,12Gail P. Risbridger,2,12and Kara L. Britt1,2,10,12,* 1Cancer Genetics Laboratory, Peter MacCallum Cancer Centre, 305 Grattan Street, Melbourne, VIC 3000, Australia 2Department of Anatomy and Developmental Biology, Monash University, Clayton, VIC 3800, Australia 3Reproductive and Developmental Biology Laboratory, National Institute of Environmental Health Sciences/NIH, Research Triangle Park, NC 27709, U SA 4MRC Centre for Inﬂammation Research, University of Edinburgh, Queen’s Medical Research Institute, Edinburgh EH16 4TJ, UK 5The Florey Institute of Neuroscience and Mental Health, University of Melbourne, Parkville, VIC 3010, Australia 6Hudson Institute of Medical Research, Clayton, VIC 3168, Australia 7Differentiation and Transcription Laboratory, Peter MacCallum Cancer Centre, 305 Grattan Street, Melbourne, VIC 3000, Australia 8Institute of Cancer Sciences, College of MVLS, University of Glasgow, Glasgow G12 8QQ, UK 9School of Veterinary Medicine, College of MVLS, University of Glasgow, Glasgow G61 1QH, UK 10The Sir Peter MacCallum Department of Oncology, University of Melbourne, Parkville, VIC 3010, Australia 11La Trobe University, Bundoora, VIC 3083, Australia 12Co-senior author *Correspondence: kara.britt@petermac.org http://dx.doi.org/10.1016/j.stemcr.2016.12.022 SUMMARY Estrogen stimulates breast development during puberty and mammary tumors in adulthood through estrogen receptor- a(ERa).",Non-OADS,/arxiv_data1/oa_pdf/d8/7b/main.PMC5312257.pdf
417 This is an open access article under the CC BY -NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/d8/7b/main.PMC5312257.pdf
with this article online at http://dx.doi.org/10.1016/j.stemcr.2016.,OADS,/arxiv_data1/oa_pdf/d8/7b/main.PMC5312257.pdf
"Stem Cell Reports Article Common T elomere Changes during In Vivo Reprogramming and Early Stages of T umorigenesis Rosa M. Mario ´n,1Isabel Lo ´pez de Silanes,1Lluc Mosteiro,2Benjamin Gamache,1Marı´a Abad,2 Carmen Guerra,3Diego Megı ´as,4Manuel Serrano,2and Maria A. Blasco1,* 1Telomeres and Telomerase Group, Molecular Oncology Program 2Tumour Suppression Group, Molecular Oncology Program 3Experimental Oncology Group, Molecular Oncology Program 4Confocal Microscopy Unit Spanish National Cancer Research Center (CNIO), Melchor Ferna ´ndez Almagro 3, Madrid 28029, Spain *Correspondence: mblasco@cnio.es http://dx.doi.org/10.1016/j.stemcr.2017.01.001 SUMMARY Reprogramming of differentiated cells into induced pluripotent stem cells has been recently achieved in vivo in mice.",Non-OADS,/arxiv_data1/oa_pdf/99/15/main.PMC5312258.pdf
This is an open access article under the CC BY -NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/99/15/main.PMC5312258.pdf
Nuclei were counterstained in a 4- mg/mL DAPI/PBS solution before mounting with Vectashield.SUPPLEMENTAL INFORMATION Supplemental Information includes Supplemental ExperimentalProcedures and six ﬁgures and can be found with this article onlineathttp://dx.doi.org/10.1016/j.stemcr.2017.01.001 .,OADS,/arxiv_data1/oa_pdf/99/15/main.PMC5312258.pdf
"Stem Cell Reports Report Thyroid Progenitors Are Robustly Derived from Embryonic Stem Cells through T ransient, Developmental Stage-Speciﬁc Overexpression of Nkx2-1 Keri Dame,1,2Steven Cincotta,1,2Alex H. Lang,3Reeti M. Sanghrajka,1,2Liye Zhang,4Jinyoung Choi,1,5 Letty Kwok,2Talitha Wilson,2Maciej M. Ka /C19ndu 1a,6Stefano Monti,4Anthony N. Hollenberg,5Pankaj Mehta,3 Darrell N. Kotton,1,2and Laertis Ikonomou1,2,* 1Center for Regenerative Medicine, Boston Medical Center and Boston University, 670 Albany Street, 2nd Floor CReM, Boston, MA 02118, USA 2The Pulmonary Center, Department of Medicine, Boston University School of Medicine, Boston, MA 02118, USA 3Department of Physics, Boston University, Boston, MA 02215, USA 4Section of Computational Biomedicine, Boston University School of Medicine, Boston, MA 02118, USA 5Division of Endocrinology, Diabetes and Metabolism, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA 02215, USA 6Chair of Bioinformatics Research Group, Boku University, 1190 Vienna, Austria *Correspondence: laertis@bu.edu http://dx.doi.org/10.1016/j.stemcr.2016.12.024 SUMMARY The clinical importance of anterior foregut endoderm (AFE) derivatives, such as thyrocytes, has led to intense research efforts for their derivation through directed differentiation of pluripotent stem cells (PSCs).",Non-OADS,/arxiv_data1/oa_pdf/f4/38/main.PMC5312259.pdf
This is an open access article under the CC BY -NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/f4/38/main.PMC5312259.pdf
"SUPPLEMENTAL INFORMATION Supplemental Information includes Supplemental Experimental Procedures, four ﬁgures, and two tables and can be found with this article online at http://dx.doi.org/10.1016/j.stemcr.",OADS,/arxiv_data1/oa_pdf/f4/38/main.PMC5312259.pdf
"Stem Cell Reports Report CDK5RAP2 Is Required to Maintain the Germ Cell Pool during Embryonic Development Sami Zaqout,1,2,3Paraskevi Bessa,1Nadine Kra ¨mer,1,2,3Gisela Stoltenburg-Didinger,1 and Angela M. Kaindl1,2,3,* 1Institute of Cell Biology and Neurobiology, Charite ´– Universita ¨tsmedizin Berlin, Charite ´platz 1, 10117 Berlin, Germany 2Center for Chronically Sick Children (Sozialpa ¨diatrisches Zentrum, SPZ), Charite ´– Universita ¨tsmedizin Berlin, Augustenburger Platz 1, 13353 Berlin, Germany 3Berlin Institute of Health (BIH), Kapelle-Ufer 2, 10117 Berlin, Germany *Correspondence: angela.kaindl@charite.de http://dx.doi.org/10.1016/j.stemcr.2017.01.002 SUMMARY Gene products linked to microcephaly have been studied foremost for their role in brain development, while their function in the devel- opment of other organs has been largely neglected.",Non-OADS,/arxiv_data1/oa_pdf/b2/fd/main.PMC5312265.pdf
This is an open access article under the CC BY -NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/b2/fd/main.PMC5312265.pdf
SUPPLEMENTAL INFORMATION Supplemental Information includes two ﬁgures and can be foundwith this article online at http://dx.doi.org/10.1016/j.stemcr.,Non-OADS,/arxiv_data1/oa_pdf/b2/fd/main.PMC5312265.pdf
"Stem Cell Reports Commentary Lessons Learned from Pioneering Neural Stem Cell Studies Sally Temple1,*and Lorenz Studer2 1Neural Stem Cell Institute, Rensselaer, NY 12144, USA 2Memorial Sloan Kettering Cancer Center, Center for Stem Cell Biology, New York, NY 10065, USA *Correspondence: sallytemple@neuralsci.org http://dx.doi.org/10.1016/j.stemcr.2017.01.024 As stem cell products are increasingly entering early stage clinical trials, we are learning from experience about how cell products may be best assessed for safety and efﬁcacy.",Non-OADS,/arxiv_data1/oa_pdf/5f/54/main.PMC5312267.pdf
191 This is an open access article under the CC BY -NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/5f/54/main.PMC5312267.pdf
http://www.isscr.org/ guidelines2016 .,Non-OADS,/arxiv_data1/oa_pdf/5f/54/main.PMC5312267.pdf
"http://dx.doi.org/10.1016/j.stemcr.2017.02.002 We welcome the opportunity for further discussion of this data, and in the paragraphs below, we brieﬂy address the comments provided by StemCells Inc. (STEM).",OADS,/arxiv_data1/oa_pdf/e9/85/main.PMC5312268.pdf
195 This is an open access article under the CC BY -NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).Stem Cell Reports Letters,Non-OADS,/arxiv_data1/oa_pdf/e9/85/main.PMC5312268.pdf
"Stem Cell Reports Article Identiﬁcation of Bone Marrow-Derived Soluble Factors Regulating Human Mesenchymal Stem Cells for Bone Regeneration Tsung-Lin Tsai1,2and Wan-Ju Li1,2,* 1Department of Orthopedics and Rehabilitation 2Department of Biomedical Engineering University of Wisconsin-Madison, Madison, WI 53705, USA *Correspondence: li@ortho.wisc.edu http://dx.doi.org/10.1016/j.stemcr.2017.01.004 SUMMARY Maintaining properties of human bone marrow-derived mesenchymal stem cells (BMSCs) in culture for regenerative applications re- mains a great challenge.",OADS,/arxiv_data1/oa_pdf/88/8b/main.PMC5312426.pdf
387 This is an open access article under the CC BY -NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/88/8b/main.PMC5312426.pdf
"SUPPLEMENTAL INFORMATION Supplemental Information includes Supplemental Experimental Procedures, three ﬁgures, and three tables and can be found with this article online at http://dx.doi.org/10.1016/j.stemcr.",OADS,/arxiv_data1/oa_pdf/88/8b/main.PMC5312426.pdf
"Stem Cell Reports Article Legumain Regulates Differentiation Fate of Human Bone Marrow Stromal Cells and Is Altered in Postmenopausal Osteoporosis Abbas Jafari,1,2Diyako Qanie,2Thomas L. Andersen,3Yuxi Zhang,4Li Chen,2Benno Postert,4Stuart Parsons,4 Nicholas Ditzel,2Sundeep Khosla,5Harald Thidemann Johansen,6Per Kjærsgaard-Andersen,7 Jean-Marie Delaisse,3Basem M. Abdallah,2,8Daniel Hesselson,4,9Rigmor Solberg,6 and Moustapha Kassem1,2,10,* 1Department of Cellular and Molecular Medicine, Danish Stem Cell Center (DanStem), University of Copenhagen, 2200 Copenhagen, Denmark 2Molecular Endocrinology & Stem Cell Research Unit (KMEB), Department of Endocrinology and Metabolism, Odense University Hospital & University of Southern Denmark, J.B. Winsloewsvej 25, 1st Floor, 5000 Odense C, Denmark 3Department of Clinical Cell Biology, Vejle/ Lillebaelt Hospital, Institute of Regional Health Research, University of Southern Denmark, 7100, Vej le, Denmark 4Diabetes and Metabolism Division, Garvan Institute of Medical Research, Sydney, NSW 2010, Australia 5Endocrine Research Unit, Mayo Clinic College of Medicine, Rochester, MN 55905, USA 6Department of Pharmaceutical Biosciences, School of Pharmacy, University of Oslo, 0363 Oslo, Norway 7Department of Orthopaedic Surgery, Vejle/Lillebaelt Hospital, 7100 Vejle, Denmark 8Department of Biological Sciences, College of Science, King Faisal University, Hofuf 6996, Saudi Arabia 9St Vincent’s Clinical School, UNSW Australia, Sydney, NSW 2010, Australia 10Stem Cell Unit, Department of Anatomy, Faculty of Medicine, King Saud University, Riyadh 12372, Saudi Arabia *Correspondence: mkassem@health.sdu.dk http://dx.doi.org/10.1016/j.stemcr.2017.01.003 SUMMARY Secreted factors are a key component of stem cell niche and their dysregulation compromises stem cell function.",Non-OADS,/arxiv_data1/oa_pdf/b9/ad/main.PMC5312427.pdf
373 This is an open access article under the CC BY -NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/b9/ad/main.PMC5312427.pdf
"SUPPLEMENTAL INFORMATION Supplemental Information includes Supplemental Experimental Procedures, two ﬁgures, and three tables and can be found with this article online at http://dx.doi.org/10.1016/j.stemcr.2017.",OADS,/arxiv_data1/oa_pdf/b9/ad/main.PMC5312427.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/98/09/main.PMC5312456.pdf
Contents lists available at ScienceDirect Annals of Medicine and Surgery journal homepage: www.annalsjournal.com http://dx.doi.org/10.1016/j.amsu.2017.02.001 2049-0801/ ©2017 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/98/09/main.PMC5312456.pdf
"This Open Access article is distributed under the terms of the Creative Commons Attribution Noncommercial License (http://creativecommons.org/licenses/by-nc/4.0/) which permits any non-commercial use, distribution, and reproduction in any medium, provided the original author(s) and the source are credited.NUCLEIC ACID THERAPEUTICS Volume 27, Number 1, 2017Mary Ann Liebert, Inc.DOI: 10.1089/nat.2016.0657 1",Non-OADS,/arxiv_data1/oa_pdf/77/11/nat.2016.0657.PMC5312460.pdf
3. http://investors.bmrn.com/r eleasedetail.cfm?ReleaseID= 973536 4.,Non-OADS,/arxiv_data1/oa_pdf/77/11/nat.2016.0657.PMC5312460.pdf
8. https://clinicaltrials.gov/ct2/show/NCT02255552 9.,Non-OADS,/arxiv_data1/oa_pdf/77/11/nat.2016.0657.PMC5312460.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/ 4.0/).,Non-OADS,/arxiv_data1/oa_pdf/b3/f7/main.PMC5312461.pdf
: 0131-650-8275 E-mail address: s.mcgrory@ed.ac.uk http://dx.doi.org/10.1016/j.dadm.2016.11.001 2352-8729/ /C2112016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/b3/f7/main.PMC5312461.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/b3/f7/main.PMC5312461.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/ca/97/main.PMC5312462.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/ca/97/main.PMC5312462.pdf
http://dx.doi.org/10.1016/j.eucr.2017.01.001Urology Case Reports 12 (2017) 4 e5,Non-OADS,/arxiv_data1/oa_pdf/ca/97/main.PMC5312462.pdf
This  is  an  open access article under  the  CC  BY-NC-ND  license  (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/d1/6a/main.PMC5312483.pdf
http://dx.doi.org/10.1016/j.ijscr.2016.12.007 2210-2612/© 2017  The  Authors.,Non-OADS,/arxiv_data1/oa_pdf/d1/6a/main.PMC5312483.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/19/13/main.PMC5312495.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/19/13/main.PMC5312495.pdf
http://dx.doi.org/10.1016/j.eucr.2017.01.003Urology Case Reports 12 (2017) 6 e8,Non-OADS,/arxiv_data1/oa_pdf/19/13/main.PMC5312495.pdf
http://dx.doi.org/10.1515/amma-2016-0011 .,Non-OADS,/arxiv_data1/oa_pdf/19/13/main.PMC5312495.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/87/b6/main.PMC5312496.pdf
Contents lists available at ScienceDirect Annals of Medicine and Surgery journal homepage: www.annalsjournal.com http://dx.doi.org/10.1016/j.amsu.2017.02.004 2049-0801/ ©2017 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/87/b6/main.PMC5312496.pdf
This  is  an  open access article  under  the  CC  BY-NC-ND  license  (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/7f/41/main.PMC5312497.pdf
"In  October  2015,  she  presented  with  the  history  of  left  groin painful  lump  for  three  months,  however,  she  denied  any  weight http://dx.doi.org/10.1016/j.ijscr.2017.01.045 2210-2612/© 2017  The  Authors.",Non-OADS,/arxiv_data1/oa_pdf/7f/41/main.PMC5312497.pdf
"34  (2016)  180–186,  http://dx.doi.org/10.1016/j.ijsu.2016.08.014 .",Non-OADS,/arxiv_data1/oa_pdf/7f/41/main.PMC5312497.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/ 4.0/).,Non-OADS,/arxiv_data1/oa_pdf/4f/43/main.PMC5312499.pdf
E-mail address: bobstern@bu.edu http://dx.doi.org/10.1016/j.dadm.2016.11.003 2352-8729/ /C2112016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/4f/43/main.PMC5312499.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/4f/43/main.PMC5312499.pdf
"As such TS is also a major prodromal factor for numerous central nervous system (CNS) disorders http://dx.doi.org/10.1016/j.redox.2017.02.007 Received 25 January 2017; Received in revised form 10 February 2017; Accepted 10 February 2017⁎Corresponding author at: Department of Pharmaceutical Sciences, School of Pharmacy, Texas Tech University Health Sciences Center, 1300 S. Coulter Street, Amarillo, TX 79106, USA.",Non-OADS,/arxiv_data1/oa_pdf/76/66/main.PMC5312505.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/BY-NC-ND/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/76/66/main.PMC5312505.pdf
http://dx.doi.org/10.1016/j.pmedr.2017.01.009 2211-3355/© 2017 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/22/07/main.PMC5312507.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/22/07/main.PMC5312507.pdf
Contents lists available at ScienceDirect Preventive Medicine Reports journal homepage: http://ees.elsevier.com/pmedr,Non-OADS,/arxiv_data1/oa_pdf/22/07/main.PMC5312507.pdf
This  is  an  open access  article  under  the  CC  BY-NC-ND  license  (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/61/f0/main.PMC5312508.pdf
A  colonoscopy  was  normal and  an  upper  GI  endoscopy  did  not  demonstrate  any  lesion  aside http://dx.doi.org/10.1016/j.ijscr.2017.01.046 2210-2612/© 2017  The  Authors.,Non-OADS,/arxiv_data1/oa_pdf/61/f0/main.PMC5312508.pdf
"Therefore, more promising antioxidant strategies might comprise http://dx.doi.org/10.1016/j.redox.2017.02.001 Received 30 December 2016; Received in revised form 30 January 2017; Accepted 1 February 2017⁎Correspondence to: Universitätsmedizin der Johannes Gutenberg-Universität Mainz, Zentrum für Kardiologie / Kardiologie 1, Labor für Molekulare Kardiologie, Langenbeckstr.",Non-OADS,/arxiv_data1/oa_pdf/a9/72/main.PMC5312509.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/BY-NC-ND/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/a9/72/main.PMC5312509.pdf
"J. Pharmacol.http://dx.doi.org/10.1111/bph.13517 , in press.",Non-OADS,/arxiv_data1/oa_pdf/a9/72/main.PMC5312509.pdf
"617 (2017) 38 –47,http://dx.doi.org/10.1016/j.abb.2016.08.021 .",Non-OADS,/arxiv_data1/oa_pdf/a9/72/main.PMC5312509.pdf
"Stem Cell Reports Letters Reaction from StemCells, Inc. to T wo Papers in Stem Cell Repor ts on the Efﬁcacy of Human NSCs in Mouse Models of Alzheimer’sDisease and Spinal Cord Injury StemCells, Inc. former management1 1Newark, CA 94560, USA; Number612@yahoo.com http://dx.doi.org/10.1016/j.stemcr.2017.02.001 The two articles in this issue of Stem Cell Reports authored by UCI researchers are based on sponsor- supported collaborations that were conducted in theeffort to develop therapies for serious and debilitatingneurological disorders that have no effective therapy:speciﬁcally, cervical spinal cord injury (SCI) and Alz-heimer’s disease (AD) ( Anderson et al., 2017; Marsh et al., 2017 ).",OADS,/arxiv_data1/oa_pdf/63/72/main.PMC5312510.pdf
"8 j194–197 jFebruary 14, 2017 jª2017 This is an open access article under the CC BY -NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).",Non-OADS,/arxiv_data1/oa_pdf/63/72/main.PMC5312510.pdf
"http://dx.doi.org/10.1016/j.stemcr.2017.02.002 We welcome the opportunity for further discussion of this data, and in the paragraphs below, we brieﬂy address the comments provided by StemCells Inc. (STEM).",OADS,/arxiv_data1/oa_pdf/63/72/main.PMC5312510.pdf
195 This is an open access article under the CC BY -NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).Stem Cell Reports Letters,Non-OADS,/arxiv_data1/oa_pdf/63/72/main.PMC5312510.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/2f/97/main.PMC5312511.pdf
Contents lists available at ScienceDirect International Journal for Parasitology: Parasites and Wildlife journal homepage: www.elsevier.com /locate/ijppaw http://dx.doi.org/10.1016/j.ijppaw.2017.01.003 2213-2244/ ©2017 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/2f/97/main.PMC5312511.pdf
Data accessibility All data are publicly available at DRYAD digital repository (http://dx.doi.org/10.5061/dryad.407c5 ).,OADS,/arxiv_data1/oa_pdf/2f/97/main.PMC5312511.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/d9/56/main.PMC5312512.pdf
Contents lists available at ScienceDirect International Journal for Parasitology: Parasites and Wildlife journal homepage: www.elsevier.com /locate/ijppaw http://dx.doi.org/10.1016/j.ijppaw.2017.01.002 2213-2244/ ©2017 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/d9/56/main.PMC5312512.pdf
Consensus 12S rRNA and cox1 sequences were subjected to BLASTn analysis ( http://blast.ncbi.nlm.nih.gov ) and compared to all S. tundra nucleotide sequences available in current databases.,OADS,/arxiv_data1/oa_pdf/d9/56/main.PMC5312512.pdf
http://bios.au.dk/ ﬁleadmin/bioscience/ePublikationer/DRGB_14_1_.pdf .,Non-OADS,/arxiv_data1/oa_pdf/d9/56/main.PMC5312512.pdf
http://dx.doi.org/10.1016/ j.mcp.2016.08.008 .,OADS,/arxiv_data1/oa_pdf/d9/56/main.PMC5312512.pdf
http://dx.doi.org/10.1016/j.stemcr.2016.12.016 SUMMARY Maternal nicotine exposure causes alteration of gene expression and cardiovascular programming.,Non-OADS,/arxiv_data1/oa_pdf/6b/b0/main.PMC5312513.pdf
"8 j290–304 jFebruary 14, 2017 jª2016 This is an open access article under the CC BY -NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).",Non-OADS,/arxiv_data1/oa_pdf/6b/b0/main.PMC5312513.pdf
BSP-speciﬁc primer pairs were designed using MethPrimer ( http://www.urogene.org/methprimer/ ).,Non-OADS,/arxiv_data1/oa_pdf/6b/b0/main.PMC5312513.pdf
"Endothelial cells are joined by tight junctions that participate http://dx.doi.org/10.1016/j.redox.2017.01.007 Received 29 November 2016; Received in revised form 4 January 2017; Accepted 5 January 2017⁎Correspondence to: UMR-1048 - CHU Rangueil, BP 84225, 31432 Toulouse Cedex 4, France.",Non-OADS,/arxiv_data1/oa_pdf/22/95/main.PMC5312547.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/BY-NC-ND/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/22/95/main.PMC5312547.pdf
glutathione reductase that catalyse the reduction of oxidised to reduced glutathione and http://dx.doi.org/10.1016/j.redox.2017.01.023 Received 5 January 2017; Received in revised form 25 January 2017; Accepted 31 January 2017⁎Corresponding author.,Non-OADS,/arxiv_data1/oa_pdf/2b/04/main.PMC5312548.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/BY-NC-ND/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/2b/04/main.PMC5312548.pdf
http://dx.doi.org/10.1194/ jlr.M026179 (PubMed PMID:22865918; PubMed Central PMCID: PMC3435540).,OADS,/arxiv_data1/oa_pdf/2b/04/main.PMC5312548.pdf
10 (10) (2009)721– 732. http://dx.doi.org/10.1038/nrm2764 (PubMed PMID: 19738628).,OADS,/arxiv_data1/oa_pdf/2b/04/main.PMC5312548.pdf
19 (6) (2013) 595– 637. http://dx.doi.org/10.1089/ars.2012.4785 .,Non-OADS,/arxiv_data1/oa_pdf/2b/04/main.PMC5312548.pdf
Retrieved from) 〈http://science.sciencemag.org/content/303/5666/2011.abstract 〉.,Non-OADS,/arxiv_data1/oa_pdf/2b/04/main.PMC5312548.pdf
92 (4) (2012) 869– 882. http://dx.doi.org/10.1189/ jlb.0512244 .,Non-OADS,/arxiv_data1/oa_pdf/2b/04/main.PMC5312548.pdf
161 (3) (2010) 407– 416. http://dx.doi.org/10.1111/j.1365-2249.2010.04213.x .,Non-OADS,/arxiv_data1/oa_pdf/2b/04/main.PMC5312548.pdf
Cell 39 (2) (2010) 171– 183. http://dx.doi.org/10.1016/ j.molcel.2010.06.022.Activation .,OADS,/arxiv_data1/oa_pdf/2b/04/main.PMC5312548.pdf
388 (2) (2009) 278– 282. http://dx.doi.org/10.1016/j.bbrc.2009.07.160 .,Non-OADS,/arxiv_data1/oa_pdf/2b/04/main.PMC5312548.pdf
53 (4) (2012) 796– 806. http://dx.doi.org/10.1016/j.freeradbiomed.2012.05.026 .,OADS,/arxiv_data1/oa_pdf/2b/04/main.PMC5312548.pdf
http://dx.doi.org/10.1016/j.jacc.2013.07.043 .,OADS,/arxiv_data1/oa_pdf/2b/04/main.PMC5312548.pdf
2 (2014 20) 430– 435. http://dx.doi.org/10.1016/ j.redox.2014.01.010 .,OADS,/arxiv_data1/oa_pdf/2b/04/main.PMC5312548.pdf
http://dx.doi.org/10.1146/annurev.pathol.4.110807.092250.Mammalian .,Non-OADS,/arxiv_data1/oa_pdf/2b/04/main.PMC5312548.pdf
2 (1) (2014)206– 210. http://dx.doi.org/10.1016/j.redox.2013.12.026 .,OADS,/arxiv_data1/oa_pdf/2b/04/main.PMC5312548.pdf
290 (1) (2015) 396– 408. http://dx.doi.org/10.1074/ jbc.M114.566349 .,Non-OADS,/arxiv_data1/oa_pdf/2b/04/main.PMC5312548.pdf
2 (2014) 68. http://dx.doi.org/10.3389/ fcell.2014.00068 Review (PubMed PMID: 25453035; PubMed Central PMCID:PMC4233936).,Non-OADS,/arxiv_data1/oa_pdf/2b/04/main.PMC5312548.pdf
2 (1) (2014) 535– 562. http://dx.doi.org/10.1016/j.redox.2014.02.006 .,OADS,/arxiv_data1/oa_pdf/2b/04/main.PMC5312548.pdf
5 (2015) 186– 194. http://dx.doi.org/ 10.1016/j.redox.2015.04.004 .,OADS,/arxiv_data1/oa_pdf/2b/04/main.PMC5312548.pdf
27 (4) (2015) 257– 266. http://dx.doi.org/ 10.1016/j.smim.2015.07.002 .,OADS,/arxiv_data1/oa_pdf/2b/04/main.PMC5312548.pdf
17 (2) (2016) 132– 139. http://dx.doi.org/10.1038/ni.3323.,Non-OADS,/arxiv_data1/oa_pdf/2b/04/main.PMC5312548.pdf
http://dx.doi.org/10.1074/ jbc.R112.404863 .,Non-OADS,/arxiv_data1/oa_pdf/2b/04/main.PMC5312548.pdf
72 (1) (2010) 219– 246. http://dx.doi.org/10.1146/annurev-physiol- 021909-135846 .,Non-OADS,/arxiv_data1/oa_pdf/2b/04/main.PMC5312548.pdf
http://dx.doi.org/10.1038/cdd.2015.86 .,OADS,/arxiv_data1/oa_pdf/2b/04/main.PMC5312548.pdf
167 (2) (2012) 261– 268. http://dx.doi.org/10.1111/j.1365- 2249.2011.04518.x.,Non-OADS,/arxiv_data1/oa_pdf/2b/04/main.PMC5312548.pdf
"Gri ﬃths, Age-associated changes in long-chain fatty acid proﬁ le during healthy aging promote pro-in ﬂammatory monocyte polarization via PPAR γ, Aging Cell 15 (1) (2016) 128– 139. http://dx.doi.org/10.1111/acel.12416 .",Non-OADS,/arxiv_data1/oa_pdf/2b/04/main.PMC5312548.pdf
12 (6) (2010) 743– 785. http://dx.doi.org/10.1089/ars.2009.2607 .,Non-OADS,/arxiv_data1/oa_pdf/2b/04/main.PMC5312548.pdf
138 (3) (2003) 501– 511. http://dx.doi.org/10.1038/ sj.bjp.0705054 .,Non-OADS,/arxiv_data1/oa_pdf/2b/04/main.PMC5312548.pdf
"Spiegelman, P. Puigserver, Nutrient control of glucose homeostasis through a complex of PGC-1[alpha] and SIRT1, Nature 434 (7029) (2005) 113– 118. http://dx.doi.org/10.1038/nat- ure03354 .",Non-OADS,/arxiv_data1/oa_pdf/2b/04/main.PMC5312548.pdf
10 (6) (2010) 427– 439. http://dx.doi.org/ 10.1038/nri2779 .,Non-OADS,/arxiv_data1/oa_pdf/2b/04/main.PMC5312548.pdf
"Auron, R.J. Xavier, L.A. O'Neill, Succinate is an inﬂammatory signal that inducesIL-1 βthrough HIF-1 α, Nature 496 (7444) (2013) 238– 241. http://dx.doi.org/10.1038/nature11986 (PubMed PMID: 23535595; PubMed Central PMCID: PMC4031686).",Non-OADS,/arxiv_data1/oa_pdf/2b/04/main.PMC5312548.pdf
"F1000 Biology Reports, 4(May), 9. https://doi.org/ http:// dx.doi.org/10.3410/B4-9 , 2012.",OADS,/arxiv_data1/oa_pdf/2b/04/main.PMC5312548.pdf
http://dx.doi.org/ 10.1038/sj.emboj.7600244 .,Non-OADS,/arxiv_data1/oa_pdf/2b/04/main.PMC5312548.pdf
http://dx.doi.org/10.1089/ars.2012.4774 .,Non-OADS,/arxiv_data1/oa_pdf/2b/04/main.PMC5312548.pdf
https://doi.org/10.,Non-OADS,/arxiv_data1/oa_pdf/2b/04/main.PMC5312548.pdf
"Dysregulation of iron, which can augment the production of reactive oxygen species (ROS), is also evident in AD http://dx.doi.org/10.1016/j.redox.2017.01.021 Received 11 January 2017; Received in revised form 20 January 2017; Accepted 30 January 2017⁎Correspondence to: Department of Cell Systems and Anatomy, University of Texas Health Science Center at San Antonio, 7703 Floyd Curl Dr., San Antonio, TX 78229, United States.",Non-OADS,/arxiv_data1/oa_pdf/d5/12/main.PMC5312549.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/BY-NC-ND/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/d5/12/main.PMC5312549.pdf
"This Open Access article is distributed under the terms of the Creative Commons Attribution Noncommercial License (http://creativecommons.org/licenses/by-nc/4.0/) which permits any noncommercial use,distribution, and reproduction in any medium, provided the original author(s) and the source are credited.AIDS PATIENT CARE and STDs Volume 31, Number 2, 2017Mary Ann Liebert, Inc.DOI: 10.1089/apc.2016.0252 43",Non-OADS,/arxiv_data1/oa_pdf/b0/65/apc.2016.0252.PMC5312551.pdf
"Additionally, upregulation or activation of pro-survival kinases such as protein kinase B (PKB/Akt) or endogenous antioxidant mechanisms, can lead to improved atherosclerotic lesion stability and http://dx.doi.org/10.1016/j.redox.2017.02.006 Received 24 January 2017; Accepted 10 February 2017⁎Corrsepondence to: Faculty of Pharmacy, Panepistimiopolis, Zografou, Athens 15771, Greece.",Non-OADS,/arxiv_data1/oa_pdf/ca/c0/main.PMC5312553.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/BY-NC-ND/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/ca/c0/main.PMC5312553.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/ by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/cf/72/main.PMC5312554.pdf
E-mail address: andrews_jeffrey_scott@lilly.com http://dx.doi.org/10.1016/j.dadm.2016.11.005 2352-8729/ /C2112016 Eli Lilly and Company.,Non-OADS,/arxiv_data1/oa_pdf/cf/72/main.PMC5312554.pdf
This is an open access article under the CC BY- NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/cf/72/main.PMC5312554.pdf
Available at: http://www.ninds.nih.gov/ disorders/dementias/detail_dementia.htm .,Non-OADS,/arxiv_data1/oa_pdf/cf/72/main.PMC5312554.pdf
Avail- able at: http://www.alz.org/documents_custom/report_alzfactsﬁgu res2010.pdf ; 2009.,Non-OADS,/arxiv_data1/oa_pdf/cf/72/main.PMC5312554.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/ by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/e8/c6/main.PMC5312555.pdf
E-mail address: wrobleski_kristin_kahle@lilly.com http://dx.doi.org/10.1016/j.dadm.2016.11.004 2352-8729/ /C2112016 Eli Lilly and Company.,Non-OADS,/arxiv_data1/oa_pdf/e8/c6/main.PMC5312555.pdf
This is an open access article under the CC BY- NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/e8/c6/main.PMC5312555.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).Keywords: StrokeMyelinWhite matterBiomarkersMotor controlAccelerometry 1.,Non-OADS,/arxiv_data1/oa_pdf/03/3e/main.PMC5312556.pdf
http://dx.doi.org/10.1016/j.nicl.2017.01.009 2213-1582/© 2017 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/03/3e/main.PMC5312556.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/03/3e/main.PMC5312556.pdf
"Cortical reconstruction Cortical reconstructions and volumetric segmentation were generat- ed with Freesurfer image analysis suite V5.3, which is documented and freely available for download online ( http://surfer.nmr.mgh.harvard.",OADS,/arxiv_data1/oa_pdf/03/3e/main.PMC5312556.pdf
http://dx.doi.org/10.1016/j.nurt.2007.05.011 .,OADS,/arxiv_data1/oa_pdf/03/3e/main.PMC5312556.pdf
73:70 –81.http://dx.doi.org/10.1002/mrm.25198 .,Non-OADS,/arxiv_data1/oa_pdf/03/3e/main.PMC5312556.pdf
NeuroImage 143:26 –39.http://dx.doi.org/10.1016/j.neuroimage.2016.08.,OADS,/arxiv_data1/oa_pdf/03/3e/main.PMC5312556.pdf
http://dx.doi.org/10.1177/1545968315583720 .,Non-OADS,/arxiv_data1/oa_pdf/03/3e/main.PMC5312556.pdf
http://dx.doi.org/10.1080/ 09638280500075717 .,Non-OADS,/arxiv_data1/oa_pdf/03/3e/main.PMC5312556.pdf
http://dx.doi.org/10.1080/09638280500243570 .,Non-OADS,/arxiv_data1/oa_pdf/03/3e/main.PMC5312556.pdf
http://dx.doi.org/10.1002/nbm.782 .,Non-OADS,/arxiv_data1/oa_pdf/03/3e/main.PMC5312556.pdf
http://dx.doi.org/10.,Non-OADS,/arxiv_data1/oa_pdf/03/3e/main.PMC5312556.pdf
http://dx.doi.org/10.1016/j.nicl.2013.04.006 .,OADS,/arxiv_data1/oa_pdf/03/3e/main.PMC5312556.pdf
http://dx.doi.org/10.1002/ana.24472 .,Non-OADS,/arxiv_data1/oa_pdf/03/3e/main.PMC5312556.pdf
1414:22 –31.http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/03/3e/main.PMC5312556.pdf
http://dx.doi.org/10.1006/ nimg.1998.0395 .,OADS,/arxiv_data1/oa_pdf/03/3e/main.PMC5312556.pdf
http://dx.doi.org/10.1016/j.neuroimage.2015.04.058 .,OADS,/arxiv_data1/oa_pdf/03/3e/main.PMC5312556.pdf
http://dx.doi.org/10.1093/cercor/ bhp216 .,Non-OADS,/arxiv_data1/oa_pdf/03/3e/main.PMC5312556.pdf
http://dx.doi.org/10.1002/ana.24510 .,Non-OADS,/arxiv_data1/oa_pdf/03/3e/main.PMC5312556.pdf
http://dx.doi.org/10.1038/nrn4023 .,Non-OADS,/arxiv_data1/oa_pdf/03/3e/main.PMC5312556.pdf
Imaging 20:70 –80.http://dx.doi.org/10.1109/42.906426 .,Non-OADS,/arxiv_data1/oa_pdf/03/3e/main.PMC5312556.pdf
1):S69 –S84.http://dx.doi.org/10.1016/ j.neuroimage.2004.07.016 .,OADS,/arxiv_data1/oa_pdf/03/3e/main.PMC5312556.pdf
http://dx.doi.org/10.1682/JRRD.2012.09.0166 .,OADS,/arxiv_data1/oa_pdf/03/3e/main.PMC5312556.pdf
http://dx.doi.org/10.1097/PHM.0000000000000045 .,Non-OADS,/arxiv_data1/oa_pdf/03/3e/main.PMC5312556.pdf
Science 344:1252304. http://dx.doi.org/10.1126/science.1252304 .,Non-OADS,/arxiv_data1/oa_pdf/03/3e/main.PMC5312556.pdf
http://dx.doi.org/10.1523/JNEUROSCI.2180-11.2011 .,Non-OADS,/arxiv_data1/oa_pdf/03/3e/main.PMC5312556.pdf
Nature http://dx.doi.org/10.,Non-OADS,/arxiv_data1/oa_pdf/03/3e/main.PMC5312556.pdf
http://dx.doi.org/10.1016/j.expneurol.2012.08.031 .,OADS,/arxiv_data1/oa_pdf/03/3e/main.PMC5312556.pdf
Neuroscientist 20:56 –70.http://dx.doi.org/10.1177/1073858413491147 .,Non-OADS,/arxiv_data1/oa_pdf/03/3e/main.PMC5312556.pdf
http://dx.doi.org/10.1371/journal.pone.0038234 .,Non-OADS,/arxiv_data1/oa_pdf/03/3e/main.PMC5312556.pdf
http://dx.doi.org/10.1016/j.neuroimage.2006.02.051 .,OADS,/arxiv_data1/oa_pdf/03/3e/main.PMC5312556.pdf
1 –18http://dx.doi.org/10.1017/BrImp.2015.21 .,Non-OADS,/arxiv_data1/oa_pdf/03/3e/main.PMC5312556.pdf
http://dx.doi.org/ 10.1016/j.apmr.2012.05.002 .,OADS,/arxiv_data1/oa_pdf/03/3e/main.PMC5312556.pdf
Neural Repair 24: 78–87.http://dx.doi.org/10.1177/1545968309345269 .,Non-OADS,/arxiv_data1/oa_pdf/03/3e/main.PMC5312556.pdf
http://dx.doi.org/10.1161/STROKEAHA.115.009616 .,Non-OADS,/arxiv_data1/oa_pdf/03/3e/main.PMC5312556.pdf
J Stroke] –> I n t .J .S t r o k e8 : 2 5 –32.http://dx.doi.org/ 10.1111/j.1747-4949.2012.00967.x .,Non-OADS,/arxiv_data1/oa_pdf/03/3e/main.PMC5312556.pdf
2016:1 –7.http://dx.doi.org/10.,Non-OADS,/arxiv_data1/oa_pdf/03/3e/main.PMC5312556.pdf
31:56 –63.http://dx.doi.org/10.1097/NPT.0b013e31806748bd .,Non-OADS,/arxiv_data1/oa_pdf/03/3e/main.PMC5312556.pdf
http://dx.doi.org/10.1007/s00415-004-0306-6 .,Non-OADS,/arxiv_data1/oa_pdf/03/3e/main.PMC5312556.pdf
http://dx.doi.org/10.1016/j.nicl.2014.,OADS,/arxiv_data1/oa_pdf/03/3e/main.PMC5312556.pdf
http://dx.doi.org/10.1126/science.1254960 .,Non-OADS,/arxiv_data1/oa_pdf/03/3e/main.PMC5312556.pdf
http://dx.doi.org/10.1161/ STROKEAHA.115.009421 .,Non-OADS,/arxiv_data1/oa_pdf/03/3e/main.PMC5312556.pdf
http://dx.doi.org/10.1111/cns.12263 .,Non-OADS,/arxiv_data1/oa_pdf/03/3e/main.PMC5312556.pdf
:1 –16http://dx.doi.org/10.1007/s00429-016- 1228-7 .,Non-OADS,/arxiv_data1/oa_pdf/03/3e/main.PMC5312556.pdf
http://dx.doi.org/10.1002/mrm.23157 .,Non-OADS,/arxiv_data1/oa_pdf/03/3e/main.PMC5312556.pdf
http://dx.doi.org/10.1016/j.neuroimage.2012.06.064 .,OADS,/arxiv_data1/oa_pdf/03/3e/main.PMC5312556.pdf
Neuropharmacology http://dx.doi.org/10.1016/j.neuropharm.2015.08.001 .,OADS,/arxiv_data1/oa_pdf/03/3e/main.PMC5312556.pdf
http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/03/3e/main.PMC5312556.pdf
http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/03/3e/main.PMC5312556.pdf
http://dx.doi.org/10.1161/STROKEAHA.108.523621 .352 B. Lakhani et al.,Non-OADS,/arxiv_data1/oa_pdf/03/3e/main.PMC5312556.pdf
Life Outcomes 8:80. http://dx.doi.org/10.1186/1477-7525-8-80 .,OADS,/arxiv_data1/oa_pdf/03/3e/main.PMC5312556.pdf
http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/03/3e/main.PMC5312556.pdf
http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/03/3e/main.PMC5312556.pdf
http://dx.doi.org/10.,Non-OADS,/arxiv_data1/oa_pdf/03/3e/main.PMC5312556.pdf
http://dx.doi.org/10.1109/TMI.2006.887364 .,Non-OADS,/arxiv_data1/oa_pdf/03/3e/main.PMC5312556.pdf
http://dx.doi.org/10.1589/jpts.26.1009 .,Non-OADS,/arxiv_data1/oa_pdf/03/3e/main.PMC5312556.pdf
http://dx.doi.org/10.1109/42.668698 .,Non-OADS,/arxiv_data1/oa_pdf/03/3e/main.PMC5312556.pdf
http://dx.doi.org/10.1016/j.neuroimage.2004.07.051 .,OADS,/arxiv_data1/oa_pdf/03/3e/main.PMC5312556.pdf
http://dx.doi.org/10.1093/brain/aws146 .,Non-OADS,/arxiv_data1/oa_pdf/03/3e/main.PMC5312556.pdf
http://dx.doi.org/10.1177/ 1545968314522349 .,Non-OADS,/arxiv_data1/oa_pdf/03/3e/main.PMC5312556.pdf
http://dx.doi.org/10.,Non-OADS,/arxiv_data1/oa_pdf/03/3e/main.PMC5312556.pdf
http://dx.doi.org/10.1016/0022-2364(89)90011-5 .,OADS,/arxiv_data1/oa_pdf/03/3e/main.PMC5312556.pdf
Group http://dx.doi.org/10.,Non-OADS,/arxiv_data1/oa_pdf/03/3e/main.PMC5312556.pdf
Imaging 20:45 –57.http://dx.doi.org/10.1109/42.906424 .353 B. Lakhani et al.,OADS,/arxiv_data1/oa_pdf/03/3e/main.PMC5312556.pdf
"This Open Access article is distributed under the terms of the Creative Commons Attribution Noncommercial License (http://creativecommons.org/licenses/by-nc/4.0/) which permits any noncommercial use,distribution, and reproduction in any medium, provided the original author(s) and the source are credited.TISSUE ENGINEERING: Part A Volume 23, Numbers 3 and 4, 2017 Mary Ann Liebert, Inc.DOI: 10.1089/ten.tea.2016.0114 124",Non-OADS,/arxiv_data1/oa_pdf/85/80/ten.tea.2016.0114.PMC5312612.pdf
The data for this study are freely available in the Leeds Data Repository http://doi.org/10.5518/39 Disclosure Statement E.I.,OADS,/arxiv_data1/oa_pdf/85/80/ten.tea.2016.0114.PMC5312612.pdf
"Online document at: https://www.spring-nutrition.org/ publications/tool-summaries/kap-survey-model-knowledge- attitudes-and-practices Accessed November 10, 2016.",Non-OADS,/arxiv_data1/oa_pdf/c0/19/acm.2016.0292.PMC5312615.pdf
"This Open Access article is distributed under the terms of the Creative Commons Attribution Noncommercial License (http://creativecommons.org/licenses/by-nc/4.0/) which permits any noncommercial use,distribution, and reproduction in any medium, provided the original author(s) and the source are credited.AIDS RESEARCH AND HUMAN RETROVIRUSES Volume 33, Number 2, 2017Mary Ann Liebert, Inc.DOI: 10.1089/aid.2016.0288 90",Non-OADS,/arxiv_data1/oa_pdf/d4/d2/aid.2016.0288.PMC5312620.pdf
This  is  an  open access article  under  the  CC  BY-NC-ND  license  (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/0b/b0/main.PMC5312641.pdf
http://dx.doi.org/10.1016/j.ijscr.2017.01.024 2210-2612/© 2017  The  Author(s).,Non-OADS,/arxiv_data1/oa_pdf/0b/b0/main.PMC5312641.pdf
During his ﬁrst clofarabine + cytarabine consolidation in January 2015 he only received 2 doses ofthe clofarabine due to an episode of hypotension and vomiting and the http://dx.doi.org/10.1016/j.lrr.2017.02.001 Received 1 December 2016; Received in revised form 6 February 2017; Accepted 12 February 2017⁎Corresponding author.,Non-OADS,/arxiv_data1/oa_pdf/7a/65/main.PMC5312643.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/BY-NC-ND/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/7a/65/main.PMC5312643.pdf
This i s an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).Keywords: Psychrobacter Genome sequencing Mercury detoxi ﬁcation Virulence factorsPhylogenetic analysis Speci ﬁcations Organism/cell line/tissuePsychrobacter spp.,Non-OADS,/arxiv_data1/oa_pdf/51/b1/main.PMC5312645.pdf
http://dx.doi.org/10.1016/j.gdata.2017.01.005 2213-5960/© 2017 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/51/b1/main.PMC5312645.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/51/b1/main.PMC5312645.pdf
"Faba bean was able to simultaneously fix N 2and take up soil N. This work has identified traits of seed mass, shoot and root biomass, root lateralReceived: 11 November 2016 Revised: 24 January 2017 Accepted: 2 February 2017 Heliyon 3 (2017) e00244 http://dx.doi.org/10.1016/j.heliyon.2017.e00244 2405-8440/© 2017 The Authors.",Non-OADS,/arxiv_data1/oa_pdf/c1/68/main.PMC5312646.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/c1/68/main.PMC5312646.pdf
Article No~e00244 2 http://dx.doi.org/10.1016/j.heliyon.2017.e00244 2405-8440/© 2017 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/c1/68/main.PMC5312646.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/c1/68/main.PMC5312646.pdf
Each rhizotron was filled with 4.1 kg of a Article No~e00244 3 http://dx.doi.org/10.1016/j.heliyon.2017.e00244 2405-8440/© 2017 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/c1/68/main.PMC5312646.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/c1/68/main.PMC5312646.pdf
Article No~e00244 4 http://dx.doi.org/10.1016/j.heliyon.2017.e00244 2405-8440/© 2017 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/c1/68/main.PMC5312646.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/c1/68/main.PMC5312646.pdf
"The pictures were analysed with ImageJ version 1.40 g (National Institutes of Health, USA;http://rsb.info.nih.gov/ij/ ) to obtain the total number of nodules.",OADS,/arxiv_data1/oa_pdf/c1/68/main.PMC5312646.pdf
"All of the samples were ground to fine powder for totalN and 15N:14N ratio measurements in the original seeds, nodulated roots, shoots, Article No~e00244 5 http://dx.doi.org/10.1016/j.heliyon.2017.e00244 2405-8440/© 2017 The Authors.",Non-OADS,/arxiv_data1/oa_pdf/c1/68/main.PMC5312646.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/c1/68/main.PMC5312646.pdf
"The effect of species on the shoot and root dry matter,root depth penetration and lateral expansion rates, nodule establishment, N Article No~e00244 6 http://dx.doi.org/10.1016/j.heliyon.2017.e00244 2405-8440/© 2017 The Authors.",Non-OADS,/arxiv_data1/oa_pdf/c1/68/main.PMC5312646.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/c1/68/main.PMC5312646.pdf
Agreater variability was observed for lateral expansion (CV = 0.55) than depth Article No~e00244 7 http://dx.doi.org/10.1016/j.heliyon.2017.e00244 2405-8440/© 2017 The Authors.,OADS,/arxiv_data1/oa_pdf/c1/68/main.PMC5312646.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/c1/68/main.PMC5312646.pdf
"The first component (PC1, 55% of the variability) consisted mostly of the level of soil N Article No~e00244 8 http://dx.doi.org/10.1016/j.heliyon.2017.e00244 2405-8440/© 2017 The Authors.",Non-OADS,/arxiv_data1/oa_pdf/c1/68/main.PMC5312646.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/c1/68/main.PMC5312646.pdf
Alfalfa Fenugreek Lentil Common vetch Soybean Pea Chickpea Peanut Faba bean CV Pvalue Shoot dry matter (Sdm) (g pl−1) 0.008 d 0.038 c 0.046 c 0.159 b 0.413 a 0.406 a 0.412 a 0.398 a 0.427 a 0.73 1.02 × 10−15*** Root dry matter (Rdm) (g pl−1) 0.007 e 0.024 d 0.028 d 0.065 c 0.219 ab 0.166 b 0.331 a 0.277 ab 0.292 ab 0.82 2.04 × 10−15*** Root:shoot ratio (R:S) 0.87 a 0.63 bc 0.62 bc 0.41 c 0.53 bc 0.40 c 0.80 ab 0.69 ab 0.68 ab 0.25 8.00 × 10−06*** Initial seed dry matter (isdm) (g) 0.002 0.012 0.024 0.051 0.177 0.273 0.364 0.407 0.539 Article No~e00244 9 http://dx.doi.org/10.1016/j.heliyon.2017.e00244 2405-8440/© 2017 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/c1/68/main.PMC5312646.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/c1/68/main.PMC5312646.pdf
Alfalfa Fenugreek Lentil Common vetch Soybean Pea Chickpea Peanut Faba bean CV Pvalue Root lateral expansion rate (Rlr) (mm day−1) 1.8 d 1.3d 3.5cd 5.2bcd 8.5ab 8.2abc 10.4 a 10.1 a 6.9abc 0.55 6.59 × 10−07*** Root depth penetration rate (Rdr) (mm day−1) 7.1 c 12.8 bc 8.2c 21.0 a 22.6 a18.6 ab 20.4 ab 16.5 ab 18.5 ab 0.35 1.56 × 10−06*** Nodule number (Nnb) (per plant) 1.5 c 4.3bc 21.5 ab 60.5 a 8.3abc 17.3 ab 4.3bc 43.5 a 48.8 a0.95 2.07 × 10−05*** Nodules dry matter (Ndm) (mg pl−1) 0.03 b 0.62 b 0.60 b 4.42 b 1.84 b 0.76 b 0.28 b10.13 ab 17.71 a1.50 7.98 × 10−05*** Article No~e00244 10 http://dx.doi.org/10.1016/j.heliyon.2017.e00244 2405-8440/© 2017 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/c1/68/main.PMC5312646.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/c1/68/main.PMC5312646.pdf
Article No~e00244 11 http://dx.doi.org/10.1016/j.heliyon.2017.e00244 2405-8440/© 2017 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/c1/68/main.PMC5312646.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/c1/68/main.PMC5312646.pdf
The lateral root Article No~e00244 12 http://dx.doi.org/10.1016/j.heliyon.2017.e00244 2405-8440/© 2017 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/c1/68/main.PMC5312646.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/c1/68/main.PMC5312646.pdf
Article No~e00244 13 http://dx.doi.org/10.1016/j.heliyon.2017.e00244 2405-8440/© 2017 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/c1/68/main.PMC5312646.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/c1/68/main.PMC5312646.pdf
Article No~e00244 14 http://dx.doi.org/10.1016/j.heliyon.2017.e00244 2405-8440/© 2017 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/c1/68/main.PMC5312646.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/c1/68/main.PMC5312646.pdf
Article No~e00244 15 http://dx.doi.org/10.1016/j.heliyon.2017.e00244 2405-8440/© 2017 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/c1/68/main.PMC5312646.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/c1/68/main.PMC5312646.pdf
Article No~e00244 16 http://dx.doi.org/10.1016/j.heliyon.2017.e00244 2405-8440/© 2017 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/c1/68/main.PMC5312646.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/c1/68/main.PMC5312646.pdf
"Conversely, fenugreek, lentil, alfalfa, and vetch could be considered weakly competitive legumes for soil N due to their small seed mass, Article No~e00244 17 http://dx.doi.org/10.1016/j.heliyon.2017.e00244 2405-8440/© 2017 The Authors.",Non-OADS,/arxiv_data1/oa_pdf/c1/68/main.PMC5312646.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/c1/68/main.PMC5312646.pdf
Article No~e00244 18 http://dx.doi.org/10.1016/j.heliyon.2017.e00244 2405-8440/© 2017 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/c1/68/main.PMC5312646.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/c1/68/main.PMC5312646.pdf
Effect of root depth penetration on soil nitrogen competitive interactions and dry matter Article No~e00244 19 http://dx.doi.org/10.1016/j.heliyon.2017.e00244 2405-8440/© 2017 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/c1/68/main.PMC5312646.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/c1/68/main.PMC5312646.pdf
Article No~e00244 20 http://dx.doi.org/10.1016/j.heliyon.2017.e00244 2405-8440/© 2017 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/c1/68/main.PMC5312646.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/c1/68/main.PMC5312646.pdf
Inhibition and recovery of symbiotic N 2fixation by peas Article No~e00244 21 http://dx.doi.org/10.1016/j.heliyon.2017.e00244 2405-8440/© 2017 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/c1/68/main.PMC5312646.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/c1/68/main.PMC5312646.pdf
http://www.R-project.org .,Non-OADS,/arxiv_data1/oa_pdf/c1/68/main.PMC5312646.pdf
Article No~e00244 22 http://dx.doi.org/10.1016/j.heliyon.2017.e00244 2405-8440/© 2017 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/c1/68/main.PMC5312646.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/c1/68/main.PMC5312646.pdf
This  is  an  open access  article  under  the  CC  BY-NC-ND  license  (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/81/00/main.PMC5312647.pdf
"March  1,  2015  treatment  Status http://dx.doi.org/10.1016/j.ijscr.2017.01.068 2210-2612/© 2017  The  Authors.",Non-OADS,/arxiv_data1/oa_pdf/81/00/main.PMC5312647.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/92/f1/main.PMC5312648.pdf
Contents lists available at ScienceDirect Annals of Medicine and Surgery journal homepage: www.annalsjournal.com http://dx.doi.org/10.1016/j.amsu.2017.02.003 2049-0801/ ©2017 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/92/f1/main.PMC5312648.pdf
This  is  an  open access article  under  the  CC  BY-NC-ND  license  (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/23/11/main.PMC5312649.pdf
http://dx.doi.org/10.1016/j.ijscr.2017.01.034 2210-2612/© 2017  The  Authors.,Non-OADS,/arxiv_data1/oa_pdf/23/11/main.PMC5312649.pdf
"[Internet]  (January  (1))  (2003)  ([cited  2016  Mar  28], CD001785,  Available from: http://www.ncbi.nlm.nih.gov/pubmed/ 12535413 ).",OADS,/arxiv_data1/oa_pdf/23/11/main.PMC5312649.pdf
[Internet] 34 (2016) 180–186 (Available  from:  http://linkinghub.elsevier.,Non-OADS,/arxiv_data1/oa_pdf/23/11/main.PMC5312649.pdf
"[Internet]  5  (April  (2))  (2009)  31–34  ([cited  2016  Mar  27], Available from:  http://www.pubmedcentral.nih.gov/articlerender.",OADS,/arxiv_data1/oa_pdf/23/11/main.PMC5312649.pdf
"17  (6)  (2007)  759–762,  http://dx.doi.org/10.",Non-OADS,/arxiv_data1/oa_pdf/23/11/main.PMC5312649.pdf
"1089/lap.2006.0231 ,  Available  from:  http://www.liebertonline.com .",Non-OADS,/arxiv_data1/oa_pdf/23/11/main.PMC5312649.pdf
"[16] F.  Mainik,  R.  Flade-Kuthe,  A.  Kuthe,  [Total  extraperitoneal  endoscopic hernioplasty  (TEP)  in  the  treatment  of  incarcerated  and  irreponible  inguinal and femoral hernias],  Zentralblatt  f¨ur  Chir  [Internet]  130  (December  (6)) (2005)  550–553  ([cited  2016  Mar  27],  Available  from:  http://www.ncbi.nlm.",Non-OADS,/arxiv_data1/oa_pdf/23/11/main.PMC5312649.pdf
"Case  Rep.  [Internet]  2  (8)  (2011)  290–292,  http://dx.doi.",Non-OADS,/arxiv_data1/oa_pdf/23/11/main.PMC5312649.pdf
[Internet]  5  (3)  (2012)  131–137  (Available from:  http://www.ncbi.nlm.nih.gov/pubmed/22776668 ).,Non-OADS,/arxiv_data1/oa_pdf/23/11/main.PMC5312649.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/9d/fb/main.PMC5312650.pdf
Contents lists available at ScienceDirect International Journal for Parasitology: Parasites and Wildlife journal homepage: www.elsevier.com/locate/ijppaw http://dx.doi.org/10.1016/j.ijppaw.2016.12.002 2213-2244/ ©2017 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/9d/fb/main.PMC5312650.pdf
This  is  an  open access article  under  the  CC  BY-NC-ND  license  (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/0a/eb/main.PMC5312652.pdf
http://dx.doi.org/10.1016/j.ijscr.2017.02.004 2210-2612/© 2017  The  Authors.,Non-OADS,/arxiv_data1/oa_pdf/0a/eb/main.PMC5312652.pdf
p53 also possesses potent redox-regulating activity through modulating various ROS-generating and antioxidant http://dx.doi.org/10.1016/j.redox.2017.02.004 Received 14 December 2016; Received in revised form 24 January 2017; Accepted 7 February 2017⁎Corresponding authors.,Non-OADS,/arxiv_data1/oa_pdf/68/26/main.PMC5312654.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/BY-NC-ND/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/68/26/main.PMC5312654.pdf
"Then the probe solutionwas removed and, after washing with PBS, the cells were trypsinized and harvested to analyze the DCF ﬂuorescence of the live cells by ﬂow cytometry in a Beckman Coulter Gallios Flow Cytometer ( λ exc=485/20 and λem=528/20) in the General Research Services SGIker of the UPV/ EHU ( http://www.ikerkuntza.ehu.es/p273-sgikerhm/en/ ).",Non-OADS,/arxiv_data1/oa_pdf/68/26/main.PMC5312654.pdf
"http://dx.doi.org/10.1016/j.redox.2017.01.020 Received 16 January 2017; Accepted 30 January 2017⁎Corresponding author at: Department of Biochemistry and Tissue Biology, Institute of Biology, Universidade Estadual de Campinas.",OADS,/arxiv_data1/oa_pdf/4b/0c/main.PMC5312655.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/BY-NC-ND/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/4b/0c/main.PMC5312655.pdf
2014 June 2016 [cited 2016 11/19]; Available from: 〈http://www.who.int/mediacentre/factsheets/fs311/en/〉.,OADS,/arxiv_data1/oa_pdf/4b/0c/main.PMC5312655.pdf
"[7] WHO, BMI classiﬁ cation, 2006 [cited; Available from: 〈http://apps.who.int/bmi/ index.jsp?IntroPage=intro_3.html 〉, 2016.",OADS,/arxiv_data1/oa_pdf/4b/0c/main.PMC5312655.pdf
"SUPPLEMENTAL INFORMATION Supplemental Information includes Supplemental Experimental Procedures, four figures, and one table and can be found with this  article online at http://dx.doi.org/10.1016/j.celrep.2013.12.010 AUTHOR CONTRIBUTIONS A.L.W.",OADS,/arxiv_data1/oa_pdf/55/c5/nihms846927.PMC5312658.pdf
"Computational Analytical Method for WGBS The software packages used in this analysis are open source and available from the USeq  (http://useq.sourceforge.net/usageBisSeq.html ) project website ( Nix et al., 2010 ).",OADS,/arxiv_data1/oa_pdf/55/c5/nihms846927.PMC5312658.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/8c/34/cia-12-335.PMC5312686.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).Clinical Interventions in Aging 2017:12 335–341Clinical Interventions in Aging Dove press submit your manuscript | www.dovepress.co m Dove press  335OrIg InAl reseArChopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/CIA.S12593 4 low FT3: a possible marker of frailty in the elderly Aldo Bertoli1 Alessia Valentini1 Maria Assunta Cianfarani1 elena gasbarra2 Umberto Tarantino2 Massimo Federici1 1Department of systems Medicine,   University of rome “T or Vergata”,   rome, Italy; 2Department of  Orthopaedics and Traumatology,   University of rome “T or Vergata”,   rome, ItalyIntroduction:  Frailty is associated with a functional decline of multiple physiological systems,  of which they may be a cause or consequence.",Non-OADS,/arxiv_data1/oa_pdf/8c/34/cia-12-335.PMC5312686.pdf
"We argue that changes in the endocrine system can play a decisive role in this process.Correspondence: Aldo Bertoli Department of systems Medicine,  University of rome “Tor Vergata”,  Via Montpellier 81, rome 00133, Italy Tel +39 06 2090 3618 Fax +39 06 2090 4955 email aldo.bertoli@uniroma2.i t Journal name: Clinical Interventions in Aging Article Designation: Original Research Y ear: 2017 Volume: 12 Running head verso: Bertoli et al Running head recto: Low FT3 in the elderly DOI: http://dx.doi.org/10.2147/CIA.S125934",Non-OADS,/arxiv_data1/oa_pdf/8c/34/cia-12-335.PMC5312686.pdf
"Clinical Interventions in Aging Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/clinical-interventions-in-aging-journa lClinical Interventions in Aging is an international, peer-reviewed journal  focusing on evidence-based reports on the value or lack thereof of treatments  intended to prevent or delay the onset of maladaptive correlates of aging  in human beings.",Non-OADS,/arxiv_data1/oa_pdf/8c/34/cia-12-335.PMC5312686.pdf
Visit http://www.dovepress.,Non-OADS,/arxiv_data1/oa_pdf/8c/34/cia-12-335.PMC5312686.pdf
Available from: http://www.ncbi.nlm.nih.gov/books/ NBK285570 /.,Non-OADS,/arxiv_data1/oa_pdf/8c/34/cia-12-335.PMC5312686.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/bf/cf/ppa-11-221.PMC5312688.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).Patient Preference and Adherence 2017:11 221–228Patient Preference and Adherence Dove press submit your manuscript | www.dovepress.co m Dove press  221OriginAl reseArchopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/PPA.S12000 3 Acceptability and efficacy of interactive short  message service intervention in improving hiV  medication adherence in chinese antiretroviral  treatment-naïve individuals Ye ruan1 Xueling Xiao2 Jia chen2 Xianhong li2 Ann Bartley Williams3 honghong Wang2 1nursing Department, second Xiangya  hospital, 2Xiangya school of n ursing,   central south University, changsha,   hunan, People’s republic of china;   3school of n ursing, Yale University,   West haven, cT, UsAAim:  The aim of this study was to examine the acceptability and efficacy of interactive short  message service (SMS) in improving medication adherence in antiretroviral treatment (ART)- naïve individuals living with HIV/AIDS in Hengyang, Hunan, China.",Non-OADS,/arxiv_data1/oa_pdf/bf/cf/ppa-11-221.PMC5312688.pdf
"Keywords:  HIV, short message service, antiretroviral treatment, adherence, China Introduction Antiretroviral treatment (ART) was initiated in 1996 and has contributed greatly to  the reduction in morbidity and mortality among people living with HIV (PLWH).1 correspondence: honghong Wang Xiangya school of nursing, central  south University, 172 Tong Zi Po road,  changsha 410013, hunan, People’s  republic of china Tel +86 731 8265 0270 Fax +86 731 8265 0266 email h onghong_wang@hotmail.co m Journal name: Patient Preference and Adherence Article Designation: Original Research Y ear: 2017 Volume: 11 Running head verso: Ruan et al Running head recto: Short message and ART adherence in People’s Republic of China DOI: http://dx.doi.org/10.2147/PPA.S120003",Non-OADS,/arxiv_data1/oa_pdf/bf/cf/ppa-11-221.PMC5312688.pdf
"Patient Preference and Adherence Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/patient-preference-and-adherence-journa lPatient Preference and Adherence is an international, peer-reviewed,  open access journal that focuses on the growing importance of patient   preference  and adherence throughout the therapeutic continuum.",Non-OADS,/arxiv_data1/oa_pdf/bf/cf/ppa-11-221.PMC5312688.pdf
"Available from: http://www.unaids.org/en/ regionscountries /countries/chin a. Accessed August 6, 2016.",Non-OADS,/arxiv_data1/oa_pdf/bf/cf/ppa-11-221.PMC5312688.pdf
The full terms of this license are available at https://www.dovepress.com/terms.,Non-OADS,/arxiv_data1/oa_pdf/38/f3/ceor-9-127.PMC5312689.pdf
"php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/).",OADS,/arxiv_data1/oa_pdf/38/f3/ceor-9-127.PMC5312689.pdf
"For  permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).ClinicoEconomics and Outcomes Research 2017:9 127–137ClinicoEconomics and Outcomes Research Dovepress submit your manuscript | www.dovepress.com Dovepress  127 ORIGINAL RESEARCH open access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/CEOR.S125301Estimating the economic consequences of  an increased medication adherence due to a  potential improvement in the inhaler technique  with Spiromax® compared with T urbuhaler®  in patients with moderate-to-severe chronic  obstructive pulmonary disease in Spain Josep Darbà1 Gabriela Ramírez2 Juan L García-Rivero3 Sagrario Mayoralas4 José Francisco Pascual5 Diego Vargas6 Adi Bijedic7 1Department of Economics,   Universitat de Barcelona, 2BCN  Health Economics & Outcomes  Research S.L., Barcelona, 3Hospital  Laredo, Cantabria, 4Hospital Ramón  y Cajal, Madrid, 5Hospital General  Universitario de Alicante, Alicante,   6Hospital de Alta Resolución el T oyo,   Andalusia, 7Market Access and HEOR  Department, TEVA Pharmaceutical,  Madrid, SpainObjective: The objective of this study was to estimate the economic impact of the introduction  of DuoResp® Spiromax®, budesonide/formoterol fixed-dose combination (FDC), focusing on  an increase in medication adherence due to an enhancement of the inhalation technique for the  treatment of COPD patients in Spain and 5 regions including Andalusia, Catalonia, Galicia,  Madrid, and Valencia.",Non-OADS,/arxiv_data1/oa_pdf/38/f3/ceor-9-127.PMC5312689.pdf
"Keywords:  dry powder inhaler, economic evaluation, region-specific estimates, payers’  perspective Introduction COPD is characterized by persistent airflow limitation related to a chronic inflam- matory response in the airways and the lung derived from inhaling toxic particles or Correspondence: Josep Darbà Department of Economics, Universitat de Barcelona, Diagonal 696, Barcelona, SpainTel +34 934 020 110Fax +34 934 039 082Email darba@ub.eduJournal name: ClinicoEconomics and Outcomes Research Article Designation: ORIGINAL RESEARCHY ear: 2017V olume: 9Running head verso: Darbà et alRunning head recto: Economic impact of Spiromax ® vs. Turbuhaler® for COPD management DOI: http://dx.doi.org/10.2147/CEOR.S125301",Non-OADS,/arxiv_data1/oa_pdf/38/f3/ceor-9-127.PMC5312689.pdf
Available from: http://www.goldcopd.org/uploads/users/files/GOLD_Pocket_2015_Feb18.pdf.,Non-OADS,/arxiv_data1/oa_pdf/38/f3/ceor-9-127.PMC5312689.pdf
Available from: http://www.who.int/chp/knowledge/publications/adherence_report/en/.,Non-OADS,/arxiv_data1/oa_pdf/38/f3/ceor-9-127.PMC5312689.pdf
Available from: https://www.boe.es/boe/dias/2015/10/17/pdfs/BOE-A-2015-11177.pdf.,Non-OADS,/arxiv_data1/oa_pdf/38/f3/ceor-9-127.PMC5312689.pdf
Available from: http://docplayer.es/9127129-Plan-de-salud-en-epoc-de-la-comunitat-valenciana-2010-2014.html.,Non-OADS,/arxiv_data1/oa_pdf/38/f3/ceor-9-127.PMC5312689.pdf
Available from: http://www.ine.es/jaxi/menu.do?type= pcaxis&path= %2Ft20%2Fp269%2F2011- 2021&file=pcaxis&L=.,OADS,/arxiv_data1/oa_pdf/38/f3/ceor-9-127.PMC5312689.pdf
Available from: https://botplusweb.portalfarma.com/.,Non-OADS,/arxiv_data1/oa_pdf/38/f3/ceor-9-127.PMC5312689.pdf
Available from: http://www.juntadeandalucia.es/boja/2005/210/28.,Non-OADS,/arxiv_data1/oa_pdf/38/f3/ceor-9-127.PMC5312689.pdf
Available from: http://www.madrid.org/wleg/servlet/Servidor?opcion=VerHtml&nmnorma=8275&cdestado=P .,OADS,/arxiv_data1/oa_pdf/38/f3/ceor-9-127.PMC5312689.pdf
Available from: http://www.xunta.es/dog/Publicados/2014/20140521/AnuncioC3K1-140514-0001_es.html.,Non-OADS,/arxiv_data1/oa_pdf/38/f3/ceor-9-127.PMC5312689.pdf
Available from: http://www.saludcastillayleon.es/institucion/es/resumen-bocyl-legislacion-sanitaria/decreto-25-2010-17-ju-nio-actualizan-precios-publicos-actos-.,Non-OADS,/arxiv_data1/oa_pdf/38/f3/ceor-9-127.PMC5312689.pdf
"ClinicoEconomics and Outcomes Research 2017:9submit your manuscript | www.dovepress.com Dovepress Dovepress ClinicoEconomics and Outcomes Research Publish your work in this journal Submit your manuscript here: https://www.dovepress.com/clinicoeconomics-and-outcomes-research-journalClinicoEconomics and Outcomes Research is an international, peer- reviewed open-access journal focusing on health technology assess-ment, pharmacoeconomics and outcomes research in the areas of   diagnosis, medical devices, and clinical, surgical and pharmacological intervention.",Non-OADS,/arxiv_data1/oa_pdf/38/f3/ceor-9-127.PMC5312689.pdf
Visit http://www.dovepress.com/testimonials.php to read real quotes from published authors.Dovepress 137 Economic impact of Spiromax® vs. T urbuhaler® for COPD management33.,Non-OADS,/arxiv_data1/oa_pdf/38/f3/ceor-9-127.PMC5312689.pdf
Available from: http://www.gobier - nodecanarias.org/boc/2013/051/001.html.,OADS,/arxiv_data1/oa_pdf/38/f3/ceor-9-127.PMC5312689.pdf
Available from: http://legislacion.derecho.com/resolucion-03-09-2012-13-setiembre-2012-servicio-de-salud-de-castilla-la-mancha-sescam-4473664.,Non-OADS,/arxiv_data1/oa_pdf/38/f3/ceor-9-127.PMC5312689.pdf
"Available from: http://portaljuridico.lexnova.es/legislacion/JURIDICO/188905/orden-de-5-de-febrero-de-2013-de-la-consejeria-de-economia-y-hacienda-por-la-que-se-publican-las-t. Accessed April 1, 2015.",Non-OADS,/arxiv_data1/oa_pdf/38/f3/ceor-9-127.PMC5312689.pdf
Available from: https://www.saludinforma.es/portalsi/web/salud/servicios-prestaciones/modificaciones-aseguramiento/legislacion;jsessionid=UO8tW+KzATD4PEs6Bza5XtWd.mov-saludinforma-01.,Non-OADS,/arxiv_data1/oa_pdf/38/f3/ceor-9-127.PMC5312689.pdf
Available from: http://www.caib.es/eboibfront/es/2012/7826.,Non-OADS,/arxiv_data1/oa_pdf/38/f3/ceor-9-127.PMC5312689.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/d6/10/ott-10-753.PMC5312690.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).OncoTargets and Therapy 2017:10 753–761OncoTargets and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  753Original researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/OTT .S12678 1 Mir-99a suppresses cell invasion and metastasis  in nasopharyngeal carcinoma through targeting  HOXA1 Jian-gang Wang1,2 Wu-Ping Tang2 Ming-chu liao1 Yan-Ping liu1 Xiao-hong ai1 1Department of radiation Oncology,   The First affiliated hospital of  University of south china, hengyang,   2Department of Oncology, shaoyang  hospital of T cM, shaoyang, People’s  republic of chinaBackground:  Recent studies reported that miRNAs play important roles in the carcinogenesis  and progression of nasopharyngeal carcinoma (NPC).",Non-OADS,/arxiv_data1/oa_pdf/d6/10/ott-10-753.PMC5312690.pdf
"MicroRNAs (miRNAs) are small noncoding RNAs ~19–25 nucleotides, and they  are highly conserved in eukaryotic.4 It has been reported that the main function of  miRNAs is to negatively regulate the gene expression through base-pairing with the  3′-untranslated region (3 ′-UTR) of its target gene and then enhancing the target gene correspondence: Xiao-hong ai Department of radiation Oncology,  The First Affiliated Hospital of University  of south china, 69 chuanshan road,  hengyang 421001, People’s republic  of china Tel +86 734 827 9467 Fax +86 734 827 9467 email 1163504926@qq.co m Journal name: OncoTargets and Therapy Article Designation: Original Research Y ear: 2017 Volume: 10 Running head verso: Wang et al Running head recto: miR-99a targets HOXA1  in NPC DOI: http://dx.doi.org/10.2147/OTT.S126781",Non-OADS,/arxiv_data1/oa_pdf/d6/10/ott-10-753.PMC5312690.pdf
"OncoTargets and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/oncotargets-and-therapy-journa lOncoTargets and Therapy is an international, peer-reviewed, open  access journal focusing on the pathological basis of all cancers, potential  targets for therapy and treatment protocols employed to improve the  management of cancer patients.",Non-OADS,/arxiv_data1/oa_pdf/d6/10/ott-10-753.PMC5312690.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/d6/10/ott-10-753.PMC5312690.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/73/47/cia-12-351.PMC5312691.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).Clinical Interventions in Aging 2017:12 351–357Clinical Interventions in Aging Dove press submit your manuscript | www.dovepress.co m Dove press  351OrIg InAl reseArChopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/CIA.S13104 7 Combination of BTracks and geri-Fit as a  targeted approach for assessing and reducing the  postural sway of older adults with high fall risk Daniel J goble Mason C hearn harsimran s Baweja school of exercise and nutritional  sciences, College of health and  human services, san Diego state  University, san Diego, CA, UsAAbstract:  Atypically high postural sway measured by a force plate is a known risk factor for  falls in older adults.",Non-OADS,/arxiv_data1/oa_pdf/73/47/cia-12-351.PMC5312691.pdf
"Second, force Correspondence: Daniel J goble school of exercise and nutritional  sciences, College of health and human  services, san Diego state University,  5500 Campanile Drive, san Diego, CA  92182 7251, UsA Tel +1 619 594 7272 Fax +1 619 594 6553 email dgoble@mail.sdsu.ed u Journal name: Clinical Interventions in Aging Article Designation: Original Research Y ear: 2017 Volume: 12 Running head verso: Goble et al Running head recto: BTrackS and Geri-Fit DOI: http://dx.doi.org/10.2147/CIA.S131047",Non-OADS,/arxiv_data1/oa_pdf/73/47/cia-12-351.PMC5312691.pdf
"Clinical Interventions in Aging Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/clinical-interventions-in-aging-journa lClinical Interventions in Aging is an international, peer-reviewed journal  focusing on evidence-based reports on the value or lack thereof of treatments  intended to prevent or delay the onset of maladaptive correlates of aging  in human beings.",Non-OADS,/arxiv_data1/oa_pdf/73/47/cia-12-351.PMC5312691.pdf
Visit http://www.dovepress.,Non-OADS,/arxiv_data1/oa_pdf/73/47/cia-12-351.PMC5312691.pdf
The full terms of this license are available at https://www.dovepress.com/terms.,Non-OADS,/arxiv_data1/oa_pdf/e3/3d/cmar-9-029.PMC5312692.pdf
"php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/).",OADS,/arxiv_data1/oa_pdf/e3/3d/cmar-9-029.PMC5312692.pdf
"For  permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).Cancer Management and Research 2017:9 29–39Cancer Management and Research Dovepress submit your manuscript | www.dovepress.com Dovepress  29 ORiginal ReseaRCh open access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/CMAR.S117703Feasibility of an exercise intervention for fatigued  breast cancer patients at a community-based  cardiac rehabilitation program stefanie De Jesus1 lyndsay Fitzgeorge2 Karen Unsworth3 David Massel4,5 neville suskin4,5 harry Prapavessis1 Michael sanatani6 1Department of Kinesiology, The  University of Western Ontario,   2school of health sciences,   Fanshawe College, 3Cardiac  Rehabilitation & secondary  Prevention Program, st. Joseph’s  hospital, 4Division of Cardiology &  Program of experimental Medicine,   schulich school of Medicine and  Dentistry, University of Western  Ontario, 5lawson health Research  institute, 6Department of Medical  Oncology, schulich school of Medicine and Dentistry, University of Western Ontario, london, On , CanadaPurpose: Exercise is beneficial to quality of life after cancer treatment, yet few cancer sur - vivors meet exercise guidelines.",Non-OADS,/arxiv_data1/oa_pdf/e3/3d/cmar-9-029.PMC5312692.pdf
"This meta-analysis showed significant improvements in fatigue levels following Correspondence: Michael sanatani Department of Medical Oncology, schulich school of Medicine and Dentistry, University of Western Ontario, 790 Commissioners Rd east, london, On n6a4l6, CanadaTel +1 519 685 8640Fax +1 519 685 8624email Michael.sanatani@lhsc.on.caJournal name: Cancer Management and Research Article Designation: Original ResearchY ear: 2017V olume: 9Running head verso: De Jesus et alRunning head recto: Exercise intervention for fatigued breast cancer patientsDOI: http://dx.doi.org/10.2147/CMAR.S117703",Non-OADS,/arxiv_data1/oa_pdf/e3/3d/cmar-9-029.PMC5312692.pdf
Available from: https://www.cancercare.on.ca/common/pages/UserFile.aspx?fileId=13262.,Non-OADS,/arxiv_data1/oa_pdf/e3/3d/cmar-9-029.PMC5312692.pdf
"Cancer Management and Research 2017:9submit your manuscript | www.dovepress.com Dovepress Dovepress Cancer Management and Research Publish your work in this journal Submit your manuscript here: https://www.dovepress.com/cancer-management-and-research-journalCancer Management and Research is an international, peer-reviewed  open access journal focusing on cancer research and the optimal use of preventative and integrated treatment interventions to achieve improved outcomes, enhanced survival and quality of life for the cancer patient.",Non-OADS,/arxiv_data1/oa_pdf/e3/3d/cmar-9-029.PMC5312692.pdf
Visit http://www.dovepress.com/testimonials.php to read real quotes from published authors.Dovepress 39 exercise intervention for fatigued breast cancer patients  39.,Non-OADS,/arxiv_data1/oa_pdf/e3/3d/cmar-9-029.PMC5312692.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/3b/cb/ndt-13-421.PMC5312693.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).Neuropsychiatric Disease and Treatment 2017:13 421–426Neuropsychiatric Disease and Treatment Dove press submit your manuscript | www.dovepress.co m Dove press  421OrigiNal researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/NDT .S12628 8 repetitive hyperbaric oxygen treatment increases  insulin sensitivity in diabetes patients with acute  intracerebral hemorrhage Qian Xu Yi-ting Wei shuang-bo Fan liang Wang Xiao-ping Zhou Department of Brain surgery, Ningbo  Zhenhai longsai hospital, Zhejiang,   People’s republic of chinaAim:  The role of hyperbaric oxygen therapy (HBOT) in the treatment of acute ischemic  stroke is controversial.",Non-OADS,/arxiv_data1/oa_pdf/3b/cb/ndt-13-421.PMC5312693.pdf
"It was reported that a 56-year-old Chinese patient suffering from acute ischemic  stroke on the left corona radiata leading to right hemiparesis and dysarthria had great  improvement after repetitive (10 dives) HBOT with lower pressure (2.0 ATA) and correspondence: Qian Xu Department of Brain surgery, Ningbo  Zhenhai longsai hospital, No 356 shengli  rd, Zhenhai District, Ningbo, Zhejiang,  315200, People’s republic of china email xuqian6521@126.co mJournal name: Neuropsychiatric Disease and Treatment Article Designation: Original Research Y ear: 2017 Volume: 13 Running head verso: Xu et al Running head recto: Repetitive hyperbaric oxygen treatment DOI: http://dx.doi.org/10.2147/NDT.S126288",Non-OADS,/arxiv_data1/oa_pdf/3b/cb/ndt-13-421.PMC5312693.pdf
"Neuropsychiatric Disease and Treatment Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/neuropsychiatric-disease-and-treatment-journa lNeuropsychiatric Disease and Treatment is an international, peer- reviewed journal of clinical therapeutics and pharmacology focusing   on concise rapid reporting of clinical or pre-clinical studies on a   range of neuropsychiatric and neurological disorders.",Non-OADS,/arxiv_data1/oa_pdf/3b/cb/ndt-13-421.PMC5312693.pdf
Visit http://www.dovepress.com/testimonials.ph p to  read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/3b/cb/ndt-13-421.PMC5312693.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/6e/eb/cia-12-325.PMC5312694.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).Clinical Interventions in Aging 2017:12 325–333Clinical Interventions in Aging Dove press submit your manuscript | www.dovepress.co m Dove press  325OrIg InAl reseArChopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/CIA.S10912 5 Drug prescription appropriateness in the elderly:  an Italian study nicola Allegri1 Federica rossi2 Federica Del signore2 Paolo Bertazzoni3 roberto Bellazzi4 giorgio sandrini5 T omaso Vecchi1 Davide liccione1 Alessia Pascale6 stefano govoni6 1Department of Brain and Behavioral  sciences, University of Pavia, 2Pavia  and Vigevano neuropsychological  Center for Alzheimer’s Disease,   3”Bertazzoni” Pharmacy general  Partnership, Vigevano, 4nephrology  and Dialysis Ward, Civil hospital  of Vigevano, 5C.",Non-OADS,/arxiv_data1/oa_pdf/6e/eb/cia-12-325.PMC5312694.pdf
"However, it should be stressed that the  evaluation of prescription appropriateness in the elderly represents a complex issue10  that should also include other clinical dimensions, such as the amount of prescribed  drugs,11 drug–drug interactions,12 and the potential sedative and anticholinergic effects  of the prescribed drugs.13,14 In this context, the aim of the present work was to evaluate the appropriateness of drug  prescription using the Beers criteria and including the assessment of the aforementioned Correspondence: nicola Allegri Pavia and Vigevano neuropsychological  Center for Alzheimer’s Disease,  Via sacchetti 1, 27029, Vigevano,  Pavia, Italy Tel +39 381 23709 473 Fax +39 381 82225 email nicola.allegri@unipv.i t Journal name: Clinical Interventions in Aging Article Designation: Original Research Y ear: 2017 Volume: 12 Running head verso: Allegri et al Running head recto: Drug appropriateness in the elderly DOI: http://dx.doi.org/10.2147/CIA.S109125",Non-OADS,/arxiv_data1/oa_pdf/6e/eb/cia-12-325.PMC5312694.pdf
"Clinical Interventions in Aging Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/clinical-interventions-in-aging-journa lClinical Interventions in Aging is an international, peer-reviewed journal  focusing on evidence-based reports on the value or lack thereof of treatments  intended to prevent or delay the onset of maladaptive correlates of aging  in human beings.",Non-OADS,/arxiv_data1/oa_pdf/6e/eb/cia-12-325.PMC5312694.pdf
Visit http://www.dovepress.,Non-OADS,/arxiv_data1/oa_pdf/6e/eb/cia-12-325.PMC5312694.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/c7/86/copd-12-571.PMC5312695.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).International Journal of COPD 2017:12 571–579International Journal of COPD Dove press submit your manuscript | www.dovepress.co m Dove press  571OrIg Inal researChopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/COPD.S12316 7 Incidence and long-term outcome of severe  asthma–COPD overlap compared to asthma  and COPD alone: a 35-year prospective study  of 57,053 middle-aged adults Camilla Boslev Baarnes1 Zorana Jovanovic  andersen2 anne Tjønneland3 Charlotte suppli Ulrik1,4 1Department of Pulmonary Medicine,   hvidovre hospital, hvidovre,   2Center for epidemiology and  screening, Department of Public  health, University of Copenhagen,   3Danish Cancer society research  Center, 4Institute of Clinical  Medicine, University of Copenhagen,   Copenhagen, DenmarkBackground:  Incidence and prognosis for severe asthma–COPD overlap is poorly characterized.",Non-OADS,/arxiv_data1/oa_pdf/c7/86/copd-12-571.PMC5312695.pdf
"However, despite  much attention, no general consensus has been reached on defining features, or even  the term itself, with some studies classifying ACO as a subphenotype of COPD,1,2  and some as a distinct phenotype by itself.3,4 The overlap between asthma and COPD,  therefore, remains a controversial issue, possibly primarily because many conflicting  aspects remain, which makes it difficult to summarize the distinctive features of this  so-called syndrome.5,6 In line with this, the currently available national guidelines,  including guidelines from Spain,7 Finland,8 and the Czech Republic,9 have defined Correspondence: Charlotte suppli Ulrik Department of Pulmonary Medicine,  hvidovre hospital, 30 Kettegård alle,  hvidovre 2650, Denmark Tel +45 3862 2177 email csulrik@dadlnet.d k Journal name: International Journal of COPD Article Designation: Original Research Y ear: 2017 Volume: 12 Running head verso: Baarnes et al Running head recto: Long-term outcome of asthma–COPD overlap DOI: http://dx.doi.org/10.2147/COPD.S123167",Non-OADS,/arxiv_data1/oa_pdf/c7/86/copd-12-571.PMC5312695.pdf
"Available from: http://www.everyday- breathing.com/media/15569/asthmacopdoverlap.pd f. Accessed January  13, 2017.",Non-OADS,/arxiv_data1/oa_pdf/c7/86/copd-12-571.PMC5312695.pdf
"International Journal of COPD Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-chronic-obstructive-pulmonary-disease-journa lThe International Journal of COPD is an international, peer-reviewed  journal of therapeutics and pharmacology focusing on concise rapid  reporting of clinical studies and reviews in COPD.",Non-OADS,/arxiv_data1/oa_pdf/c7/86/copd-12-571.PMC5312695.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/c7/86/copd-12-571.PMC5312695.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/a0/2c/ott-10-617.PMC5312696.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).OncoTargets and Therapy 2017:10 617–625OncoTargets and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  617Original researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/OTT .S12349 4 high expression of glucose-regulated protein 78  (grP78) is associated with metastasis and poor  prognosis in patients with esophageal squamous  cell carcinoma Peng ren chuangui chen Jie Yue Jianguo Zhang Zhentao Yu Department of esophageal cancer,   Tianjin Medical University cancer  institute and hospital, national  clinical research center of cancer,   Key laboratory of cancer Prevention  and Therapy of Tianjin city, Tianjin,   People’s republic of chinaBackground:  Glucose-regulated protein 78 (GRP78) plays an important role in the invasion  and metastasis of many human cancers.",Non-OADS,/arxiv_data1/oa_pdf/a0/2c/ott-10-617.PMC5312696.pdf
"The 5-year overall survival (OS) rate of patients diagnosed with esophageal cancer  ranges from 15% to 20%.2 Therefore, in-depth studies on the molecular mechanism  of invasion and metastasis in ESCC should be performed and effective prevention and  treatment measures should be developed to improve therapeutic outcomes for patients  with esophageal cancer.correspondence: Zhentao Yu Department of esophageal cancer,  Tianjin Medical University cancer  institute and hospital, national clinical  research center of cancer, Key  laboratory of cancer Prevention and  Therapy of Tianjin city, huanhuxi road,  Tiyuanbei, hexi District, Tianjin 300060,  People’s republic of china Tel +86 22 2334 0123 Fax +86 22 2335 9984 email zhentao_yutj@163.co m Journal name: OncoTargets and Therapy Article Designation: Original Research Y ear: 2017 Volume: 10 Running head verso: Ren et al Running head recto: High expression of GRP78 in esophageal squamous cell carcinoma DOI: http://dx.doi.org/10.2147/OTT.S123494",Non-OADS,/arxiv_data1/oa_pdf/a0/2c/ott-10-617.PMC5312696.pdf
"OncoTargets and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/oncotargets-and-therapy-journa lOncoTargets and Therapy is an international, peer-reviewed, open  access journal focusing on the pathological basis of all cancers, potential  targets for therapy and treatment protocols employed to improve the  management of cancer patients.",Non-OADS,/arxiv_data1/oa_pdf/a0/2c/ott-10-617.PMC5312696.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/a0/2c/ott-10-617.PMC5312696.pdf
The full terms of this license are available at https://www.dovepress.com/terms.,Non-OADS,/arxiv_data1/oa_pdf/52/4e/clep-9-083.PMC5312705.pdf
"php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/).",OADS,/arxiv_data1/oa_pdf/52/4e/clep-9-083.PMC5312705.pdf
"For  permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).Clinical Epidemiology 2017:9 83–91Clinical Epidemiology Dovepress submit your manuscript | www.dovepress.com Dovepress 83 ORIGINAL RESEARCH open access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/CLEP .S124674 Risk of gynecomastia and breast cancer associated  with the use of 5-alpha reductase inhibitors for  benign prostatic hyperplasia Katrina Wilcox Hagberg1  Hozefa A Divan2  Shona C Fang2  J Curtis Nickel3  Susan S Jick1 1Boston Collaborative Drug  Surveillance Program, Boston  University School of Public Health,  Lexington,  2New England Research  Institutes, Inc., Watertown, MA, USA;   3Kingston General Hospital, Queen’s  University, Kingston, ON, CanadaBackground: Clinical trial results suggest that 5-alpha reductase inhibitors (5ARIs) for the  treatment of benign prostatic hyperplasia (BPH) may increase the risk of gynecomastia and  male breast cancer, but epidemiological studies have been limited.",Non-OADS,/arxiv_data1/oa_pdf/52/4e/clep-9-083.PMC5312705.pdf
"10Correspondence: Katrina Wilcox  Hagberg   Boston Collaborative Drug Surveillance Program, 11 Muzzey Street, Lexington, MA 02421, USA Tel +1 781 862 6660   Fax +1 781 862 1680   Email khagberg@bu.eduJournal name: Clinical Epidemiology Article Designation: ORIGINAL RESEARCHY ear: 2017V olume: 9Running head verso: Hagberg et alRunning head recto: 5ARIs and risk of gynecomastia and breast cancerDOI: http://dx.doi.org/10.2147/CLEP .S124674",Non-OADS,/arxiv_data1/oa_pdf/52/4e/clep-9-083.PMC5312705.pdf
"Clinical Epidemiology 2017:9submit your manuscript | www.dovepress.com Dovepress Dovepress Clinical Epidemiology Publish your work in this journal Submit your manuscript here: https://www.dovepress.com/clinical-epidemiology-journalClinical Epidemiology is an international, peer-reviewed, open access,  online journal focusing on disease and drug epidemiology, identifica-tion of risk factors and screening procedures to develop optimal pre-ventative initiatives and programs.",Non-OADS,/arxiv_data1/oa_pdf/52/4e/clep-9-083.PMC5312705.pdf
Available from: https://www.gov.uk/drug-safety-update/finasteride-potential-risk-of-male-breast-cancer.,Non-OADS,/arxiv_data1/oa_pdf/52/4e/clep-9-083.PMC5312705.pdf
Available from: http://www.fda.gov/Drugs/GuidanceComplianceRegulatoryInformation/Surveillance/AdverseDrugEffects/ucm210293.,Non-OADS,/arxiv_data1/oa_pdf/52/4e/clep-9-083.PMC5312705.pdf
"This pointed Lighting up microtubule cytoskeleton dynamics in skeletal muscle Andrius Masedunskas1,*, Mark Appaduray2, Peter W Gunning1, and Edna C Hardeman2 1Oncology Research Unit; School of Medical Sciences; UNSW Australia; Sydney, NSW Australia; 2Neuromuscular and Regenerative Medicine Unit; School of  Medical Sciences; UNSW Australia; Sydney, NSW Australia Keywords:  intravital, microscopy,  microtubules, cytoskeleton, muscle, fiber, muscular, dystrophy *Correspondence to: Andrius Masedunskas;   Email: a.masedunskas@unsw.edu.au Submitted: 05/19/2014Accepted: 05/20/2014Published Online: 05/30/2014http://dx.doi.org/10.4161/intv.29293",Non-OADS,/arxiv_data1/oa_pdf/f1/1a/kinv-03-01-10929293.PMC5312709.pdf
J Cell Biol 2013; 201:969-79; PMID:23798727 ;  http://dx.doi.org/10.1083/jcb.201212130 3.,Non-OADS,/arxiv_data1/oa_pdf/f1/1a/kinv-03-01-10929293.PMC5312709.pdf
J Cell Biol 2013; 203:205-13;  PMID:24145165 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/f1/1a/kinv-03-01-10929293.PMC5312709.pdf
Nat Rev Cancer 2010; 10:194-204; PMID:20147901 ; http://dx.doi.org/10.1038/ nrc2803 5.,Non-OADS,/arxiv_data1/oa_pdf/f1/1a/kinv-03-01-10929293.PMC5312709.pdf
Sci Signal 2012; 5:ra56;  PMID:22871609 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/f1/1a/kinv-03-01-10929293.PMC5312709.pdf
Mol Biol Cell 2001; 12:971- 80; PMID:11294900 ; http://dx.doi.org/10.1091/ mbc.12.4.971 8.,Non-OADS,/arxiv_data1/oa_pdf/f1/1a/kinv-03-01-10929293.PMC5312709.pdf
Cell Motil Cytoskeleton 2005; 60:1-13; PMID :15532031 ; http://dx.doi.org/10.1002/ cm.20042 10.,OADS,/arxiv_data1/oa_pdf/f1/1a/kinv-03-01-10929293.PMC5312709.pdf
PLoS One 2011; 6:e29057; PMID:22216166 ; http://dx.doi.org/10.1371/journal.,Non-OADS,/arxiv_data1/oa_pdf/f1/1a/kinv-03-01-10929293.PMC5312709.pdf
Exp Cell Res 2003; 289:47-57;  PMID:12941603 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/f1/1a/kinv-03-01-10929293.PMC5312709.pdf
J Cell Biol 2009; 186:363-9;  PMID:19651889 ; http://dx.doi.org/10.1083/ jcb.200905048 14.,Non-OADS,/arxiv_data1/oa_pdf/f1/1a/kinv-03-01-10929293.PMC5312709.pdf
J Cell Biol 2004; 166:685-96; PMID:15337777 ;  http://dx.doi.org/10.1083/jcb.200406181 15.,Non-OADS,/arxiv_data1/oa_pdf/f1/1a/kinv-03-01-10929293.PMC5312709.pdf
Cell Motil Cytoskeleton 2008; 65:73- 85; PMID:17968984 ; http://dx.doi.org/10.1002/ cm.20245 16.,Non-OADS,/arxiv_data1/oa_pdf/f1/1a/kinv-03-01-10929293.PMC5312709.pdf
Traffic 2007;  8:1424-39;  PMID:17714427 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/f1/1a/kinv-03-01-10929293.PMC5312709.pdf
"©Mirela B /C21alan and Friedemann Kiefer *Correspondence to: Friedemann Kiefer; Email: fkiefer@mpi-muenster.mpg.deSubmitted: 03/06/2015; Revised: 06/15/2015; Accepted: 06/18/2015 http://dx.doi.org/10.1080/21659087.2015.1066949 This is an Open Access article distributed under the terms of the Creative Commons Attribution-Non-Commercial License (http://creativecommons.o rg/licenses/ by-nc/3.0/), which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/8b/be/kinv-04-02-1066949.PMC5312711.pdf
2015; 25 (3):148- 57; PMID:25529933; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/8b/be/kinv-04-02-1066949.PMC5312711.pdf
Blood 2009; 114 (2):290-8; PMID:19357397; http://dx.doi.org/10.1182/blood-2008-12-195644 4.,Non-OADS,/arxiv_data1/oa_pdf/8b/be/kinv-04-02-1066949.PMC5312711.pdf
Nature 2005; 435 (7044):969-73; PMID:15959517; http://dx.doi.org/ 10.1038/nature03703 5.,Non-OADS,/arxiv_data1/oa_pdf/8b/be/kinv-04-02-1066949.PMC5312711.pdf
Blood 2013; 121 (24):4821-31; PMID:23589674; http://dx.doi.org/ 10.1182/blood-2012-12-475483 7.,Non-OADS,/arxiv_data1/oa_pdf/8b/be/kinv-04-02-1066949.PMC5312711.pdf
Blood 2013; 122 (10):1730-40; PMID:23814020; http://dx.doi.org/10.1182/blood- 2012-11-467498 8.,Non-OADS,/arxiv_data1/oa_pdf/8b/be/kinv-04-02-1066949.PMC5312711.pdf
2009; 467:305-17; PMID:19301680; http://dx.doi.org/10.1007/978-1-59745-241-0_19 9.,Non-OADS,/arxiv_data1/oa_pdf/8b/be/kinv-04-02-1066949.PMC5312711.pdf
1997; 17(1):1-9; PMID:9176719; http://dx.doi.org/10.1159/ 000179199 10.,Non-OADS,/arxiv_data1/oa_pdf/8b/be/kinv-04-02-1066949.PMC5312711.pdf
1999; 70 (4):374-80;PMID:10569268; http://dx.doi.org/10.3109/ 17453679908997827 12.,Non-OADS,/arxiv_data1/oa_pdf/8b/be/kinv-04-02-1066949.PMC5312711.pdf
J Histochem Cytochem 2007; 55 (12):1245-55; PMID:17875658; http://dx.doi.org/ 10.1369/jhc.7A7263.2007 14.,Non-OADS,/arxiv_data1/oa_pdf/8b/be/kinv-04-02-1066949.PMC5312711.pdf
J Investig Dermatol 2002; 119 (6):1388-93; PMID:12485444; http://dx.doi.org/ 10.1046/j.1523-1747.2002.19647.x 15.,Non-OADS,/arxiv_data1/oa_pdf/8b/be/kinv-04-02-1066949.PMC5312711.pdf
Nature 2014; 507 (7492):323- C; PMID:24646994; http://dx.doi.org/10.1038/ nature13145 16.,Non-OADS,/arxiv_data1/oa_pdf/8b/be/kinv-04-02-1066949.PMC5312711.pdf
Nature 2010; 468 (7323):557-61; PMID:20944627; http://dx.doi.org/ 10.1038/nature09522 17.,Non-OADS,/arxiv_data1/oa_pdf/8b/be/kinv-04-02-1066949.PMC5312711.pdf
J Orthop Res 2008; 26 ((10):1384-9; PMID:18464248; http://dx.doi.org/ 10.1002/jor.20667 20.,Non-OADS,/arxiv_data1/oa_pdf/8b/be/kinv-04-02-1066949.PMC5312711.pdf
J Bone Miner Metab 1999; 17 (3):171-7; PMID:10757676; http://dx.doi.org/ 10.1007/s007740050081 21.,Non-OADS,/arxiv_data1/oa_pdf/8b/be/kinv-04-02-1066949.PMC5312711.pdf
2003; 124 (6):747-57; PMID:12782418; http://dx.doi.org/10.1016/S0047-6374(03)00088-522.,Non-OADS,/arxiv_data1/oa_pdf/8b/be/kinv-04-02-1066949.PMC5312711.pdf
1988; 59 (6):704-7; PMID:3213461; http://dx.doi.org/10.3109/ 17453678809149430 23.,Non-OADS,/arxiv_data1/oa_pdf/8b/be/kinv-04-02-1066949.PMC5312711.pdf
"Invest 1994; 93 (6):2490-6; PMID:8200985; http://dx.doi.org/ 10.1172/JCI117258 2 4 .F u c h sS ,B a f f o u rR ,Z h o uY F ,S h o uM ,P i e r r eA , Tio FO, Weissman NJ, Leon MB, Epstein SE, Kor- nowski R. Transendocardial delivery of autologous bone marrow enhances collateral perfusion and regional function in pigs with chronic experimentalmyocardial ischemia.",Non-OADS,/arxiv_data1/oa_pdf/8b/be/kinv-04-02-1066949.PMC5312711.pdf
J Am College Cardiol 2001; 37 (6):1726-32; PMID:11345391; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/8b/be/kinv-04-02-1066949.PMC5312711.pdf
Angiogenesis 2013; 16 (1):71-83; PMID:22941228; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/8b/be/kinv-04-02-1066949.PMC5312711.pdf
Anatomical Record 2001; 264 (3):294-304; PMID:11596011; http://dx.doi.org/10.1002/ar.1166 29.,Non-OADS,/arxiv_data1/oa_pdf/8b/be/kinv-04-02-1066949.PMC5312711.pdf
1976; 186 (2):161-84; PMID:984472; http://dx.doi.org/10.1002/ar.1091860204 30.,Non-OADS,/arxiv_data1/oa_pdf/8b/be/kinv-04-02-1066949.PMC5312711.pdf
Microcirculation 2005; 12 (2):151- 60; PMID:15824037; http://dx.doi.org/10.1080/10739680590904955 31.,Non-OADS,/arxiv_data1/oa_pdf/8b/be/kinv-04-02-1066949.PMC5312711.pdf
Nature Methods 2010; 7 (3):168-9;PMID:20195247; http://dx.doi.org/10.1038/ nmeth0310-168 32.,Non-OADS,/arxiv_data1/oa_pdf/8b/be/kinv-04-02-1066949.PMC5312711.pdf
Development 2008; 135 (1):145-57; PMID:18045844; http://dx.doi.org/10.1242/dev.,OADS,/arxiv_data1/oa_pdf/8b/be/kinv-04-02-1066949.PMC5312711.pdf
Eur J Immunol 2007; 37(1):43-53; PMID:17171761; http://dx.doi.org/ 10.1002/eji.200636745 35.,Non-OADS,/arxiv_data1/oa_pdf/8b/be/kinv-04-02-1066949.PMC5312711.pdf
2001; 1:4; PMID:11299042; http://dx.doi.org/10.1186/1471- 213X-1-4 36.,Non-OADS,/arxiv_data1/oa_pdf/8b/be/kinv-04-02-1066949.PMC5312711.pdf
Nat Methods 2012; 9 (7):676-82;PMID:22743772; http://dx.doi.org/10.1038/ nmeth.2019 www.tandfonline.com e1066949-13 IntraVital,Non-OADS,/arxiv_data1/oa_pdf/8b/be/kinv-04-02-1066949.PMC5312711.pdf
IntraVital 2014; 3:e29653; http://dx.doi.org/10.4161/intv.29653 Commentary to: Schofield R. The relationship between the spleen colony-forming cell and the haemopoietic stem cell.,Non-OADS,/arxiv_data1/oa_pdf/36/4f/kinv-03-02-10929653.PMC5312712.pdf
Science  2000; 290:328-30;  PMID:11030649 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/36/4f/kinv-03-02-10929653.PMC5312712.pdf
Nature  2014; 507:362-5;  PMID:24531760 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/36/4f/kinv-03-02-10929653.PMC5312712.pdf
Cell 2010; 143:134-44;  PMID:20887898 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/36/4f/kinv-03-02-10929653.PMC5312712.pdf
Proc Natl Acad Sci U S A 2003; 100:4633- 8; PMID:12676994 ; http://dx.doi.org/10.1073/ pnas.0830856100 8.,OADS,/arxiv_data1/oa_pdf/36/4f/kinv-03-02-10929653.PMC5312712.pdf
Cell 2006; 126:663- 76; PMID:16904174 ; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/36/4f/kinv-03-02-10929653.PMC5312712.pdf
"Interestingly, smallKeywords: B-Raf, cancer, ERK, FRET, intravital microscopy, MAP kinase,Melanoma *Correspondence to: Kurt I Anderson; Email: k.anderson@beatson.gla.ac.uk Submitted: 07/10/2015Revised: 01/02/2015Accepted: 07/10/2015http://dx.doi.org/10.1080/21659087.2015.1074788 © Kurt I Anderson This is an Open Access article distributed under the terms of the Creative Commons Attribution-Non- Commercial License (http://creativecommons.org/licenses/by-nc/3.0/), which permits unrestrictednon-commercial use, distribution, and reproduction in any medium, provided the original work is prop- erly cited.",Non-OADS,/arxiv_data1/oa_pdf/c4/58/kinv-04-02-1074788.PMC5312714.pdf
Cancer Cell 2015 Apr 13;27(4): 574-88; http://dx.doi.org/10.1016/j.ccell.2015.,OADS,/arxiv_data1/oa_pdf/c4/58/kinv-04-02-1074788.PMC5312714.pdf
Nat Rev Cancer 2014;14:314-28; PMID:24739578; http://dx.doi.org/ 10.1038/nrc3724 2.,Non-OADS,/arxiv_data1/oa_pdf/c4/58/kinv-04-02-1074788.PMC5312714.pdf
Nature 2002; 417:949-54; PMID:12068308; http://dx.doi.org/10.1038/nature00766 4.,Non-OADS,/arxiv_data1/oa_pdf/c4/58/kinv-04-02-1074788.PMC5312714.pdf
N Engl J Med 2010; 363:809-19; PMID:20818844; http://dx.doi.org/10.1056/ NEJMoa1002011 5.,OADS,/arxiv_data1/oa_pdf/c4/58/kinv-04-02-1074788.PMC5312714.pdf
Cancer Cell 2015; 27:574-88; PMID: 25873177; http://dx.doi.org/10.1016/j.ccell.2015.,OADS,/arxiv_data1/oa_pdf/c4/58/kinv-04-02-1074788.PMC5312714.pdf
"Mol Biol Cell 2011; 22:4647-56; PMID:21976697; http://dx.doi.org/10.1091/mbc.E11-01-0072 7. de Bruin EC, McGranahan N, Mitter R, Salm M, Wedge DC, Yates L, Jamal-Hanjani M, Shaﬁ S, Muru- gaesu N, Rowan AJ, et al.",OADS,/arxiv_data1/oa_pdf/c4/58/kinv-04-02-1074788.PMC5312714.pdf
Science 2014; 346:251-6; PMID:25301630; http://dx.doi.org/10.1126/science.1253462 8.,Non-OADS,/arxiv_data1/oa_pdf/c4/58/kinv-04-02-1074788.PMC5312714.pdf
Cancer Cell 2012; 21:418-29; PMID:22439937; http://dx.doi.org/10.1016/j.ccr.2012.01.007 www.tandfonline.com e1074788-3 IntraVital,Non-OADS,/arxiv_data1/oa_pdf/c4/58/kinv-04-02-1074788.PMC5312714.pdf
"IntraVital 2014; 3:e27935; http://dx.doi.org/10.4161/intv.27935Optimization of the dorsal skinfold window  chamber model and multi-parametric  characterization of tumor-associated vasculature Azusa Maeda and r alph S DaCosta* ontario Cancer Institute; University h ealth Network; t oronto, o N Canada; Department of Medical Biophysics; University of t oronto; t oronto, o N Canada Keywords:  dorsal skinfold window chamber model, vascular imaging, fluorescence, perfusion, vascularity, tortuosity the dorsal skinfold window chamber (DSWC) model is a unique tool that enables analysis of various aspects of tumor  biology and therapeutic response.",Non-OADS,/arxiv_data1/oa_pdf/a8/8d/kinv-03-01-10927935.PMC5312716.pdf
Clin  Exp Metastasis 2009; 26:329-44; PMID:19190882 ;  http://dx.doi.org/10.1007/s10585-008-9234-7 2.,Non-OADS,/arxiv_data1/oa_pdf/a8/8d/kinv-03-01-10927935.PMC5312716.pdf
Histochem  Cell Biol 2008; 130:1147-54;  PMID:18987875 ;  http://dx.doi.org/10.1007/s00418-008-0529-1 3.,Non-OADS,/arxiv_data1/oa_pdf/a8/8d/kinv-03-01-10927935.PMC5312716.pdf
Curr Opin Cell Biol 2013; 25:659-71; PMID:23896198 ; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/a8/8d/kinv-03-01-10927935.PMC5312716.pdf
Neoplasia  2000; 2:53-61;  PMID:10933068 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/a8/8d/kinv-03-01-10927935.PMC5312716.pdf
J Natl Cancer Inst 2000; 92:143-7;  PMID:10639516 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/a8/8d/kinv-03-01-10927935.PMC5312716.pdf
Int J Exp Pathol 2002; 83:21-38;  PMID:12059907 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/a8/8d/kinv-03-01-10927935.PMC5312716.pdf
Neoplasia  2007; 9:128-35;  PMID:17356709 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/a8/8d/kinv-03-01-10927935.PMC5312716.pdf
Proc Natl Acad Sci U S A 2008; 105:9343-8;  PMID:18607000 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/a8/8d/kinv-03-01-10927935.PMC5312716.pdf
Cancer Res  2012; 72:5566-75;  PMID:22952218 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/a8/8d/kinv-03-01-10927935.PMC5312716.pdf
Mol Cancer Ther  2007; 6:599-606;  PMID:17308057 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/a8/8d/kinv-03-01-10927935.PMC5312716.pdf
PLoS One 2012; 7:e42133; PMID:22927920 ;  http://dx.doi.org/10.1371/journal.pone.0042133 13.,Non-OADS,/arxiv_data1/oa_pdf/a8/8d/kinv-03-01-10927935.PMC5312716.pdf
J Biomed Opt 2010; 15:036004; PMID:20615006 ;  http://dx.doi.org/10.1117/1.3431095 14.,Non-OADS,/arxiv_data1/oa_pdf/a8/8d/kinv-03-01-10927935.PMC5312716.pdf
Nat Protoc 2011; 6:1355-66;  PMID:21886101 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/a8/8d/kinv-03-01-10927935.PMC5312716.pdf
Mol Metab 2012; 2:5- 9; PMID:24024125 ; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/a8/8d/kinv-03-01-10927935.PMC5312716.pdf
Pancreas 2010; 39:425-35; PMID:20418756 ;  http://dx.doi.org/10.1097/MPA.0b013e3181c15963 18.,Non-OADS,/arxiv_data1/oa_pdf/a8/8d/kinv-03-01-10927935.PMC5312716.pdf
"IEEE Transactions on Systems,  Man and Cybernetics 1979; 9:62-6; http://dx.doi.",OADS,/arxiv_data1/oa_pdf/a8/8d/kinv-03-01-10927935.PMC5312716.pdf
Microsc Res Tech 2010; 73:1019-29;  PMID:20232465 ; http://dx.doi.org/10.1002/ jemt.2082920.,Non-OADS,/arxiv_data1/oa_pdf/a8/8d/kinv-03-01-10927935.PMC5312716.pdf
Cell 2011; 146:873- 87; PMID:21925313 ; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/a8/8d/kinv-03-01-10927935.PMC5312716.pdf
Ultrasound Med Biol 2012; 38:1859-69;  PMID:22975041 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/a8/8d/kinv-03-01-10927935.PMC5312716.pdf
Acad Radiol  2005; 12:1232-40;  PMID:16179200 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/a8/8d/kinv-03-01-10927935.PMC5312716.pdf
Physiol Rev 2011; 91:1071-121; PMID:21742796 ;  http://dx.doi.org/10.1152/physrev.00038.2010 24.,Non-OADS,/arxiv_data1/oa_pdf/a8/8d/kinv-03-01-10927935.PMC5312716.pdf
Microvasc Res 2011; 82:199-209; PMID:21787792 ; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/a8/8d/kinv-03-01-10927935.PMC5312716.pdf
IntraVital 2013; 2:e24790; http://dx.doi.org/10.4161/intv.24790 27.,OADS,/arxiv_data1/oa_pdf/a8/8d/kinv-03-01-10927935.PMC5312716.pdf
J Microsc 2003;  211:54-62;  PMID:12839551 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/a8/8d/kinv-03-01-10927935.PMC5312716.pdf
Nat Protoc 2013; 8:583-94; PMID:23429719 ; http://dx.doi.org/10.1038/ nprot.2013.026,OADS,/arxiv_data1/oa_pdf/a8/8d/kinv-03-01-10927935.PMC5312716.pdf
"*Correspondence to: Yu Chen; Email: yuchen@umd.edu Submitted: 02/07/2014; Revised: 04/01/2014; Accepted: 04/03/2014;Published Online: 04/30/2014; http://dx.doi.org/10.4161/intv.28770Clinical applications of optical coherence  tomography in urology Hsing- wen w ang and Yu Chen* Fischell Department of Bioengineering; University of Maryland; College Park, MD USA Keywords:  optical coherence tomography, doppler optical coherence tomography, bladder, kidney, ureter Abbreviations:  OCT, optical coherence tomography; SS-OCT, swept source/OCT; OFDI, optical frequency domain imaging;  DOCT, doppler optical coherence tomography; UHR, ultrahigh-resolution; TCC, transitional-cell carcinoma; CIS, carcinoma in  situ; HFUS, high-frequency ultrasound Since optical coherence tomography (OCT) was first  demonstrated in 1991, it has advanced significantly in technical  aspects such as imaging speed and resolution, and has  been clinically demonstrated in a diverse set of medical and  surgical applications, including ophthalmology, cardiology, gastroenterology, dermatology, oncology, among others.",Non-OADS,/arxiv_data1/oa_pdf/67/03/kinv-03-01-10928770.PMC5312717.pdf
Nat Med  1995 ; 1:970- 2; PMID:7585229 ; http://dx.doi.org/10.1038/ nm0995-970 3.,Non-OADS,/arxiv_data1/oa_pdf/67/03/kinv-03-01-10928770.PMC5312717.pdf
J Biomed Opt   2006 ; 11:063001 ; PMID:17212523 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/67/03/kinv-03-01-10928770.PMC5312717.pdf
Current Medical  Imaging Reviews  2012 ; 8:174-93; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/67/03/kinv-03-01-10928770.PMC5312717.pdf
"Opt Express 2003 ; 11:2183 - 9; PMID:19466106 ; http://dx.doi.org/10.1364/ OE.11.002183 6. de Boer JF, Cense  B, Park BH, Pierce  MC, Tearney   GJ, Bouma  BE.",OADS,/arxiv_data1/oa_pdf/67/03/kinv-03-01-10928770.PMC5312717.pdf
Opt Lett 2003 ; 28:2067 - 9; PMID:14587817 ; http://dx.doi.org/10.1364/ OL.28.002067 7.,OADS,/arxiv_data1/oa_pdf/67/03/kinv-03-01-10928770.PMC5312717.pdf
Opt Express 2003 ; 11:889-94;  PMID:19461802 ; http://dx.doi.org/10.1364/ OE.11.0008898.,Non-OADS,/arxiv_data1/oa_pdf/67/03/kinv-03-01-10928770.PMC5312717.pdf
Opt Commun  1995 ; 117:43-8; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/67/03/kinv-03-01-10928770.PMC5312717.pdf
J  Biomed Opt  2002 ; 7:457-63; PMID:12175297 ;  http://dx.doi.org/10.1117/1.1482379 10.,Non-OADS,/arxiv_data1/oa_pdf/67/03/kinv-03-01-10928770.PMC5312717.pdf
Opt Lett 1997 ; 22:340- 2; PMID:18183195 ; http://dx.doi.org/10.1364/ OL.22.000340 11.,OADS,/arxiv_data1/oa_pdf/67/03/kinv-03-01-10928770.PMC5312717.pdf
Opt Lett  1997 ; 22:1704 -6; PMID:18188341 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/67/03/kinv-03-01-10928770.PMC5312717.pdf
Nat Photonics   2007 ; 1:709-16; http://dx.doi.org/10.1038/ nphoton.2007.228 14.,OADS,/arxiv_data1/oa_pdf/67/03/kinv-03-01-10928770.PMC5312717.pdf
Gastrointest Endosc  2007 ; 65:898-905;  PMID:17383652 ; http://dx.doi.org/10.1016/j.,Non-OADS,/arxiv_data1/oa_pdf/67/03/kinv-03-01-10928770.PMC5312717.pdf
Therap Adv  Gastroenterol  2009 ; 2:149-56; PMID:20593010 ;  http://dx.doi.org/10.1177/1756283X0810334116.,Non-OADS,/arxiv_data1/oa_pdf/67/03/kinv-03-01-10928770.PMC5312717.pdf
Gastrointest Endosc  2012 ; 76:32- 40; PMID:22482920 ; http://dx.doi.org/10.1016/j.,Non-OADS,/arxiv_data1/oa_pdf/67/03/kinv-03-01-10928770.PMC5312717.pdf
J  Biomed Opt  2007 ; 12:051403 ; PMID:17994864 ;  http://dx.doi.org/10.1117/1.2793736 18.,Non-OADS,/arxiv_data1/oa_pdf/67/03/kinv-03-01-10928770.PMC5312717.pdf
Opt Express 2004 ;  12:3532 -42; PMID:19483882 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/67/03/kinv-03-01-10928770.PMC5312717.pdf
Gynecol Oncol   2009 ; 114:188-94; PMID:19481241 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/67/03/kinv-03-01-10928770.PMC5312717.pdf
J Biomed Opt  2008 ; 13:020505 ; PMID:18465947 ;  http://dx.doi.org/10.1117/1.2904664 24.,Non-OADS,/arxiv_data1/oa_pdf/67/03/kinv-03-01-10928770.PMC5312717.pdf
Opt Express 2011 ; 19:26283 -94;  PMID:22274213 ; http://dx.doi.org/10.1364/ OE.19.026283 27.,Non-OADS,/arxiv_data1/oa_pdf/67/03/kinv-03-01-10928770.PMC5312717.pdf
Biomed Opt Express   2013 ; 4:1045 -50; PMID:23847730 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/67/03/kinv-03-01-10928770.PMC5312717.pdf
Opt Express 1997 ; 1:432-40;  PMID:19377567 ; http://dx.doi.org/10.1364/ OE.1.000432 29.,Non-OADS,/arxiv_data1/oa_pdf/67/03/kinv-03-01-10928770.PMC5312717.pdf
Opt Lett 2001 ; 26:1966 -8; PMID:18059747 ;  http://dx.doi.org/10.1364/OL.26.001966 30.,OADS,/arxiv_data1/oa_pdf/67/03/kinv-03-01-10928770.PMC5312717.pdf
Sens Actuators A Phys  2003 ; A103 :237-41; http://dx.doi.org/10.1016/ S0924-4247(02)00347-3 31.,OADS,/arxiv_data1/oa_pdf/67/03/kinv-03-01-10928770.PMC5312717.pdf
IEEE J Sel Top  Quantum Electron  2004 ; 10:636-42; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/67/03/kinv-03-01-10928770.PMC5312717.pdf
Opt Lett 2004 ; 29:2261 - 3; PMID :15524374 ; http://dx.doi.org/10.1364/ OL.29.002261 35.,Non-OADS,/arxiv_data1/oa_pdf/67/03/kinv-03-01-10928770.PMC5312717.pdf
Opt Lett  2004 ; 29:1763 -5; PMID :15352362 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/67/03/kinv-03-01-10928770.PMC5312717.pdf
Appl Opt  2004 ; 43:113- 21; PMID:14714651 ; http://dx.doi.org/10.1364/ AO.43.00011337.,OADS,/arxiv_data1/oa_pdf/67/03/kinv-03-01-10928770.PMC5312717.pdf
Sens Actuators A Phys  2005 ; 117:331-40; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/67/03/kinv-03-01-10928770.PMC5312717.pdf
Opt Express 2006 ; 14:3238 -46;  PMID:19516465 ; http://dx.doi.org/10.1364/ OE.14.003238 41.,OADS,/arxiv_data1/oa_pdf/67/03/kinv-03-01-10928770.PMC5312717.pdf
Minim Invasive  Neurosurg  2006 ; 49: 269-75; PMID:17163339 ;  http://dx.doi.org/10.1055/s-2006-954574 42.,Non-OADS,/arxiv_data1/oa_pdf/67/03/kinv-03-01-10928770.PMC5312717.pdf
Opt Lett  2006 ; 31:1265 -7; PMID:16642080 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/67/03/kinv-03-01-10928770.PMC5312717.pdf
Rep Prog Phys 2003 ; 66:239-303;  http://dx.doi.org/10.1088/0034-4885/66/2/204 45.,Non-OADS,/arxiv_data1/oa_pdf/67/03/kinv-03-01-10928770.PMC5312717.pdf
Nat Biotechnol   2003 ; 21:1361 -7; PMID:14595364 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/67/03/kinv-03-01-10928770.PMC5312717.pdf
Acad Radiol  2002 ; 9:942- 53; PMID:12186444 ; http://dx.doi.org/10.1016/ S1076-6332(03)80465-8 47.,OADS,/arxiv_data1/oa_pdf/67/03/kinv-03-01-10928770.PMC5312717.pdf
Prog Retin Eye Res  2008 ; 27:45-88; PMID:18036865 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/67/03/kinv-03-01-10928770.PMC5312717.pdf
Am J Cardiol  1996 ; 77:92-3; PMID:8540467 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/67/03/kinv-03-01-10928770.PMC5312717.pdf
Circulation  2001 ;  104:2754 ; PMID:11723031 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/67/03/kinv-03-01-10928770.PMC5312717.pdf
J  Biomed Opt  2007 ; 12:051403 ; PMID:17994864 ;  http://dx.doi.org/10.1117/1.279373653.,Non-OADS,/arxiv_data1/oa_pdf/67/03/kinv-03-01-10928770.PMC5312717.pdf
IEEE J Sel Top  Quantum Electron  1996 ; 2:1017-28; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/67/03/kinv-03-01-10928770.PMC5312717.pdf
Gastrointest Endosc  2000 ; 51:467- 74; PMID:10744824 ; http://dx.doi.org/10.1016/ S0016-5107(00)70449-4 57.,Non-OADS,/arxiv_data1/oa_pdf/67/03/kinv-03-01-10928770.PMC5312717.pdf
Endoscopy  2000 ;  32:921-30; PMID:11147939 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/67/03/kinv-03-01-10928770.PMC5312717.pdf
Endoscopy  2000 ; 32:743-9; PMID:11068832 ;  http://dx.doi.org/10.1055/s-2000-7711 60.,Non-OADS,/arxiv_data1/oa_pdf/67/03/kinv-03-01-10928770.PMC5312717.pdf
Am J Gastroenterol  2001 ; 96 :2633 -9; PMID :11569687 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/67/03/kinv-03-01-10928770.PMC5312717.pdf
Gastroenterology  2001 ; 120:7-12;  PMID:11208708 ; http://dx.doi.org/10.1053/ gast.2001.20911 62.,Non-OADS,/arxiv_data1/oa_pdf/67/03/kinv-03-01-10928770.PMC5312717.pdf
Gastrointest Endosc  2002 ; 55:84-8;  PMID:11756925 ; http://dx.doi.org/10.1067/ mge.2002.120098 63.,Non-OADS,/arxiv_data1/oa_pdf/67/03/kinv-03-01-10928770.PMC5312717.pdf
Gastrointest Endosc  2005 ; 61:879- 90; PMID:15933695 ; http://dx.doi.org/10.1016/ S0016-5107(05)00323-8,Non-OADS,/arxiv_data1/oa_pdf/67/03/kinv-03-01-10928770.PMC5312717.pdf
Clin Gastroenterol Hepatol  2006 ; 4:38- 43; PMID:16431303 ; http://dx.doi.org/10.1016/ S1542-3565(05)00746-9 67.,Non-OADS,/arxiv_data1/oa_pdf/67/03/kinv-03-01-10928770.PMC5312717.pdf
Endoscopy  2007 ;  39:599-605; PMID:17611914 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/67/03/kinv-03-01-10928770.PMC5312717.pdf
J Am Acad Dermatol 1997 ; 37:958-63;  PMID:9418764 ; http://dx.doi.org/10.1016/ S0190-9622(97)70072-0 69.,Non-OADS,/arxiv_data1/oa_pdf/67/03/kinv-03-01-10928770.PMC5312717.pdf
Curr  Probl Dermatol  1998 ; 26:27-37; PMID:9597313 ;  http://dx.doi.org/10.1159/000060573 70.,Non-OADS,/arxiv_data1/oa_pdf/67/03/kinv-03-01-10928770.PMC5312717.pdf
Br J Dermatol 2004 ;  150:220-5; PMID:14996091 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/67/03/kinv-03-01-10928770.PMC5312717.pdf
J Am Dent Assoc 2000 ;  131:511-4; PMID:10770016 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/67/03/kinv-03-01-10928770.PMC5312717.pdf
J Biomed Opt   2005 ; 10:064027 ; PMID:16409092 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/67/03/kinv-03-01-10928770.PMC5312717.pdf
Urology   2000 ; 55:783-7; PMID:10792101 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/67/03/kinv-03-01-10928770.PMC5312717.pdf
J Urol  2002 ; 167:1492 -6; PMID:11832776 ;  http://dx.doi.org/10.1016/S0022-5347(05)65351-7 77.,OADS,/arxiv_data1/oa_pdf/67/03/kinv-03-01-10928770.PMC5312717.pdf
J Endourol  2005 ; 19:570- 4; PMID :15989448 ; http://dx.doi.org/10.1089/ end.2005.19.57078.,OADS,/arxiv_data1/oa_pdf/67/03/kinv-03-01-10928770.PMC5312717.pdf
Br J Obstet Gynaecol  1999 ; 106:1071 -7; PMID:10519434 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/67/03/kinv-03-01-10928770.PMC5312717.pdf
Breast Cancer Res Treat 2004 ;  84:85-97; PMID:14999139 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/67/03/kinv-03-01-10928770.PMC5312717.pdf
Radiology  2007 ; 244:865- 74; PMID:17630358 ; http://dx.doi.org/10.1148/ radiol.2443061536 83.,Non-OADS,/arxiv_data1/oa_pdf/67/03/kinv-03-01-10928770.PMC5312717.pdf
J Biomed Opt   2008 ; 13:014014 ; PMID:18315372 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/67/03/kinv-03-01-10928770.PMC5312717.pdf
Cancer Res 2009 ; 69:8790 -6; PMID:19910294 ;  http://dx.doi.org/10.1158/0008-5472.,Non-OADS,/arxiv_data1/oa_pdf/67/03/kinv-03-01-10928770.PMC5312717.pdf
Cancer Res 2010 ; 70:10071 -9;  PMID:21056988 ; http://dx.doi.org/10.1158/0008- 5472.CAN-10-2968 86.,Non-OADS,/arxiv_data1/oa_pdf/67/03/kinv-03-01-10928770.PMC5312717.pdf
Med Phys 2001 ;  28:2432 -40; PMID:11797946 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/67/03/kinv-03-01-10928770.PMC5312717.pdf
J  Biomed Opt  2008 ; 13:054007 ; PMID:19021387 ;  http://dx.doi.org/10.1117/1.2978059 88.,Non-OADS,/arxiv_data1/oa_pdf/67/03/kinv-03-01-10928770.PMC5312717.pdf
J Biomed Opt   2008 ; 13:024003 ; PMID:18465966 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/67/03/kinv-03-01-10928770.PMC5312717.pdf
Urology  2008 ; 72:133- 7; PMID:18598789 ; http://dx.doi.org/10.1016/j.,Non-OADS,/arxiv_data1/oa_pdf/67/03/kinv-03-01-10928770.PMC5312717.pdf
Neurosurgery  1998 ;  43:834-41; PMID:9766311 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/67/03/kinv-03-01-10928770.PMC5312717.pdf
Lasers Surg Med 2006 ; 38:588-97; PMID:16736504 ;  http://dx.doi.org/10.1002/lsm.20353 93.,Non-OADS,/arxiv_data1/oa_pdf/67/03/kinv-03-01-10928770.PMC5312717.pdf
J Biomed Opt  2006 ;  11:044010 ; PMID:16965167 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/67/03/kinv-03-01-10928770.PMC5312717.pdf
World J Gastroenterol 2008 ; 14:6444- 52; PMID:19030194 ; http://dx.doi.org/10.3748/ wjg.14.6444 95.,Non-OADS,/arxiv_data1/oa_pdf/67/03/kinv-03-01-10928770.PMC5312717.pdf
Int J Gynecol Cancer  2004 ; 14:470-4; PMID:15228420 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/67/03/kinv-03-01-10928770.PMC5312717.pdf
Int J Gynecol Cancer 2006 ;  16:1815 -22; PMID:17009977 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/67/03/kinv-03-01-10928770.PMC5312717.pdf
Dermatol Surg  2009 ; 35:965-72; PMID:19397661 ;  http://dx.doi.org/10.1111/j.1524-4725.2009.01164.x 99.,Non-OADS,/arxiv_data1/oa_pdf/67/03/kinv-03-01-10928770.PMC5312717.pdf
J Surg Oncol  2001 ; 77:253-8; PMID:11473374 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/67/03/kinv-03-01-10928770.PMC5312717.pdf
Laryngoscope  2006 ; 116:1107 -13;  PMID:16826043 ; http://dx.doi.org/10.1097/01.,Non-OADS,/arxiv_data1/oa_pdf/67/03/kinv-03-01-10928770.PMC5312717.pdf
IEEE J Sel Top Quantum Electron 2005 ; 11:811-7;  http://dx.doi.org/10.1109/JSTQE.2005.857678,OADS,/arxiv_data1/oa_pdf/67/03/kinv-03-01-10928770.PMC5312717.pdf
J  Biomed Opt  2008 ; 13:044012 ; PMID:19021340 ;  http://dx.doi.org/10.1117/1.2960632 103.,Non-OADS,/arxiv_data1/oa_pdf/67/03/kinv-03-01-10928770.PMC5312717.pdf
Urology  2008 ; 72:677- 81; PMID:18455778 ; http://dx.doi.org/10.1016/j.,Non-OADS,/arxiv_data1/oa_pdf/67/03/kinv-03-01-10928770.PMC5312717.pdf
Urology  2009 ;  74:1351 -7; PMID:19660795 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/67/03/kinv-03-01-10928770.PMC5312717.pdf
J Biophotonics  2008 ; 1:114-28;  PMID:19343643 ; http://dx.doi.org/10.1002/ jbio.200710017 109.,Non-OADS,/arxiv_data1/oa_pdf/67/03/kinv-03-01-10928770.PMC5312717.pdf
J  Biomed Opt  2007 ; 12:034009 ; PMID:17614717 ;  http://dx.doi.org/10.1117/1.2749744 110.,Non-OADS,/arxiv_data1/oa_pdf/67/03/kinv-03-01-10928770.PMC5312717.pdf
Indian J Urol 2011 ;  27:245-51; PMID:21814317 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/67/03/kinv-03-01-10928770.PMC5312717.pdf
Eur Urol  1999 ; 35:52-6; PMID:9933795 ;  http://dx.doi.org/10.1159/000019819 112.,Non-OADS,/arxiv_data1/oa_pdf/67/03/kinv-03-01-10928770.PMC5312717.pdf
"J Urol  1996 ; 155:105-9, discussion  109-10 ; PMID:7490803 ; http://dx.doi.org/10.1016/ S0022-5347(01)66559-5 113.",Non-OADS,/arxiv_data1/oa_pdf/67/03/kinv-03-01-10928770.PMC5312717.pdf
BMC  Urol 2013 ; 13:65; PMID:24289823 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/67/03/kinv-03-01-10928770.PMC5312717.pdf
J Urol  2012 ; 188:361-8;  PMID:22698620 ; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/67/03/kinv-03-01-10928770.PMC5312717.pdf
Opt Lett 2003 ; 28:2485 - 7; PMID:14690122 ; http://dx.doi.org/10.1364/ OL.28.002485 116.,OADS,/arxiv_data1/oa_pdf/67/03/kinv-03-01-10928770.PMC5312717.pdf
"Urology  2004 ; 63:647-50, discussion  650; PMID:15072870 ; http://dx.doi.org/10.1016/j.",Non-OADS,/arxiv_data1/oa_pdf/67/03/kinv-03-01-10928770.PMC5312717.pdf
Eur Radiol  2006 ; 16:2259 -64; PMID:16572332 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/67/03/kinv-03-01-10928770.PMC5312717.pdf
Urology   2011 ; 77:1254 -8; PMID:21256548 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/67/03/kinv-03-01-10928770.PMC5312717.pdf
J Urol  2013 ; 190:2236 - 42; PMID:23954585 ; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/67/03/kinv-03-01-10928770.PMC5312717.pdf
BJU Int  2012 ; 110(8  Pt B ):E415 -20; PMID:22574685 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/67/03/kinv-03-01-10928770.PMC5312717.pdf
BJU Int  2011 ;  108:1820 -4; PMID :21592299 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/67/03/kinv-03-01-10928770.PMC5312717.pdf
Opt Express 2009 ;  17:16000 -16; PMID:19724599 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/67/03/kinv-03-01-10928770.PMC5312717.pdf
J Urol  2010 ; 183:2090 -4; PMID:20303512 ;  http://dx.doi.org/10.1016/j.juro.2009.12.091125.,OADS,/arxiv_data1/oa_pdf/67/03/kinv-03-01-10928770.PMC5312717.pdf
Journal of  Innovative Optical Health Sciences 2014 ; 7:1350064 ;  http://dx.doi.org/10.1142/S1793545813500648 127.,Non-OADS,/arxiv_data1/oa_pdf/67/03/kinv-03-01-10928770.PMC5312717.pdf
J Urol   2003 ; 170:2217 -20; PMID:14634382 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/67/03/kinv-03-01-10928770.PMC5312717.pdf
J Urol  2009 ; 182:1271 -9; PMID:19683266 ;  http://dx.doi.org/10.1016/j.juro.2009.07.004 129.,OADS,/arxiv_data1/oa_pdf/67/03/kinv-03-01-10928770.PMC5312717.pdf
Transplantation   1984 ; 38:643-8; PMID:6390827 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/67/03/kinv-03-01-10928770.PMC5312717.pdf
Electron Lett   2012 ; 48:867-9; PMID:23976788 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/67/03/kinv-03-01-10928770.PMC5312717.pdf
J Urol  2013 ; 190:2236 - 42; PMID:23954585 ; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/67/03/kinv-03-01-10928770.PMC5312717.pdf
BJU Int  2012 ; 110(8  Pt B ):E415 -20; PMID:22574685 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/67/03/kinv-03-01-10928770.PMC5312717.pdf
"15 Since that time  this imaging window has been widely used to study neocortical plasticity and structure, 16,17 cerebral circulation,18 and pathologi- cal processes that take place in the brain such as ischemic stroke,19  injury,20 degenerative disease,21 and cancer.22 To visualize skin tissue, Algire developed the dorsal skinfold  chamber (DSC) by adapting earlier “transparent-chamber tech - niques” from the rabbit ear and skin to mice.23,24 The chamber  has proven popular for studying various processes including microcirculation, 25 tumor growth,26 angiogenesis,27 and ischemic  reperfusion.28 More recently, the mammary imaging window *Correspondence to: Jacco van Rheenen: j.vanrheenen@hubrecht.eu Submitted: 05/21/2014; Revised: 07/10/2014; Accepted: 07/11/2014; Published Online: 08/11/2014; http://dx.doi.org/10.4161/intv.29917Imaging windows for long-term intravital imaging General overview and technical insights Maria Alieva1,†, laila r itsma2,3,†, randy J Giedt4, ralph Weissleder4,5, and Jacco van r heenen1,* 1cancer Genomics Netherlands; h ubrecht i nstitute-KNAW and University Medical c entre Utrecht; ct Utrecht, t he Netherlands; 2center for c ancer r esearch and c enter for  regenerative Medicine; Massachusetts General h ospital; r ichard B. s imches r esearch c enter; h arvard Medical s chool; Boston, MA U sA; 3Broad i nstitute of h arvard and  Massachusetts i nstitute for t echnology; c ambridge, MA U sA; 4center for s ystems Biology; Massachusetts General h ospital; r ichard B. s imches r esearch c enter; h arvard  Medical s chool; Boston, MA U sA; 5department of s ystems Biology; h arvard Medical s chool; Boston, MA U sA †these authors contributed equally to this work.",Non-OADS,/arxiv_data1/oa_pdf/bb/62/kinv-03-02-10929917.PMC5312719.pdf
Cold Spring Harb Perspect Biol 2010; 2:a003848;  PMID:20861158 ; http://dx.doi.org/10.1101/cshper - spect.a003848 2.,OADS,/arxiv_data1/oa_pdf/bb/62/kinv-03-02-10929917.PMC5312719.pdf
IntraVital 2012;  1:2-10; http://dx.doi.org/10.4161/intv.20802 3.,OADS,/arxiv_data1/oa_pdf/bb/62/kinv-03-02-10929917.PMC5312719.pdf
Cell  2011; 147:983-91;  PMID:22118457 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/bb/62/kinv-03-02-10929917.PMC5312719.pdf
Nat Rev Cancer 2014; 14:406- 18; PMID:24854083 ; http://dx.doi.org/10.1038/ nrc3742 5.,Non-OADS,/arxiv_data1/oa_pdf/bb/62/kinv-03-02-10929917.PMC5312719.pdf
Dis Model Mech  2013; 6:580-93;  PMID:23616077 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/bb/62/kinv-03-02-10929917.PMC5312719.pdf
Cold Spring Harb Protoc 2011; 2011:t5562;  PMID:21285262 ; http://dx.doi.org/10.1101/pdb.,Non-OADS,/arxiv_data1/oa_pdf/bb/62/kinv-03-02-10929917.PMC5312719.pdf
Cold Spring Harb Protoc 2011;  2011:1167-84;  PMID:21969629 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/bb/62/kinv-03-02-10929917.PMC5312719.pdf
J Neurosci 2011; 31:624- 9; PMID:21228171 ; http://dx.doi.org/10.1523/ JNEUROSCI.5147-10.201111.,Non-OADS,/arxiv_data1/oa_pdf/bb/62/kinv-03-02-10929917.PMC5312719.pdf
Nature  2014; 507:362-5;  PMID:24531760 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/bb/62/kinv-03-02-10929917.PMC5312719.pdf
Arch Neurol Psychiatry 1928; 19:751-61; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/bb/62/kinv-03-02-10929917.PMC5312719.pdf
Nat Protoc 2009; 4:1128-44; PMID:19617885 ;  http://dx.doi.org/10.1038/nprot.2009.89 17.,Non-OADS,/arxiv_data1/oa_pdf/bb/62/kinv-03-02-10929917.PMC5312719.pdf
Nature  2002; 420:812-6;  PMID:12490949 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/bb/62/kinv-03-02-10929917.PMC5312719.pdf
J Vis Exp 2008; 678;  PMID:19066563 ; http://dx.doi.org/10.3791/678 19.,Non-OADS,/arxiv_data1/oa_pdf/bb/62/kinv-03-02-10929917.PMC5312719.pdf
Stroke 2013; 44:490- 6; PMID:23287786 ; http://dx.doi.org/10.1161/ STROKEAHA.112.660589 20.,Non-OADS,/arxiv_data1/oa_pdf/bb/62/kinv-03-02-10929917.PMC5312719.pdf
J Neurotrauma 2013; 30:1664-71;  PMID:23796228 ;  http://dx.doi.org/10.1089/neu.2013.299521.,Non-OADS,/arxiv_data1/oa_pdf/bb/62/kinv-03-02-10929917.PMC5312719.pdf
Nat Med 2010; 16:116- 22; PMID:20023634 ; http://dx.doi.org/10.1038/ nm.2072 23.,OADS,/arxiv_data1/oa_pdf/bb/62/kinv-03-02-10929917.PMC5312719.pdf
Anat Rec 1924; 28:281-7; http://dx.doi.org/10.1002/ar.1090280403 25.,Non-OADS,/arxiv_data1/oa_pdf/bb/62/kinv-03-02-10929917.PMC5312719.pdf
Histochem Cell Biol 2008; 130:1147-54;  PMID:18987875 ;  http://dx.doi.org/10.1007/s00418-008-0529-1 27.,Non-OADS,/arxiv_data1/oa_pdf/bb/62/kinv-03-02-10929917.PMC5312719.pdf
Microsurgery 1994; 15:383-9; PMID:7968463 ;  http://dx.doi.org/10.1002/micr.1920150605 29.,Non-OADS,/arxiv_data1/oa_pdf/bb/62/kinv-03-02-10929917.PMC5312719.pdf
Nat Methods 2008; 5:1019- 21; PMID:18997781 ; http://dx.doi.org/10.1038/ nmeth.1269 30.,OADS,/arxiv_data1/oa_pdf/bb/62/kinv-03-02-10929917.PMC5312719.pdf
Microvasc Res 2003; 65:109-17; PMID:12686168 ; http://dx.doi.org/10.1016/ S0026-2862(02)00017-1,OADS,/arxiv_data1/oa_pdf/bb/62/kinv-03-02-10929917.PMC5312719.pdf
Nat Protoc 2013; 8:583- 94; PMID:23429719 ; http://dx.doi.org/10.1038/ nprot.2013.026 32.,OADS,/arxiv_data1/oa_pdf/bb/62/kinv-03-02-10929917.PMC5312719.pdf
Sci Transl Med 2012; 4:ra145; PMID :23115354 ;  http://dx.doi.org/10.1126/scitranslmed.3004394 33.,Non-OADS,/arxiv_data1/oa_pdf/bb/62/kinv-03-02-10929917.PMC5312719.pdf
Nat Methods 2012; 9:297-302; PMID:22266542 ;  http://dx.doi.org/10.1038/nmeth.1856 34.,OADS,/arxiv_data1/oa_pdf/bb/62/kinv-03-02-10929917.PMC5312719.pdf
J Physiol 2012; 590:3665-75; PMID:22641787 ;  http://dx.doi.org/10.1113/jphysiol.2012.230532 35.,Non-OADS,/arxiv_data1/oa_pdf/bb/62/kinv-03-02-10929917.PMC5312719.pdf
Am J Pathol 2011; 179:75-82; PMID:21703395 ; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/bb/62/kinv-03-02-10929917.PMC5312719.pdf
ILAR J 2012; 53:E55-69;   PMID:23382271 ; http://dx.doi.org/10.1093/ ilar.53.1.55 38.,OADS,/arxiv_data1/oa_pdf/bb/62/kinv-03-02-10929917.PMC5312719.pdf
J Vis Exp 2008; 680; PMID:19066562 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/bb/62/kinv-03-02-10929917.PMC5312719.pdf
Nat Protoc  2011; 6:1355-66;  PMID:21886101 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/bb/62/kinv-03-02-10929917.PMC5312719.pdf
Cold Spring Harb Protoc 2011; 2011:t5563;   PMID:21285263 ; http://dx.doi.org/10.1101/pdb.,Non-OADS,/arxiv_data1/oa_pdf/bb/62/kinv-03-02-10929917.PMC5312719.pdf
Anesthesiology 1998;  89:954-60;  PMID:9778013 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/bb/62/kinv-03-02-10929917.PMC5312719.pdf
J Cereb Blood  Flow Metab 1987; 7:806-11; PMID:3121648 ;  http://dx.doi.org/10.1038/jcbfm.1987.13845.,Non-OADS,/arxiv_data1/oa_pdf/bb/62/kinv-03-02-10929917.PMC5312719.pdf
Anesthesiology 2007;  106:365-91;  PMID:17264732 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/bb/62/kinv-03-02-10929917.PMC5312719.pdf
Exp Biol Med (Maywood) 2014;  239:737-46;  PMID:24668552 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/bb/62/kinv-03-02-10929917.PMC5312719.pdf
Biol Pharm Bull 2007; 30:1716- 20; PMID:17827727 ; http://dx.doi.org/10.1248/ bpb.30.1716 48.,Non-OADS,/arxiv_data1/oa_pdf/bb/62/kinv-03-02-10929917.PMC5312719.pdf
Clin Exp Metastasis  2003; 20:733-44;  PMID:14713107 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/bb/62/kinv-03-02-10929917.PMC5312719.pdf
J Clin Invest 2008; 118:1924-33; PMID:18382768 ;  http://dx.doi.org/10.1172/JCI33308 50.,Non-OADS,/arxiv_data1/oa_pdf/bb/62/kinv-03-02-10929917.PMC5312719.pdf
J Med Ethics 2002; 28:164-9;  PMID:12042401 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/bb/62/kinv-03-02-10929917.PMC5312719.pdf
Neuron 2012; 74:374- 83; PMID:22542189 ; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/bb/62/kinv-03-02-10929917.PMC5312719.pdf
J Neurosci 2011; 31:7967- 73; PMID:21632918 ; http://dx.doi.org/10.1523/ JNEUROSCI.0782-11.2011 56.,Non-OADS,/arxiv_data1/oa_pdf/bb/62/kinv-03-02-10929917.PMC5312719.pdf
J Neurosurg  2000; 93:634-9;  PMID:11014542 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/bb/62/kinv-03-02-10929917.PMC5312719.pdf
Inflammation 2012; 35:58-64; PMID:21213030 ;  http://dx.doi.org/10.1007/s10753-010-9289-x 58.,Non-OADS,/arxiv_data1/oa_pdf/bb/62/kinv-03-02-10929917.PMC5312719.pdf
"Nat Commun 2013; 4:2366; PMID:23978961 ;  http://dx.doi.org/10.1038/ncomms3366 60. de Visser KE, Coussens LM.",OADS,/arxiv_data1/oa_pdf/bb/62/kinv-03-02-10929917.PMC5312719.pdf
Contrib Microbiol 2006; 13:118-37;  PMID:16627962 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/bb/62/kinv-03-02-10929917.PMC5312719.pdf
Gut 1995; 37:191-4;  PMID:7557566 ; http://dx.doi.org/10.1136/ gut.37.2.191 62.,Non-OADS,/arxiv_data1/oa_pdf/bb/62/kinv-03-02-10929917.PMC5312719.pdf
J Clin Pharmacol 1974;  14:112-7;  PMID:4813080 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/bb/62/kinv-03-02-10929917.PMC5312719.pdf
Proc Natl Acad Sci U S A  2006; 103:4946-51;  PMID:16543381 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/bb/62/kinv-03-02-10929917.PMC5312719.pdf
Cell Tissue Res  2013; 352:149-59;  PMID:23435993 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/bb/62/kinv-03-02-10929917.PMC5312719.pdf
J Vis  Exp 2012; 3742; PMID:22433225 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/bb/62/kinv-03-02-10929917.PMC5312719.pdf
IntraVital 2014; 3:e29728;  http://dx.doi.org/10.4161/intv.29728 70.,OADS,/arxiv_data1/oa_pdf/bb/62/kinv-03-02-10929917.PMC5312719.pdf
Nat Neurosci 2007; 10:549-51;   PMID:17417634 ; http://dx.doi.org/10.1038/nn1883 71.,Non-OADS,/arxiv_data1/oa_pdf/bb/62/kinv-03-02-10929917.PMC5312719.pdf
Microvasc Res 2011; 82:199- 209; PMID:21787792 ; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/bb/62/kinv-03-02-10929917.PMC5312719.pdf
IntraVital 2012; 1:32-43; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/bb/62/kinv-03-02-10929917.PMC5312719.pdf
IntraVital 2014; 3:e27935; http://dx.doi.org/10.4161/ intv.27935 78.,OADS,/arxiv_data1/oa_pdf/bb/62/kinv-03-02-10929917.PMC5312719.pdf
Cancer Chemother  Pharmacol 2013; 72:777-88;  PMID:23975242 ;  http://dx.doi.org/10.1007/s00280-013-2253-3 80.,Non-OADS,/arxiv_data1/oa_pdf/bb/62/kinv-03-02-10929917.PMC5312719.pdf
J Natl Cancer Inst  2010; 102:1855-73;  PMID:21088277 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/bb/62/kinv-03-02-10929917.PMC5312719.pdf
J Vis Exp 2009; 1278;   PMID:19578330 ; http://dx.doi.org/10.3791/1278 82.,Non-OADS,/arxiv_data1/oa_pdf/bb/62/kinv-03-02-10929917.PMC5312719.pdf
PLoS One 2013; 8:e64029;  PMID:23691140 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/bb/62/kinv-03-02-10929917.PMC5312719.pdf
J Biomed Opt  2012; 17:96018-1;  PMID:23085919 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/bb/62/kinv-03-02-10929917.PMC5312719.pdf
Nat Methods 2009;  6:143-5;  PMID:19151720 ; http://dx.doi.org/10.1038/ nmeth.1295 85.,OADS,/arxiv_data1/oa_pdf/bb/62/kinv-03-02-10929917.PMC5312719.pdf
Histochem Cell Biol  2004; 122:183-90;  PMID :15258769 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/bb/62/kinv-03-02-10929917.PMC5312719.pdf
Biophys  J 2002; 82:493-508; PMID:11751336 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/bb/62/kinv-03-02-10929917.PMC5312719.pdf
Intravital 2013; 2:2; PMID:24349895 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/bb/62/kinv-03-02-10929917.PMC5312719.pdf
Nat Med 2011; 17:504- 9; PMID:21441917 ; http://dx.doi.org/10.1038/ nm.2338 89.,Non-OADS,/arxiv_data1/oa_pdf/bb/62/kinv-03-02-10929917.PMC5312719.pdf
Cell  2010; 143:134-44;  PMID:20887898 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/bb/62/kinv-03-02-10929917.PMC5312719.pdf
Appl Phys Lett  2012; 101:33703;  PMID:22893732 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/bb/62/kinv-03-02-10929917.PMC5312719.pdf
Sci Rep 2014; 4:4690;   PMID:24732947 ; http://dx.doi.org/10.1038/ srep04690 92.,OADS,/arxiv_data1/oa_pdf/bb/62/kinv-03-02-10929917.PMC5312719.pdf
Nat Methods 2008;  5:935-8;  PMID:18836457 ; http://dx.doi.org/10.1038/ nmeth.1256 93.,OADS,/arxiv_data1/oa_pdf/bb/62/kinv-03-02-10929917.PMC5312719.pdf
Opt Lett 2009; 34:2309-11; PMID:19649080 ; http://dx.doi.org/10.1364/ OL.34.002309 94.,OADS,/arxiv_data1/oa_pdf/bb/62/kinv-03-02-10929917.PMC5312719.pdf
Nat Methods 2009; 6:511-2; PMID:19525959 ;  http://dx.doi.org/10.1038/nmeth.133995.,OADS,/arxiv_data1/oa_pdf/bb/62/kinv-03-02-10929917.PMC5312719.pdf
Nat Commun 2012;  3:1054;  PMID:22968700 ; http://dx.doi.org/10.1038/ ncomms2060 96.,OADS,/arxiv_data1/oa_pdf/bb/62/kinv-03-02-10929917.PMC5312719.pdf
J  Biomed Opt 2011; 16:106014; PMID:22029361 ;  http://dx.doi.org/10.1117/1.3646209 98.,Non-OADS,/arxiv_data1/oa_pdf/bb/62/kinv-03-02-10929917.PMC5312719.pdf
Nat  Med 2011; 17:223-8;  PMID:21240263 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/bb/62/kinv-03-02-10929917.PMC5312719.pdf
J Oncol 2012; 2012:265487; PMID:22131993 ;  http://dx.doi.org/10.1155/2012/265487 100.,Non-OADS,/arxiv_data1/oa_pdf/bb/62/kinv-03-02-10929917.PMC5312719.pdf
Cancer Cell 2004; 5:429-41;   PMID:15144951 ; http://dx.doi.org/10.1016/ S1535-6108(04) 00115-1 103.,Non-OADS,/arxiv_data1/oa_pdf/bb/62/kinv-03-02-10929917.PMC5312719.pdf
IEEE J Sel Top  Quantum Electron 2014; 20; PMID:24273405 ;  http://dx.doi.org/10.1109/JSTQE.2013.2279314 104.,OADS,/arxiv_data1/oa_pdf/bb/62/kinv-03-02-10929917.PMC5312719.pdf
Sci Rep 2014; 4:4507;  PMID:24676021 ; http://dx.doi.org/10.1038/ srep04507,Non-OADS,/arxiv_data1/oa_pdf/bb/62/kinv-03-02-10929917.PMC5312719.pdf
"One patient was excluded from the FAS as he completed study activities despite having no recorded bleeding episodes during the ﬁrst 2 months of inclusion in the study; details are shown Supplementary Table 2, http://links.lww.com/BCF/A25.",Non-OADS,/arxiv_data1/oa_pdf/a8/66/blcof-28-145.PMC5312720.pdf
Direct URL citations  appear in the printed text and are provided in the HTML and PDF versions of this article on the journal’s website (http://journals.lww.com/ccmjournal).,Non-OADS,/arxiv_data1/oa_pdf/9c/04/ccm-45-e306.PMC5312725.pdf
"In light of the variable pharmacokinetics among the available CCBs  (6, 7), the altered pharmacokinetics following overdose (8, 9)  and the loss of selectivity at very high CCB doses (10, 11), the  workgroup adopted a pragmatic clinical approach and did not focus on individual agents (for complementary information con- cerning CCB poisoning, see Appendix 1, Supplemental Digital Content 1, http://links.lww.com/CCM/C94).",Non-OADS,/arxiv_data1/oa_pdf/9c/04/ccm-45-e306.PMC5312725.pdf
"The workgroup (T able 1) was created as detailed in Appendix 2 (Supplemental Digital Content 1, http://links.lww.com/CCM/C94), and an analytical framework illustrating the links between key questions (KQ) to be answered (Fig.",Non-OADS,/arxiv_data1/oa_pdf/9c/04/ccm-45-e306.PMC5312725.pdf
"The level of evidence was determined using Grading of Recommendations Assessment, Development and Evaluation (14) and the strength of recommendation using a modified Delphi like it has been used in consensus recommendations for extracorpo-real treatments (T able 2) (Appendix 2, Supplemental Digital Content 1, http://links.lww.com/CCM/C94) (Fig.",Non-OADS,/arxiv_data1/oa_pdf/9c/04/ccm-45-e306.PMC5312725.pdf
"Supplemental T able 1 (Supplemental Digital Content 2, http://links.lww.com/CCM/C95) (also, see Appendix 6, Sup - plemental Digital Content 1, http://links.lww.com/CCM/C94) details the rationale for each recommendation, and Figure 3 illustrates the progression of care for key recommendations.",Non-OADS,/arxiv_data1/oa_pdf/9c/04/ccm-45-e306.PMC5312725.pdf
"3; Supplemental Table 1, Supplemental  Digital Content 2, http://links.lww.com/CCM/C95).",Non-OADS,/arxiv_data1/oa_pdf/9c/04/ccm-45-e306.PMC5312725.pdf
"A description of values and preferences,  the result of the review process, and the planned implementa- tion and revisions are available in Appendix 2 (Supplemental  Digital Content 1, http://links.lww.com/CCM/C94).DISCUSSION The target population for these recommendations includes  CCB-poisoned adults.",Non-OADS,/arxiv_data1/oa_pdf/9c/04/ccm-45-e306.PMC5312725.pdf
"The results of the repeat pharmacokinetic analysis were generally comparable to the initial results (Supple- mentary Table 1, http://links.lww.com/BCF/A27).",Non-OADS,/arxiv_data1/oa_pdf/71/11/blcof-28-152.PMC5312726.pdf
"Adverse events During the on-demand phase of the study (arm 2), 13 study participants (61.9%) reported a total of 63 treat- ment-emergent adverse events (TEAEs) (Supple- mentary Table 2, http://links.lww.com/BCF/A27).",Non-OADS,/arxiv_data1/oa_pdf/71/11/blcof-28-152.PMC5312726.pdf
"Neither pathogen was more or less likely to be associated with the youngest age group (Table 2, Fig., Supplemental Digital Content 1, http://links.lww.com/INF/C612) than with older ages.",Non-OADS,/arxiv_data1/oa_pdf/36/12/inf-36-274.PMC5312727.pdf
"Clinical Severity by Etiology Encapsulated Hflu isolates were more frequently associated  with high severity of tympanic membrane bulging and inflammation (73% were OS-6/7), compared with Spn or NTHi or Mcat (30%–35% OS-6/7), whereas Spyo cases were only infrequently severe (8%–9%, Table, Supplemental Digital Content 2, http://links.lww.",Non-OADS,/arxiv_data1/oa_pdf/36/12/inf-36-274.PMC5312727.pdf
"Both major otopathogens were thus associated with a range  of disease severity (Table 2, Fig., Supplemental Digital Content 1, http://links.lww.com/INF/C612): Hflu was more likely to be identi-fied in cases with an OS-6 or 7 than in less severe cases (RR: 1.35; 1.06–1.71), and Spn was more likely to be identified in children with reported ear pain or a temperature ≥38.5°C (RR: 1.42; 1.01–2.01).",Non-OADS,/arxiv_data1/oa_pdf/36/12/inf-36-274.PMC5312727.pdf
"It was also more likely to be isolated from a treatment failure (RR: 1.63; 1.32–2.01) in vaccinated but not in unvaccinated children, and less likely to be identified in a first-reported episode in the youngest children (RR: 0.58; 0.37–0.91) (Table 2, Fig., Sup-plemental Digital Content 1, http://links.lww.com/INF/C612).",Non-OADS,/arxiv_data1/oa_pdf/36/12/inf-36-274.PMC5312727.pdf
"In unvaccinated children, Hflu was less likely to be found in a child  with severe symptoms such as ear pain or high fever (RR: 0.63;  0.43–0.91) than the one with milder symptoms (Table 2, Fig., Supplemental Digital Content 1, http://links.lww.com/INF/C612).",Non-OADS,/arxiv_data1/oa_pdf/36/12/inf-36-274.PMC5312727.pdf
Available at: http://www.jhsph.edu/research/ centers-and-institutes/ivac/resources/maps.html.,Non-OADS,/arxiv_data1/oa_pdf/36/12/inf-36-274.PMC5312727.pdf
Available at:http://www.healthforallchildren.co.uk.,Non-OADS,/arxiv_data1/oa_pdf/b5/2a/mpa-46-358.PMC5312728.pdf
"Stratification by the number of DTaP doses received before the  index date also revealed differences in follow-up health care costs, par - ticularly for inpatient costs (Table, Supplemental Digital Content 1,  http://links.lww.com/INF/C611).",Non-OADS,/arxiv_data1/oa_pdf/5c/63/inf-36-e54.PMC5312729.pdf
Available at: http://data.bls.gov/cgi-bin/surveymost?su.,OADS,/arxiv_data1/oa_pdf/5c/63/inf-36-e54.PMC5312729.pdf
Lamb) http://dx.doi.org/10.1016/j.adro.2016.07.004 2452-1094/Copyright /C2112016 the Authors.,Non-OADS,/arxiv_data1/oa_pdf/8f/f1/main.PMC5312778.pdf
"This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).Advances in Radiation Oncology (2016) 1, 333-343 www.advancesradonc.org",Non-OADS,/arxiv_data1/oa_pdf/8f/f1/main.PMC5312778.pdf
http://dx.doi.org/10.14309/crj.2016.107.,Non-OADS,/arxiv_data1/oa_pdf/07/9f/CG-CGCR170003.PMC5312801.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/4.0.",Non-OADS,/arxiv_data1/oa_pdf/07/9f/CG-CGCR170003.PMC5312801.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/7e/6c/main.PMC5312809.pdf
9Contents lists available at ScienceDirect journal homepage: www.elsevier.com/locate/nbscrNeurobiology of Sleep and Circadian Rhythms http://dx.doi.org/10.1016/j.nbscr.2016.08.002 2451-9944/ &2016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/7e/6c/main.PMC5312809.pdf
"This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).Abbreviations: Aβ, amyloid β; AD, Alzheimer's disease; APP, amyloid precursor protein; BF, basal forebrain; bvFTD, behavioral variant FTD; CBD, corticobasal degeneration; CSF, cerebrospinal ﬂuid; DLB, dementia with Lewy bodies; DR, dorsal raphe; EDS, excessive daytime sleepiness; EEG, electroencephalography; FTD, Frontotemporal De- mentia; htau, human tau; ISF, interstitial ﬂuid; LC, locus coeruleus; LDT, laterodorsal tegmental nucleus; LH, lateral hypothalamus; mPB, medial parabrachial nucleus; NBM, nucleus basalis of Meynert; NFT, neuro ﬁbrillary tangle; NREM, non-rapid eye movement; PAG, periaqueductal gray matter; PLMD, periodic limb movement disorder; PPT, pedunculopontine tegmental nucleus; PSP, progressive supranuclear palsy; PFZ, parafacial zone; RBD, REM sleep behavior disorder; REM, rapid eye m ovement; SCN, su- prachiasmatic nucleus; SLD, sublaterodorsal area; SWS, slow wave sleep; TMN, tuberomammillary nucleus; VLPO, ventrolateral preoptic nucleus; vP AG, ventral periaque- ductal gray nCorresponding author.",Non-OADS,/arxiv_data1/oa_pdf/7e/6c/main.PMC5312809.pdf
Medicine (2017) 96:6(e5240)Received: 19 August 2016 / Received in ﬁnal form: 3 October 2016 / Accepted: 8 October 2016 http://dx.doi.org/10.1097/MD.0000000000005240Clinical Case Report Medicine® OPEN 1,Non-OADS,/arxiv_data1/oa_pdf/a5/e7/medi-96-e5240.PMC5312978.pdf
Medicine (2017) 96:6(e5446)Received: 21 July 2016 / Received in ﬁnal form: 7 October 2016 / Accepted: 28 October 2016 http://dx.doi.org/10.1097/MD.0000000000005446Clinical Case Report Medicine® OPEN 1,Non-OADS,/arxiv_data1/oa_pdf/ad/f2/medi-96-e5446.PMC5312979.pdf
Medicine (2017) 96:6(e5480)Received: 10 March 2016 / Received in ﬁnal form: 6 October 2016 / Accepted: 1 November 2016 http://dx.doi.org/10.1097/MD.0000000000005480Observational Study Medicine® OPEN 1,Non-OADS,/arxiv_data1/oa_pdf/cf/40/medi-96-e5480.PMC5312980.pdf
Medicine (2017) 96:6(e5621)Received: 9 May 2016 / Received in ﬁnal form: 13 October 2016 / Accepted: 15 November 2016 http://dx.doi.org/10.1097/MD.0000000000005621Clinical Case Report Medicine® OPEN 1,Non-OADS,/arxiv_data1/oa_pdf/52/e1/medi-96-e5621.PMC5312981.pdf
"For major details, see the Methods section in the Supplements, http://links.lww.com/MD/B531.",Non-OADS,/arxiv_data1/oa_pdf/52/e1/medi-96-e5621.PMC5312981.pdf
"Given the intolerance to conventional chemotherapy and the systemic disease progression, baseline ICAM-1 level wasmeasured in order to favor a prompt shift to new potential more effective therapy (see Methods section in the Supplements, http://links.lww.com/MD/B531).",Non-OADS,/arxiv_data1/oa_pdf/52/e1/medi-96-e5621.PMC5312981.pdf
"For major details, see Methods section in the Supplements, http://links.lww.com/MD/B531.",Non-OADS,/arxiv_data1/oa_pdf/52/e1/medi-96-e5621.PMC5312981.pdf
"1-S1, http://links.lww.com/MD/B531).",Non-OADS,/arxiv_data1/oa_pdf/52/e1/medi-96-e5621.PMC5312981.pdf
"For major details, see Methods section in the Supplements, http://links.lww.com/MD/B531.",Non-OADS,/arxiv_data1/oa_pdf/52/e1/medi-96-e5621.PMC5312981.pdf
"S2, http://links.lww.com/MD/B531).",Non-OADS,/arxiv_data1/oa_pdf/52/e1/medi-96-e5621.PMC5312981.pdf
Medicine (2017) 96:6(e5847)Received: 29 April 2016 / Received in ﬁnal form: 17 November 2016 / Accepted: 15 December 2016 http://dx.doi.org/10.1097/MD.0000000000005847Clinical Case Report Medicine® OPEN 1,Non-OADS,/arxiv_data1/oa_pdf/eb/cd/medi-96-e5847.PMC5312984.pdf
Medicine (2017) 96:6(e5851)Received: 14 June 2016 / Received in ﬁnal form: 16 December 2016 / Accepted: 19 December 2016 http://dx.doi.org/10.1097/MD.0000000000005851Observational Study Medicine® OPEN 1,Non-OADS,/arxiv_data1/oa_pdf/24/45/medi-96-e5851.PMC5312985.pdf
http://www.cdc.,Non-OADS,/arxiv_data1/oa_pdf/24/45/medi-96-e5851.PMC5312985.pdf
http://www.cdc.gov/prams/methodology.htm.,Non-OADS,/arxiv_data1/oa_pdf/24/45/medi-96-e5851.PMC5312985.pdf
http://www.cdc.gov/prams/questionnaire.htm.,OADS,/arxiv_data1/oa_pdf/24/45/medi-96-e5851.PMC5312985.pdf
Medicine (2017) 96:6(e5903)Received: 14 June 2016 / Received in ﬁnal form: 4 October 2016 / Accepted: 23 December 2016 http://dx.doi.org/10.1097/MD.0000000000005903Clinical Trial/Experimental Study Medicine® OPEN 1,Non-OADS,/arxiv_data1/oa_pdf/ee/c2/medi-96-e5903.PMC5312986.pdf
Medicine (2017) 96:6(e5905)Received: 25 September 2016 / Received in ﬁnal form: 13 December 2016 / Accepted: 27 December 2016 http://dx.doi.org/10.1097/MD.0000000000005905Observational Study Medicine® OPEN 1,Non-OADS,/arxiv_data1/oa_pdf/c6/7c/medi-96-e5905.PMC5312987.pdf
Medicine (2017) 96:6(e5913)Received: 30 September 2016 / Received in ﬁnal form: 20 December 2016 / Accepted: 27 December 2016 http://dx.doi.org/10.1097/MD.0000000000005913Systematic Review and Meta-Analysis Medicine® OPEN 1,Non-OADS,/arxiv_data1/oa_pdf/fa/37/medi-96-e5913.PMC5312988.pdf
Medicine (2017) 96:6(e5936)Received: 20 December 2015 / Received in ﬁnal form: 16 December 2016 / Accepted: 29 December 2016 http://dx.doi.org/10.1097/MD.0000000000005936Observational Study Medicine® OPEN 1,Non-OADS,/arxiv_data1/oa_pdf/9f/72/medi-96-e5936.PMC5312990.pdf
Medicine (2017) 96:6(e5941)Received: 28 July 2016 / Received in ﬁnal form: 19 December 2016 / Accepted: 27 December 2016 http://dx.doi.org/10.1097/MD.0000000000005941Observational Study Medicine® OPEN 1,Non-OADS,/arxiv_data1/oa_pdf/cc/86/medi-96-e5941.PMC5312991.pdf
"(See ﬁgure, Supplemental Content, which illustrates the data processing of CRC records for included and excludes cases, http://links.lww.com/MD/B550.)",Non-OADS,/arxiv_data1/oa_pdf/cc/86/medi-96-e5941.PMC5312991.pdf
Medicine (2017) 96:6(e5947)Received: 15 January 2016 / Received in ﬁnal form: 18 December 2016 / Accepted: 29 December 2016 http://dx.doi.org/10.1097/MD.0000000000005947Systematic Review and Meta-Analysis Medicine® OPEN 1,Non-OADS,/arxiv_data1/oa_pdf/7f/4a/medi-96-e5947.PMC5312992.pdf
"First, we did standard pairwise meta-analysis for direct comparisons between CDAs and ACDF to evaluate pooled odds ratio (OR) and 95% con ﬁdence intervals (CI) with Review Manager v5.3.5 (http://tech.cochrane.org/revman/ download).",OADS,/arxiv_data1/oa_pdf/7f/4a/medi-96-e5947.PMC5312992.pdf
"Second, a random-effects Bayesian network meta-analysis using Markov chain Monte Carlo (MCMC) methods was run andappraised with WinBUGS version 1.4.3 (http://www.mrc-bsu.",OADS,/arxiv_data1/oa_pdf/7f/4a/medi-96-e5947.PMC5312992.pdf
"We set the number of iterations for the burn-in period as 1000 and updated MCMC model with 20,000 iterations.NetMetaXL version 1.6.1 (http://netmetaxl.com/download.html)wasapplied to assess convergence using the Brooks-Gelman-Rubin method by checking whether the Monte Carlo error is <5% of the standard deviation of the effect estimates and between-studyvariance.",OADS,/arxiv_data1/oa_pdf/7f/4a/medi-96-e5947.PMC5312992.pdf
"Quality of evidence Grading of Recommendations Assessment, Development, and Evaluation (GRADE) method was adopted to appraise the qualityof evidences of this network meta-analysis with the online application of Guideline Developing Tool (http://www.guideline development.org/).",OADS,/arxiv_data1/oa_pdf/7f/4a/medi-96-e5947.PMC5312992.pdf
"Discover, and ACDF ( P>0.05) (Supplementary Digital Content, Figures 1 –8, http://links.lww.com/MD/B553).",OADS,/arxiv_data1/oa_pdf/7f/4a/medi-96-e5947.PMC5312992.pdf
Medicine (2017) 96:6(e5995)Received: 1 September 2016 / Received in ﬁnal form: 31 December 2016 / Accepted: 2 January 2017 http://dx.doi.org/10.1097/MD.0000000000005995Clinical Case Report Medicine® OPEN 1,Non-OADS,/arxiv_data1/oa_pdf/c4/b2/medi-96-e5995.PMC5312997.pdf
Medicine (2017) 96:6(e6020)Received: 14 November 2016 / Received in ﬁnal form: 3 January 2017 / Accepted: 9 January 2017 http://dx.doi.org/10.1097/MD.0000000000006020Clinical Case Report Medicine® OPEN 1,Non-OADS,/arxiv_data1/oa_pdf/8f/2e/medi-96-e6020.PMC5312998.pdf
Medicine (2017) 96:6(e6021)Received: 21 June 2016 / Received in ﬁnal form: 28 December 2016 / Accepted: 29 December 2016 http://dx.doi.org/10.1097/MD.0000000000006021Clinical Case Report Medicine® OPEN 1,Non-OADS,/arxiv_data1/oa_pdf/13/c0/medi-96-e6021.PMC5312999.pdf
Medicine (2017) 96:6(e6025)Received: 19 May 2016 / Received in ﬁnal form: 10 November 2016 / Accepted: 9 January 2017 http://dx.doi.org/10.1097/MD.0000000000006025Observational Study Medicine® OPEN 1,Non-OADS,/arxiv_data1/oa_pdf/b9/e6/medi-96-e6025.PMC5313000.pdf
"The loadings of the 1st factor (F1) mainly consisted of diet, physical activity (log-transformed), andpsychosocial score, whereas the loadings of the 2nd factor (F2) were exclusively WC for each of the age and gender subgroups (see Table S1, Supplementary Content, http://links.lww.com/MD/B545), accounting for approximately 34% and 25% of the total variations, respectively.",Non-OADS,/arxiv_data1/oa_pdf/b9/e6/medi-96-e6025.PMC5313000.pdf
"The cutoffs for F1 and F2 were determined by the maximum sumof the sensitivity and speci ﬁcity of DM at baseline using the receiver-operating characteristic (see Table S1, SupplementaryContent, http://links.lww.com/MD/B545).",Non-OADS,/arxiv_data1/oa_pdf/b9/e6/medi-96-e6025.PMC5313000.pdf
"Supplementary Content, http://links.lww.com/MD/B545).",Non-OADS,/arxiv_data1/oa_pdf/b9/e6/medi-96-e6025.PMC5313000.pdf
"S1, Supplementary Content, http://links.lww.com/MD/ B545).",Non-OADS,/arxiv_data1/oa_pdf/b9/e6/medi-96-e6025.PMC5313000.pdf
"[36,37] The study results showed that DM participants had consis- tently lower DASH scores than their counterparts without DM, especially in the 75+ age group (Table 1 and Table S2,Supplementary Content, http://links.lww.com/MD/B545).",Non-OADS,/arxiv_data1/oa_pdf/b9/e6/medi-96-e6025.PMC5313000.pdf
"The risk score identi ﬁed is similar to those of other studies, [48,49]but is more speci ﬁc to the elderly and is exclusively based on lifestyle and WC (see Supplementary Content for numerical examples, http://links.lww.com/MD/B545).",Non-OADS,/arxiv_data1/oa_pdf/b9/e6/medi-96-e6025.PMC5313000.pdf
Available at http://www.hpa.gov.tw/Bhpnet/Web/News/News.aspx?No=201510270001.,Non-OADS,/arxiv_data1/oa_pdf/b9/e6/medi-96-e6025.PMC5313000.pdf
Medicine (2017) 96:6(e6041)Received: 20 October 2016 / Received in ﬁnal form: 9 January 2017 / Accepted: 11 January 2017 http://dx.doi.org/10.1097/MD.0000000000006041Observational Study Medicine® OPEN 1,Non-OADS,/arxiv_data1/oa_pdf/59/71/medi-96-e6041.PMC5313003.pdf
URL https://www.R-project.org/.,Non-OADS,/arxiv_data1/oa_pdf/59/71/medi-96-e6041.PMC5313003.pdf
Medicine (2017) 96:6(e6044)Received: 19 December 2016 / Received in ﬁnal form: 10 January 2017 / Accepted: 11 January 2017 http://dx.doi.org/10.1097/MD.0000000000006044Clinical Case Report Medicine® OPEN 1,Non-OADS,/arxiv_data1/oa_pdf/ba/da/medi-96-e6044.PMC5313004.pdf
Medicine (2017) 96:6(e6045)Received: 18 April 2016 / Received in ﬁnal form: 6 January 2017 / Accepted: 11 January 2017 http://dx.doi.org/10.1097/MD.0000000000006045Observational Study Medicine® OPEN 1,Non-OADS,/arxiv_data1/oa_pdf/36/ab/medi-96-e6045.PMC5313005.pdf
Medicine (2017) 96:6(e6046)Received: 1 September 2016 / Received in ﬁnal form: 3 December 2016 / Accepted: 11 January 2017 http://dx.doi.org/10.1097/MD.0000000000006046Clinical Trial/Experimental Study Medicine® OPEN 1,Non-OADS,/arxiv_data1/oa_pdf/3d/59/medi-96-e6046.PMC5313006.pdf
Medicine (2017) 96:6(e6047)Received: 22 November 2016 / Received in ﬁnal form: 11 January 2017 / Accepted: 12 January 2017 http://dx.doi.org/10.1097/MD.0000000000006047Clinical Trial/Experimental Study Medicine® OPEN 1,Non-OADS,/arxiv_data1/oa_pdf/4b/32/medi-96-e6047.PMC5313007.pdf
Medicine (2017) 96:6(e6048)Received: 25 October 2016 / Received in ﬁnal form: 11 January 2017 / Accepted: 12 January 2017 http://dx.doi.org/10.1097/MD.0000000000006048Quality Improvement Study Medicine® OPEN 1,Non-OADS,/arxiv_data1/oa_pdf/2b/7c/medi-96-e6048.PMC5313008.pdf
Medicine (2017) 96:6(e6050)Received: 16 August 2016 / Received in ﬁnal form: 2 January 2017 / Accepted: 12 January 2017 http://dx.doi.org/10.1097/MD.0000000000006050Observational Study Medicine® OPEN 1,Non-OADS,/arxiv_data1/oa_pdf/a2/69/medi-96-e6050.PMC5313009.pdf
Medicine (2017) 96:6(e6062)Received: 29 July 2016 / Received in ﬁnal form: 28 November 2016 / Accepted: 13 January 2017 http://dx.doi.org/10.1097/MD.0000000000006062Clinical Case Report Medicine® OPEN 1,Non-OADS,/arxiv_data1/oa_pdf/43/a0/medi-96-e6062.PMC5313014.pdf
Medicine (2017) 96:6(e6063)Received: 16 November 2016 / Received in ﬁnal form: 3 January 2017 / Accepted: 11 January 2017 http://dx.doi.org/10.1097/MD.0000000000006063Clinical Case Report Medicine® OPEN 1,Non-OADS,/arxiv_data1/oa_pdf/e8/b3/medi-96-e6063.PMC5313015.pdf
Medicine (2017) 96:6(e6071)Received: 14 October 2016 / Received in ﬁnal form: 13 January 2017 / Accepted: 16 January 2017 http://dx.doi.org/10.1097/MD.0000000000006071Observational Study Medicine® OPEN 1,Non-OADS,/arxiv_data1/oa_pdf/32/3d/medi-96-e6071.PMC5313019.pdf
Medicine (2017) 96:6(e6072)Received: 18 October 2016 / Received in ﬁnal form: 22 December 2016 / Accepted: 16 January 2017 http://dx.doi.org/10.1097/MD.0000000000006072Observational Study Medicine® OPEN 1,Non-OADS,/arxiv_data1/oa_pdf/cb/b7/medi-96-e6072.PMC5313020.pdf
Medicine (2017) 96:6(e6073)Received: 5 September 2016 / Received in ﬁnal form: 18 December 2016 / Accepted: 14 January 2017 http://dx.doi.org/10.1097/MD.0000000000006073Observational Study Medicine® OPEN 1,Non-OADS,/arxiv_data1/oa_pdf/c6/98/medi-96-e6073.PMC5313021.pdf
Medicine (2017) 96:6(e6080)Received: 6 November 2016 / Received in ﬁnal form: 2 January 2017 / Accepted: 15 January 2017 http://dx.doi.org/10.1097/MD.0000000000006080Observational Study Medicine® OPEN 1,Non-OADS,/arxiv_data1/oa_pdf/79/2c/medi-96-e6080.PMC5313022.pdf
"S1, http://links.lww.com/MD/B560).",Non-OADS,/arxiv_data1/oa_pdf/79/2c/medi-96-e6080.PMC5313022.pdf
"S2 and S3, http://links.lww.com/MD/B560).",Non-OADS,/arxiv_data1/oa_pdf/79/2c/medi-96-e6080.PMC5313022.pdf
Medicine (2017) 96:6(e6085)Received: 9 December 2016 / Received in ﬁnal form: 16 January 2017 / Accepted: 16 January 2017 http://dx.doi.org/10.1097/MD.0000000000006085Clinical Case Report Medicine® OPEN 1,Non-OADS,/arxiv_data1/oa_pdf/23/60/medi-96-e6085.PMC5313024.pdf
Medicine (2017) 96:6(e6087)Received: 11 October 2016 / Received in ﬁnal form: 16 January 2017 / Accepted: 17 January 2017 http://dx.doi.org/10.1097/MD.0000000000006087Clinical Case Report Medicine® OPEN 1,Non-OADS,/arxiv_data1/oa_pdf/34/72/medi-96-e6087.PMC5313025.pdf
"[11] National Comprehensive Cancer Network Clinical Practice Guidelines in Oncology (NCCN Guidelines ®), Non-Small Cell Lung Cancer Version 7.2015, https://www.nccn.org.",Non-OADS,/arxiv_data1/oa_pdf/34/72/medi-96-e6087.PMC5313025.pdf
Medicine (2017) 96:6(e6090)Received: 9 June 2016 / Received in ﬁnal form: 2 January 2017 / Accepted: 18 January 2017 http://dx.doi.org/10.1097/MD.0000000000006090Observational Study Medicine® OPEN 1,Non-OADS,/arxiv_data1/oa_pdf/2c/62/medi-96-e6090.PMC5313026.pdf
Medicine (2017) 96:6(e6108)Received: 28 November 2016 / Received in ﬁnal form: 16 January 2017 / Accepted: 20 January 2017 http://dx.doi.org/10.1097/MD.0000000000006108Systematic Review and Meta-Analysis Medicine® OPEN 1,Non-OADS,/arxiv_data1/oa_pdf/3c/85/medi-96-e6108.PMC5313029.pdf
Protocol and registration We registered this systematic review at http://www.crd.york.ac.,Non-OADS,/arxiv_data1/oa_pdf/3c/85/medi-96-e6108.PMC5313029.pdf
"[35] The included databases were Cochrane Central Library (http://www.cochranelibrary.com/), PubMed (http://www.ncbi.nlm.nih.gov/pubmed/), Ovid (medline), Embase (medline), and some other resources such as Google Scholar and bibliographies of included literatures.",OADS,/arxiv_data1/oa_pdf/3c/85/medi-96-e6108.PMC5313029.pdf
Medicine (2017) 96:6(e6109)Received: 6 June 2016 / Received in ﬁnal form: 6 December 2016 / Accepted: 20 January 2017 http://dx.doi.org/10.1097/MD.0000000000006109Observational Study Medicine® OPEN 1,Non-OADS,/arxiv_data1/oa_pdf/3e/1d/medi-96-e6109.PMC5313030.pdf
"The ﬂowchart of the recruitment of patients is shown in Supplemental Figure 1, http://links.lww.com/MD/B562.",Non-OADS,/arxiv_data1/oa_pdf/3e/1d/medi-96-e6109.PMC5313030.pdf
"Evaluation of C1-INH activity, C4, and clinical background Evaluations of C1-INH activity, C4, and the clinical background of HAE and non-HAE patients are shown in Table 2, and those of each HAE patient are shown in Supplemental Table 1, http://links.lww.com/MD/B562.",OADS,/arxiv_data1/oa_pdf/3e/1d/medi-96-e6109.PMC5313030.pdf
"She had a past history of infectious enteritis involving abdominal pain, intestinal edema, and ascites (Supplemental Figure 2, http://links.lww.com/MD/B562), facial, hand and leg edema, and asthma attacks.",Non-OADS,/arxiv_data1/oa_pdf/3e/1d/medi-96-e6109.PMC5313030.pdf
"Aphotograph of his facial edema on day 2 can be seen in Supplemental Figure 3, http://links.lww.com/MD/B562.",Non-OADS,/arxiv_data1/oa_pdf/3e/1d/medi-96-e6109.PMC5313030.pdf
"1 and 2), and the patient in Case 3 had suffered asphyxia twice in his life (Supplemental Figure 3, http://links.lww.com/MD/B562).",Non-OADS,/arxiv_data1/oa_pdf/3e/1d/medi-96-e6109.PMC5313030.pdf
Medicine (2017) 96:6(e6128)Received: 27 September 2016 / Received in ﬁnal form: 6 January 2017 / Accepted: 23 January 2017 http://dx.doi.org/10.1097/MD.0000000000006128Observational Study Medicine® OPEN 1,Non-OADS,/arxiv_data1/oa_pdf/b9/0f/medi-96-e6128.PMC5313031.pdf
Available at: http://www.who.int/mediacentre/factsheets/fs164/en/ (accessed July 2016).,Non-OADS,/arxiv_data1/oa_pdf/b9/0f/medi-96-e6128.PMC5313031.pdf
Medicine (2017) 96:6(e6154)Received: 17 January 2017 / Received in ﬁnal form: 24 January 2017 / Accepted: 26 January 2017 http://dx.doi.org/10.1097/MD.0000000000006154Clinical Trial/Experimental Study Medicine® OPEN 1,Non-OADS,/arxiv_data1/oa_pdf/ac/02/medi-96-e6154.PMC5313032.pdf
"1, Issue 1       http://www.ntno.org  80   NNaannootthheerraannoossttiiccss   2017; 1(1): 80-102. doi: 10.7150/ ntno .18216  Review  Gold Nanoparticle Based Platforms for Circulating  Cancer Marker Detection   Xiaohua Huang, Ryan O’Connor, and Elyahb Allie Kwizera   Department of Chemistry, The University of Memphis, Memphis, TN 38152 , USA .",Non-OADS,/arxiv_data1/oa_pdf/d8/1f/ntnov01p0080.PMC5313055.pdf
This is an open access article distributed under the terms of the Creative Commons Attribution (CC B Y-NC) license  (https://creativecommons.org/licenses/by -nc/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/d8/1f/ntnov01p0080.PMC5313055.pdf
See http://ivyspring.com/terms for full terms and conditions.,Non-OADS,/arxiv_data1/oa_pdf/d8/1f/ntnov01p0080.PMC5313055.pdf
"1, Issue 1     http://www.ntno.org  81  companion diagnostic test to detect defined mutations  of the EGFR gene that makes patients with non- small  cell lung cancer for treatmen t with the targeted  therapy erlotinib.",Non-OADS,/arxiv_data1/oa_pdf/d8/1f/ntnov01p0080.PMC5313055.pdf
"1, Issue 1     http://www.ntno.org  82  circulating cancer markers categorized by the types of  targets - CTCs, circulating vesicles, CNAs and  circulating proteins ( Figure 1) .",Non-OADS,/arxiv_data1/oa_pdf/d8/1f/ntnov01p0080.PMC5313055.pdf
"1, Issue 1     http://www.ntno.org  83  Circulating Tumor Cells (CTCs)   CTCs are a hallmark of invasive behavior of  cancer.",Non-OADS,/arxiv_data1/oa_pdf/d8/1f/ntnov01p0080.PMC5313055.pdf
"1, Issue 1     http://www.ntno.org  84  binding to WBCs.",Non-OADS,/arxiv_data1/oa_pdf/d8/1f/ntnov01p0080.PMC5313055.pdf
"1, Issue 1     http://www.ntno.org  85  flow using t he X- ray imaging technique [79] .",Non-OADS,/arxiv_data1/oa_pdf/d8/1f/ntnov01p0080.PMC5313055.pdf
"1, Issue 1     http://www.ntno.org  86    Figure 3.",Non-OADS,/arxiv_data1/oa_pdf/d8/1f/ntnov01p0080.PMC5313055.pdf
"1, Issue 1     http://www.ntno.org  87  amplification strategy led to a 1000 -fold increase in  detecting carcinoembryonic antigen (CEA) gene  fragments compared to off -chip test.",Non-OADS,/arxiv_data1/oa_pdf/d8/1f/ntnov01p0080.PMC5313055.pdf
"1, Issue 1     http://www.ntno.org  88  detection and profiling, named nanoplasmonic  exosome (nPLEX) assay [19]  (Figure 4 ).",OADS,/arxiv_data1/oa_pdf/d8/1f/ntnov01p0080.PMC5313055.pdf
"1, Issue 1     http://www.ntno.org  89    Figure 4.",Non-OADS,/arxiv_data1/oa_pdf/d8/1f/ntnov01p0080.PMC5313055.pdf
"1, Issue 1     http://www.ntno.org  90  oligonucleotide -functionalized Au NP probes with  sequences complementary to different segments of  the targeted polynucleotides.",Non-OADS,/arxiv_data1/oa_pdf/d8/1f/ntnov01p0080.PMC5313055.pdf
"1, Issue 1     http://www.ntno.org  91  recovery via direct detection of the target in plasma  without the ne ed of sample separation and signal  amplification.",Non-OADS,/arxiv_data1/oa_pdf/d8/1f/ntnov01p0080.PMC5313055.pdf
"1, Issue 1     http://www.ntno.org  92  prognosis and therapeutic response.",Non-OADS,/arxiv_data1/oa_pdf/d8/1f/ntnov01p0080.PMC5313055.pdf
"1, Issue 1     http://www.ntno.org  93  patients under prostatectomy that could not be  detected by commercial assays [195] .",Non-OADS,/arxiv_data1/oa_pdf/d8/1f/ntnov01p0080.PMC5313055.pdf
"1, Issue 1     http://www.ntno.org  94    Figure 7.",Non-OADS,/arxiv_data1/oa_pdf/d8/1f/ntnov01p0080.PMC5313055.pdf
"1, Issue 1     http://www.ntno.org  95  they monitored the CEA level in a LS174T xenograft  mouse model and showed that the CEA serum  concentration was correlated to the tum or volume.",Non-OADS,/arxiv_data1/oa_pdf/d8/1f/ntnov01p0080.PMC5313055.pdf
"1, Issue 1     http://www.ntno.org  96  isothiocyanate as the Raman reporter) as the detection  agents and Au triangle nanoarray as the substrate  [215] .",Non-OADS,/arxiv_data1/oa_pdf/d8/1f/ntnov01p0080.PMC5313055.pdf
"1, Issue 1     http://www.ntno.org  97  formed on the Au NP surface may differ between  cancerous and noncancerous human blood.",Non-OADS,/arxiv_data1/oa_pdf/d8/1f/ntnov01p0080.PMC5313055.pdf
"1, Issue 1     http://www.ntno.org  98  NP-based methods are mainly based on  proof -of-concept studies on synthetic samples.",Non-OADS,/arxiv_data1/oa_pdf/d8/1f/ntnov01p0080.PMC5313055.pdf
"1, Issue 1     http://www.ntno.org  99  35.",Non-OADS,/arxiv_data1/oa_pdf/d8/1f/ntnov01p0080.PMC5313055.pdf
"1, Issue 1     http://www.ntno.org  100  91.",Non-OADS,/arxiv_data1/oa_pdf/d8/1f/ntnov01p0080.PMC5313055.pdf
"1, Issue 1     http://www.ntno.org  101  152.",Non-OADS,/arxiv_data1/oa_pdf/d8/1f/ntnov01p0080.PMC5313055.pdf
"1, Issue 1     http://www.ntno.org  102  213.",Non-OADS,/arxiv_data1/oa_pdf/d8/1f/ntnov01p0080.PMC5313055.pdf
Review Obstet Gynecol Sci 2017;60(1):1-7 https://doi.org/10.5468/ogs.2017.60.1.1 pISSN 2287-8572  · eISSN 2287-8580www.ogscience.org 1Introduction The cervix is a cylindrical structure that is proximally con - nected to the uterus and distally to the vaginal cavity.,Non-OADS,/arxiv_data1/oa_pdf/fc/e0/ogs-60-1.PMC5313350.pdf
"Corresponding author: Han Sung Hwang Department of Obstetrics and Gynecology, Konkuk University School of  Medicine, 120 Neungdong-ro, Gwangjin-gu, Seoul 05029, Korea Tel: +82-2-2030-7747  Fax: +82-2-2030-7748 E-mail: hwanghs@kuh.ac.kr http://orcid.org/0000-000 3-0622-0701",Non-OADS,/arxiv_data1/oa_pdf/fc/e0/ogs-60-1.PMC5313350.pdf
Available from: http://www.samsungmedison.,Non-OADS,/arxiv_data1/oa_pdf/fc/e0/ogs-60-1.PMC5313350.pdf
Original  Article Obstet Gynecol Sci 2017;60(1):100-105 https://doi.org/10.5468/ogs.2017.60.1.100 pISSN 2287-8572  · eISSN 2287-8580www.ogscience.org 100Introduction Premenstrual syndrome (PMS) affects millions of women and  is recognized as the most significant disorder among women  [1].,Non-OADS,/arxiv_data1/oa_pdf/cb/cf/ogs-60-100.PMC5313351.pdf
"Corresponding author: Ensiyeh Jenabi Department of Midwifery, Tuyserkan Branch, Islamic Azad University,  Tuyserkan, Iran   Tel: +98-081-34920253   Fax: +98-081-34925353 E-mail: e.jenabi@yahoo.com http://orcid.org/ 0000-0002-4536-0814",Non-OADS,/arxiv_data1/oa_pdf/cb/cf/ogs-60-100.PMC5313351.pdf
Case Report Obstet Gynecol Sci 2017;60(1):106-109 https://doi.org/10.5468/ogs.2017.60.1.106 pISSN 2287-8572  · eISSN 2287-8580www.ogscience.org 106Introduction Aortic stenosis (AS) is defined as an obstruction of the left  ventricular outflow caused by aortic valve narrowing.,Non-OADS,/arxiv_data1/oa_pdf/fc/e0/ogs-60-106.PMC5313352.pdf
"Corresponding author: Hye-Sung Won Department of Obstetrics and Gynecology, Asan Medical Center, 88  Olympic-ro 43-gil, Songpa-gu, Seoul 05505, Korea Tel: +82-2-3010-3644  Fax: +82-2-3010-6944 E-mail: hswon@amc.seoul.kr http://orcid.org/0000-0003-0611-2401",Non-OADS,/arxiv_data1/oa_pdf/fc/e0/ogs-60-106.PMC5313352.pdf
Supplemental Video Supplementary videos associated with this article can be  found online at https://doi.org/10.5468/ogs.2017.60.1.106.,Non-OADS,/arxiv_data1/oa_pdf/fc/e0/ogs-60-106.PMC5313352.pdf
Case Report Obstet Gynecol Sci 2017;60(1):110-114 https://doi.org/10.5468/ogs.2017.60.1.110 pISSN 2287-8572  · eISSN 2287-8580www.ogscience.org 110Introduction Laparoscopic surgeries are routinely used to perform gyneco - logical operations and technological advances have enabled  the use of laparoscopy in gynecological oncology operations  [1].,Non-OADS,/arxiv_data1/oa_pdf/66/40/ogs-60-110.PMC5313353.pdf
"Corresponding author: Chel Hun Choi Department of Obstetrics and Gynecology, Samsung Medical Center,  Sungkyunkwan University School of Medicine, 81 Irwon-ro, Gangnam- gu, Seoul 06351, Korea Tel: +82-2-3410-3519  Fax: +82-2-3410-0630 E-mail: chelhun.choi@samsung.com http://orcid.org/ 0000-0002-0199-6669",Non-OADS,/arxiv_data1/oa_pdf/66/40/ogs-60-110.PMC5313353.pdf
"Case Report Obstet Gynecol Sci 2017;60(1):115-117 https://doi.org/10.5468/ogs.2017.60.1.115 pISSN 2287-8572  · eISSN 2287-8580www.ogscience.org 115Introduction The syndrome of inappropriate antidiuretic hormone secre - tion (SIADH) is defined as impaired water excretion resulting  in dilutional hyponatremia, leading to central nervous system  symptoms [1,2].",Non-OADS,/arxiv_data1/oa_pdf/2f/71/ogs-60-115.PMC5313354.pdf
"Corresponding author: Kyung Do Ki Department of Obstetrics and Gynecology, Kyung Hee University  Hospital at Gangdong, 892 Dongnam-ro, Gangdong-gu, Seoul 05278,  Korea  Tel: +82-2-440-7880  Fax: +82-2-440-7894 E-mail: diners99@naver.com http://orcid.org/ 0000-0002-1060-2297",Non-OADS,/arxiv_data1/oa_pdf/2f/71/ogs-60-115.PMC5313354.pdf
Case Report Obstet Gynecol Sci 2017;60(1):118-123 https://doi.org/10.5468/ogs.2017.60.1.118 pISSN 2287-8572  · eISSN 2287-8580www.ogscience.org 118Introduction Lymphoepithelioma carcinoma is a common type of poorly- differentiated epithelial cells in the nasopharynx [1-3].,Non-OADS,/arxiv_data1/oa_pdf/c3/c1/ogs-60-118.PMC5313355.pdf
"Corresponding author: Y ong Jung Song Department of Obstetrics and Gynecology, Pusan National University  Y angsan Hospital, Pusan National University School of Medicine, 20  Geumo-ro, Mulgeum-eup, Y angsan 50612, Korea Tel: +82-55-360-2130  Fax: +82-55-360-2160 E-mail: syjabc@pusan.ac.kr http://orcid.org/ 0000-0002-6103-2466",Non-OADS,/arxiv_data1/oa_pdf/c3/c1/ogs-60-118.PMC5313355.pdf
"Case Report Obstet Gynecol Sci 2017;60(1):124-128 https://doi.org/10.5468/ogs.2017.60.1.124 pISSN 2287-8572  · eISSN 2287-8580www.ogscience.org 124Introduction Gestational trophoblastic disease (GTD) encompasses a group  of relevant diseases, which occur after pregnancy.",Non-OADS,/arxiv_data1/oa_pdf/92/c9/ogs-60-124.PMC5313356.pdf
"Corresponding author: Jeong-Won Lee Department of Obstetrics and Gynecology, Samsung Medical Center,  Sungkyunkwan University School of Medicine, 81 Irwon-ro, Gangnam- gu, Seoul 06351, Korea  Tel: +82-2-3410-1382  Fax: +82-2-3410-0630  E-mail: garden.lee@samsung.com http://orcid.org/ 0000-0002-6945-0398  *These two authors contributed equally to this work.",Non-OADS,/arxiv_data1/oa_pdf/92/c9/ogs-60-124.PMC5313356.pdf
"Case Report Obstet Gynecol Sci 2017;60(1):129-132 https://doi.org/10.5468/ogs.2017.60.1.129 pISSN 2287-8572  · eISSN 2287-8580www.ogscience.org 129Introduction Cervical cancer frequently spreads to vaginal mucosa and  myometrium of the lower uterine segment but the common  extrapelvic sites of spread include lungs, bone and supracla - vicular lymph nodes [1,2].",Non-OADS,/arxiv_data1/oa_pdf/ca/44/ogs-60-129.PMC5313357.pdf
"Corresponding author: Kyung Do Ki Department of Obstetrics and Gynecology, Kyung Hee University  Hospital at Gangdong, 892 Dongnam-ro, Gangdong-gu, Seoul 05278,  Korea Tel: +82-2-440-6139  Fax: +82-2-440-7894 E-mail: diners99@naver.com http://orcid.org/ 0000-0002-1060-2297",Non-OADS,/arxiv_data1/oa_pdf/ca/44/ogs-60-129.PMC5313357.pdf
Case Report Obstet Gynecol Sci 2017;60(1):133-137 https://doi.org/10.5468/ogs.2017.60.1.133 pISSN 2287-8572  · eISSN 2287-8580www.ogscience.org 133Introduction Osteoporosis is the most common bone disease in humans.,Non-OADS,/arxiv_data1/oa_pdf/5d/7d/ogs-60-133.PMC5313358.pdf
"Corresponding author: Jong Kil Joo Department of Obstetrics and Gynecology, Pusan National University  School of Medicine, 179 Gudeok-ro, Seo-gu, Busan 49241, Korea Tel: +82-51-240-7287  Fax: +82-51-248-2384 E-mail: jongkilj@hanmail.net http://orcid.org/ 0000-0002-6338-1512",Non-OADS,/arxiv_data1/oa_pdf/5d/7d/ogs-60-133.PMC5313358.pdf
"Original  Article Obstet Gynecol Sci 2017;60(1):18-25 https://doi.org/10.5468/ogs.2017.60.1.18 pISSN 2287-8572  · eISSN 2287-8580www.ogscience.org 18Introduction Placental adhesion including accreta, increta, and percreta is  a serious complication of pregnancy, associated with major  adverse outcomes of pregnancy, including life-threatening  maternal hemorrhage, large-volume blood transfusion, peri - partum hysterectomy and maternal and neonatal morbidity  and mortality [1,2].",Non-OADS,/arxiv_data1/oa_pdf/be/78/ogs-60-18.PMC5313359.pdf
"Corresponding author: Suk Y oung Kim Department of Obstetrics and Gynecology, Gachon University Gil Medical  Center, 21 Namdong-daero 774beon-gil, Namdong-gu, Incheon 21565,  Korea Tel: +82-32-460-3254  Fax: +82-32-460-3290 E-mail: ksyob@gilhospital.com  http://orcid.org/ 0000-0003-3600-9691",Non-OADS,/arxiv_data1/oa_pdf/be/78/ogs-60-18.PMC5313359.pdf
"Original  Article Obstet Gynecol Sci 2017;60(1):26-31 https://doi.org/10.5468/ogs.2017.60.1.26 pISSN 2287-8572  · eISSN 2287-8580www.ogscience.org 26Introduction The incidence of breast cancer has risen continuously over  the past 10 years, and it is the second most common cancer  in Korean women.",Non-OADS,/arxiv_data1/oa_pdf/6c/56/ogs-60-26.PMC5313360.pdf
"Corresponding author: Maria Lee Department of Obstetrics and Gynecology, Seoul National University  College of Medicine, 101 Daehak-ro, Jongno-gu, Seoul 03080, Korea Tel: +82-2-2072-2842  Fax: +82-2-762-3599 E-mail: marialeemd@gmail.com http://orcid.org/ 0000-0002-8017-3176",Non-OADS,/arxiv_data1/oa_pdf/6c/56/ogs-60-26.PMC5313360.pdf
"Original  Article Obstet Gynecol Sci 2017;60(1):32-38 https://doi.org/10.5468/ogs.2017.60.1.32 pISSN 2287-8572  · eISSN 2287-8580www.ogscience.org 32Introduction Adnexal tumor, including ovarian cyst and paratubal cyst, is  one of the most common diseases in gynecology and gener - ally occurs during reproductive years.",Non-OADS,/arxiv_data1/oa_pdf/44/b5/ogs-60-32.PMC5313361.pdf
"Corresponding author: Chul Jung Kim Department of Obstetrics and Gynecology, Konyang University College  of Medicine, 158 Gwanjeodong-ro, Daejeon 35365, Korea Tel: +82-42-600-9202  Fax: +82-42-600-9090 E-mail: kcj0307@kyuh.ac.kr http://orcid.org/ 0000-0002-6774-1861",Non-OADS,/arxiv_data1/oa_pdf/44/b5/ogs-60-32.PMC5313361.pdf
Original  Article Obstet Gynecol Sci 2017;60(1):39-45 https://doi.org/10.5468/ogs.2017.60.1.39 pISSN 2287-8572  · eISSN 2287-8580www.ogscience.org 39Introduction Ovarian sex cord-stromal tumors are a heterogeneous group  of ovarian tumors that comprise approximately 5% to 8% of  all ovarian malignancies [1].,Non-OADS,/arxiv_data1/oa_pdf/fc/7b/ogs-60-39.PMC5313362.pdf
"Corresponding author: Y oung Tae Kim Department of Obstetrics and Gynecology, Y onsei University College of  Medicine, 50-1 Y onsei-ro, Seodaemun-gu, Seoul 03722, Korea Tel: +82-2-2228-2240  Fax: +82-2-313-8350 E-mail: ytkchoi@yuhs.ac http://orcid.org/ 0000-0002-7347-1052",Non-OADS,/arxiv_data1/oa_pdf/fc/7b/ogs-60-39.PMC5313362.pdf
"Original  Article Obstet Gynecol Sci 2017;60(1):46-52 https://doi.org/10.5468/ogs.2017.60.1.46 pISSN 2287-8572  · eISSN 2287-8580www.ogscience.org 46Introduction Diminished ovarian reserve (DOR) is often associated with  poor ovarian stimulation response, a high cancellation rate,  and a significant decline in pregnancy rate during in vitro   fertilization (IVF) cycle.",Non-OADS,/arxiv_data1/oa_pdf/e2/75/ogs-60-46.PMC5313363.pdf
"Corresponding author: Byung Seok Lee Department of Obstetrics and Gynecology, Severance Hospital, Y onsei  University College of Medicine, 50 Y onsei-ro, Seodaemun-gu, Seoul  03722, Korea Tel: +82-2-2228-2230  Fax: +82-2-313-8357 E-mail: dr222@yuhs.ac http://orcid.org/ 0000-0002-4669-8892",Non-OADS,/arxiv_data1/oa_pdf/e2/75/ogs-60-46.PMC5313363.pdf
"Original  Article Obstet Gynecol Sci 2017;60(1):53-62 https://doi.org/10.5468/ogs.2017.60.1.53 pISSN 2287-8572  · eISSN 2287-8580www.ogscience.org 53Introduction The life expectancy of women is increasing, but the average  age of women at the time of menopause is about 50 years.",Non-OADS,/arxiv_data1/oa_pdf/10/5a/ogs-60-53.PMC5313364.pdf
"Corresponding author: Seok Kyo Seo Department of Obstetrics and Gynecology, Severance Hospital, Y onsei  University College of Medicine, 50 Y onsei-ro, Seodaemun-gu, Seoul  03722, Korea Tel: +82-2-2228-2230  Fax: +82-2-313-8357 E-mail: tudeolseo@yuhs.ac http://orcid.org/ 0000-0003-3404-0484",Non-OADS,/arxiv_data1/oa_pdf/10/5a/ogs-60-53.PMC5313364.pdf
Available from: http://www.who.int/ kobe_centre/publications/annual_report_2012/en/.,Non-OADS,/arxiv_data1/oa_pdf/10/5a/ogs-60-53.PMC5313364.pdf
"Original  Article Obstet Gynecol Sci 2017;60(1):63-68 https://doi.org/10.5468/ogs.2017.60.1.63 pISSN 2287-8572  · eISSN 2287-8580www.ogscience.org 63Introduction Approximately 10% of women under age 40 have elevated  serum follicle stimulating hormone (FSH) level which does  not correspond to the strict definition of premature ovarian  failure [1,2].",Non-OADS,/arxiv_data1/oa_pdf/98/e0/ogs-60-63.PMC5313365.pdf
"Corresponding author: Seul Ki Kim Department of Obstetrics and Gynecology, Seoul National University  Bundang Hospital, 82 Gumi-ro 173beon-gil, Bundang-gu, Seongnam  13620, Korea Tel: +82-31-787-7264  Fax: 82-31-787-4054 E-mail: skkim@snubh.org http://orcid.org/ 0000-0002-1647-6711",Non-OADS,/arxiv_data1/oa_pdf/98/e0/ogs-60-63.PMC5313365.pdf
"Original  Article Obstet Gynecol Sci 2017;60(1):69-73 https://doi.org/10.5468/ogs.2017.60.1.69 pISSN 2287-8572  · eISSN 2287-8580www.ogscience.org 69Introduction Uterine fibroids, also termed leiomyomas or myomas, are the  most common benign gynecologic tumors reportedly occur - ring in 20% to 40% of reproductive-age women [1].",Non-OADS,/arxiv_data1/oa_pdf/91/82/ogs-60-69.PMC5313366.pdf
"Corresponding author: Bo Seong Yun Department of Obstetrics and Gynecology, CHA Gangnam Medical  Center, CHA University, 566 Nonhyon-ro, Gangnam-gu, Seoul 06135,  Korea Tel: +82-2-3468-2634  Fax: +82-2-558-1112 E-mail: bosungyun@hanmail.net http://orcid.org/ 0000-0003-4352-1693",Non-OADS,/arxiv_data1/oa_pdf/91/82/ogs-60-69.PMC5313366.pdf
Original  Article Obstet Gynecol Sci 2017;60(1):74-78 https://doi.org/10.5468/ogs.2017.60.1.74 pISSN 2287-8572  · eISSN 2287-8580www.ogscience.org 74Introduction Myofibroblastoma is a very rare benign mesenchymal tumor  composed of spindle tumor cells with myofibroblastic-like  differentiation.,Non-OADS,/arxiv_data1/oa_pdf/38/4e/ogs-60-74.PMC5313367.pdf
"Corresponding author: Byung Chul Jee Department of Obstetrics and Gynecology, Seoul National University  Bundang Hospital, 82 Gumi-ro 173beon-gil, Bundang-gu, Seongnam  13620, Korea Tel: +82-31-787-7254  Fax: +82-31-787-4054 E-mail: blasto@snubh.org http://orcid.org/ 0000-0003-2289-6090",Non-OADS,/arxiv_data1/oa_pdf/38/4e/ogs-60-74.PMC5313367.pdf
Original  Article Obstet Gynecol Sci 2017;60(1):79-86 https://doi.org/10.5468/ogs.2017.60.1.79 pISSN 2287-8572  · eISSN 2287-8580www.ogscience.org 79Introduction Ectopic pregnancies account for 4% to 6% of all maternal  death [1].,Non-OADS,/arxiv_data1/oa_pdf/c0/38/ogs-60-79.PMC5313368.pdf
"Corresponding author: Byung Chul Jee Department of Obstetrics and Gynecology, Seoul National University  Bundang Hospital, 82 Gumi-ro 173beon-gil, Bundang-gu, Seongnam  13620, Korea Tel: +82-31-787-7254  Fax: +82-31-787-4054 E-mail: blasto@snubh.org http://orcid.org/ 0000-0003-2289-6090",Non-OADS,/arxiv_data1/oa_pdf/c0/38/ogs-60-79.PMC5313368.pdf
"Original  Article Obstet Gynecol Sci 2017;60(1):8-17 https://doi.org/10.5468/ogs.2017.60.1.8 pISSN 2287-8572  · eISSN 2287-8580www.ogscience.org 8Introduction The corpus callosum connects two interhemispheres [1],  and agenesis of corpus callosum (ACC) is the most common  central nervous system defect [2].",Non-OADS,/arxiv_data1/oa_pdf/c6/46/ogs-60-8.PMC5313369.pdf
"Corresponding author: Soo-young Oh Department of Obstetrics and Gynecology, Samsung Medical Center,  Sungkyunkwan University School of Medicine, 81 Irwon-ro, Gangnam- gu, Seoul 06351, Korea Tel: +82-2-3410-3517  Fax: +82-2-3410-0630 E-mail: ohsymd@skku.edu http://orcid.org/ 0000-0003-3002-0048",Non-OADS,/arxiv_data1/oa_pdf/c6/46/ogs-60-8.PMC5313369.pdf
